<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Res</journal-id><journal-id journal-id-type="iso-abbrev">Cell Res</journal-id><journal-id journal-id-type="pmc-domain-id">1475</journal-id><journal-id journal-id-type="pmc-domain">cellres</journal-id><journal-title-group><journal-title>Cell Research</journal-title></journal-title-group><issn pub-type="ppub">1001-0602</issn><issn pub-type="epub">1748-7838</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12765899</article-id><article-id pub-id-type="pmcid-ver">PMC12765899.1</article-id><article-id pub-id-type="pmcaid">12765899</article-id><article-id pub-id-type="pmcaiid">12765899</article-id><article-id pub-id-type="pmid">41486294</article-id><article-id pub-id-type="doi">10.1038/s41422-025-01203-7</article-id><article-id pub-id-type="publisher-id">1203</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Mitophagy in the pathogenesis and management of disease</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9239-1998</contrib-id><name name-style="western"><surname>Wang</surname><given-names initials="Q">Qi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2392-2043</contrib-id><name name-style="western"><surname>Sun</surname><given-names initials="Y">Yu</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3684-7935</contrib-id><name name-style="western"><surname>Li</surname><given-names initials="TY">Terytty Yang</given-names></name><address><email>teryttyliyang@fudan.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5065-5393</contrib-id><name name-style="western"><surname>Auwerx</surname><given-names initials="J">Johan</given-names></name><address><email>admin.auwerx@epfl.ch</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02s376052</institution-id><institution-id institution-id-type="GRID">grid.5333.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2183 9049</institution-id><institution>Laboratory of Integrative Systems Physiology, Interfaculty Institute of Bioengineering, </institution><institution>&#201;cole Polytechnique F&#233;d&#233;rale de Lausanne, </institution></institution-wrap>Lausanne, Switzerland </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/013q1eq08</institution-id><institution-id institution-id-type="GRID">grid.8547.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0125 2443</institution-id><institution>Shanghai Key Laboratory of Metabolic Remodeling and Health, Laboratory of Longevity and Metabolic Adaptations, Institute of Metabolism and Integrative Biology, </institution><institution>Fudan University, </institution></institution-wrap>Shanghai, China </aff></contrib-group><pub-date pub-type="epub"><day>5</day><month>1</month><year>2026</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2026</year></pub-date><volume>36</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">503939</issue-id><fpage>11</fpage><lpage>37</lpage><history><date date-type="received"><day>7</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>10</day><month>11</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>05</day><month>01</month><year>2026</year></date></event><event event-type="pmc-live"><date><day>06</day><month>01</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2026-01-06 00:25:12.393"><day>06</day><month>01</month><year>2026</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2026</copyright-statement><copyright-year>2026</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41422_2025_Article_1203.pdf"/><abstract id="Abs1"><p id="Par1">Mitophagy, an evolutionarily conserved quality-control process, selectively removes damaged mitochondria to maintain cellular homeostasis. Recent advances in our understanding of the molecular machinery underlying mitophagy&#160;&#8212;&#160;from receptors and stress-responsive triggers to lysosomal degradation&#160;&#8212;&#160;illustrate its key role in maintaining mitochondrial integrity and adapting mitochondrial function to ever-changing physiological demands. In this review, we outline the fundamental mechanisms of mitophagy and discuss how dysregulation of this pathway disrupts mitochondrial function and metabolic balance, driving a wide range of disorders, including neurodegenerative, cardiovascular, metabolic, and immune-related diseases, as well as cancer. We explore the dual role of mitophagy as both a disease driver and a therapeutic target, highlighting the efforts and challenges of translating mechanistic insights into precision therapies. Targeting mitophagy to restore mitochondrial homeostasis may be at the center of a large range of translational opportunities for improving human health.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Autophagy</kwd><kwd>Cell signalling</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur F&#246;rderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)</institution></institution-wrap></funding-source><award-id>SNSF 31003A_179435</award-id><award-id>Sinergia CRSII5_202302</award-id><principal-award-recipient><name name-style="western"><surname>Auwerx</surname><given-names>Johan</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100004410</institution-id><institution>European Molecular Biology Organization (EMBO)</institution></institution-wrap></funding-source><award-id>ALTF 111-2021</award-id><principal-award-recipient><name name-style="western"><surname>Wang</surname><given-names>Qi</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100006312</institution-id><institution>BrightFocus Foundation (BrightFocus)</institution></institution-wrap></funding-source><award-id>A2023018F</award-id><principal-award-recipient><name name-style="western"><surname>Wang</surname><given-names>Qi</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100002858</institution-id><institution>China Postdoctoral Science Foundation</institution></institution-wrap></funding-source><award-id>2023TQ0080</award-id><principal-award-recipient><name name-style="western"><surname>Sun</surname><given-names>Yu</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China (National Science Foundation of China)</institution></institution-wrap></funding-source><award-id>82300708</award-id><award-id>2021hwyq47</award-id><award-id>32470816</award-id><principal-award-recipient><name name-style="western"><surname>Sun</surname><given-names>Yu</given-names></name><name name-style="western"><surname>Li</surname><given-names>Terytty Yang</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences 2026</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Mitochondria are central metabolic hubs essential for cellular homeostasis. In addition to their well-known role as powerhouses of the cell, generating ATP through oxidative phosphorylation (OXPHOS), mitochondria also regulate fatty acid metabolism,<sup><xref ref-type="bibr" rid="CR1">1</xref></sup> calcium homeostasis,<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> reactive oxygen species (ROS) generation,<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> innate immune signaling,<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup> and cell death,<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> making them important signaling integration platforms.<sup><xref ref-type="bibr" rid="CR7">7</xref>&#8211;<xref ref-type="bibr" rid="CR9">9</xref></sup> Maintaining mitochondrial integrity is crucial for cellular, tissue, and organismal health, as mitochondrial dysfunction is a shared feature of aging and numerous diseases.<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup></p><p id="Par3">Unlike other organelles, mitochondria originate from &#945;-proteobacteria<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup> that symbiotically evolved within eukaryotic cells. They retain vestiges of their bacterial genome, mitochondrial DNA (mtDNA),<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> which encodes essential components of the electron transport chain (ETC). However, most mitochondrial proteins (~1400) are nuclear encoded,<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> requiring precise coordination between nuclear DNA (nDNA) and mtDNA to ensure proper mitochondrial function. This complex regulatory interplay subjects mitochondria to multiple levels of transcriptional, translational, and post-translational control, making them particularly susceptible to mitonuclear imbalance and proteotoxic stress.<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup></p><p id="Par4">To maintain homeostasis, mitochondria engage in dynamic quality-control processes, including biogenesis, mitochondrial dynamics (fission and fusion), proteostasis, and stress responses such as the mitochondrial unfolded protein response (UPR<sup>mt</sup>).<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR16">16</xref>&#8211;<xref ref-type="bibr" rid="CR18">18</xref></sup> When mitochondria sustain irreparable damage, degradation pathways are activated to prevent the accumulation of dysfunctional organelles. Mitophagy is a selective form of macroautophagy that serves as the primary mechanism for eliminating damaged mitochondria through the lysosome, ensuring cellular adaptation to metabolic and environmental stresses. Additional mitochondrial clearance pathways, including mitochondria-derived vesicles (MDVs),<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup> mitochondrial-derived structures positive for the outer mitochondrial membrane (SPOT),<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> vesicles derived from the inner mitochondrial membrane (VDIMs),<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> and mitochondrial disposal via mitocytosis,<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> have also been identified. In this review, we summarize the mechanisms of mitophagy (Supplementary information,&#160;Table&#160;<xref rid="MOESM1" ref-type="media">S1</xref>), discuss its role in disease pathogenesis, and explore emerging therapeutic strategies that target mitophagy to restore mitochondrial homeostasis.</p></sec><sec id="Sec2"><title>Mitophagy pathways</title><p id="Par5">Mitophagy was first observed in the 1970s,<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> but specific mitophagy pathways have only recently been characterized. The selective removal of damaged or superfluous mitochondria relies on &#8220;eat me&#8221; signals, generated either by ubiquitin (Ub)-dependent or receptor-mediated pathways. In the Ub-dependent pathway, ubiquitin chains are conjugated to damaged mitochondria to recruit autophagy receptor proteins and subsequent autophagy machinery. In the receptor-mediated pathway, mitochondrially-localized receptor proteins directly engage with the autophagy machinery to initiate mitophagy. Regardless of the pathway, the targeted mitochondria are degraded by macroautophagy (hereafter autophagy), which involves the sequestration of cytoplasmic components by double-membrane autophagosomes that then deliver them to lysosomes for degradation.</p><sec id="Sec3"><title>Ubiquitin-mediated mitophagy pathway</title><p id="Par6">Ubiquitination not only tags proteins for proteasomal degradation but also serves as a platform for recruiting the autophagy machinery (Box&#160;<xref rid="Sec4" ref-type="sec">1</xref>). The PTEN-induced kinase 1 (PINK1)&#8211;Parkin pathway, first identified through disease-causing mutations of early-onset Parkinson&#8217;s disease (PD),<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup> is one of the most well-characterized Ub-dependent mitophagy pathways (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>).<sup><xref ref-type="bibr" rid="CR27">27</xref></sup><fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><title>PINK1&#8211;Parkin-mediated mitophagy.</title><p><bold>a</bold> The rapid turnover of PINK1 under normal conditions. The N-terminus of PINK1 is imported into healthy mitochondria and processed by MPP and PARL, generating a cleaved PINK1 that is recognized by ubiquitin ligases and targeted for proteasomal degradation. <bold>b</bold> PINK1 accumulation on damaged mitochondria leads to Parkin recruitment and ubiquitin chain buildup. Mitochondrial damage causes mitochondrial depolarization, which inhibits PINK1 import, allowing PINK1 to complex with TOM on the OMM. Accumulated PINK1 undergoes dimerization and transactivation, phosphorylating Ser65 of the ubiquitin on OMM proteins to generate pUb. Parkin binds to these pUbs and becomes activated, decorating damaged mitochondria with ubiquitin chains. <bold>c</bold> Ubiquitinated mitochondria recruit selective autophagy receptors to drive mitophagy. Selective autophagy receptors such as NDP52 and OPTN bind to ubiquitin chains on the mitochondria and interact with upstream autophagy modules to initiate autophagosome formation. OMM outer mitochondrial membrane, IMS intermembrane space, IMM inner mitochondrial membrane, TOM translocase of the outer membrane, TIM translocase of the inner membrane, &#916;&#968; membrane potential.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e367" position="float" orientation="portrait" xlink:href="41422_2025_1203_Fig1_HTML.jpg"/></fig></p><p id="Par7">PINK1 is a mitochondrial serine/threonine-protein kinase encoded by nDNA, translated in the cytosol, and imported into mitochondria under the guidance of its N-terminal mitochondrial targeting sequence (MTS).<sup><xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref></sup> Its role as a mitochondrial damage sensor arises from its different processing in healthy versus damaged mitochondria. Under normal conditions, the 63&#8201;kDa full-length PINK1 is imported across the inner mitochondrial membrane (IMM) through the translocase of the outer membrane (TOM) and inner membrane (TIM) complexes, where the mitochondrial processing protease (MPP) cleaves off its MTS,<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> generating a 60-kDa intermediate. This intermediate is further processed by PINK1/PGAM5-associated rhomboid-like protease (also known as Presenilin-associated rhomboid-like, PARL) to produce a&#8201;~50-kDa fragment<sup><xref ref-type="bibr" rid="CR32">32</xref>&#8211;<xref ref-type="bibr" rid="CR35">35</xref></sup> that is released into the cytosol and degraded by the proteasome.<sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup> Such rapid turnover ensures low endogenous PINK1 levels&#160;(Fig.&#160;<xref rid="Fig1" ref-type="fig">1a</xref>). By contrast, sustained mitochondrial damage or dysfunction disrupts mitochondrial membrane potential (&#916;&#968;), blocking PINK1 import and preventing its degradation. Instead, PINK1 stabilizes and accumulates on the outer mitochondrial membrane (OMM) and binds to TOM.<sup><xref ref-type="bibr" rid="CR38">38</xref>&#8211;<xref ref-type="bibr" rid="CR40">40</xref></sup> If mitochondrial dysfunction is not resolved in a timely manner, persistent PINK1 accumulation leads to PINK1 dimerization and trans-autophosphorylation,<sup><xref ref-type="bibr" rid="CR41">41</xref>&#8211;<xref ref-type="bibr" rid="CR46">46</xref></sup> activating PINK1 to bind and phosphorylate its substrates, serine (Ser) 65 on the ubiquitin chains of OMM proteins<sup><xref ref-type="bibr" rid="CR47">47</xref>&#8211;<xref ref-type="bibr" rid="CR49">49</xref></sup> (Fig.&#160;<xref rid="Fig1" ref-type="fig">1b</xref>).</p><p id="Par8">The accumulation of phosphorylated-ubiquitin (pUb) on the OMM recruits Parkin,<sup><xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR50">50</xref></sup> a RING-between-RING E3 ligase.<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> Recruited Parkin is subsequently phosphorylated by PINK1 at Ser65 of its ubiquitin-like domain (Ubl).<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> While pUb binding releases Parkin from its autoinhibited state, Ubl phosphorylation further stabilizes Parkin&#8217;s open and active conformation.<sup><xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR52">52</xref>&#8211;<xref ref-type="bibr" rid="CR58">58</xref></sup> Upon activation, Parkin exhibits enhanced E3 ligase activity, ubiquitinating OMM proteins such as mitofusin 1/2 (MFN1/2), dynamin-related protein 1 (DRP1), mitochondrial Rho GTPase 1/2 (MIRO1/2, also known as RHOT1/2), and voltage-dependent anion channel 1/2 (VDAC1/2),<sup><xref ref-type="bibr" rid="CR59">59</xref>&#8211;<xref ref-type="bibr" rid="CR61">61</xref></sup> thereby marking mitochondria as damaged. Additional E3 ligases also contribute to mitochondrial ubiquitination (Box&#160;<xref rid="Sec5" ref-type="sec">2</xref>). By contrast, USP30, a deubiquitinase (DUB) that localizes on the OMM, antagonizes Parkin-mediated mitophagy by removing ubiquitin from mitochondrial proteins.<sup><xref ref-type="bibr" rid="CR62">62</xref>&#8211;<xref ref-type="bibr" rid="CR64">64</xref></sup> Notably, USP30 is also a substrate of Parkin.<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> The newly formed ubiquitin chains are further phosphorylated by PINK1, amplifying Parkin recruitment and reinforcing a feedforward cascade (Fig.&#160;<xref rid="Fig1" ref-type="fig">1b</xref>). Together, PINK1 and Parkin synergize in building pUb chains that recruit Ub-binding autophagy receptors, driving autophagosome formation.</p><p id="Par9">Several Ub-binding selective autophagy receptors have been characterized, including optineurin (OPTN),<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> nuclear dot protein 52 (NDP52, also known as CALCOCO2),<sup><xref ref-type="bibr" rid="CR66">66</xref></sup> Tax1-binding protein 1 (TAX1BP1),<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> p62 (also known as sequestosome 1, SQSTM1),<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> and next to the BRCA1 gene 1 (NBR1).<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> These receptors all contain both Ub-binding domains (UBDs) and an ATG8-interacting motif (also known as the LC3-interacting region, LIR),<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> enabling them to recruit autophagic membranes to labeled cargo. However, arguing against the proposal that selective autophagy receptors recruit autophagy machinery through their binding to LC3, cells that lack ATG8 family LC3/GABARAP proteins can sequester mitochondria in fully formed autophagosomes,<sup><xref ref-type="bibr" rid="CR70">70</xref>,<xref ref-type="bibr" rid="CR71">71</xref></sup> despite exhibiting smaller autophagosomes and a slower initial rate of autophagosome biogenesis. In line with this observation, among the five selective autophagy receptors, OPTN, NDP52, and to a lesser extent, TAX1BP1, are indispensable for mitophagy,<sup><xref ref-type="bibr" rid="CR72">72</xref>&#8211;<xref ref-type="bibr" rid="CR75">75</xref></sup> whereas, p62 and NBR1 are recruited to depolarized mitochondria and are involved in mitochondrial clustering.<sup><xref ref-type="bibr" rid="CR76">76</xref>,<xref ref-type="bibr" rid="CR77">77</xref></sup> More recent work suggests that OPTN and NDP52 recruit upstream autophagy modules to initiate autophagosome formation at pUb-decorated mitochondria.<sup><xref ref-type="bibr" rid="CR78">78</xref>&#8211;<xref ref-type="bibr" rid="CR81">81</xref></sup> Specifically, NDP52 interacts with the ULK1 complex subunit FIP200,<sup><xref ref-type="bibr" rid="CR78">78</xref>,<xref ref-type="bibr" rid="CR79">79</xref></sup> whereas OPTN recruits ATG9 vesicles that are important for de novo autophagosome biogenesis<sup><xref ref-type="bibr" rid="CR80">80</xref>,<xref ref-type="bibr" rid="CR81">81</xref></sup> (Fig.&#160;<xref rid="Fig1" ref-type="fig">1c</xref>). In addition, TANK-binding kinase 1 (TBK1), a serine/threonine protein kinase with known functions in the innate immune pathway,<sup><xref ref-type="bibr" rid="CR82">82</xref>,<xref ref-type="bibr" rid="CR83">83</xref></sup> is co-recruited to depolarized mitochondria with OPTN and becomes activated.<sup><xref ref-type="bibr" rid="CR74">74</xref>,<xref ref-type="bibr" rid="CR75">75</xref></sup> Activated TBK1, in turn, phosphorylates NDP52 and OPTN at multiple sites, enhancing their binding to Ub chains<sup><xref ref-type="bibr" rid="CR74">74</xref>,<xref ref-type="bibr" rid="CR84">84</xref></sup> and the autophagy complex<sup><xref ref-type="bibr" rid="CR78">78</xref></sup> to promote mitophagy. TBK1 also directly binds to PI3KC3 complex I, further facilitating mitophagy initiation.<sup><xref ref-type="bibr" rid="CR85">85</xref></sup> ATG8 family members play important roles in amplifying mitophagy<sup><xref ref-type="bibr" rid="CR86">86</xref></sup> and mediating autophagosome&#8211;lysosome fusion.<sup><xref ref-type="bibr" rid="CR70">70</xref>,<xref ref-type="bibr" rid="CR71">71</xref></sup></p><p id="Par10">Although the PINK1&#8211;Parkin pathway is well characterized in cultured cells, its relevance to mitophagy in vivo is debated. Emerging evidence suggests that basal mitophagy can proceed independently of PINK1 in vivo. <italic toggle="yes">Mito</italic>-QC is a fluorescence-based reporter system composed of a tandem mCherry&#8211;GFP fusion protein targeted to the OMM that enables the visualization of mitochondrial structure and mitophagy at single-cell resolution within tissues.<sup><xref ref-type="bibr" rid="CR87">87</xref></sup> A seminal study crossed <italic toggle="yes">Pink1</italic> knockout mice with <italic toggle="yes">mito</italic>-QC mice and demonstrated that <italic toggle="yes">Pink1</italic> knockout mice exhibited normal levels of basal mitophagy across multiple high-metabolic-demand tissues, with the exception of pancreatic islets.<sup><xref ref-type="bibr" rid="CR88">88</xref></sup> Similarly, in transgenic <italic toggle="yes">Drosophila</italic> expressing <italic toggle="yes">mito</italic>-QC or mt-Keima, another mitochondrially targeted pH-sensitive fluorescent reporter,<sup><xref ref-type="bibr" rid="CR89">89</xref></sup>
<italic toggle="yes">Pink1</italic> or <italic toggle="yes">Prkn</italic> (the gene encoding Parkin) deficiency had minimal effects on basal mitophagy levels.<sup><xref ref-type="bibr" rid="CR90">90</xref>,<xref ref-type="bibr" rid="CR91">91</xref></sup> Nonetheless, the PINK1&#8211;Parkin pathway is essential for mitophagy induction upon hypoxia exposure and rotenone treatment in <italic toggle="yes">Drosophila</italic>,<sup><xref ref-type="bibr" rid="CR91">91</xref></sup> and exhaustive exercise also activates PINK1&#8211;Parkin mitophagy in the mouse heart.<sup><xref ref-type="bibr" rid="CR92">92</xref></sup> These findings suggest that mammalian cells employ multiple pathways to regulate mitophagy and maintain mitochondrial integrity in a context-dependent manner.</p></sec><sec id="Sec4"><boxed-text position="float" orientation="portrait"><label>Box 1 Crosstalk between autophagy and ubiquitin&#8211;proteasome systems</label><p id="Par11">Both autophagy and the ubiquitin&#8211;proteasome system are evolutionarily conserved catabolic processes responsible for the degradation, processing, and recycling of cellular components. Whereas autophagy primarily eliminates long-lived and insoluble protein aggregates, lipid droplets, pathogens, and dysfunctional or superfluous organelles,<sup><xref ref-type="bibr" rid="CR439">439</xref></sup> ubiquitin is known mainly for mediating selective proteasomal degradation of short-lived proteins.<sup><xref ref-type="bibr" rid="CR440">440</xref>,<xref ref-type="bibr" rid="CR441">441</xref></sup> Recent advances in the understanding of selective autophagy mechanisms, exemplified by mitophagy, have revealed the intertwinement of the autophagy and ubiquitin&#8211;proteasome systems,<sup><xref ref-type="bibr" rid="CR442">442</xref>,<xref ref-type="bibr" rid="CR443">443</xref></sup> highlighting their coordinated roles in maintaining cellular homeostasis.</p><p id="Par12">Ubiquitin is a small protein consisting of 76 amino acids that serves as a molecular tag for proteasomal degradation. Proteins targeted for degradation are covalently ligated with ubiquitin following a three-enzyme cascade consisting of a ubiquitin-activating enzyme E1, a ubiquitin-conjugating enzyme E2, and a ubiquitin-protein ligase E3.<sup><xref ref-type="bibr" rid="CR444">444</xref></sup> First, the E1 enzyme activates ubiquitin by adenylating its C-terminal glycine residue in an ATP-dependent manner, enabling its binding to the active-site cysteine residue of E1 through a thioester linkage.<sup><xref ref-type="bibr" rid="CR445">445</xref></sup> The activated ubiquitin is then transferred to the active-site cysteine residue of an E2 enzyme.<sup><xref ref-type="bibr" rid="CR446">446</xref></sup> Finally, an E3 enzyme catalyzes the formation of an iso-peptide bond between the C terminus of ubiquitin and a lysine residue of the substrate protein<sup><xref ref-type="bibr" rid="CR447">447</xref>,<xref ref-type="bibr" rid="CR448">448</xref></sup> (Fig. B1). Diverse E1, E2, and E3 proteins have been identified. The human genome is estimated to encode 2 E1s, at least 38 E2s, and over 600 E3s,<sup><xref ref-type="bibr" rid="CR448">448</xref></sup> among which the E3s play critical roles in determining substrate specificity and regulating elongation of the ubiquitin chain.<sup><xref ref-type="bibr" rid="CR449">449</xref></sup> DUBs, which are a type of protease, counteract this process by removing ubiquitin modifications.<sup><xref ref-type="bibr" rid="CR409">409</xref>,<xref ref-type="bibr" rid="CR441">441</xref></sup><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="d33e715" orientation="portrait" xlink:href="41422_2025_1203_Figa_HTML.jpg"/></p><p id="Par13">Autophagy is a lysosomal degradation pathway that includes macroautophagy, microautophagy, and chaperone-mediated autophagy. In this review, we specifically refer to macroautophagy, which can occur in either a nonselective &#8216;bulk&#8217; or selective manner. The autophagy process involves several core modules: (i) The unc51-like kinase (ULK) complex, comprising ULK1 or ULK2, autophagy-related protein 13 (ATG13), ATG101, and focal adhesion kinase family kinase-interacting protein of 200&#8201;kDa (FIP200). This complex integrates upstream signals from AMP-activated protein kinase (AMPK) and the mammalian target of rapamycin complex 1 (mTORC1)<sup><xref ref-type="bibr" rid="CR450">450</xref>&#8211;<xref ref-type="bibr" rid="CR454">454</xref></sup> to regulate autophagosome initiation. (ii) The transmembrane protein ATG9, which is potentially involved in lipid supply for autophagosome biogenesis.<sup><xref ref-type="bibr" rid="CR455">455</xref></sup> (iii) The class III phosphatidylinositol 3-kinase (PI3KC3) complex, consisting of Beclin 1, the lipid kinase VPS34, the regulatory scaffold VPS15, and ATG14.<sup><xref ref-type="bibr" rid="CR456">456</xref></sup> The PI3KC3 complex synthesizes phosphatidylinositol 3-phosphate (PI3P) from phosphatidylinositol (PI). (iv) The WD-repeat proteins interacting with phosphoinositides (WIPIs), which bind PI3P during early steps of autophagy and recruit the ATG16L1 complex. (v) The ATG5&#8211;ATG12/ATG16L1 complex, which acts as an E3 ligase-like ATG8 lipidation machinery.<sup><xref ref-type="bibr" rid="CR457">457</xref></sup> This lipidation process involves a ubiquitin-like conjugation system that also requires the E1-like enzyme ATG7<sup><xref ref-type="bibr" rid="CR458">458</xref>,<xref ref-type="bibr" rid="CR459">459</xref></sup> and the E2-like ATG3.<sup><xref ref-type="bibr" rid="CR460">460</xref>,<xref ref-type="bibr" rid="CR461">461</xref></sup> (vi) The ATG8 family, including microtubule-associated protein 1&#8201;A/1B-light chain 3 (LC3) and &#947;-aminobutyric acid receptor-associated protein (GABARAP) subfamily proteins.<sup><xref ref-type="bibr" rid="CR462">462</xref></sup> ATG8 proteins are conjugated to the membrane lipid phosphatidylethanolamine (PE) through a process termed lipidation, which is analogous to ubiquitination, to promote autophagosome maturation and, eventually, autophagosome&#8211;lysosome fusion.</p><p id="Par14">ATG8 proteins, in addition to their classic conjugation to double membranes, can also be recruited to various single membranes, such as endosomes, phagosomes, macropinosomes, and the plasma membrane, via non-canonical pathways<sup><xref ref-type="bibr" rid="CR463">463</xref>&#8211;<xref ref-type="bibr" rid="CR465">465</xref></sup> in a process termed conjugation of ATG8 to single membranes (CASM). The function of this process varies by membrane type, ranging from degradation and secretion to membrane repair. In CASM, ATG8 can be conjugated to PE, as mentioned earlier, but also to phosphatidylserine (PS).<sup><xref ref-type="bibr" rid="CR466">466</xref>,<xref ref-type="bibr" rid="CR467">467</xref></sup> Notably, single-membrane lipidation shows limited reliance on classical upstream autophagy initiators (e.g., mTORC1, ULK1 complexes) but retains most canonical ubiquitin-like conjugation steps.</p><p id="Par15">The identification of autophagy receptor proteins that bind both ubiquitin and components of the autophagosome assembly machinery establishes a molecular link between the autophagy and proteasome systems.<sup><xref ref-type="bibr" rid="CR442">442</xref>,<xref ref-type="bibr" rid="CR443">443</xref>,<xref ref-type="bibr" rid="CR462">462</xref>,<xref ref-type="bibr" rid="CR468">468</xref></sup> Autophagy receptors are characterized by the presence of both a UBD and an LIR. During ubiquitin-dependent mitophagy events, UBDs recognize ubiquitinated mitochondria, while LIRs interact with autophagy machinery proteins.<sup><xref ref-type="bibr" rid="CR468">468</xref></sup> Such a structure enables the autophagy machinery to selectively capture ubiquitinated organelles for lysosomal degradation.</p></boxed-text></sec><sec id="Sec5"><boxed-text position="float" orientation="portrait"><label>Box 2 E3 ligases in Parkin-independent mitophagy</label><p id="Par16">The observation that mitochondrial ubiquitin alone is sufficient to induce mitophagy, even in the absence of PINK1 and Parkin,<sup><xref ref-type="bibr" rid="CR80">80</xref></sup> raises the question of whether other ubiquitin ligases contribute to Parkin-independent mitophagy. Given the large number of putative human E3 ligases,<sup><xref ref-type="bibr" rid="CR447">447</xref></sup> it is plausible that multiple ligases participate in this process, despite Parkin being the most well-established E3 ligase in mitophagy.</p><p id="Par17">Indeed, several E3 ligases have been identified as mediators of mitophagy, including mitochondrial ubiquitin ligase 1 (MUL1), seven in absentia homolog 1 (SIAH1), and ariadne RBR E3 ubiquitin ligase 1 (ARIH1). MUL1 (also known as MAPL/MULAN/GIDE) is a mitochondrial OMM-localized E3 ligase with both ubiquitination and SUMOylation activities.<sup><xref ref-type="bibr" rid="CR469">469</xref></sup> MUL1 has been shown to regulate mitochondrial dynamics by modifying MFN2 and DRP1.<sup><xref ref-type="bibr" rid="CR470">470</xref>,<xref ref-type="bibr" rid="CR471">471</xref></sup> It modifies and interacts with ULK1,<sup><xref ref-type="bibr" rid="CR472">472</xref></sup> and it functions synergistically with Parkin to eliminate paternal mitochondria.<sup><xref ref-type="bibr" rid="CR473">473</xref></sup> SIAH1 promotes mitochondrial protein ubiquitination and subsequent mitophagy in a PINK1&#8211;synphilin-1-dependent manner<sup><xref ref-type="bibr" rid="CR474">474</xref></sup>; ARIH1 was identified as a PINK1-dependent mitophagy regulator in cancer cells.<sup><xref ref-type="bibr" rid="CR300">300</xref></sup></p><p id="Par18">In addition, in receptor-mediated mitophagy, HUWE1 (HECT, UBA, and WWE domain containing E3 ubiquitin protein ligase 1) regulates AMBRA1-mediated mitophagy,<sup><xref ref-type="bibr" rid="CR155">155</xref></sup> and MARCH5 (membrane-associated RING finger 5) ubiquitinates FUNDC1 to regulate mitophagy under hypoxic stress.<sup><xref ref-type="bibr" rid="CR136">136</xref></sup></p></boxed-text></sec><sec id="Sec6"><title>Receptor-mediated mitophagy</title><p id="Par19">Mitophagy can also occur independently of ubiquitin. In this case, mitochondrial membrane proteins mediate the delivery of mitochondria to autophagosomes. These proteins, collectively termed &#8220;mitophagy receptors&#8221;, engage the autophagy machinery via their LIR domains, which interact primarily with ATG8s. Here, we focus on the key features and regulatory mechanisms of the most well-characterized receptors (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>); their physiological roles are explored in further detail elsewhere.<sup><xref ref-type="bibr" rid="CR93">93</xref>&#8211;<xref ref-type="bibr" rid="CR95">95</xref></sup><fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><title>Receptor-mediated mitophagy pathways.</title><p>PINK1&#8211;Parkin-independent regulatory mechanisms are shown. <bold>a</bold>, <bold>b</bold> BNIP3/NIX-mediated mitophagy. <bold>a</bold> Functional domains of BNIP3 and NIX are shown on top. Under normal conditions, the mitochondrial E3 ligase complex SCF<sup>FBXL4</sup>, which is composed of CUL1&#8211;SKP1&#8211;FBXL4, interacts with RBX1 and the E2 enzyme to ubiquitinate BNIP3 and NIX for proteasomal degradation. OM-PPTC7 facilitates the interaction between SCF<sup>FBXL4</sup> and BNIP3/NIX. <bold>b</bold> Under hypoxia, HIF-1&#945; upregulates the transcription of BNIP3/NIX. JNK1/2 phosphorylate BNIP3 to inhibit its degradation. Accumulated BNIP3/NIX proteins form homodimers and recruit LC3 via their LIR. ULK1 phosphorylates BNIP3/NIX to promote mitophagy. <bold>c</bold> FUNDC1-mediated mitophagy. Functional domains of FUNDC1 are shown on top. Under normal conditions, CK2 and Src phosphorylate FUNDC1 to prevent its interaction with LC3. The E3 ligase MARCH5 ubiquitinates FUNDC1 for proteasomal degradation, and this is antagonized by USP19. Upon hypoxia or a decrease in membrane potential, PGAM5 dephosphorylates FUNDC1 to promote its binding with LC3. ULK1 phosphorylates FUNDC1 to facilitate its LC3 recruitment. <bold>d</bold> BCL2L13, FKBP8, AMBRA1, and PHB2 as mitophagy receptors. Functional domains of BCL2L13, FKBP8, AMBRA1, and PHB2 are shown. These receptors mediate mitophagy by recruiting LC3 via their LIR domains. In addition, BCL2L13 complexes with ULK1 and LC3 during the initiation of mitophagy. AMBRA1 recruits the E3 ligase HUWE1 to ubiquitinate MFN2 and other OMM proteins to facilitate mitophagy, and its phosphorylation by IKK&#945; also promotes mitophagy. PHB2, an IMM-located mitophagy receptor, acquires access to LC3 upon outer membrane rupture. OMM outer mitochondrial membrane, IMS intermembrane space, IMM inner mitochondrial membrane; LIR LC3-interacting region, BH1&#8211;4 Bcl-2 homology domain 1&#8211;4, TM transmembrane domain, WD40 WD40 domain, PHB prohibitin domain.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e885" position="float" orientation="portrait" xlink:href="41422_2025_1203_Fig2_HTML.jpg"/></fig></p><sec id="Sec7"><title>BNIP3 and BNIP3L/NIX</title><p id="Par20">BNIP3 (BCL-2/adenovirus E1B 19&#8201;kDa protein-interacting protein 3) and BNIP3L (BNIP3-like, also known as NIX) are BCL-2 homology domain 3 (BH3)-only family proteins involved in diverse cellular processes, including apoptosis and mitophagy.<sup><xref ref-type="bibr" rid="CR96">96</xref>&#8211;<xref ref-type="bibr" rid="CR98">98</xref></sup> BNIP3 and NIX regulate mitochondrial clearance under various conditions.<sup><xref ref-type="bibr" rid="CR99">99</xref>&#8211;<xref ref-type="bibr" rid="CR104">104</xref></sup> For example, BNIP3 mediates mitophagy under hypoxia,<sup><xref ref-type="bibr" rid="CR99">99</xref>,<xref ref-type="bibr" rid="CR102">102</xref></sup> whereas NIX is essential for mitochondrial elimination during reticulocyte maturation,<sup><xref ref-type="bibr" rid="CR100">100</xref></sup> erythroid cell maturation,<sup><xref ref-type="bibr" rid="CR101">101</xref></sup> and retinal ganglion cell differentiation.<sup><xref ref-type="bibr" rid="CR105">105</xref></sup> Furthermore, NIX induction restores CCCP-induced mitophagy in cells derived from early-onset PD patients with PINK1 or Parkin deficiency.<sup><xref ref-type="bibr" rid="CR106">106</xref></sup> Both BNIP3 and NIX possess a characteristic C-terminal transmembrane domain that is responsible for homodimerization and OMM anchoring<sup><xref ref-type="bibr" rid="CR107">107</xref>&#8211;<xref ref-type="bibr" rid="CR109">109</xref></sup> and an LIR domain that binds LC3/GABARAP.<sup><xref ref-type="bibr" rid="CR104">104</xref>,<xref ref-type="bibr" rid="CR110">110</xref></sup> Upon activation, BNIP3 and NIX homodimerize via their transmembrane domains and are targeted to the OMM.<sup><xref ref-type="bibr" rid="CR111">111</xref></sup></p><p id="Par21">BNIP3/NIX are regulated at both the transcriptional and post-translational levels. Hypoxia is a key stress factor that induces BNIP3/NIX-mediated mitophagy,<sup><xref ref-type="bibr" rid="CR112">112</xref></sup> as both genes can be transcriptionally upregulated by stabilized hypoxia-inducible factor-1alpha (HIF-1&#945;).<sup><xref ref-type="bibr" rid="CR113">113</xref>,<xref ref-type="bibr" rid="CR114">114</xref></sup> However, further investigation is needed to fully clarify the molecular mechanisms of this pathway.<sup><xref ref-type="bibr" rid="CR115">115</xref></sup> Post-translational modifications of BNIP3 and NIX include phosphorylation and ubiquitination. Phosphorylation of BNIP3 at Ser17 and Ser24 and of NIX at Ser34 and Ser35 promote mitophagy by stabilizing their ATG8 binding via their LIR domains.<sup><xref ref-type="bibr" rid="CR96">96</xref>,<xref ref-type="bibr" rid="CR116">116</xref></sup> ULK1 phosphorylates BNIP3 at Ser17 and NIX at Ser35 to promote mitophagy.<sup><xref ref-type="bibr" rid="CR117">117</xref></sup> c-Jun N-terminal kinase 1/2 (JNK1/2) phosphorylate BNIP3 at Ser60 and threonine (Thr) 66 to prevent its proteasomal degradation and enhance hypoxia-induced mitophagy.<sup><xref ref-type="bibr" rid="CR118">118</xref></sup> The mitochondrial E3 ligase, SCF<sup>FBXL4</sup>, which is composed of the adaptor protein S-phase kinase-associated protein 1 (SKP1), a Cullin 1 (CUL1) backbone, and the mitochondrially localized F-box protein FBXL4, binds RING-box protein 1 (RBX1) and E2 ubiquitin-conjugating enzyme to ubiquitinate BNIP3 and NIX for proteasomal degradation.<sup><xref ref-type="bibr" rid="CR119">119</xref>&#8211;<xref ref-type="bibr" rid="CR121">121</xref></sup> Protein phosphatase targeting COQ7 (PPTC7), a PP2C phosphatase localized predominantly to the mitochondrial matrix, cooperates with FBXL4 to mediate the turnover of BNIP3 and NIX, thereby regulating mitophagy.<sup><xref ref-type="bibr" rid="CR122">122</xref>&#8211;<xref ref-type="bibr" rid="CR125">125</xref></sup> The PPTC7 precursor is trapped at the OMM (OM-PPTC7) by BNIP3 and NIX, where it scaffolds the assembly of the substrate&#8211;PPTC7&#8211;FBXL4 complex to degrade BNIP3 and NIX,<sup><xref ref-type="bibr" rid="CR122">122</xref>,<xref ref-type="bibr" rid="CR123">123</xref></sup> forming a homeostatic regulatory loop <bold>(</bold>Fig.&#160;<xref rid="Fig2" ref-type="fig">2a, b</xref>). Starvation has been shown to upregulate PPTC7 expression in mouse liver to repress BNIP3/NIX-mediated mitophagy, which prevents starvation-induced hepatic mitochondrial and metabolic derangements.<sup><xref ref-type="bibr" rid="CR123">123</xref></sup></p><p id="Par22">Several lines of evidence suggest that BNIP3 and NIX may also be involved in PINK1&#8211;Parkin-mediated mitophagy. BNIP3 interacts with PINK1 and inhibits its proteolytic cleavage<sup><xref ref-type="bibr" rid="CR126">126</xref></sup>; it also regulates the mitochondrial dynamics proteins DRP1 and optic atrophy protein 1 (OPA1),<sup><xref ref-type="bibr" rid="CR127">127</xref>,<xref ref-type="bibr" rid="CR128">128</xref></sup> which favor mitophagy by inhibiting fusion and promoting fission. NIX, on the other hand, is essential for uncoupler-induced mitophagy.<sup><xref ref-type="bibr" rid="CR129">129</xref></sup> NIX can be ubiquitinated by Parkin, and ubiquitinated NIX in turn recruits NBR1 to promote mitophagy.<sup><xref ref-type="bibr" rid="CR130">130</xref></sup></p></sec><sec id="Sec8"><title>FUNDC1</title><p id="Par23">FUN14 domain-containing 1 (FUNDC1) is an integral OMM protein that serves as a receptor for hypoxia-induced mitophagy.<sup><xref ref-type="bibr" rid="CR131">131</xref></sup> It contains three transmembrane domains and a characteristic N-terminal Tyr (tyrosine)-X-X-Leu (leucine) (Y<sup>18</sup>xxL<sup>21</sup>) LIR motif that interacts with LC3B.<sup><xref ref-type="bibr" rid="CR131">131</xref></sup> Post-translational modifications play a crucial role in regulating FUNDC1 function. Under basal conditions, casein kinase 2 (CK2) phosphorylates FUNDC1 at Ser13, while the tyrosine kinase Src phosphorylates FUNDC1 at Tyr18, preventing LIR&#8211;LC3B binding.<sup><xref ref-type="bibr" rid="CR131">131</xref>&#8211;<xref ref-type="bibr" rid="CR133">133</xref></sup> In response to hypoxia or uncoupler-induced mitochondrial depolarization, the mitochondrial Ser/Thr protein phosphatase PGAM5 dephosphorylates FUNDC1 at Ser13, which, together with dephosphorylation at Tyr18, enhances the FUNDC1&#8211;LC3 interaction to promote mitophagy.<sup><xref ref-type="bibr" rid="CR131">131</xref>&#8211;<xref ref-type="bibr" rid="CR133">133</xref></sup> In addition, ULK1 phosphorylates FUNDC1 at Ser17 under hypoxic conditions or upon mitochondrial uncoupling, further increasing LC3 binding affinity.<sup><xref ref-type="bibr" rid="CR133">133</xref>,<xref ref-type="bibr" rid="CR134">134</xref></sup> In addition to its role in mitophagy, FUNDC1 also coordinates mitochondrial dynamics through its interaction with both DRP1 and OPA1. Under mitochondrial stress, such as selenite or FCCP exposure, FUNDC1 reduces its interaction with OPA1 and enhances its association with DRP1.<sup><xref ref-type="bibr" rid="CR135">135</xref></sup> These interactions are regulated by the phosphorylation status of FUNDC1 at Ser13.<sup><xref ref-type="bibr" rid="CR135">135</xref></sup> FUNDC1 stability is regulated by ubiquitination at Lys119 catalyzed by the mitochondrial E3 ligase MARCH5, whereas deubiquitination by USP19 counteracts this process, fine-tuning mitophagy<sup><xref ref-type="bibr" rid="CR136">136</xref>,<xref ref-type="bibr" rid="CR137">137</xref></sup> (Fig.&#160;<xref rid="Fig2" ref-type="fig">2c</xref>).</p></sec><sec id="Sec9"><title>BCL2L13</title><p id="Par24">BCL2-like 13 (BCL2L13, also known as BCL-RAMBO) is an OMM-localized protein that contains several conserved BCL-2 homology domains (BH1, BH2, BH3, BH4), two LIR motifs, and a C-terminal transmembrane domain.<sup><xref ref-type="bibr" rid="CR138">138</xref></sup> Similar to BNIP3 and NIX, BCL2L13 was initially identified as a pro-apoptotic protein.<sup><xref ref-type="bibr" rid="CR139">139</xref></sup> It was later characterized as a mammalian homologue of Atg32, mediating mitochondrial fragmentation and mitophagy in a Parkin-independent manner.<sup><xref ref-type="bibr" rid="CR138">138</xref></sup> Upon mitophagy induction, BCL2L13 recruits LC3B to the OMM, accompanied by recruitment of the ULK1 complex, thus forming a BCL2L13&#8211;ULK1&#8211;LC3B complex<sup><xref ref-type="bibr" rid="CR140">140</xref></sup> (Fig.&#160;<xref rid="Fig2" ref-type="fig">2d</xref>). In glioblastoma, BCL2L13 is upregulated, and BCL2L13 overexpression promotes mitophagy.<sup><xref ref-type="bibr" rid="CR141">141</xref></sup> Mitochondrial fission may play a role in this process, as deficiency of BCL2L13 leads to reduced phosphorylation of DRP1 at Ser616, but not Ser637, corresponding to decreased DRP1 activity. In support of this notion, the DRP1-specific inhibitor Mdivi-1 suppresses BCL2L13-induced mitophagy.<sup><xref ref-type="bibr" rid="CR141">141</xref></sup> In addition, BCL2L13 may contribute to autophagosome formation at MERCS by acting as a mitochondrial partner.<sup><xref ref-type="bibr" rid="CR142">142</xref></sup> 5&#8242;-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK&#945;2) was recently shown to phosphorylate BCL2L13 at Ser272 to promote its activation.<sup><xref ref-type="bibr" rid="CR143">143</xref></sup> In the heart, AMPK&#945;2 associates with BCL2L13, and pressure overload upregulates this interaction, suggesting its potential involvement in the development of cardiac dysfunction.</p></sec><sec id="Sec10"><title>FKBP8</title><p id="Par25">FKBP8 (also known as FKBP38) is a unique FKBP family member with diverse functions, including anti-apoptotic activity through anchoring BCL-2 and BCL2L1 to the mitochondrion.<sup><xref ref-type="bibr" rid="CR144">144</xref></sup> FKBP8 is anchored to the OMM by its transmembrane domain and recruits lipidated LC3A via its LIR domain. Carbonyl cyanide m-chlorophenylhydrazone (CCCP) enhances the binding between FKBP8 and LC3A, and co-expression of FKBP8 and ATG8 proteins, particularly LC3A, induces mitophagy<sup><xref ref-type="bibr" rid="CR145">145</xref></sup> (Fig.&#160;<xref rid="Fig2" ref-type="fig">2d</xref>). In addition, FKBP8 contains an LIR-motif-like sequence (LIRL) essential for its interaction with OPA1, suggesting potential coupling of mitochondrial fragmentation to FKBP8-mediated mitophagy.<sup><xref ref-type="bibr" rid="CR146">146</xref></sup> Notably, during mitophagy, FKBP8 translocates from mitochondria to the ER to escape degradation, a process that depends on the dual-localization properties of its TM domain and occurs in both Parkin-dependent and Parkin-independent manners.<sup><xref ref-type="bibr" rid="CR145">145</xref>,<xref ref-type="bibr" rid="CR147">147</xref></sup> The mechanism of FKBP8 activation, its interplay with other mitophagy pathways, and its physiological significance all require further investigation.</p></sec><sec id="Sec11"><title>AMBRA1</title><p id="Par26">Activating molecule in Beclin 1 regulated autophagy protein 1 (AMBRA1) was first identified as a WD40-domain-containing protein that positively regulates autophagy and is required for Beclin 1 activity. It has a crucial role in embryonic neural development.<sup><xref ref-type="bibr" rid="CR148">148</xref></sup> Subsequent studies revealed its role in cell-cycle regulation through the ubiquitination and proteasomal degradation of D-type cyclins (cyclin Ds) during development and cancer.<sup><xref ref-type="bibr" rid="CR149">149</xref>&#8211;<xref ref-type="bibr" rid="CR151">151</xref></sup> After mitophagy induction, AMBRA1 binds LC3 through its LIR motif, an interaction that is crucial for regulating both Parkin-dependent and -independent mitochondrial clearance.<sup><xref ref-type="bibr" rid="CR152">152</xref></sup> In addition, in Parkin-dependent mitophagy, the interaction between AMBRA1 and Parkin strongly increases during prolonged mitochondrial depolarization, and AMBRA1 at the perinuclear clusters of depolarized mitochondria promotes autophagosome formation by stimulating the activity of the upstream PI3K complex.<sup><xref ref-type="bibr" rid="CR153">153</xref></sup> On the OMM, AMBRA1 interacts with PINK1, increasing its stability by preventing its degradation by the mitochondrial protease LONP1, thereby enhancing PINK1 accumulation.<sup><xref ref-type="bibr" rid="CR154">154</xref></sup> Although AMBRA1 potentiates Parkin-mediated mitophagy, it can also induce mitophagy independently of Parkin, as forcing AMBRA1 localization to the mitochondria unleashes massive mitophagy in Parkin-deficient cells. Most importantly, overexpression of wild-type AMBRA1, in combination with FCCP treatment, induces mitochondrial clearance in cells that lack Parkin or PINK1.<sup><xref ref-type="bibr" rid="CR152">152</xref></sup> The E3 ligase HUWE1 plays a key role in this process by ubiquitinating and degrading MFN2, while also stimulating the IKK&#945;-mediated phosphorylation of AMBRA1 at Ser1014, which increases LC3 binding<sup><xref ref-type="bibr" rid="CR155">155</xref></sup> (Fig.&#160;<xref rid="Fig2" ref-type="fig">2d</xref>). The pleiotropic roles of AMBRA1 warrant further exploration of its molecular mechanisms, pathological implications, and therapeutic potential.<sup><xref ref-type="bibr" rid="CR156">156</xref></sup></p></sec><sec id="Sec12"><title>PHB2</title><p id="Par27">Prohibitin 2 (PHB2) is a ubiquitously expressed protein that forms a heterodimeric complex with PHB1. These dimers assemble into a ring-like structure on the IMM.<sup><xref ref-type="bibr" rid="CR157">157</xref>,<xref ref-type="bibr" rid="CR158">158</xref></sup> The PHB complex regulates membrane-protein degradation, cristae morphogenesis, mitochondrial genome stability, and the functional integrity of mitochondria.<sup><xref ref-type="bibr" rid="CR159">159</xref>,<xref ref-type="bibr" rid="CR160">160</xref></sup> A recent study suggested that PHB2 is an IMM-resident mitophagy receptor during Parkin-mediated mitophagy.<sup><xref ref-type="bibr" rid="CR161">161</xref></sup> Upon CCCP-induced mitochondrial depolarization or inhibition of mitochondrial respiration induced by oligomycin and antimycin (OA), and in the presence of Parkin, OMM rupture exposes the PHB1/2 heterodimer, enabling its interaction with LC3-II through an LIR domain of PHB2.<sup><xref ref-type="bibr" rid="CR161">161</xref></sup> Knockdown of PHB2 disrupts the association between the phagophore and the IMM. Consistent with this scenario, knockdown of PHB2 or mutation of the PHB2 LIR domain abolishes OA-induced mitophagy. These findings suggest that PHB2 is essential for autophagosomal sequestration of damaged mitochondria in Parkin-mediated mitophagy<sup><xref ref-type="bibr" rid="CR161">161</xref></sup> (Fig.&#160;<xref rid="Fig2" ref-type="fig">2d</xref>). Notably, although proteasome-dependent OMM rupture is required for the PHB2&#8211;LC3 interaction, PHB2 ubiquitination was not detected, and purified PHB2 binds LC3 in vitro, suggesting that ubiquitin is not required for this process.<sup><xref ref-type="bibr" rid="CR161">161</xref></sup> In addition, independently of its LC3 binding ability, PHB2 stabilizes PINK1 on damaged mitochondria by negatively modulating PARL activity.<sup><xref ref-type="bibr" rid="CR162">162</xref></sup> In <italic toggle="yes">C. elegans</italic>, PHB2 is essential for paternal mitochondrial elimination.<sup><xref ref-type="bibr" rid="CR161">161</xref></sup> The pleiotropic role played by PHB2 in mitophagy warrants further investigation.</p></sec><sec id="Sec13"><title>Lipids as mitophagy receptors</title><p id="Par28">Emerging evidence suggests that specific lipids, such as cardiolipin (CL) and ceramides, can function as mitophagy receptors upon mitochondrial damage.</p><sec id="FPar1"><title>Cardiolipin</title><p id="Par29">CL is a unique phospholipid localized primarily to the IMM and to contact sites between the IMM and the OMM, constituting ~15% of IMM phospholipid mass.<sup><xref ref-type="bibr" rid="CR163">163</xref>,<xref ref-type="bibr" rid="CR164">164</xref></sup> Whereas other phospholipids consist of a glycerol backbone, a polar head group, and two hydrophobic acyl chains, CL has a unique dimeric structure composed of two glycerol moieties linked by a third and bearing four acyl chains. This structure enables CL to interact with IMM proteins involved in the ETC and maintain the organization of mitochondrial cristae.<sup><xref ref-type="bibr" rid="CR165">165</xref></sup> In healthy mitochondria, most CL is localized on the IMM, where it affects diverse cellular processes<sup><xref ref-type="bibr" rid="CR166">166</xref></sup>; upon mitochondrial damage, it translocates to the OMM, increasing its local concentration on the OMM.<sup><xref ref-type="bibr" rid="CR167">167</xref></sup> This redistribution enables CL to access and bind LC3, particularly LC3A, facilitating mitophagy.<sup><xref ref-type="bibr" rid="CR167">167</xref>,<xref ref-type="bibr" rid="CR168">168</xref></sup></p><p id="Par30">Disruption of CL function &#8212; whether by blocking its synthesis via CL synthase knockdown, inhibiting its translocation to the OMM via phospholipid scramblase-3 knockdown,<sup><xref ref-type="bibr" rid="CR169">169</xref></sup> or interrupting its remodeling via knockdown of the phospholipid transacylase tafazzin<sup><xref ref-type="bibr" rid="CR170">170</xref></sup> &#8212; impairs mitophagy.</p><p id="Par31">CL also engages other effector proteins to facilitate mitophagy. Beclin 1, for example, has an evolutionarily conserved domain with high affinity for CL-enriched membranes and binds CL via its aromatic finger, inducing deformation of membranes and liposomes.<sup><xref ref-type="bibr" rid="CR171">171</xref></sup> Proteins related to mitochondrial dynamics, such as OPA1<sup><xref ref-type="bibr" rid="CR172">172</xref></sup> and DRP1,<sup><xref ref-type="bibr" rid="CR173">173</xref>,<xref ref-type="bibr" rid="CR174">174</xref></sup> also interact with CL, which promotes their oligomerization and functional activation. The intermembrane-space-protein nucleoside diphosphate kinase D (NDPK-D, also known as NM23-H4) binds CL and facilitates its redistribution to the OMM.<sup><xref ref-type="bibr" rid="CR175">175</xref>,<xref ref-type="bibr" rid="CR176">176</xref></sup> In addition, NDPK-D also forms a complex with OPA1, a process closely associated with its mitophagy-inducing CL-transfer activity.<sup><xref ref-type="bibr" rid="CR176">176</xref></sup> Collectively, these findings suggest that fission&#8211;fusion dynamics are involved in the regulation of mitophagy.</p></sec><sec id="FPar2"><title>Ceramides</title><p id="Par32">Ceramides are central molecules of sphingolipid metabolism; they are composed of a sphingosine base linked to an acyl chain that varies in length from C14 to C26.<sup><xref ref-type="bibr" rid="CR177">177</xref></sup> Their subcellular localization and acyl chain length are important for cellular function. Expression of ceramide synthase 1 (CerS1) promotes the production of C18-ceramide, which mediates LC3B lipidation and LC3B-II formation. C18-ceramide subsequently interacts with LC3B-II, directing LC3B-II-containing autophagosomes to the mitochondria to initiate mitophagy, ultimately inhibiting mitochondrial function and reducing oxygen consumption.<sup><xref ref-type="bibr" rid="CR178">178</xref></sup> This interaction is regulated by DRP1, and depletion of DRP1 alters the mitochondrial localization of ceramides and prevents the mitochondrial targeting of autophagosomes.<sup><xref ref-type="bibr" rid="CR178">178</xref></sup> Upon sodium selenite treatment, mitochondrial membrane rearrangements drive recruitment of the p17/PERMIT-CerS1 complex, and loss of p17/PERMIT reduces CerS1 translocation and ceramide-mediated mitophagy both in vitro and in vivo. Notably, p17/PERMIT knockout mice demonstrate aging-dependent sensorimotor deficiency that can be mitigated by administration of a ceramide analog.<sup><xref ref-type="bibr" rid="CR179">179</xref></sup> This aligns with findings that CerS1 inhibition exacerbates age-related skeletal muscle dysfunction.<sup><xref ref-type="bibr" rid="CR180">180</xref></sup> Activating this pathway with sodium selenite further improved motor-neuron deficits in aged wild-type mice.<sup><xref ref-type="bibr" rid="CR179">179</xref></sup> The outcome of modulating ceramide-mediated mitophagy varies depending on the cellular and physiological context. For example, in multiple human head and neck squamous cell carcinoma (HNSCC) cell lines, C18-ceramide-mediated mitophagy triggers caspase-independent autophagic cell death, which leads to tumor-suppressive effects in vivo.<sup><xref ref-type="bibr" rid="CR178">178</xref></sup> Furthermore, ceramide-mediated mitophagy is upregulated upon PINK1 deficiency, suggesting a compensatory mechanism for maintenance of mitochondrial quality control.<sup><xref ref-type="bibr" rid="CR181">181</xref></sup></p></sec></sec></sec><sec id="Sec14"><title>Piecemeal mitophagy</title><p id="Par33">In addition to wholesale mitophagy, a specialized form of mitophagy known as piecemeal mitophagy selectively engulfs and degrades individual mitochondrial proteins or protein complexes. Unlike bulk mitophagy, piecemeal mitophagy occurs independently of mitochondrial depolarization and Parkin overexpression, functioning as a basal quality-control mechanism essential for maintenance of a healthy mitochondrial network. Certain mitochondrial proteins, e.g., SAMM50 and metaxin 1 (MTX1) from the sorting and assembly machinery (SAM) complex and mitochondrial inner membrane protein (IMMT, also known as MIC60) from the mitochondrial contact site and cristae organizing system (MICOS) complex, become autophagy cargo by interacting with ATG8 family proteins, facilitating their autophagosomal degradation in a p62-dependent manner.<sup><xref ref-type="bibr" rid="CR182">182</xref>,<xref ref-type="bibr" rid="CR183">183</xref></sup></p><p id="Par34">Under hypoxia-mimicking conditions, PX-domain-containing protein sorting nexin 10 (SNX10) translocates from early endosomal compartments to late endosomal structures containing piecemeal mitophagy markers. SNX10 acts as a negative regulator of the piecemeal mitophagy of OXPHOS machinery components, and its depletion leads to enhanced degradation of specific mitochondrial proteins, reduced OXPHOS activity, and increased ROS accumulation.<sup><xref ref-type="bibr" rid="CR184">184</xref></sup> This suggests that piecemeal mitophagy plays a crucial role in rewiring cellular metabolism toward OXPHOS. The dual localization of SNX10 under normal and hypoxia-mimicking conditions further implies that interorganellar communication is essential for the coordination of mitophagy quality control.</p><p id="Par35">Notably, piecemeal mitophagy extends beyond proteins to include damaged mtDNA. mtDNA is particularly susceptible to damage under oxidative stress, and under such conditions, the primate-specific mitophagy receptor ATPase family AAA domain-containing protein 3B (ATAD3B) mediates piecemeal mitophagy to selectively remove damaged mtDNA.<sup><xref ref-type="bibr" rid="CR185">185</xref></sup> Mechanistically, ATAD3B normally hetero-oligomerizes with ATAD3A, localizing its C-terminus to the mitochondrial intermembrane space. mtDNA damage or depletion disrupts the complex, exposing the ATAD3B C-terminus on the OMM to recruit LC3 and trigger mitophagy. This mechanism aligns with the characteristics of piecemeal mitophagy, which targets discrete mitochondrial components rather than entire organelles&#160;(Box <xref rid="Sec15" ref-type="sec">3</xref>).</p></sec><sec id="Sec15"><boxed-text position="float" orientation="portrait"><label>Box 3 Mitochondria-derived vesicles</label><p id="Par49">In addition to mitophagy, mitochondria can also shed vesicles containing mitochondrial components for degradation to facilitate mitochondrial quality control. Such mechanisms include MDVs,<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup> SPOTs,<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> and VDIMs,<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> among which MDVs are the best characterized.<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> MDVs are mitochondria-derived single- or double-membraned structures with sizes of 60&#8211;150&#8201;nm. Under basal and stressed conditions, different populations of MDVs carry selected mitochondrial components to multivesicular bodies/lysosomes for degradation.<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR475">475</xref>,<xref ref-type="bibr" rid="CR476">476</xref></sup> For example, steady-state MDVs contain the TOM complex, and their formation is initiated by MIRO1/2-dependent thin membrane protrusions and requires DRP1-mediated scission.<sup><xref ref-type="bibr" rid="CR476">476</xref></sup> By contrast, TOM20-negative MDVs form upon oxidative stress induced by antimycin A and deliver selected components of the mitochondrial matrix and IMM to lysosomes.<sup><xref ref-type="bibr" rid="CR477">477</xref></sup> This process requires both PINK1 and Parkin for its generation and involves syntaxin-17-mediated fusion with lysosomes.<sup><xref ref-type="bibr" rid="CR477">477</xref>,<xref ref-type="bibr" rid="CR478">478</xref></sup> The MDV pathway appears to fine-tune the mitochondrial proteome upon mild mitochondrial stress, as it enables the timely removal of damaged mitochondrial components. However, when mitochondrial damage exceeds a certain threshold, mitophagy is activated to degrade the entire organelle. Consistent with this scenario, rare surviving autophagy-deficient cancer cells adapt to the loss of autophagy/mitophagy, possibly through increased mitochondrial fusion and MDV formation.<sup><xref ref-type="bibr" rid="CR479">479</xref></sup> In addition, loss of USP30 has been shown to increase TOM<sup>+</sup> MDVs.<sup><xref ref-type="bibr" rid="CR476">476</xref></sup></p></boxed-text></sec></sec><sec id="Sec16"><title>Mitophagy in disease</title><p id="Par40">Dysregulated mitophagy is increasingly recognized as a contributor to the pathogenesis of diverse diseases, including neurodegenerative, cardiovascular, and metabolic disorders, as well as autoimmune diseases and cancer. Different organ systems display various levels of tolerance to mitophagy deficiency. Tissues differ in their metabolic demands, and those with greater reliance on mitochondrial function are more vulnerable to the consequences of mitochondrial decline; mitochondrial quality control relies on multiple mechanisms, including mitophagy, mitochondrial dynamics, biogenesis, and stress-response pathways.<sup><xref ref-type="bibr" rid="CR186">186</xref></sup> Organs or cell populations often differ in their preferred pathways, leading to heterogeneous susceptibility to mitophagy deficiency. For instance, mitochondrial protein turnover is reported to be faster in the heart than in the brain.<sup><xref ref-type="bibr" rid="CR187">187</xref></sup> Moreover, even within the same organ, mitophagy levels vary across regions or cell types. For example, the dentate gyrus exhibits enriched mitophagy, whereas the substantia nigra shows modest levels; the Purkinje cell layer in the cerebellum displays high levels of mitophagy.<sup><xref ref-type="bibr" rid="CR89">89</xref></sup> On the other hand, enhancing mitophagy can also lead to undesirable outcomes under certain circumstances, such as during acute infection or cancer development. This section will explore the roles of mitophagy in specific diseases (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>), highlighting key findings from recent research and underscoring the physiological relevance of the diverse mitophagy pathways.<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><title>Summary of mitophagy-associated human diseases.</title><p>This review discusses the mitophagy dysregulation underlying neurodegenerative, cardiovascular, metabolic, and immune-related disorders, as well as cancer.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1463" position="float" orientation="portrait" xlink:href="41422_2025_1203_Fig3_HTML.jpg"/></fig></p><sec id="Sec17"><title>Neurodegenerative diseases</title><p id="Par41">Neurodegenerative diseases represent a heterogeneous group of disorders characterized by progressive neuronal loss and functional decline in the central nervous system (CNS). Emerging evidence underscores the pivotal role of mitophagy in the pathogenesis of conditions such as PD, Alzheimer&#8217;s disease (AD), Huntington&#8217;s disease (HD), and amyotrophic lateral sclerosis (ALS). Dysregulation of mitophagy disrupts mitochondrial homeostasis, leading to energy deficits, dysregulated signal transmission, oxidative stress, neuroinflammation, and apoptotic signaling, which collectively drive neurodegeneration.<sup><xref ref-type="bibr" rid="CR188">188</xref>&#8211;<xref ref-type="bibr" rid="CR190">190</xref></sup></p><sec id="Sec18"><title>Parkinson&#8217;s disease</title><p id="Par42">PD is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra, leading to hallmark motor symptoms such as tremors, rigidity, and bradykinesia. Mitophagy impairment is a key pathological feature observed in PD patient tissues and experimental models. Mutations in genes encoding PINK1 and Parkin are associated with early-onset PD,<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR190">190</xref>&#8211;<xref ref-type="bibr" rid="CR192">192</xref></sup> and human genetic analyses have implicated multiple additional genes in PD pathogenesis.<sup><xref ref-type="bibr" rid="CR193">193</xref>&#8211;<xref ref-type="bibr" rid="CR195">195</xref></sup> Pathogenic variants in key regulators of the PINK1&#8211;Parkin mitophagy pathway lead to defective mitochondrial clearance, resulting in accumulation of dysfunctional mitochondria, exacerbated oxidative stress, and bioenergetic deficits &#8212; hallmarks of dopaminergic neuron degeneration.</p><p id="Par43">Pathogenic mutations in the <italic toggle="yes">PRKN</italic> gene, ranging from point substitutions to large deletions, often result in loss of enzymatic activity, impaired substrate ubiquitination, and protein destabilization, which collectively disrupt proteasomal degradation pathways.<sup><xref ref-type="bibr" rid="CR196">196</xref>&#8211;<xref ref-type="bibr" rid="CR198">198</xref></sup> In parallel, &#945;-synuclein (&#945;Syn), a protein prone to aggregation in PD, exacerbates mitochondrial damage by disrupting PINK1 stabilization and Parkin recruitment.<sup><xref ref-type="bibr" rid="CR199">199</xref>,<xref ref-type="bibr" rid="CR200">200</xref></sup> The mutant &#945;Syn variant A53T activates p38 MAPK, which phosphorylates Parkin at Ser131, impairing its E3 ligase activity and promoting neuronal death.<sup><xref ref-type="bibr" rid="CR201">201</xref></sup>
<italic toggle="yes">Drosophila</italic> models further confirm that loss of PINK1&#8211;Parkin leads to mitochondrial fragmentation, locomotor defects, and dopaminergic neuron loss, underscoring the evolutionary conservation of this pathway.<sup><xref ref-type="bibr" rid="CR202">202</xref>,<xref ref-type="bibr" rid="CR203">203</xref></sup></p><p id="Par44">Similar to mutations in <italic toggle="yes">PINK1</italic> and <italic toggle="yes">PRKN</italic>, mutations in other mitophagy-related genes also contribute to PD pathogenesis. For example, the leucine-rich repeat kinase 2 (<italic toggle="yes">LRRK2</italic>) G2019S mutation delays mitochondrial arrest and promotes PD onset by preventing MIRO1 removal from the OMM, thereby reducing OPTN-dependent mitophagy.<sup><xref ref-type="bibr" rid="CR204">204</xref>,<xref ref-type="bibr" rid="CR205">205</xref></sup> Promoting MIRO1 degradation enhances clearance of damaged mitochondria and protects PD neurons against mitochondrial stress<sup><xref ref-type="bibr" rid="CR206">206</xref></sup> (related to Box&#160;<xref rid="Sec22" ref-type="sec">4</xref>). Intriguingly, LRRK2 inhibitors restore mitophagic flux independently of the PINK1&#8211;Parkin pathway, suggesting alternative mechanisms for therapeutic targeting.<sup><xref ref-type="bibr" rid="CR207">207</xref></sup> These findings highlight the complexity of mitophagy regulation and its intersection with PD pathology.</p></sec><sec id="Sec19"><title>Alzheimer&#8217;s disease</title><p id="Par45">AD is the most prevalent neurodegenerative disease, characterized by amyloid-&#946; (A&#946;) plaques and hyperphosphorylated Tau (pTau).<sup><xref ref-type="bibr" rid="CR208">208</xref></sup> Mitochondrial dysfunction and oxidative stress are early events in AD pathogenesis.<sup><xref ref-type="bibr" rid="CR209">209</xref></sup> Functional mitochondria help to reduce aberrant amyloid precursor protein (APP) processing and prevent excessive A&#946; accumulation. Recent evidence indicates that mitophagy is impaired in the hippocampus of AD patients, human AD neurons derived from induced pluripotent stem cells (iPSCs), and AD animal models.<sup><xref ref-type="bibr" rid="CR210">210</xref></sup> Moreover, mitophagy defects are strongly correlated with AD progression.<sup><xref ref-type="bibr" rid="CR211">211</xref>&#8211;<xref ref-type="bibr" rid="CR213">213</xref></sup> In animal models of AD, impaired mitophagy is associated with reduced cytosolic Parkin levels and aberrant PINK1 accumulation, exacerbating A&#946;-induced toxicity.<sup><xref ref-type="bibr" rid="CR214">214</xref></sup> Consistent with these findings, restoration of Parkin expression mitigates mitochondrial deficits, reduces A&#946; burden, lowers neuroinflammation, and ameliorates cognitive decline.<sup><xref ref-type="bibr" rid="CR210">210</xref>,<xref ref-type="bibr" rid="CR215">215</xref></sup></p><p id="Par46">Tau pathology further complicates mitochondrial dynamics. On one hand, N-terminal tau fragments have been reported to&#160;sequester Parkin and ubiquitin C-terminal hydrolase L1 (UCHL1), redirecting them to mitochondria and triggering excessive organelle clearance.<sup><xref ref-type="bibr" rid="CR216">216</xref></sup> On the other hand, full-length tau inhibits Parkin translocation by elevating mitochondrial membrane potential or by directly binding Parkin in the cytosol.<sup><xref ref-type="bibr" rid="CR217">217</xref></sup> This dual role of tau&#160;&#8212;&#160;acting as both a mitophagy inducer and suppressor&#160;&#8212;&#160;reflects its stage-dependent effect on neuronal survival. Notably, enhancement of mitophagy through pharmacological and genetic interventions reduces AD-related tau hyperphosphorylation in human neuronal cells and restores memory function in transgenic tau nematodes and mice.<sup><xref ref-type="bibr" rid="CR210">210</xref></sup></p></sec><sec id="Sec20"><title>Huntington&#8217;s Disease</title><p id="Par47">HD is an inherited neurodegenerative disorder typically caused by a mutation in the gene encoding huntingtin (HTT), which leads to the accumulation of mutant huntingtin (mHTT) protein with polyglutamine (polyQ) repeats at the N terminus.<sup><xref ref-type="bibr" rid="CR218">218</xref></sup> HD is characterized by motor dysfunction, cognitive decline, and psychiatric symptoms such as depression and irritability. HD patients exhibit fragmented mitochondria and reduced mitochondrial mass. Moreover, mHTT severely impairs ATP production and respiration rate, suggesting that dysregulated energy metabolism may be a key feature of HD.<sup><xref ref-type="bibr" rid="CR219">219</xref></sup> Mounting evidence indicates that impaired mitochondrial clearance in HD reflects dysregulation of mitophagic pathways.<sup><xref ref-type="bibr" rid="CR220">220</xref>,<xref ref-type="bibr" rid="CR221">221</xref></sup> mHTT shows reduced binding affinity with the selective autophagy receptor p62<sup><xref ref-type="bibr" rid="CR220">220</xref></sup> and impaired ULK1/PI3KC3 complex formation, hindering autophagosome&#8211;lysosome fusion.<sup><xref ref-type="bibr" rid="CR221">221</xref></sup> Consequently, damaged mitochondria accumulate, amplifying ROS production and caspase activation. PINK1 overexpression partially restores mitophagy in HD models, indicating that compensatory pathways may bypass some mHTT-induced defects.<sup><xref ref-type="bibr" rid="CR222">222</xref></sup> Interestingly, regional analysis of <italic toggle="yes">Pink1</italic>-deficient models reveals striking neuroanatomical heterogeneity in mitophagic activity,<sup><xref ref-type="bibr" rid="CR223">223</xref></sup> implying that differences in neuronal susceptibility may stem from distinct reliance on Parkin-dependent versus alternative mitochondrial clearance mechanisms under varying physiological conditions. Thus, precise modulation of mitophagy is critical for maintaining redox balance and cellular homeostasis in HD.</p></sec><sec id="Sec21"><title>Amyotrophic Lateral Sclerosis</title><p id="Par48">ALS is a motor neuron disease, a progressive and ultimately fatal neurodegenerative disorder characterized by motor neuron degeneration and subsequent muscle atrophy. A key pathological feature of ALS is the presence of abnormal protein aggregates, known as inclusion bodies, in the cytoplasm of neurons, which contribute to a vicious cycle that exacerbates oxidative damage.<sup><xref ref-type="bibr" rid="CR224">224</xref>,<xref ref-type="bibr" rid="CR225">225</xref></sup> Mitochondrial dysfunction is a hallmark of ALS, and emerging evidence suggests that impaired mitophagy plays a critical role in disease progression. Several ALS-associated genes, including <italic toggle="yes">C9ORF72</italic>,<sup><xref ref-type="bibr" rid="CR226">226</xref></sup> superoxide dismutase 1 (<italic toggle="yes">SOD1</italic>),<sup><xref ref-type="bibr" rid="CR227">227</xref></sup>
<italic toggle="yes">OPTN</italic>,<sup><xref ref-type="bibr" rid="CR228">228</xref>,<xref ref-type="bibr" rid="CR229">229</xref></sup>
<italic toggle="yes">TBK1</italic>,<sup><xref ref-type="bibr" rid="CR229">229</xref>,<xref ref-type="bibr" rid="CR230">230</xref></sup> and TAR DNA-binding protein 43 (<italic toggle="yes">TDP-43</italic>),<sup><xref ref-type="bibr" rid="CR231">231</xref></sup> are directly implicated in the regulation of mitophagy. Mutations in these genes typically disrupt mitochondrial quality control, leading to the accumulation of damaged mitochondria and neurotoxic protein aggregates that are key pathological features of ALS. For instance, <italic toggle="yes">C9ORF72</italic> mutations, the most common genetic cause of ALS, are strongly linked to mitochondrial dysfunction. Its pathogenic GGGGCC repeat expansion leads to the production of toxic dipeptide repeat proteins, which interact with mitochondria, disrupt membrane potential, and elevate ROS levels, ultimately impairing mitophagy.<sup><xref ref-type="bibr" rid="CR226">226</xref></sup> Similarly, mutant SOD1 aggregates within the mitochondrial intermembrane space, disrupts mitochondrial retrograde transport, and sequesters OPTN, suppressing mitophagosome formation.<sup><xref ref-type="bibr" rid="CR227">227</xref></sup> However, <italic toggle="yes">Prkn</italic> knockout in <italic toggle="yes">SOD1</italic> G93A models unexpectedly mitigates mitochondrial depletion, delaying ALS progression and prolonging survival.<sup><xref ref-type="bibr" rid="CR232">232</xref></sup> These contrasting outcomes suggest that mitophagy requirements in ALS may be cell type- and mutation-specific, emphasizing the need for personalized therapeutic strategies.</p></sec></sec><sec id="Sec22"><boxed-text position="float" orientation="portrait"><label>Box 4 Mitochondrial dynamics and mitophagy</label><p id="Par36">Mitochondrial fusion, fission, and transport are collectively referred to as mitochondrial dynamics. Disruption of these processes has been linked to numerous human diseases.<sup><xref ref-type="bibr" rid="CR480">480</xref>&#8211;<xref ref-type="bibr" rid="CR482">482</xref></sup> Mitochondrial dynamics is tightly coupled with mitophagy to maintain a healthy mitochondrial network.</p><p id="Par37">Mitochondrial fusion joins two mitochondria at the OMM and IMM, a process mediated by three membrane GTPases, namely MFN1, MFN2,<sup><xref ref-type="bibr" rid="CR483">483</xref>,<xref ref-type="bibr" rid="CR484">484</xref></sup> and OPA1.<sup><xref ref-type="bibr" rid="CR485">485</xref></sup> MFN1 and MFN2 are primarily responsible for OMM tethering and fusion, whereas OPA1 mediates IMM fusion. Mitochondrial fission is the division of a single mitochondrion into two mitochondria, mainly orchestrated by DRP1<sup><xref ref-type="bibr" rid="CR486">486</xref></sup> and OMM-located receptors such as the mitochondrial fission factor (MFF), mitochondrial dynamics proteins 49 and 51 (MID49/51), and mitochondrial fission protein 1 (FIS1).<sup><xref ref-type="bibr" rid="CR487">487</xref></sup> Fission occurs primarily at mitochondria&#8211;endoplasmic reticulum (ER) contact sites (MERCS),<sup><xref ref-type="bibr" rid="CR488">488</xref></sup> where the ER and actin coordinate to drive initial mitochondrial constrictions.<sup><xref ref-type="bibr" rid="CR487">487</xref></sup> Recruited DRP1 forms a ring-like structure around the mitochondrion to drive scission.<sup><xref ref-type="bibr" rid="CR486">486</xref></sup></p><p id="Par38">Fusion enables mitochondria to exchange intramitochondrial components for optimal function, whereas fission is required for the generation of new mitochondria<sup><xref ref-type="bibr" rid="CR489">489</xref></sup> and enables the segregation of damaged mitochondrial components for disposal.<sup><xref ref-type="bibr" rid="CR490">490</xref></sup> Mitochondria go through frequent cycles of fusion and fission in a &#8216;kiss and run&#8217; pattern, which coordinates with mitophagy to ensure mitochondrial homeostasis. For example, during starvation, mitochondria become elongated and interconnected and are spared from autophagic degradation to preserve ATP production.<sup><xref ref-type="bibr" rid="CR491">491</xref>,<xref ref-type="bibr" rid="CR492">492</xref></sup> Asymmetric fission can lead to the creation of unequal daughter organelles, with one daughter mitochondrion showing increased membrane potential and a high probability of fusion, whereas the other has decreased membrane potential and is preferentially targeted by mitophagy.<sup><xref ref-type="bibr" rid="CR490">490</xref>,<xref ref-type="bibr" rid="CR493">493</xref></sup> Furthermore, the proteins that control mitochondrial dynamics can directly interact with those that regulate mitophagy. For example, in PINK1&#8211;Parkin-mediated mitophagy, MFN2 mediates Parkin recruitment to damaged mitochondria in a PINK1-dependent manner.<sup><xref ref-type="bibr" rid="CR494">494</xref></sup> Recruited Parkin then ubiquitinates MFN1/2 for proteasomal degradation,<sup><xref ref-type="bibr" rid="CR61">61</xref>,<xref ref-type="bibr" rid="CR495">495</xref></sup> enabling dissociation of mitochondria from the ER<sup><xref ref-type="bibr" rid="CR496">496</xref>,<xref ref-type="bibr" rid="CR497">497</xref></sup> to prevent refusion and drive mitophagy. The engagement of mitochondrial dynamics in other mitophagy pathways is discussed further in the receptor-mediated mitophagy section.</p><p id="Par39">The transport of mitochondria is essential to meet local demands. To transport mitochondria as cargo, MIRO1/2<sup><xref ref-type="bibr" rid="CR498">498</xref></sup> recruit trafficking kinesin-binding protein 1/2 (TRAK1/2) adaptor proteins,<sup><xref ref-type="bibr" rid="CR499">499</xref>,<xref ref-type="bibr" rid="CR500">500</xref></sup> which in turn recruit motor proteins, namely kinesin and dynein-dynactin, to transport mitochondria toward the plus- and minus-ends of microtubules, respectively. Mitochondrial trafficking is especially critical in neurons, as mitochondria must travel long distances along microtubules to axons, synapses, and dendrites &#8212; a process that could take days.<sup><xref ref-type="bibr" rid="CR501">501</xref></sup> It is plausible that mitophagy and transport cooperate to ensure adequate ATP supply and calcium buffering. Several lines of evidence support this idea. (i) Upon mitochondrial depolarization, activation of the PINK1&#8211;Parkin pathway triggers rapid degradation of MIRO1/2, releasing kinesin from mitochondria and thereby arresting mitochondrial movement.<sup><xref ref-type="bibr" rid="CR502">502</xref></sup> (ii) Deficiency of MIRO1/2 suppresses mitophagy.<sup><xref ref-type="bibr" rid="CR503">503</xref></sup> (iii) <italic toggle="yes">Pink1</italic> mRNA is cotransported with mitochondria to neurites, enabling local translation of the short-lived PINK1 and ensuring that the PINK1&#8211;Parkin pathway can effectively monitor mitochondrial health even at sites distal to the soma.<sup><xref ref-type="bibr" rid="CR504">504</xref></sup> Furthermore, recent evidence suggests that aberrant MIRO accumulation is associated with PD, and promoting MIRO1 degradation can rescue dopaminergic neurodegeneration.<sup><xref ref-type="bibr" rid="CR204">204</xref>,<xref ref-type="bibr" rid="CR206">206</xref></sup> Deciphering the crosstalk between mitochondrial transport and mitophagy may unlock novel therapeutic strategies for neurodegenerative disorders.<sup><xref ref-type="bibr" rid="CR505">505</xref></sup></p></boxed-text></sec><sec id="Sec23"><title>Inflammation and Immune-related Diseases</title><p id="Par50">Mitophagy has emerged as a linchpin connecting mitochondrial integrity to immune homeostasis. By regulating inflammasome activity, interferon production, chemotaxis, lymphocyte metabolism, and pathogen responses, it ensures balanced immune activation while preventing chronic inflammation. Dysregulation of mitophagy is closely linked to the pathogenesis of various immune-related disorders.<sup><xref ref-type="bibr" rid="CR5">5</xref></sup></p><sec id="Sec24"><title>Inflammation</title><p id="Par51">Many mitochondrial components share similar structures with those of their bacterial ancestor. These components, such as mtDNA, mitochondrial RNA (mtRNA), mitochondrial ROS (mtROS), and N-formyl peptides, can be released upon mitochondrial stress or damage. They function as endogenous damage-associated molecular patterns (DAMPs) and are recognized by pattern recognition receptors (PRRs) to initiate inflammatory responses.<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR233">233</xref>&#8211;<xref ref-type="bibr" rid="CR236">236</xref></sup></p><p id="Par52">mtDNA is among the most widely investigated mitochondrion-derived DAMPs<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR233">233</xref>&#8211;<xref ref-type="bibr" rid="CR235">235</xref>,<xref ref-type="bibr" rid="CR237">237</xref></sup> and resembles bacterial DNA in being circular and having unmethylated cytidine-phosphate-guanosine (CpG) motifs. Upon release into the cytosol, mtDNA can activate the cyclic GMP&#8211;AMP synthase (cGAS)&#8211;stimulator of interferon genes (STING) pathway to promote type I interferon (IFN) production.<sup><xref ref-type="bibr" rid="CR238">238</xref>&#8211;<xref ref-type="bibr" rid="CR241">241</xref></sup> It can also activate the absent in melanoma 2 (AIM2) inflammasome.<sup><xref ref-type="bibr" rid="CR242">242</xref></sup> Furthermore, mtDNA can activate the NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome in a ROS-dependent manner,<sup><xref ref-type="bibr" rid="CR243">243</xref>&#8211;<xref ref-type="bibr" rid="CR245">245</xref></sup> leading to caspase-1-dependent secretion of interleukin-1&#946; (IL-1&#946;) and IL-18 cytokines. Moreover, circulating or cytosolic mtDNA can also activate Toll-like receptor 9 (TLR9)-mediated immune responses.<sup><xref ref-type="bibr" rid="CR246">246</xref>&#8211;<xref ref-type="bibr" rid="CR248">248</xref></sup></p><p id="Par53">Double-stranded mtRNA can also be recognized by cytosolic RNA virus receptors, including retinoic acid-inducible gene I (RIG-I)<sup><xref ref-type="bibr" rid="CR249">249</xref></sup> and melanoma differentiation-associated protein 5 (MDA5),<sup><xref ref-type="bibr" rid="CR250">250</xref></sup> to activate mitochondrial antiviral signaling protein (MAVS) and induce type I IFN expression. Mitochondria-derived N-formyl peptides can activate formyl-peptide receptors (FPRs),<sup><xref ref-type="bibr" rid="CR247">247</xref>,<xref ref-type="bibr" rid="CR251">251</xref></sup> and mtROS further contribute to the inflammatory responses of immune cells.<sup><xref ref-type="bibr" rid="CR252">252</xref>,<xref ref-type="bibr" rid="CR253">253</xref></sup></p><p id="Par54">Mitophagy removes dysfunctional mitochondria, thereby preventing the release of mitochondrial components into the cytosol or extracellular space and reducing inflammation. Consistent with this notion, the depletion of autophagic proteins, such as LC3B and Beclin 1, causes accumulation of dysfunctional mitochondria and cytosolic release of mtDNA, leading to enhanced secretion of IL-1&#946; and IL-18 in macrophages.<sup><xref ref-type="bibr" rid="CR244">244</xref></sup> Upon pressure overload, lysosomal deoxyribonuclease (DNase) II deficiency in cardiomyocytes leads to mtDNA accumulation in autolysosomes, which subsequently activates TLR9 signaling-mediated inflammatory responses, contributing to heart failure.<sup><xref ref-type="bibr" rid="CR254">254</xref></sup> Accordingly, enhancement of mitophagy can put the brakes on inflammatory responses. For example, nuclear factor &#954;B (NF-&#954;B), a key activator of the inflammatory response, restrains its own inflammation-promoting activity by inducing p62-dependent mitophagy, which in turn inhibits NLRP3 inflammasome activity. Macrophages lacking p62, Parkin, or ATG7 display pronounced inflammasome activation.<sup><xref ref-type="bibr" rid="CR255">255</xref></sup> A combination of Pink1 overexpression and Torin-1 treatment restores mitophagic flux in aged macrophages, thereby inhibiting cGAS&#8211;STING activation.<sup><xref ref-type="bibr" rid="CR256">256</xref></sup></p><p id="Par55">Intriguingly, mitophagy contributes to immune regulation beyond the control of mitochondrial DAMPs. (i) Mitophagy is involved in metabolic reprogramming during immune cell activation. For instance, macrophages stimulated by proinflammatory factors such as lipopolysaccharide (LPS) and IFN&#947; have lower mitochondrial mass than those stimulated by the anti-inflammatory cytokines IL-4/IL-13. Inhibition of autophagy/mitophagy reduces the proinflammatory activation of macrophages by limiting the glycolytic switch in response to proinflammatory stimuli.<sup><xref ref-type="bibr" rid="CR105">105</xref></sup> In line with this, IL-10 exerts its anti-inflammatory effect by counteracting LPS-induced metabolic reprogramming of macrophages, a process that involves mitophagy induction to limit the accumulation of dysfunctional mitochondria and mtROS.<sup><xref ref-type="bibr" rid="CR257">257</xref></sup> (ii) Mitophagy and inflammation share several common regulators, with TBK1 being a prominent example. As mentioned above, TBK1 plays important roles in Parkin-mediated mitophagy and innate immunity. Upon ligand binding, PRRs such as RIG-I, cGAS, and TLR3/4 activate the downstream immune adaptor proteins MAVS, STING, and TIR domain-containing adapter-inducing interferon-&#946; (TRIF), respectively. Activated adaptor proteins then recruit and activate TBK1, as evidenced by the activating phosphorylation of TBK1 at Ser172, which in turn phosphorylates the immune adaptor proteins and interferon regulatory factor 3 (IRF3) to trigger type I IFN responses.<sup><xref ref-type="bibr" rid="CR258">258</xref></sup> During mitophagy, mitochondrial depolarization leads to TBK1 phosphorylation at Ser172, and TBK1 subsequently recruits selective autophagy receptors, including OPTN and NDP52.<sup><xref ref-type="bibr" rid="CR74">74</xref></sup> Interestingly, although TBK1 activation upon LPS stimulation leads to OPTN phosphorylation,<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> its activation upon mitochondrial depolarization does not activate IRF3.<sup><xref ref-type="bibr" rid="CR74">74</xref></sup> How this functional compartmentalization of TBK1 is achieved remains to be explored. The immune receptor protein MAVS provides another link, as mitochondria provide a scaffold for MAVS, and activated MAVS can induce mitophagy.<sup><xref ref-type="bibr" rid="CR259">259</xref></sup> These findings add further complexity to the role of mitophagy in inflammation, and a clearer picture of its diverse functions is only beginning to emerge.</p><p id="Par56">Nonetheless, it is important to bear in mind that inflammation acts as a double-edged sword. Although an appropriate host inflammatory response is crucial for controlling infection, dysregulated inflammation can lead to organ failure and is a common feature of many diseases. Thus, although enhancing mitophagy generally reduces inflammation, its effects are highly dependent on context. For example, the release of mtDNA plays a crucial role in immune activation, as it fuels cGAS&#8211;STING signaling in response to intracellular pathogens such as herpesvirus,<sup><xref ref-type="bibr" rid="CR241">241</xref></sup> influenza virus,<sup><xref ref-type="bibr" rid="CR260">260</xref></sup> dengue virus,<sup><xref ref-type="bibr" rid="CR261">261</xref></sup> and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),<sup><xref ref-type="bibr" rid="CR262">262</xref></sup> as well as extracellular bacteria such as <italic toggle="yes">Pseudomonas aeruginosa</italic>.<sup><xref ref-type="bibr" rid="CR263">263</xref></sup> In such cases, mitophagy limits the release of mtDNA and may dampen protective immune responses against pathogens. By contrast, in aged mice, pharmacological induction of mitophagy attenuates cGAS&#8211;STING activation and ameliorates age-associated neurological decline.<sup><xref ref-type="bibr" rid="CR264">264</xref></sup> Further examples are discussed in the following sections on autoimmune diseases and viral or bacterial infections.</p></sec><sec id="Sec25"><title>Autoimmune diseases</title><p id="Par57">Aberrant mitophagy has been implicated in autoimmune diseases such as systemic lupus erythematosus (SLE) and inflammatory bowel disease (IBD).<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> Impaired mitophagy contributes to mitochondrial dysfunction in lupus T cells, leading to necrosis and the release of immunogenic debris that triggers autoantibody production and type I IFN responses.<sup><xref ref-type="bibr" rid="CR265">265</xref></sup> In addition, SLE neutrophils exhibit defective mitophagy, resulting in the retention of oxidized mtDNA, which activates dendritic cells and promotes pathogenic autoimmunity via AIM2 inflammasome activation and TLR9 signaling.<sup><xref ref-type="bibr" rid="CR266">266</xref></sup> Patients with SLE exhibit reduced expression of mitophagy-related genes, which correlates with disease severity.<sup><xref ref-type="bibr" rid="CR267">267</xref></sup></p><p id="Par58">Moreover, genetic variants of mitophagy-related genes, such as <italic toggle="yes">ATG16L1</italic> and immunity-related GTPase M (<italic toggle="yes">IRGM</italic>), disrupt mitochondrial quality control in IBD. The <italic toggle="yes">ATG16L1</italic> T300A variant impairs mitophagic flux, resulting in ROS accumulation, NLRP3 inflammasome activation, and elevated IL-1&#946; secretion in macrophages.<sup><xref ref-type="bibr" rid="CR268">268</xref></sup> Likewise, IRGM deficiency exacerbates mitochondrial dysfunction, causing Paneth cell abnormalities and impaired bacterial clearance, which are hallmarks of Crohn&#8217;s disease.<sup><xref ref-type="bibr" rid="CR269">269</xref></sup></p></sec><sec id="Sec26"><title>Viral/bacterial infection</title><p id="Par59">Mitophagy plays a key role in the host response to infections. As a case in point, LPS and IFN&#947; can inhibit PINK1-dependent mitophagy in macrophages, which in turn triggers macrophage activation in an mtROS-dependent manner.<sup><xref ref-type="bibr" rid="CR270">270</xref></sup> In a mouse model of polymicrobial infection, transfer of <italic toggle="yes">Pink1</italic>-deficient bone marrow or pharmacological inhibition of mitophagy improved bactericidal clearance and increased survival rate, whereas the promotion of mitophagy led to increased bacterial load and lower survival rate.<sup><xref ref-type="bibr" rid="CR270">270</xref></sup> Consistent with these findings, <italic toggle="yes">Prkn</italic> knockout mice exhibit enhanced activation of the NLRP3 inflammasome by ROS, elevated innate antiviral inflammation, and increased viral clearance.<sup><xref ref-type="bibr" rid="CR271">271</xref></sup> In addition, Parkin expression was reduced in peripheral blood mononuclear cells from virally infected patients,<sup><xref ref-type="bibr" rid="CR271">271</xref></sup> while, in critically ill cases, patients with sepsis showed inhibited mitophagy in their blood monocytes compared with non-septic patients, suggesting its potential utility as a biomarker for sepsis diagnosis.<sup><xref ref-type="bibr" rid="CR270">270</xref></sup></p><p id="Par60">However, some pathogens can exploit mitophagy to promote their survival. Viral proteins, such as the matrix protein of human parainfluenza virus 3 (HPIV3) and PB1-F2 of influenza A virus (IAV), directly interact with autophagy-related proteins like ATG8 and mitochondrial Tu translation elongation factor (TUFM) to induce ubiquitin-independent mitophagy. This process disrupts MAVS-dependent interferon production, thereby dampening antiviral responses.<sup><xref ref-type="bibr" rid="CR272">272</xref>&#8211;<xref ref-type="bibr" rid="CR274">274</xref></sup> Similarly, SARS-CoV-2 open reading frame 10 (ORF10) bridges NIX and LC3B to activate mitophagy, impairing MAVS signaling and promoting viral persistence.<sup><xref ref-type="bibr" rid="CR275">275</xref></sup></p></sec></sec><sec id="Sec27"><title>Cancer</title><p id="Par61">Cancer is characterized by uncontrolled cell proliferation and survival, often driven by metabolic reprogramming and mitochondrial dysfunction. Emerging evidence highlights the dual roles of mitophagy in cancer biology: mitophagy can function as either a tumor suppressor or a promoter depending on context-specific factors such as cancer type, stage, and genetic background.<sup><xref ref-type="bibr" rid="CR95">95</xref></sup></p><sec id="Sec28"><title>Metabolic Reprogramming</title><p id="Par62">Cancer cells often exhibit metabolic reprogramming, favoring glycolysis over OXPHOS even under aerobic conditions, a phenomenon known as the Warburg effect. Mitophagy contributes to this metabolic shift by reducing mitochondrial mass and suppressing OXPHOS. In <italic toggle="yes">KRAS</italic> mutant pancreatic cancer cells, elevated NIX-mediated mitophagy diminishes mitochondrial networks, thereby enhancing glycolytic flux to meet the bioenergetic demands of rapid cell proliferation.<sup><xref ref-type="bibr" rid="CR276">276</xref></sup> Parkin orchestrates glycolytic regulation through diverse molecular pathways. For example, it binds directly to and suppresses the enzymatic activity of pyruvate kinase M2 (PKM2), thereby regulating the glycolytic pathway in glioblastoma and lung cancer cells.<sup><xref ref-type="bibr" rid="CR277">277</xref></sup> Parkin also affects cancer metabolism by targeting HIF-1&#945; for proteasomal degradation, leading to attenuation of breast cancer metastasis.<sup><xref ref-type="bibr" rid="CR278">278</xref></sup> Genetic ablation of <italic toggle="yes">Prkn</italic> disrupts cellular homeostasis through PTEN destabilization, resulting in constitutive activation of the PI3K/AKT pathway and promotion of tumorigenesis.<sup><xref ref-type="bibr" rid="CR279">279</xref></sup> In addition to these direct interactions, mitophagy participates in metabolic reprogramming by selectively degrading hexokinase 2 (HK2), thereby coupling mitochondrial surveillance to glycolytic enzyme turnover.<sup><xref ref-type="bibr" rid="CR280">280</xref></sup></p></sec><sec id="Sec29"><title>Cancer Development</title><p id="Par63">The regulatory role of mitophagy in cancer progression exhibits significant tissue-specific heterogeneity. Parkin is frequently deleted or mutated in cancers such as glioblastoma, breast cancer, colorectal cancer, and ovarian cancer.<sup><xref ref-type="bibr" rid="CR281">281</xref>&#8211;<xref ref-type="bibr" rid="CR284">284</xref></sup> Experimental models have revealed that Parkin-knockout mice are highly susceptible to spontaneous hepatocellular carcinoma (HCC).<sup><xref ref-type="bibr" rid="CR285">285</xref></sup> Loss of Parkin promotes tumorigenesis by disrupting mitophagy, leading to ROS accumulation, genomic instability, and resistance to apoptosis. Consistent with these findings, pharmacological activation of PINK1&#8211;Parkin-mediated mitophagy inhibits the growth of HCC,<sup><xref ref-type="bibr" rid="CR286">286</xref></sup> colorectal cancer,<sup><xref ref-type="bibr" rid="CR287">287</xref></sup> and pancreatic cancer.<sup><xref ref-type="bibr" rid="CR288">288</xref></sup> By contrast, Parkin exhibits an oncogenic function in melanoma models, as its genetic ablation inhibits tumor growth and metastasis by destabilizing MFN2.<sup><xref ref-type="bibr" rid="CR289">289</xref></sup></p><p id="Par64">Some mitophagy-related proteins also exhibit dual oncogenic and tumor-suppressive functions. For instance, loss of PINK1 in glioblastoma stabilizes HIF-1&#945;, stimulating the Warburg effect and tumor proliferation,<sup><xref ref-type="bibr" rid="CR290">290</xref></sup> whereas <italic toggle="yes">PINK1</italic> silencing blocks the cell cycle and promotes apoptosis of lung cancer cells.<sup><xref ref-type="bibr" rid="CR291">291</xref></sup> The subcellular localization of BNIP3 significantly influences its function in cancer progression. Nuclear BNIP3 in non-small cell lung cancer is associated with poor survival,<sup><xref ref-type="bibr" rid="CR292">292</xref></sup> whereas cytoplasmic localization of BNIP3 in breast cancer may suppress malignancy by modulating ROS levels.<sup><xref ref-type="bibr" rid="CR293">293</xref></sup> FUNDC1, another hypoxia-induced mitophagy receptor, also plays a dual role in modulating cancer development and progression. In early-stage cervical cancer, FUNDC1 expression is significantly elevated in tumor cells compared with normal tissues, and its high expression is associated with poor patient prognosis. Inhibition of FUNDC1 enhances the sensitivity of cancer cells to ionizing radiation and cisplatin, suggesting its involvement in therapeutic resistance.<sup><xref ref-type="bibr" rid="CR294">294</xref></sup> Conversely, in hepatocytes, FUNDC1 silencing leads to the accumulation of dysfunctional mitochondria, release of mtDNA, overactivation of caspase-1, and excessive IL-1&#946; production, thus promoting the initiation and progression of HCC.<sup><xref ref-type="bibr" rid="CR295">295</xref></sup> These opposing outcomes emphasize the need to evaluate the context-dependent role of mitophagy in cancer development.</p></sec><sec id="Sec30"><title>Cancer stemness</title><p id="Par65">Cancer stem cells (CSCs) are a subpopulation with self-renewal capacity that rely on mitophagy to preserve their stem-like properties. In hematopoietic stem cells, PINK1/Parkin-mediated mitophagy preserves self-renewal capacity, whereas its disruption impairs stem cell function.<sup><xref ref-type="bibr" rid="CR296">296</xref></sup> Consistent with these observations, hepatic CSCs use mitophagy to degrade the tumor suppressor p53, preventing its nuclear translocation and thus evading apoptosis, which is critical for stemness maintenance.<sup><xref ref-type="bibr" rid="CR297">297</xref></sup> Mitochondrial dynamics also modulate CSC behavior through coupling with mitophagy. For instance, FIS1 is required for the activation of mitophagy in leukemia stem cells, which sustains their self-renewal capacity and inhibits differentiation.<sup><xref ref-type="bibr" rid="CR298">298</xref></sup> Moreover, mitochondrial fission factor is significantly upregulated in liver cancer-initiating cells, enhancing mitochondrial fission and directing healthy mitochondria to daughter CSCs while targeting damaged ones for degradation by mitophagy, thereby promoting tumor-initiating potential.<sup><xref ref-type="bibr" rid="CR299">299</xref></sup></p></sec><sec id="Sec31"><title>Cancer Therapy</title><p id="Par66">Mitophagy affects cancer therapy through pleiotropic mechanisms involving mtDNA release, immune signaling pathways, and crosstalk with treatments like chemotherapy, radiation, and immunotherapy.</p><p id="Par67">Chemotherapeutic agents often induce mitochondrial damage in cancer cells, triggering mitophagy as a protective mechanism that promotes cancer cell survival and drives drug resistance.<sup><xref ref-type="bibr" rid="CR300">300</xref>,<xref ref-type="bibr" rid="CR301">301</xref></sup> As mentioned previously, ARIH1-mediated mitophagy enhances chemoresistance in breast and lung adenocarcinomas by supporting tumor cell survival.<sup><xref ref-type="bibr" rid="CR300">300</xref></sup> Moreover, tumor cells express programmed death-ligand 1 (PD-L1) to engage with PD-1 on T cells, thereby escaping antitumor immunity. Paclitaxel, a widely used chemotherapeutic agent, increases ATAD3A expression and thereby prevents PINK1-dependent mitophagy, which impairs the degradation of PD-L1 and contributes to therapy resistance.<sup><xref ref-type="bibr" rid="CR301">301</xref></sup></p><p id="Par68">On the other hand, mitophagy affects anti-tumor immunity via the cGAS&#8211;STING pathway. For example, autophagy deficiency increases the efficacy of radiotherapy in breast cancer by promoting mtDNA release, which activates the cGAS&#8211;STING pathway to induce type I IFN secretion.<sup><xref ref-type="bibr" rid="CR302">302</xref></sup> Similarly, pharmacological inhibition of caspase-9 with emricasan restores tumor-intrinsic mtDNA sensing, and its combination with radiation and anti-PD-L1 therapy improves therapeutic efficacy in colon adenocarcinoma cells.<sup><xref ref-type="bibr" rid="CR303">303</xref></sup> Furthermore, the BCL-2 inhibitor ABT-199 induces VDAC1 oligomerization to promote mtDNA release, thereby activating STING signaling to enhance chemokine expression and cytotoxic T cell infiltration. In vivo studies have shown that ABT-199 significantly improves the antitumor efficacy of anti-PD-L1 therapy.<sup><xref ref-type="bibr" rid="CR304">304</xref></sup></p><p id="Par69">Mitophagy also plays a pivotal role in optimizing antitumor T cell therapy. A major challenge in cancer immunotherapy is the exhaustion of tumor-infiltrating T cells, and recent studies suggest that the modulation of mitophagy could mitigate this effect. Specifically, PINK1-mediated mitophagy triggered by urolithin A (UA) promotes the expansion of T memory stem cells (T<sub>SCM</sub>), ultimately enhancing the efficacy of immunotherapy in colorectal cancer.<sup><xref ref-type="bibr" rid="CR287">287</xref></sup> In addition, genetic or pharmacological inhibition of USP30 restores mitophagy, rejuvenates exhausted T cell function, and suppresses tumor growth in murine colon adenocarcinoma.<sup><xref ref-type="bibr" rid="CR305">305</xref></sup></p><p id="Par70">Although cancer therapy is often focused on the elimination of tumor cells, minimizing treatment-induced side effects is equally important, and mitophagy affects this aspect as well. Bax/Bak-mediated apoptosis activates AMPK/ULK1-dependent mitophagy to clear damaged mitochondria. This mitophagic activity suppresses the secretion of IFN-&#946;, thereby maintaining immunological silence during cell death. This mechanism is critical for preventing inflammation-driven complications in cancer therapy.<sup><xref ref-type="bibr" rid="CR306">306</xref></sup></p><p id="Par71">Overall, mitophagy exerts multifaceted effects in cancer therapy. It can promote cancer cell survival and therapy resistance while also enhancing antitumor immunity, either by triggering mtDNA release to activate the cGAS&#8211;STING pathway or by optimizing T cell therapy. Future strategies should aim to dynamically fine-tune mitophagy on the basis of immune context (activation or suppression) and to develop combinations targeting ATAD3A or PINK1 pathways.</p></sec></sec><sec id="Sec32"><title>Metabolic Diseases</title><p id="Par72">Metabolic diseases, including obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD), are characterized by dysregulation of glucose and lipid metabolism. Mitochondrial dysfunction and impaired mitophagy contribute to the pathogenesis of these diseases.</p><sec id="Sec33"><title>Obesity</title><p id="Par73">Obesity, characterized by excessive fat accumulation and adipocyte hypertrophy, is closely associated with mitochondrial dysfunction, which contributes to metabolic disturbances such as insulin resistance, chronic inflammation, and oxidative stress.<sup><xref ref-type="bibr" rid="CR307">307</xref></sup> The interplay between mitophagy and obesity is complex, with mitophagy acting as both a protective and detrimental mechanism, depending on the context and extent of its activation.<sup><xref ref-type="bibr" rid="CR308">308</xref></sup> For example, global or brown adipocyte-specific deletion of <italic toggle="yes">Pink1</italic> induces brown adipose tissue dysfunction and an obesity-prone phenotype in mice.<sup><xref ref-type="bibr" rid="CR309">309</xref></sup> Consistent with these findings, mice with a deficiency in FUNDC1 exhibit defective mitophagy and develop more severe obesity and insulin resistance when fed a high-fat diet (HFD).<sup><xref ref-type="bibr" rid="CR310">310</xref></sup> However, excessive mitophagy may also have detrimental effects on lipid metabolism. For example, adipose-specific deletion of the mitochondrial redox gene <italic toggle="yes">Trx2</italic> induces excessive mitophagy, resulting in reduced mitochondrial mass and impaired energy production in white adipose tissue. This, in turn, increases lipolysis, exacerbates metabolic dysfunction, and contributes to the progression of obesity-related complications such as hyperglycemia, insulin resistance, and hepatic steatosis.<sup><xref ref-type="bibr" rid="CR311">311</xref></sup> Therefore, the regulation of mitophagy must be finely balanced to ensure optimal mitochondrial function and metabolic health.</p></sec><sec id="Sec34"><title>Type 2 Diabetes</title><p id="Par74">Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder characterized by chronic hyperglycemia, insulin resistance, and impaired pancreatic &#946;-cell function.<sup><xref ref-type="bibr" rid="CR312">312</xref></sup> The pathogenesis of T2DM is complex, involving multiple factors such as age, obesity, physical inactivity, oxidative stress, mitochondrial dysfunction, and chronic inflammation. Among these, mitochondrial dysfunction and mitophagy have emerged as critical players.<sup><xref ref-type="bibr" rid="CR313">313</xref></sup> PINK1&#8211;Parkin-mediated mitophagy is activated in the submandibular gland cells of diabetic mice.<sup><xref ref-type="bibr" rid="CR314">314</xref></sup> In peripheral blood mononuclear cells of individuals with T2DM, deregulated mitophagy is associated with the accumulation of dysfunctional mitochondria and increased ROS generation.<sup><xref ref-type="bibr" rid="CR315">315</xref></sup> Mutations in mitophagy-related genes, including <italic toggle="yes">PRKN</italic>, <italic toggle="yes">PINK1</italic>, <italic toggle="yes">PDX1</italic>, and <italic toggle="yes">CLEC16A</italic>, have been shown to contribute to the development of T2DM in both humans and mice.<sup><xref ref-type="bibr" rid="CR316">316</xref>&#8211;<xref ref-type="bibr" rid="CR318">318</xref></sup> Growing evidence supports the necessity of fine-tuning mitophagic activity in &#946;-cells to ensure their proper function.<sup><xref ref-type="bibr" rid="CR308">308</xref>,<xref ref-type="bibr" rid="CR319">319</xref></sup></p></sec><sec id="Sec35"><title>Metabolic Dysfunction-Associated Steatotic Liver Disease</title><p id="Par75">MASLD is characterized by fat accumulation in the liver and is a major cause of chronic liver disease.<sup><xref ref-type="bibr" rid="CR320">320</xref></sup> Emerging evidence suggests that mitophagy plays a critical role in modulating hepatic lipid metabolism and mitigating MASLD progression.<sup><xref ref-type="bibr" rid="CR321">321</xref></sup> In the early stages of MASLD, compensatory activation of mitophagy serves as a protective mechanism to counteract lipid overload.<sup><xref ref-type="bibr" rid="CR322">322</xref>,<xref ref-type="bibr" rid="CR323">323</xref></sup> Indeed, PINK1&#8211;Parkin-mediated mitophagy facilitates the removal of dysfunctional mitochondria to maintain energy balance and reduce oxidative stress, thus alleviating MASLD progression.<sup><xref ref-type="bibr" rid="CR322">322</xref></sup> This process is essential for the maintenance of mitochondrial integrity, as impairment of mitophagy by PINK1 or Parkin disruption contributes to increased oxidative stress, exacerbating hepatic steatosis and inflammation.<sup><xref ref-type="bibr" rid="CR324">324</xref></sup> In addition to the PINK1&#8211;Parkin pathway, alternative mitophagy receptors and regulators also contribute to mitochondrial quality control in MASLD. For example, sirtuin 3 (SIRT3), a nicotinamide adenine dinucleotide (NAD<sup>+</sup>)-dependent deacetylase, enhances BNIP3-dependent mitophagy via the ERK&#8211;CREB signaling axis, thereby attenuating apoptosis and lipid deposition in hepatocytes.<sup><xref ref-type="bibr" rid="CR325">325</xref></sup> Likewise, the KEAP1&#8211;Rbx1 complex, recruited to mitochondria by p62, promotes ubiquitination of damaged organelles, restoring mitophagic flux and mitigating MASLD in a Parkin-independent manner.<sup><xref ref-type="bibr" rid="CR326">326</xref></sup> These findings underscore the diversity of molecular mechanisms that govern mitophagy in hepatocytes.</p></sec></sec><sec id="Sec36"><title>Cardiovascular Diseases</title><p id="Par76">Cardiovascular diseases remain the leading cause of mortality worldwide, with mitochondrial dysfunction playing a pivotal role in their pathogenesis. As the primary energy producers of the heart, mitochondria are essential for maintaining cardiomyocyte function through ATP production, calcium homeostasis, and redox balance. Given the heart&#8217;s high metabolic demand, mitochondrial quality control mechanisms, particularly mitophagy, are crucial for cellular homeostasis.<sup><xref ref-type="bibr" rid="CR327">327</xref></sup> Dysregulation of mitophagy has been implicated in the pathogenesis of diverse cardiovascular disorders,<sup><xref ref-type="bibr" rid="CR328">328</xref></sup> including ischemia&#8211;reperfusion (I/R) injury, cardiomyopathy, myocardial hypertrophy, atherosclerosis, and heart failure.</p><sec id="Sec37"><title>Ischemia&#8211;Reperfusion Injury</title><p id="Par77">I/R injury occurs when blood flow is restored to tissue following a period of ischemia, triggering mitochondrial calcium overload, mitochondrial permeability transition pore (mPTP) opening, and excessive ROS production.<sup><xref ref-type="bibr" rid="CR329">329</xref></sup> Mitophagy plays a key role in minimizing damage by clearing dysfunctional mitochondria, although its regulation may have varying effects at different stages of I/R injury. During ischemia, AMPK activation induces protective mitophagy to clear dysfunctional mitochondria.<sup><xref ref-type="bibr" rid="CR330">330</xref></sup> Both PINK1 and Parkin are upregulated during I/R injury, and this is necessary for the induction of ischemic preconditioning.<sup><xref ref-type="bibr" rid="CR331">331</xref></sup> By contrast, reperfusion disrupts this balance, resulting in increased mitochondrial fission and apoptosis. <italic toggle="yes">Prkn</italic>-knockout mice show disrupted mitophagy after I/R injury, leading to a larger infarct area, more severe heart damage, and decreased cell survival, emphasizing the role of Parkin in mitophagic clearance.<sup><xref ref-type="bibr" rid="CR332">332</xref></sup> Conversely, the inhibition of autophagy has been shown to reduce heart injury in certain cases. For example, <italic toggle="yes">Beclin 1</italic> heterozygous mice are protected against reperfusion damage by attenuating excessive autophagosome formation.<sup><xref ref-type="bibr" rid="CR333">333</xref></sup> These findings demonstrate that mitophagy acts as a double-edged sword, and requires precise modulation to avoid detrimental outcomes.</p></sec><sec id="Sec38"><title>Heart Failure</title><p id="Par78">Heart failure is a condition in which the heart is unable to pump blood effectively to meet the body&#8217;s needs. It can result from conditions such as hypertension, coronary artery disease, or cardiomyopathy. Mitochondrial dysfunction and cardiomyocyte apoptosis, often driven by insufficient mitophagy, are key contributors to heart failure progression.<sup><xref ref-type="bibr" rid="CR329">329</xref></sup> Biopsies of heart failure patients have revealed a modest decrease in the expression of autophagy-related markers such as LC3 and Beclin 1,<sup><xref ref-type="bibr" rid="CR334">334</xref></sup> together with a significant reduction in PINK1 levels.<sup><xref ref-type="bibr" rid="CR335">335</xref></sup> PINK1 knockout mice display impaired mitochondrial function, increased oxidative stress, cardiomyocyte apoptosis, and ventricular dysfunction.<sup><xref ref-type="bibr" rid="CR335">335</xref></sup> Moreover, as a key regulator of mitophagy, AMPK&#945; exhibits isoform-specific effects on heart failure. AMPK&#945;2 promotes mitophagy and prevents disease progression by phosphorylating PINK1, whereas a transition from the AMPK&#945;2 isoform to the AMPK&#945;1 isoform impairs mitophagy and accelerates heart failure.<sup><xref ref-type="bibr" rid="CR336">336</xref></sup> Consistent with these findings, MFN2 deficiency impairs mitochondrial fusion and Parkin recruitment, leading to cardiac hypertrophy and heart failure.<sup><xref ref-type="bibr" rid="CR337">337</xref>,<xref ref-type="bibr" rid="CR338">338</xref></sup></p></sec></sec></sec><sec id="Sec39"><title>Therapeutic Interventions Targeting Mitophagy Pathways</title><p id="Par79">Given the broad effects of dysregulated mitophagy in aging and age-related disorders, the modulation of mitophagy pathways has emerged as a promising therapeutic strategy. To date, most efforts have focused on enhancing mitophagy, as its deficiency contributes to multiple diseases and the restoration of mitophagy promotes mitochondrial health. However, the inhibition of mitophagy is also of interest in certain contexts, such as antiviral defense and cancer therapy.</p><sec id="Sec40"><title>Mitophagy Activators</title><p id="Par80">Mitophagy can be triggered by a variety of stimuli. Foremost among these bioactive molecules, the naturally occurring postbiotic compound UA is a prominent mitophagy inducer<sup><xref ref-type="bibr" rid="CR339">339</xref>,<xref ref-type="bibr" rid="CR340">340</xref></sup> whose effects have been confirmed in humans.<sup><xref ref-type="bibr" rid="CR341">341</xref>,<xref ref-type="bibr" rid="CR342">342</xref></sup> Thymol, a terpenoid abundant in essential oils derived from thyme, has recently been suggested to induce mitophagy through the PINK1&#8211;Parkin pathway.<sup><xref ref-type="bibr" rid="CR343">343</xref></sup> Nutritional interventions that replenish NAD<sup>+</sup> through its precursors &#8212; nicotinamide riboside (NR), nicotinamide (NAM), and nicotinamide mononucleotide (NMN) &#8212; can enhance mitochondrial biogenesis and restore mitophagy.<sup><xref ref-type="bibr" rid="CR344">344</xref>&#8211;<xref ref-type="bibr" rid="CR349">349</xref></sup> Similarly, the natural polyamine spermidine promotes both autophagy and mitophagy.<sup><xref ref-type="bibr" rid="CR350">350</xref>&#8211;<xref ref-type="bibr" rid="CR352">352</xref></sup> Physical activity, including different types of exercise, has also been shown to boost mitophagy in both mice and humans, potentially via AMPK-mediated ULK1 phosphorylation.<sup><xref ref-type="bibr" rid="CR353">353</xref>&#8211;<xref ref-type="bibr" rid="CR355">355</xref></sup> In addition, pharmacological agents such as the PARP inhibitor AZD2281 (also known as Olaparib)<sup><xref ref-type="bibr" rid="CR356">356</xref>,<xref ref-type="bibr" rid="CR357">357</xref></sup> and the mTOR inhibitor rapamycin<sup><xref ref-type="bibr" rid="CR358">358</xref></sup> have been reported to induce mitophagy.</p><p id="Par81">Most known modulators act on global autophagy, and only a few show preference for mitophagy, underscoring the need for truly selective modulators. The following section focuses on selective nutraceutical and pharmacological mitophagy activators, summarizing recent preclinical and clinical advances in the development of mitophagy-targeting interventions.</p><sec id="Sec41"><title>Urolithin A: A Natural Compound that Boosts MMtophagy and Mitochondrial Function</title><p id="Par82">UA is a natural postbiotic compound produced by gut microflora through the metabolism of ingested polyphenols such as ellagitannins (ETs) and ellagic acid (EA), which are abundant in pomegranate, berries, and nuts.<sup><xref ref-type="bibr" rid="CR359">359</xref></sup> Approximately 40% of individuals can naturally convert dietary precursors into UA at variable levels.<sup><xref ref-type="bibr" rid="CR360">360</xref>,<xref ref-type="bibr" rid="CR361">361</xref></sup> The benefits of UA supplementation were first described in <italic toggle="yes">C. elegans</italic> and mice<sup><xref ref-type="bibr" rid="CR339">339</xref></sup> and have since been confirmed in humans<sup><xref ref-type="bibr" rid="CR210">210</xref>,<xref ref-type="bibr" rid="CR340">340</xref>&#8211;<xref ref-type="bibr" rid="CR342">342</xref></sup> (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). UA is now recognized as a mitochondrial modulator that enhances mitophagy, although its molecular target remains to be determined.<sup><xref ref-type="bibr" rid="CR190">190</xref></sup> Its mechanism involves the stabilization of PINK1, the accumulation of pUb,<sup><xref ref-type="bibr" rid="CR210">210</xref>,<xref ref-type="bibr" rid="CR339">339</xref>,<xref ref-type="bibr" rid="CR340">340</xref></sup> and potentially the activation of BNIP3.<sup><xref ref-type="bibr" rid="CR210">210</xref>,<xref ref-type="bibr" rid="CR340">340</xref></sup> UA supplementation has demonstrated wide-ranging benefits across various models of aging and diseases. In <italic toggle="yes">C. elegans</italic>, it extends lifespan, and in mice, it improves health outcomes in neurodegenerative disorders, muscle dysfunction, cardiovascular diseases, and aging, with anti-inflammatory effects commonly observed across several preclinical human disease models. Human clinical trials have demonstrated that UA induces mitophagy in muscle, improves muscular function, ameliorates inflammation, and elevates plasma biomarkers of mitochondrial health.<sup><xref ref-type="bibr" rid="CR342">342</xref>,<xref ref-type="bibr" rid="CR360">360</xref>,<xref ref-type="bibr" rid="CR362">362</xref></sup> To date, UA remains the only clinically validated bioactive compound shown to enhance mitophagy in humans, highlighting its therapeutic potential as a proof of concept for mitophagy-targeted interventions.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Clinical trials of Urolithin A.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Trial ID</th><th colspan="1" rowspan="1">Eligibility</th><th colspan="1" rowspan="1">Study Focus</th><th colspan="1" rowspan="1">Trial status/Key Findings</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02655393">NCT02655393</ext-link></td><td align="left" colspan="1" rowspan="1"><p>Adults &#8805; 61 and &#8804; 85 years of age,</p><p>BMI&#8201;&#8805;&#8201;18 and &#8804; 32&#8201;kg/m<sup>2</sup>.</p></td><td align="left" colspan="1" rowspan="1">Safety, pharmacokinetic and pharmacodynamic assessment</td><td align="left" colspan="1" rowspan="1">Completed. UA is safe and bioavailable in humans. UA modulated muscle and mitochondrial biomarkers.<sup><xref ref-type="bibr" rid="CR341">341</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04160312">NCT04160312</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 18 and &#8804; 80 years of age.</td><td align="left" colspan="1" rowspan="1">Bioavailability</td><td align="left" colspan="1" rowspan="1">Completed. Direct supplementation with UA significantly increased plasma levels of UA.<sup><xref ref-type="bibr" rid="CR361">361</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06362018">NCT06362018</ext-link>/<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06853197">NCT06853197</ext-link></td><td align="left" colspan="1" rowspan="1"><p>Adults &#8805; 8 and &#8804; 45 years of age,</p><p>BMI&#8201;&#8805;&#8201;18.5 and &#8804; 30&#8201;kg/m<sup>2</sup>.</p></td><td align="left" colspan="1" rowspan="1">Bioavailability</td><td align="left" colspan="1" rowspan="1">Completed. Results pending*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03464500">NCT03464500</ext-link></td><td align="left" colspan="1" rowspan="1"><p>Adults &#8805; 40 and &#8804; 65 years of age,</p><p>BMI&#8201;&#8805;&#8201;25 and &#8804; 34.9&#8201;kg/m<sup>2</sup>.</p></td><td align="left" colspan="1" rowspan="1">Muscle function</td><td align="left" colspan="1" rowspan="1">Completed. Improved muscle strength, peak O<sub>2</sub> consumption, 6&#8201;min walk distance, reduced plasma inflammation marker.<sup><xref ref-type="bibr" rid="CR342">342</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03283462">NCT03283462</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 65 and &#8804; 90 years of age.</td><td align="left" colspan="1" rowspan="1">Muscle function</td><td align="left" colspan="1" rowspan="1">Completed. Improved muscle endurance measured by the number of muscle contractions until fatigue, reduced plasma inflammation marker.<sup><xref ref-type="bibr" rid="CR379">379</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04783207">NCT04783207</ext-link></td><td align="left" colspan="1" rowspan="1">Male adults &#8805; 18 and &#8804; 40 years of age, elite and sub-elite endurance runners.</td><td align="left" colspan="1" rowspan="1">Muscle function</td><td align="left" colspan="1" rowspan="1">Completed. Reduced rates of perceived exertion and indirect markers of post-exercise muscle damage, improved maximal O<sub>2</sub> consumption. Did not further enhance performance in highly trained endurance runners.<sup><xref ref-type="bibr" rid="CR380">380</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06556706">NCT06556706</ext-link></td><td align="left" colspan="1" rowspan="1"><p>Frail adults &#8805; 65 and &#8804; 85 years of age,</p><p>BMI&#8201;&#8805;&#8201;18 and &#8804; 35&#8201;kg/m<sup>2</sup>.</p></td><td align="left" colspan="1" rowspan="1">Mitochondrial quality in muscle</td><td align="left" colspan="1" rowspan="1">Completed. Results pending*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05735886">NCT05735886</ext-link></td><td align="left" colspan="1" rowspan="1"><p>Adults &#8805; 45 and &#8804; 70 years of age,</p><p>BMI&#8201;&#8804;&#8201;34.9&#8201;kg/m<sup>2</sup>.</p></td><td align="left" colspan="1" rowspan="1">Mitochondrial activity in immune cells, immune function</td><td align="left" colspan="1" rowspan="1">Completed. UA elicits immune remodeling, characterized by changes in mitochondrial measurements and immune markers.<sup><xref ref-type="bibr" rid="CR377">377</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05921266">NCT05921266</ext-link></td><td align="left" colspan="1" rowspan="1"><p>Obese adults &#8805; 40 and &#8804; 64 years of age,</p><p>BMI&#8201;&#8805;&#8201;30&#8201;kg/m<sup>2</sup>.</p></td><td align="left" colspan="1" rowspan="1">Endothelial and cerebrovascular function</td><td align="left" colspan="1" rowspan="1">Completed.<sup><xref ref-type="bibr" rid="CR382">382</xref></sup> Results pending*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06022822">NCT06022822</ext-link></td><td align="left" colspan="1" rowspan="1">Males &#8805; 18, with confirmed prostate cancer undergoing radical prostatectomy.</td><td align="left" colspan="1" rowspan="1">Oxidative stress in tumor tissue</td><td align="left" colspan="1" rowspan="1">Recruiting*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06274749">NCT06274749</ext-link></td><td align="left" colspan="1" rowspan="1"><p>Adults &#8805; 55 and &#8804; 64 years of age,</p><p>BMI&#8201;&#8805;&#8201;27&#8201;kg/m<sup>2.</sup></p></td><td align="left" colspan="1" rowspan="1">Insulin levels and glucose tolerance</td><td align="left" colspan="1" rowspan="1">Recruiting*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06324214">NCT06324214</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &gt; 40 years of age, with &#8805; 10 pack-years of smoking history, with chronic obstructive pulmonary disease (COPD), during pulmonary rehabilitation.</td><td align="left" colspan="1" rowspan="1">Exercise endurance capacity</td><td align="left" colspan="1" rowspan="1">Recruiting*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT07161310">NCT07161310</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 18 years of age, with untreated solid cancer and planned Immune checkpoint inhibitor therapy.</td><td align="left" colspan="1" rowspan="1">Immune system</td><td align="left" colspan="1" rowspan="1">Not yet recruiting*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06990256">NCT06990256</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 45 and &#8804; 70 years of age, with Pittsburgh Sleep Quality Index &gt; 5.</td><td align="left" colspan="1" rowspan="1">Sleep quality, aging markers</td><td align="left" colspan="1" rowspan="1">Not yet recruiting*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT07060898">NCT07060898</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 40 years of age.</td><td align="left" colspan="1" rowspan="1">Cognitive function</td><td align="left" colspan="1" rowspan="1">Active*.</td></tr></tbody></table><table-wrap-foot><p>*Status as of November 30, 2025; only ClinicalTrials.gov entries.</p></table-wrap-foot></table-wrap></p><sec id="FPar3"><title>Neurodegenerative Disorders</title><p id="Par83">UA targets mitochondrial dysfunction and inflammation&#160;&#8212;&#160;key drivers of neurodegenerative disorders<sup><xref ref-type="bibr" rid="CR363">363</xref>&#160;</sup>&#8212;&#160;positioning mitophagy enhancement as a novel therapeutic approach for PD and AD. In 6-hydroxydopamine (6-OHDA)-induced and neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced mouse models of PD, UA improved motor dysfunction, alleviated dopaminergic neurotoxicity,<sup><xref ref-type="bibr" rid="CR364">364</xref>,<xref ref-type="bibr" rid="CR365">365</xref></sup> and reduced neuroinflammation.<sup><xref ref-type="bibr" rid="CR364">364</xref></sup> In an APP/PS1 mouse model of AD that carries human AD-linked mutations in <italic toggle="yes">APP</italic> and <italic toggle="yes">PSEN</italic>1 genes, UA restored neuronal mitophagy, ameliorated cognitive decline, reduced A&#946; pathology, and mitigated neuroinflammation.<sup><xref ref-type="bibr" rid="CR210">210</xref>,<xref ref-type="bibr" rid="CR366">366</xref></sup> Similar benefits were observed in models of AD with tau pathology or DNA repair-deficiency, in which UA reduced tau pathology and DNA damage.<sup><xref ref-type="bibr" rid="CR367">367</xref>,<xref ref-type="bibr" rid="CR368">368</xref></sup> The neuroprotective effects of UA extend to other CNS disorders. UA alleviated locomotor symptoms in a zebrafish model of ALS that expresses glycine-proline dipeptide repeats in a <italic toggle="yes">c9orf72</italic> knockout context.<sup><xref ref-type="bibr" rid="CR226">226</xref></sup> In a mouse model of ALS carrying the human <italic toggle="yes">SOD1</italic> G93A mutation and exposed to copper, UA activated mitophagy, reduced neuroinflammation, and improved muscle atrophy and motor dysfunction.<sup><xref ref-type="bibr" rid="CR369">369</xref></sup> In the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis, UA reduced demyelination and inflammation.<sup><xref ref-type="bibr" rid="CR370">370</xref></sup> The potential effects of UA on cognitive function in humans are being investigated (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT07060898">NCT07060898</ext-link>).</p></sec><sec id="FPar4"><title>Immune Function</title><p id="Par84">UA directly modulates the function and status of multiple immune cell types, including macrophages,<sup><xref ref-type="bibr" rid="CR371">371</xref>&#8211;<xref ref-type="bibr" rid="CR373">373</xref></sup> dendritic cells,<sup><xref ref-type="bibr" rid="CR370">370</xref></sup> and T cells.<sup><xref ref-type="bibr" rid="CR287">287</xref>,<xref ref-type="bibr" rid="CR370">370</xref>,<xref ref-type="bibr" rid="CR374">374</xref>&#8211;<xref ref-type="bibr" rid="CR377">377</xref></sup></p><p id="Par85">In addition to the brain,<sup><xref ref-type="bibr" rid="CR210">210</xref>,<xref ref-type="bibr" rid="CR366">366</xref>,<xref ref-type="bibr" rid="CR368">368</xref>,<xref ref-type="bibr" rid="CR370">370</xref></sup> UA exerts anti-inflammatory actions in muscle,<sup><xref ref-type="bibr" rid="CR339">339</xref>,<xref ref-type="bibr" rid="CR340">340</xref></sup> liver, and adipose tissue,<sup><xref ref-type="bibr" rid="CR378">378</xref></sup> as well as systemically.<sup><xref ref-type="bibr" rid="CR342">342</xref>,<xref ref-type="bibr" rid="CR377">377</xref></sup> In macrophages, UA suppresses LPS-induced NF-&#954;B activation, ROS generation, and proinflammatory cytokines such as IL-1&#946;, IL-6, and tumor necrosis factor-&#945; (TNF-&#945;),<sup><xref ref-type="bibr" rid="CR371">371</xref>&#8211;<xref ref-type="bibr" rid="CR373">373</xref></sup> thereby inhibiting M1 polarization. Similarly, UA restrains the activation of dendritic cells and microglia and prevents the differentiation of CD4<sup>+</sup> T cells into T helper 17 cells (Th17) and the infiltration of T cells into the CNS, suppressing the progression of experimental autoimmune encephalomyelitis (EAE) in vivo.<sup><xref ref-type="bibr" rid="CR370">370</xref></sup></p><p id="Par86">On the other hand, UA increases the number of CD8<sup>+</sup> T<sub>SCM</sub>, a subset of minimally differentiated T cells. In the tumor microenvironment, such expansion of T<sub>SCM</sub> confers superior CD8<sup>+</sup>-mediated anti-tumor immunity and facilitates the production of potent chimeric antigen receptor (CAR) T<sub>SCM</sub>.<sup><xref ref-type="bibr" rid="CR287">287</xref></sup> Consistent with these observations, UA enhances the persistence and effector functions of CD8<sup>+</sup> cytotoxic T lymphocytes (CTLs) and human CAR T cells<sup><xref ref-type="bibr" rid="CR376">376</xref></sup> and promotes CD8<sup>+</sup> T cell-dependent cancer immunosurveillance. In aged mice, UA boosts hematopoietic capacity, leading to the restoration of effector CD8<sup>+</sup> T cell differentiation and function, thus improving viral control.<sup><xref ref-type="bibr" rid="CR374">374</xref></sup></p><p id="Par87">The context-dependent immunomodulatory effects of UA await further exploration. Its effects on the human immune system have been investigated in a clinical trial (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05735886">NCT05735886</ext-link>). It was suggested that short-term UA supplementation modulates human immune cell composition and function.&#160;For example, UA expanded peripheral naive-like, less terminally exhausted CD8<sup>+</sup> cells, while increased&#160;CD8<sup>+</sup> fatty acid oxidation capacity.<sup><xref ref-type="bibr" rid="CR377">377</xref></sup> Its effects on cancer therapy are also being investigated (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06022822">NCT06022822</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT07161310">NCT07161310</ext-link>). These findings highlight UA as an immunometabolic modulator with potential in both autoimmune and cancer immunotherapy contexts.</p></sec><sec id="FPar5"><title>Muscle Function</title><p id="Par88">UA consistently improves muscle health. In middle-aged mice on an HFD, 8 months of UA supplementation improved spontaneous exercise and grip strength, and 6 weeks of treatment boosted running endurance in aged mice.<sup><xref ref-type="bibr" rid="CR339">339</xref></sup> Young rats also showed increased running capacity after 2 weeks of UA.<sup><xref ref-type="bibr" rid="CR339">339</xref></sup> In Duchenne muscular dystrophy (DMD) models, UA rescued mitophagy and mitochondrial respiratory capacity in muscle fibers and muscle stem cells, reduced inflammation, and improved muscle integrity and function.<sup><xref ref-type="bibr" rid="CR340">340</xref></sup> UA also reduced inflammation in the diaphragm and increased the survival rate.<sup><xref ref-type="bibr" rid="CR340">340</xref></sup></p><p id="Par89">Double-blind, randomized, placebo-controlled human clinical trials reinforce these findings.<sup><xref ref-type="bibr" rid="CR362">362</xref></sup> In middle-aged individuals with high BMI (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03464500">NCT03464500</ext-link>), 4 months of UA supplementation significantly improved muscle strength and led to clinically relevant improvements in peak oxygen consumption and 6-min walk distance, together with reduced plasma inflammatory markers and increased phosphorylated Parkin in skeletal muscle.<sup><xref ref-type="bibr" rid="CR342">342</xref></sup> In healthy elderly individuals (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03283462">NCT03283462</ext-link>), UA significantly improved muscle endurance.<sup><xref ref-type="bibr" rid="CR379">379</xref></sup> A trial studying the effect of UA on muscle performance and endurance in elite and sub-elite endurance runners (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04783207">NCT04783207</ext-link>) showed that UA supplementation significantly lowered ratings of perceived exertion and reduced indirect markers of post-exercise muscle damage, although running performance was not significantly improved.<sup><xref ref-type="bibr" rid="CR380">380</xref></sup> Another ongoing study is investigating the effects of UA on mitochondrial quality in the muscle of frail elderly individuals (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06556706">NCT06556706</ext-link>), which will provide further insight into its therapeutic potential for muscle-related dysfunctions.</p></sec><sec id="FPar6"><title>Cardiovascular and Metabolic Function</title><p id="Par90">UA demonstrates protective effects against cardiovascular dysfunction. In DMD models, it reduced cardiac muscle fibrosis and hypertrophy.<sup><xref ref-type="bibr" rid="CR340">340</xref></sup> In HFD-fed mice, UA prevented diastolic dysfunction and cardiac remodeling.<sup><xref ref-type="bibr" rid="CR381">381</xref></sup> In a rat myocardial infarction model, post-surgery UA administration restored mitochondrial gene expression and improved systolic function.<sup><xref ref-type="bibr" rid="CR328">328</xref></sup> In addition, UA improved diastolic cardiac function in aged mice<sup><xref ref-type="bibr" rid="CR328">328</xref></sup> and reduced plasma ceramides linked to cardiovascular disease risk in both mice and humans.<sup><xref ref-type="bibr" rid="CR328">328</xref></sup> A recently completed clinical trial (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05921266">NCT05921266</ext-link>) will reveal the effect of UA on cerebral blood flow in middle-aged adults with obesity.<sup><xref ref-type="bibr" rid="CR382">382</xref></sup></p><p id="Par91">In HFD-fed mice, UA prevented obesity, liver steatosis, systemic inflammation, glucose intolerance,<sup><xref ref-type="bibr" rid="CR383">383</xref></sup> and insulin resistance.<sup><xref ref-type="bibr" rid="CR378">378</xref>,<xref ref-type="bibr" rid="CR383">383</xref></sup> In therapeutic settings, UA also reversed obesity and restored glucose homeostasis.<sup><xref ref-type="bibr" rid="CR383">383</xref></sup> Similar anti-obesity effects were observed in the <italic toggle="yes">ob/ob</italic> genetic mouse models of obesity.<sup><xref ref-type="bibr" rid="CR383">383</xref></sup> An ongoing clinical trial (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06274749">NCT06274749</ext-link>) is investigating whether UA supplementation can improve insulin levels and glucose tolerance in overweight elderly adults.</p></sec></sec><sec id="Sec42"><title>Spermidine: A Natural Polyamine With Pleiotropic Effects</title><p id="Par92">The naturally occurring polyamine spermidine is found ubiquitously in various organisms, including humans. It is abundant in foods such as wheat germ, soybeans, nuts, and certain fruits and vegetables. In addition to dietary sources, spermidine is also synthesized through intracellular biosynthesis and by the gut microbiota.<sup><xref ref-type="bibr" rid="CR352">352</xref></sup> It plays crucial roles in cellular processes, including DNA and RNA stabilization, oxidative stress regulation, cell proliferation, apoptosis, and immune regulation.<sup><xref ref-type="bibr" rid="CR384">384</xref>,<xref ref-type="bibr" rid="CR385">385</xref></sup></p><p id="Par93">Tissue spermidine levels decline with aging,<sup><xref ref-type="bibr" rid="CR386">386</xref>,<xref ref-type="bibr" rid="CR387">387</xref></sup> and spermidine supplementation has been shown to improve cellular health.<sup><xref ref-type="bibr" rid="CR352">352</xref></sup> Notably, spermidine administration extends both healthspan and lifespan in flies, worms, and mice by inducing autophagy.<sup><xref ref-type="bibr" rid="CR350">350</xref>,<xref ref-type="bibr" rid="CR386">386</xref></sup> Its bioavailability<sup><xref ref-type="bibr" rid="CR388">388</xref></sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06017219">NCT06017219</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05017428">NCT05017428</ext-link>), biological effects (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05459961">NCT05459961</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04823806">NCT04823806</ext-link>), and potential association with mortality<sup><xref ref-type="bibr" rid="CR389">389</xref></sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03378843">NCT03378843</ext-link>) are active areas of clinical research (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Clinical trials of Spermidine.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Trial ID</th><th colspan="1" rowspan="1">Eligibility</th><th colspan="1" rowspan="1">Study Focus</th><th colspan="1" rowspan="1">Trial status / Key Findings</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06017219">NCT06017219</ext-link></td><td align="left" colspan="1" rowspan="1"><p>Male adults &#8805; 18 and &#8804; 70 years of age,</p><p>BMI&#8201;&#8805;&#8201;18.5 and &#8804; 28&#8201;kg/m<sup>2</sup>.</p></td><td align="left" colspan="1" rowspan="1">Bioavailability</td><td align="left" colspan="1" rowspan="1">Active*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05017428">NCT05017428</ext-link></td><td align="left" colspan="1" rowspan="1"><p>Adults &#8805; 20 and &#8804; 40 years of age,</p><p>BMI&#8201;&#8805;&#8201;19 and &#8804; 27&#8201;kg/m<sup>2</sup>.</p></td><td align="left" colspan="1" rowspan="1">Bioavailability</td><td align="left" colspan="1" rowspan="1">Completed. Spermidine intake prevented the decrease in its concentrations in the control arm group.<sup><xref ref-type="bibr" rid="CR392">392</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03378843">NCT03378843</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 40 and &#8804; 79 years of age in 1990.</td><td align="left" colspan="1" rowspan="1">Association with mortality</td><td align="left" colspan="1" rowspan="1">Completed. Nutrition rich in spermidine is linked to increased survival in humans.<sup><xref ref-type="bibr" rid="CR388">388</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04823806">NCT04823806</ext-link></td><td align="left" colspan="1" rowspan="1"><p>Adults &#8805; 18 and &#8804; 75 years of age,</p><p>BMI&#8201;&#8805;&#8201;17 and &#8804; 40&#8201;kg/m<sup>2</sup>.</p></td><td align="left" colspan="1" rowspan="1">Multi-level molecular response</td><td align="left" colspan="1" rowspan="1">Unknown*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05459961">NCT05459961</ext-link></td><td align="left" colspan="1" rowspan="1">Caucasian male adults &#8805; 50 and &#8804; 70 years of age.</td><td align="left" colspan="1" rowspan="1">Metabolic response</td><td align="left" colspan="1" rowspan="1">Active*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05128331">NCT05128331</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 50 and &#8804; 100 years of age, with diastolic heart failure.</td><td align="left" colspan="1" rowspan="1">Metabolic, neurological-cognitive, and cardiovascular function</td><td align="left" colspan="1" rowspan="1">Unknown*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06186102">NCT06186102</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 65 years of age, with coronary artery disease and carries risk factors.</td><td align="left" colspan="1" rowspan="1">Cardiovascular, muscular, metabolic, and physical function, and inflammation</td><td align="left" colspan="1" rowspan="1">Recruiting*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04405388">NCT04405388</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 19 and &#8804; 99 years of age, with persistent arterial hypertension.</td><td align="left" colspan="1" rowspan="1">Blood pressure</td><td align="left" colspan="1" rowspan="1">Unknown*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03094546">NCT03094546</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 60 and &#8804; 90 years of age.</td><td align="left" colspan="1" rowspan="1">Cognitive function</td><td align="left" colspan="1" rowspan="1">Completed. Higher dietary spermidine intake was positively associated with several structural brain measures.<sup><xref ref-type="bibr" rid="CR393">393</xref>,<xref ref-type="bibr" rid="CR394">394</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04138134">NCT04138134</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 18 and &#8804; 85 years of age, with venous dysfunction.</td><td align="left" colspan="1" rowspan="1">Venous function upon autophagy activation</td><td align="left" colspan="1" rowspan="1">Unknown*.</td></tr><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05421546">NCT05421546</ext-link></td><td align="left" colspan="1" rowspan="1">Adults &#8805; 60 and &#8804; 90 years of age.</td><td align="left" colspan="1" rowspan="1">Vaccination upon autophagy activation</td><td align="left" colspan="1" rowspan="1">Completed. Results pending*.</td></tr></tbody></table><table-wrap-foot><p>*Status as of November 30, 2025; only ClinicalTrials.gov entries.</p></table-wrap-foot></table-wrap></p><p id="Par94">Spermidine also stimulates mitophagy<sup><xref ref-type="bibr" rid="CR350">350</xref></sup> by triggering mitochondrial depolarization, enhancing PINK1 accumulation and Parkin translocation to damaged mitochondria<sup><xref ref-type="bibr" rid="CR351">351</xref></sup>; the ataxia telangiectasia mutated protein (ATM) drives the initiation of this mitophagic cascade.<sup><xref ref-type="bibr" rid="CR351">351</xref></sup> Spermidine-induced mitophagy has been observed in various tissues, with significant physiological benefits. In geriatric mice, spermidine administration restores mitophagy in muscle stem cells (satellite cells), reversing senescence and rejuvenating regenerative functions.<sup><xref ref-type="bibr" rid="CR390">390</xref></sup> In D-gal-induced aging rats, spermidine reduces damaged, swollen, and fused mitochondria in skeletal muscle, suggesting enhanced clearance of dysfunctional mitochondria via mitophagy.<sup><xref ref-type="bibr" rid="CR391">391</xref></sup> In addition, spermidine promotes follicle development, oocyte maturation, early embryonic development, and fertility in aged female mice.<sup><xref ref-type="bibr" rid="CR392">392</xref></sup> In cardiomyocytes, it induces mitophagy in both young and aged cells, improving cardiomyocyte health.<sup><xref ref-type="bibr" rid="CR350">350</xref></sup></p><p id="Par95">These findings underscore the potential of spermidine as a nutraceutical, prompting ongoing clinical trials. One study is evaluating spermidine treatment in elderly patients with coronary artery disease (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06186102">NCT06186102</ext-link>), and another is investigating its role in enhancing exercise training outcomes in patients with heart failure (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05128331">NCT05128331</ext-link>). Orally supplemented spermidine crosses the blood&#8211;brain barrier (BBB), promotes cerebral mitochondrial quality control, and enhances hippocampal mitochondrial function, leading to improved spatial and temporal memory in aged mice.<sup><xref ref-type="bibr" rid="CR393">393</xref></sup> In humans, higher dietary spermidine intake is correlated with enhanced cognitive function.<sup><xref ref-type="bibr" rid="CR393">393</xref></sup> A clinical trial investigating a polyamine-rich diet in individuals with subjective cognitive decline (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03094546">NCT03094546</ext-link>) found a positive association between higher spermidine intake and several brain structural measures, including cortical thickness and hippocampal volume.<sup><xref ref-type="bibr" rid="CR394">394</xref>,<xref ref-type="bibr" rid="CR395">395</xref></sup></p><p id="Par96">Although spermidine exhibits a wide range of beneficial effects in addition to mitophagy,<sup><xref ref-type="bibr" rid="CR352">352</xref></sup> the extent to which mitophagy activation underlies these broader benefits remains to be clarified. Further research is needed to determine whether mitophagy is a primary driver of these effects.</p></sec><sec id="Sec43"><title>Activation of the PINK&#8211;Parkin Mitophagy Pathway with New Chemical Entities</title><p id="Par97">The enhancement of mitophagy shows broad therapeutic potential, as demonstrated by the beneficial effects of UA and spermidine. Advances in mitophagy research have led to the development of targeted therapies, often using new chemical entities (NCEs), particularly for PD.<sup><xref ref-type="bibr" rid="CR190">190</xref>,<xref ref-type="bibr" rid="CR396">396</xref></sup> Here, we summarize emerging pharmaceutical strategies aimed at boosting PINK1&#8211;Parkin-mediated mitophagy (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><title>Selective mitophagy inducers targeting the PINK1&#8211;Parkin pathway.</title><p><bold>a</bold> Schematic overview of mitophagy activators and their targets. <bold>b</bold> Structure of PINK1 activators. <bold>c</bold> Structure of a PARL inhibitor. <bold>d</bold> Structure of a Parkin activator. <bold>e</bold> Structure of USP30 inhibitors.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e3350" position="float" orientation="portrait" xlink:href="41422_2025_1203_Fig4_HTML.jpg"/></fig></p><sec id="FPar7"><title>PINK1 Activators</title><p id="Par98">PINK1 serves as the gatekeeper of the PINK1&#8211;Parkin mitophagy pathway, and its stabilization and accumulation on depolarized mitochondria are a crucial step in the initiation of mitophagy.<sup><xref ref-type="bibr" rid="CR38">38</xref>&#8211;<xref ref-type="bibr" rid="CR40">40</xref></sup> One approach to PINK1 activation involves the design of neo-substrates that directly increase its activity. The ATP analog kinetin triphosphate (KTP) was shown to increase the catalytic activity of both wild-type and G309D mutant PINK1<sup><xref ref-type="bibr" rid="CR397">397</xref></sup> independently of mitochondrial depolarization.<sup><xref ref-type="bibr" rid="CR398">398</xref></sup> However, long-term administration of its precursor, kinetin, which can be taken up by cells and converted to KTP, failed to prevent &#945;Syn-induced neurodegeneration in PD rodent models. This was likely due to its low potency, poor pharmacokinetics, and limited brain penetrance.<sup><xref ref-type="bibr" rid="CR399">399</xref></sup> Moreover, recently reported cryogenic electron microscopy structures revealed that KTP does not bind human wild-type PINK1.<sup><xref ref-type="bibr" rid="CR400">400</xref></sup></p><p id="Par99">Follow-up work has led to the design, synthesis, and characterization of additional kinetin derivatives.<sup><xref ref-type="bibr" rid="CR401">401</xref>&#8211;<xref ref-type="bibr" rid="CR403">403</xref></sup> In the exploration of N<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>-substituted adenines and adenosines, many of the nucleoside analogues were able to activate PINK1, as determined by the phosphorylation of Parkin.<sup><xref ref-type="bibr" rid="CR401">401</xref>,<xref ref-type="bibr" rid="CR402">402</xref></sup> The effort to discover novel small-molecule PINK1 activators with drug-like properties led to the development of the kinetin derivative MTK458 (WO2021168446A1)<sup><xref ref-type="bibr" rid="CR403">403</xref></sup> by Mitokinin (now part of AbbVie). MTK458 induces mitophagy in the presence of the mitochondrial stressors, FCCP and oligomycin, while exhibiting low mitochondrial toxicity, favorable oral pharmacokinetics, and high brain penetrance.<sup><xref ref-type="bibr" rid="CR403">403</xref></sup> MTK458 binds to PINK1 and stabilizes the PINK1&#8211;TOM complex, promoting the clearance of accumulated pUb and &#945;Syn pathology both in vitro and in vivo.<sup><xref ref-type="bibr" rid="CR403">403</xref></sup> MTK458, now named ABBV-1088, is currently in a Phase I clinical trial to evaluate its single-dose safety, tolerability, and pharmacokinetic properties in healthy adults (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06414798">NCT06414798</ext-link>). Further studies are planned to assess multiple ascending doses, drug&#8211;drug interactions, and pharmacokinetics in Asian populations (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06579300">NCT06579300</ext-link>).</p><p id="Par100">Thymol, a natural compound, has also been reported to activate PINK1-mediated mitophagy in <italic toggle="yes">C. elegans</italic>, zebrafish, and mice.<sup><xref ref-type="bibr" rid="CR343">343</xref></sup> Thymol lowers mitochondrial membrane potential, inhibits mitochondrial respiration, and increases mtROS, with effects that are transient and reversible. Functionally, thymol prevents liver fat accumulation in HFD-fed mice, and in <italic toggle="yes">C. elegans</italic>, it enhances thermotolerance in a PINK1-dependent manner.<sup><xref ref-type="bibr" rid="CR343">343</xref></sup> Further characterization of thymol-mediated mitophagy may inform novel strategies for PINK1 activation.</p></sec><sec id="FPar8"><title>PARL Inhibitors</title><p id="Par101">In healthy mitochondria, mitochondria-localized PINK1 is processed by MPP and PARL before being degraded by the proteasome.<sup><xref ref-type="bibr" rid="CR31">31</xref>&#8211;<xref ref-type="bibr" rid="CR37">37</xref></sup> Targeting PARL represents an alternative approach for stabilizing PINK1. A pilot study identified N-substituted peptidyl &#945;-ketoamides as selective inhibitors of rhomboid proteases, acting at nanomolar concentrations by covalently and reversibly binding to the catalytic serine at its active site, mimicking its substrates.<sup><xref ref-type="bibr" rid="CR404">404</xref></sup> Building on this, a ketoamide inhibitor of PARL, PARL-IN-1, was developed by modifying a fragment of the human PINK1 sequence located at the PARL cleavage site and incorporating a phenyl-butyl substituent at its amidic nitrogen.<sup><xref ref-type="bibr" rid="CR405">405</xref></sup> PARL-IN-1 effectively inhibits PARL activity in vitro, with a half-maximal inhibitory concentration (IC<sub>50</sub>) of 28&#8201;nM. In cells, PARL-IN-1 has a considerable effect on PARL inhibition, as endogenous PINK1 remains largely uncleaved and is stabilized in its 66&#8201;kDa form.<sup><xref ref-type="bibr" rid="CR405">405</xref></sup> Stabilized PINK1 further recruits Parkin to the mitochondria without affecting mitochondrial membrane potential. However, PARL inhibition by PARL-IN-1 reveals alternative PINK1 trafficking pathways, leading to the accumulation of MPP-cleaved PINK1 in the mitochondria and partial degradation of PINK1 by the IMM metalloprotease OMA1.<sup><xref ref-type="bibr" rid="CR405">405</xref></sup></p></sec><sec id="FPar9"><title>Parkin Activators</title><p id="Par102">Parkin is the major amplifier of PINK1&#8211;Parkin-mediated mitophagy.<sup><xref ref-type="bibr" rid="CR60">60</xref>,<xref ref-type="bibr" rid="CR61">61</xref></sup> To screen for Parkin activators, Biogen developed a high-throughput screening system using a Parkin autoubiquitination in vitro reaction system combined with a time-resolved F&#246;rster resonance energy transfer (TR-FRET) assay. Structure&#8211;activity relationship (SAR) studies were performed to optimize the original hits, and this led to a potent lead candidate, BIO-2007817.<sup><xref ref-type="bibr" rid="CR406">406</xref></sup> Interestingly, BIO-2007817 is not a direct activator of Parkin, since it has a low affinity for Parkin in the absence of pUb,<sup><xref ref-type="bibr" rid="CR407">407</xref></sup> and it does not increase Parkin&#8217;s translocation to mitochondria or affect mitophagy in cells.<sup><xref ref-type="bibr" rid="CR406">406</xref></sup> Instead, BIO-2007817 amplifies the existing activation mechanism, acting as a positive allosteric modulator (PAM) to activate Parkin in a regulated manner.<sup><xref ref-type="bibr" rid="CR407">407</xref>,<xref ref-type="bibr" rid="CR408">408</xref></sup> BIO-2007817 functions as a molecular glue, enhancing the ability of pUb to activate Parkin by releasing the catalytic RING2 domain from RING0, shifting Parkin toward its active conformation in a manner analogous to Parkin activation by phosphorylation.<sup><xref ref-type="bibr" rid="CR407">407</xref></sup> BIO-1975900 is closely related to BIO-2007817, and the two compounds bind to Parkin at the same location. Crystallography revealed the binding of BIO-1975900 to the RING0 domain of Parkin, close to pUb, making contacts with both Parkin and pUb.<sup><xref ref-type="bibr" rid="CR407">407</xref></sup> This mechanism enables BIO-2007817 to specifically rescue ubiquitination and mitophagy of pathological <italic toggle="yes">PRKN</italic> variants that lack a functional Ubl domain, such as R42P and V56E.<sup><xref ref-type="bibr" rid="CR407">407</xref></sup></p></sec><sec id="FPar10"><title>USP30 Inhibitors</title><p id="Par103">DUBs are endogenous proteins that antagonize Parkin-mediated mitophagy,<sup><xref ref-type="bibr" rid="CR62">62</xref>&#8211;<xref ref-type="bibr" rid="CR64">64</xref>,<xref ref-type="bibr" rid="CR409">409</xref></sup> and inhibition of DUBs could promote mitophagy,<sup><xref ref-type="bibr" rid="CR410">410</xref></sup> making them attractive therapeutic targets.<sup><xref ref-type="bibr" rid="CR411">411</xref></sup> Several DUBs, including USP30,<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> USP15,<sup><xref ref-type="bibr" rid="CR412">412</xref></sup> and USP8,<sup><xref ref-type="bibr" rid="CR413">413</xref></sup> have been shown to negatively regulate mitophagy. USP30 is distinguished from other DUBs by its localization on the OMM<sup><xref ref-type="bibr" rid="CR62">62</xref>,<xref ref-type="bibr" rid="CR414">414</xref></sup> and has been a focus of intensive inhibitor development.</p><p id="Par104">Mission Therapeutics has described covalent inhibitors of USP30, including N-cyanopyrrolidine-based MTX325 (also known as MTX115325), which exhibits good oral bioavailability and CNS penetration (WO2021249909A1).<sup><xref ref-type="bibr" rid="CR415">415</xref></sup> Treatment with MTX325 for 24&#8201;hours or 7 days upregulated TOM20 ubiquitylation in iPSC-derived dopaminergic neurons.<sup><xref ref-type="bibr" rid="CR415">415</xref></sup> In an AAV1/2-A53T-SNCA &#945;Syn overexpression PD mouse model that shows dopaminergic neurodegeneration and motor deficits, 10 weeks of oral MTX325 treatment protected mice against &#945;Syn-induced loss of TH-positive neurons and abrogated the depletion of dopamine and its metabolites.<sup><xref ref-type="bibr" rid="CR415">415</xref></sup> MTX325 is currently under a Phase I clinical trial in healthy volunteers and patients (ISRCTN20898392). Another Mission Therapeutics USP30 inhibitor, MTX652 (also known as MTX115652), promotes the ubiquitination of TOM20 in cells and protects mice from transverse aortic constriction-induced cardiac hypertrophy and left ventricular dysfunction.<sup><xref ref-type="bibr" rid="CR416">416</xref></sup> MTX652 has finished a Phase I clinical trial (EudraCT number: 2021-006764-24)<sup><xref ref-type="bibr" rid="CR417">417</xref></sup> and has received FDA clearance for a Phase II clinical trial. FT385 is an N-cyanopyrrolidine-modified USP30 inhibitor (WO2019071073A1) from FORMA Therapeutics (now part of Novo Nordisk). FT385-mediated USP30 inhibition phenocopies <italic toggle="yes">USP30</italic> knockout in enhancing basal mitophagy and promoting TOM20 ubiquitination upon mitochondrial depolarization.<sup><xref ref-type="bibr" rid="CR418">418</xref></sup></p><p id="Par105">Compounds from other structural classes have also been shown to inhibit USP30. For example, the diterpenoid derivative 15-oxospiramilactone (S3) activates mitochondrial fusion and restores the mitochondrial network via USP30 inhibition.<sup><xref ref-type="bibr" rid="CR419">419</xref></sup> Starting from a racemic phenylalanine derivative, Mitobridge (now part of Astellas) performed SAR studies and developed several potent, non-covalent, specific inhibitors of USP30, such as MF-094.<sup><xref ref-type="bibr" rid="CR420">420</xref></sup> Another Mitobridge entity, compound 39 from their benzenesulfonamide series, enhances TOM20 ubiquitination following mitochondrial depolarization and restores mitophagy in patient-derived iPSC dopaminergic neurons.<sup><xref ref-type="bibr" rid="CR421">421</xref></sup> In addition, a novel peptide derived from the transmembrane domain of USP30 can directly target USP30 through an allosteric autoinhibition mechanism, thereby increasing mitophagy.<sup><xref ref-type="bibr" rid="CR422">422</xref></sup> Further preclinical investigations are needed to verify their therapeutic potential in the treatment of neurodegenerative disorders.</p><p id="Par106">In addition, USP30 depletion enhances CCCP- and BH3 mimetic-induced cell death.<sup><xref ref-type="bibr" rid="CR64">64</xref></sup> This indicates that USP30 inhibition, in addition to promoting mitophagy in neurodegeneration, may potentially serve as a target for cancer therapy. Consistent with this notion, a recent study suggests that USP30 is upregulated in the liver of mice fed with HFD and treated with N-nitrosodiethylamine (DEN), as well as in human HCC samples. Overexpressing a stabilized form of USP30 promoted tumor growth in DEN/CCl<sub>4</sub>-induced HCC, whereas USP30 knockout reduced tumorigenesis in mice.<sup><xref ref-type="bibr" rid="CR423">423</xref></sup> Furthermore, it has been shown that mitophagy is suppressed during T cell exhaustion; knockout of USP30 or inhibition of USP30 by the specific inhibitor ST-539<sup><xref ref-type="bibr" rid="CR424">424</xref></sup> rejuvenates effector function in exhausted CD8<sup>+</sup> T cells, enhancing their antitumor immunity.<sup><xref ref-type="bibr" rid="CR305">305</xref></sup> Together, these findings provide proof of concept that USP30 inhibition may be exploited not only for neurodegenerative disorders but also for cancer therapy.</p></sec></sec><sec id="Sec44"><title>Activation of Alternative Mitophagy Pathways</title><p id="Par107">In addition to targeting the PINK1&#8211;Parkin pathway, targeting alternative mitophagy pathways has also yielded promising preclinical outcomes. For instance, induced myeloid leukemia cell differentiation protein 1 (MCL1) is an anti-apoptotic BCL-2 family protein. The MCL1 isoform, located in the mitochondrial matrix, is an important mitochondrial homeostasis regulator<sup><xref ref-type="bibr" rid="CR425">425</xref></sup> and a putative mitophagy receptor,<sup><xref ref-type="bibr" rid="CR426">426</xref>,<xref ref-type="bibr" rid="CR427">427</xref></sup> although conflicting results have been reported regarding its function.<sup><xref ref-type="bibr" rid="CR428">428</xref></sup> The FDA-approved BH3 mimetic UMI-77, which targets MCL1, has been shown to activate mitophagy without causing mitochondrial damage or apoptosis.<sup><xref ref-type="bibr" rid="CR429">429</xref></sup> Notably, this effect occurs independently of Parkin or selective autophagy receptors.<sup><xref ref-type="bibr" rid="CR429">429</xref></sup> Most importantly, intraperitoneal injection of UMI-77 induces mitophagy in the mouse brain, improving the learning and memory of APP/PS1 mice.<sup><xref ref-type="bibr" rid="CR429">429</xref></sup></p><p id="Par108">Another novel mitophagy inducer is mitophagy-inducing coumarin (MIC),<sup><xref ref-type="bibr" rid="CR430">430</xref></sup> a benzocoumarin compound that is abundant in various edible vegetables and plants. MIC enhances TFEB (HLH-30 in <italic toggle="yes">C. elegans</italic>) expression and lysosomal function by inhibiting ligand-induced activation of the nuclear hormone receptor DAF-12 (in <italic toggle="yes">C. elegans</italic>)/FXR (in mammals), thereby triggering mitophagy. MIC robustly extends lifespan in <italic toggle="yes">C. elegans</italic> and alleviates mitochondrial dysfunction in mammalian cells, highlighting its therapeutic potential in aging and age-related diseases. Interestingly, emerging evidence suggests that UA, like MIC, may also modulate FXR activity.<sup><xref ref-type="bibr" rid="CR430">430</xref></sup> Determining whether DAF-12/FXR directly regulates UA-mediated mitophagy could provide deeper mechanistic insight into the efficacy of UA.</p><p id="Par109">New small-molecule mitophagy boosters are also entering development. Capacity Bio has developed CAP-1902, a small-molecule mitophagy booster that functions as an agonist of the Mas-related G-protein coupled receptor (WO2022165189A1), and its effects on the brain, cardiac tissue, liver, and muscles are being investigated.<sup><xref ref-type="bibr" rid="CR431">431</xref>,<xref ref-type="bibr" rid="CR432">432</xref></sup> Furthermore, Vandria has developed VNA-318, another small-molecule mitophagy inducer designed for mild cognitive impairment (WO2024025953A2), which is undergoing a Phase I clinical trial in healthy males (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06721091">NCT06721091</ext-link>). These advances underscore the therapeutic promise of activating mitophagy through alternative druggable pathways in addition to the PINK1&#8211;Parkin cascade.</p></sec></sec><sec id="Sec45"><title>Mitophagy Inhibitors</title><p id="Par110">Compared with the extensive research on mitophagy activators, efforts to identify mitophagy inhibitors remain preliminary. Nevertheless, several candidate molecules and pathways have been described.</p><p id="Par111">The fission inhibitor Mdivi-1 is widely used as a mitophagy inhibitor.<sup><xref ref-type="bibr" rid="CR270">270</xref></sup> In dopaminergic neuronal cell lines, Mdivi-1 counteracts the overall fission effect caused by mutant human <italic toggle="yes">PINK1</italic>.<sup><xref ref-type="bibr" rid="CR433">433</xref></sup> It has also been shown to inhibit BCL2L13-mediated mitophagy, thereby reducing the migration and invasion of glioblastoma cells.<sup><xref ref-type="bibr" rid="CR141">141</xref></sup></p><p id="Par112">Another inhibitory regulator is PTEN-long (PTEN-L), an N-terminal extended isoform of PTEN that localizes to the OMM.<sup><xref ref-type="bibr" rid="CR434">434</xref></sup> PTEN-L acts as a protein phosphatase for ubiquitin, dephosphorylating pUb at Ser65. This prevents Parkin recruitment and subsequent phosphorylation, thereby inhibiting FCCP- or Oligomycin-induced mitophagy.<sup><xref ref-type="bibr" rid="CR435">435</xref></sup> In SH-SY5Y cells, prion protein peptide treatment induces PTEN-L accumulation and mitochondrial localization, which in turn exacerbate mitophagy dysfunction and promote cell apoptosis. Further investigation of PTEN-L&#8217;s mechanism of action may clarify its role in disease modulation and guide drug development.</p><p id="Par113">The small molecule IGS2.7 has also been identified as a mitophagy inhibitor. In U2OS cells, IGS2.7 was shown to inhibit deferiprone-induced mitophagy, and in ARPE-19 cells with high levels of basal mitophagy, IGS2.7 further inhibits basal mitophagy. Mechanistically, IGS2.7 inhibits ULK1 activity. In cell and mouse models of ALS, IGS2.7 restores autophagy and mitochondrial protein levels to control levels.<sup><xref ref-type="bibr" rid="CR436">436</xref></sup> However, IGS2.7 also targets casein kinase 1, complicating its use as a basis for the development of selective mitophagy inhibitors.</p></sec></sec><sec id="Sec46"><title>Concluding Remarks</title><p id="Par114">Mitophagy plays an essential role in maintaining cellular homeostasis by selectively eliminating damaged or surplus mitochondrial components, and its dysregulation is increasingly recognized as a prominent contributor to various diseases. Over the past two decades, starting from the discovery of&#160;PD-associated PINK1 and Parkin, significant progress has been made in deciphering the molecular mechanisms that underlie mitophagy &#8212; from ubiquitin-mediated pathways to receptor- and lipid-mediated mechanisms, as well as emerging concepts such as piecemeal mitophagy. Mounting evidence indicates that mitophagy is highly context-dependent and engages distinct molecular pathways, but how these pathways coordinate mitochondrial turnover in different cell populations under physiological and pathological conditions remains unclear. Advances in mitophagy detection techniques, such as fluorescent reporters like <italic toggle="yes">mito</italic>-QC,<sup><xref ref-type="bibr" rid="CR87">87</xref></sup> mt-Keima,<sup><xref ref-type="bibr" rid="CR89">89</xref>,<xref ref-type="bibr" rid="CR437">437</xref></sup> and mito-SRAI,<sup><xref ref-type="bibr" rid="CR438">438</xref></sup> will accelerate progress in this field. Integrating these tools with genetic, pharmacological, and single-cell and spatial omics approaches promises to further advance our understanding of mitophagy, thereby directing the development of specific and selective mitophagy-targeting therapies across diverse disease scenarios.</p><p id="Par115">Recent translational efforts have identified promising mitophagy modulators, particularly activators, from natural compounds, such as UA, to novel chemical entities with improved pharmacological profiles. Optimizing their specificity, bioavailability, and safety for long-term use remains a major challenge. Importantly, mitophagy inhibition can also provide therapeutic benefits in settings such as infection-driven inflammation and cancer therapy, underscoring the need to consider these aspects when developing activators and to explore selective inhibitors. Moving forward, elucidating context-specific mitophagic alterations, their underlying pathways, and their in vivo relevance will be critical. Such insights should pave the way for cell type- and pathway-selective modulation of mitophagy, potentially offering more precise and safer therapeutic strategies across a wide spectrum of diseases.</p></sec><sec id="Sec47" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41422_2025_1203_MOESM1_ESM.xlsx" position="float" orientation="portrait"><caption><p>Supplementary information, Table S1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Qi Wang, Yu Sun.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41422-025-01203-7.</p></sec><ack><title>Acknowledgements</title><p>We thank Davide D&#8217;Amico (Amazentis), P&#233;n&#233;lope A. Andreux (Vandria), Tanes Lima (Vandria), and Yasmine J. Liu (EPFL) for their helpful comments on the manuscript. We apologize for the omission of many relevant studies due to space constraints. Authors of this manuscript were supported by the European Research Council (ERC-AdG-787702 to J.A.), the Swiss National Science Foundation (SNSF 31003A_179435 and Sinergia CRSII5_202302 to J.A.), the Innosuisse &#8211; Swiss Innovation Agency (Confederation Suisse) (56184.1 IP-LS, to J.A.), European Molecular Biology Organization (ALTF 111-2021 to Q.W.), BrightFocus Foundation - Alzheimer's Disease Research (A2023018F to Q.W.), China Postdoctoral Science Foundation (2023TQ0080 to Y.S.), Shanghai Magnolia Talent Plan Pujiang Project (2023PJD004 to Y.S.), National Natural Science Foundation of China (82300708 to Y.S., 2021hwyq47 and 32470816 to T.Y.L.), Key Research and Development Program of China (2024YFA1803003 to T.Y.L.).</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Q.W., Y.S., and T.Y.L. wrote the initial drafts. Q.W. generated the figures with BioRender.com. J.A. supervised and revised the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by EPFL Lausanne.</p></notes><notes id="FPar11" notes-type="COI-statement"><title>Competing interests</title><p id="Par116">J.A. is a scientific advisor to Amazentis, MetroBiotech, and OrsoBio, and co-founder and advisor of Vandria.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>H</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>JL</given-names></name><name name-style="western"><surname>Haigis</surname><given-names>MC</given-names></name><name name-style="western"><surname>Greka</surname><given-names>A</given-names></name></person-group><article-title>Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity</article-title><source>Mol. Cell</source><year>2021</year><volume>81</volume><fpage>3708</fpage><lpage>3730</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2021.08.027</pub-id><pub-id pub-id-type="pmid">34547235</pub-id><pub-id pub-id-type="pmcid">PMC8620413</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Yoon, H., Shaw, J. L., Haigis, M. C. &amp; Greka, A. Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity. <italic toggle="yes">Mol. Cell</italic><bold>81</bold>, 3708&#8211;3730 (2021).<pub-id pub-id-type="pmid">34547235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2021.08.027</pub-id><pub-id pub-id-type="pmcid">PMC8620413</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giorgi</surname><given-names>C</given-names></name><name name-style="western"><surname>Marchi</surname><given-names>S</given-names></name><name name-style="western"><surname>Pinton</surname><given-names>P</given-names></name></person-group><article-title>The machineries, regulation and cellular functions of mitochondrial calcium</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2018</year><volume>19</volume><fpage>713</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1038/s41580-018-0052-8</pub-id><pub-id pub-id-type="pmid">30143745</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Giorgi, C., Marchi, S. &amp; Pinton, P. The machineries, regulation and cellular functions of mitochondrial calcium. <italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic><bold>19</bold>, 713&#8211;730 (2018).<pub-id pub-id-type="pmid">30143745</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41580-018-0052-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>MP</given-names></name></person-group><article-title>How mitochondria produce reactive oxygen species</article-title><source>Biochem. J.</source><year>2009</year><volume>417</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1042/BJ20081386</pub-id><pub-id pub-id-type="pmid">19061483</pub-id><pub-id pub-id-type="pmcid">PMC2605959</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Murphy, M. P. How mitochondria produce reactive oxygen species. <italic toggle="yes">Biochem. J.</italic><bold>417</bold>, 1&#8211;13 (2009).<pub-id pub-id-type="pmid">19061483</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/BJ20081386</pub-id><pub-id pub-id-type="pmcid">PMC2605959</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mills</surname><given-names>EL</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>B</given-names></name><name name-style="western"><surname>O&#8217;Neill</surname><given-names>LAJ</given-names></name></person-group><article-title>Mitochondria are the powerhouses of immunity</article-title><source>Nat. Immunol.</source><year>2017</year><volume>18</volume><fpage>488</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1038/ni.3704</pub-id><pub-id pub-id-type="pmid">28418387</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Mills, E. L., Kelly, B. &amp; O&#8217;Neill, L. A. J. Mitochondria are the powerhouses of immunity. <italic toggle="yes">Nat. Immunol.</italic><bold>18</bold>, 488&#8211;498 (2017).<pub-id pub-id-type="pmid">28418387</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3704</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marchi</surname><given-names>S</given-names></name><name name-style="western"><surname>Guilbaud</surname><given-names>E</given-names></name><name name-style="western"><surname>Tait</surname><given-names>SWG</given-names></name><name name-style="western"><surname>Yamazaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name></person-group><article-title>Mitochondrial control of inflammation</article-title><source>Nat. Rev. Immunol.</source><year>2023</year><volume>23</volume><fpage>159</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1038/s41577-022-00760-x</pub-id><pub-id pub-id-type="pmid">35879417</pub-id><pub-id pub-id-type="pmcid">PMC9310369</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T. &amp; Galluzzi, L. Mitochondrial control of inflammation. <italic toggle="yes">Nat. Rev. Immunol.</italic><bold>23</bold>, 159&#8211;173 (2023).<pub-id pub-id-type="pmid">35879417</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41577-022-00760-x</pub-id><pub-id pub-id-type="pmcid">PMC9310369</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glover</surname><given-names>HL</given-names></name><name name-style="western"><surname>Schreiner</surname><given-names>A</given-names></name><name name-style="western"><surname>Dewson</surname><given-names>G</given-names></name><name name-style="western"><surname>Tait</surname><given-names>SWG</given-names></name></person-group><article-title>Mitochondria and cell death</article-title><source>Nat. Cell Biol.</source><year>2024</year><volume>26</volume><fpage>1434</fpage><lpage>1446</lpage><pub-id pub-id-type="doi">10.1038/s41556-024-01429-4</pub-id><pub-id pub-id-type="pmid">38902422</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Glover, H. L., Schreiner, A., Dewson, G. &amp; Tait, S. W. G. Mitochondria and cell death. <italic toggle="yes">Nat. Cell Biol.</italic><bold>26</bold>, 1434&#8211;1446 (2024).<pub-id pub-id-type="pmid">38902422</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41556-024-01429-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quir&#243;s</surname><given-names>PM</given-names></name><name name-style="western"><surname>Mottis</surname><given-names>A</given-names></name><name name-style="western"><surname>Auwerx</surname><given-names>J</given-names></name></person-group><article-title>Mitonuclear communication in homeostasis and stress</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2016</year><volume>17</volume><fpage>213</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1038/nrm.2016.23</pub-id><pub-id pub-id-type="pmid">26956194</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Quir&#243;s, P. M., Mottis, A. &amp; Auwerx, J. Mitonuclear communication in homeostasis and stress. <italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic><bold>17</bold>, 213&#8211;226 (2016).<pub-id pub-id-type="pmid">26956194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm.2016.23</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mottis</surname><given-names>A</given-names></name><name name-style="western"><surname>Herzig</surname><given-names>S</given-names></name><name name-style="western"><surname>Auwerx</surname><given-names>J</given-names></name></person-group><article-title>Mitocellular communication: Shaping health and disease</article-title><source>Science</source><year>2019</year><volume>366</volume><fpage>827</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1126/science.aax3768</pub-id><pub-id pub-id-type="pmid">31727828</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Mottis, A., Herzig, S. &amp; Auwerx, J. Mitocellular communication: Shaping health and disease. <italic toggle="yes">Science</italic><bold>366</bold>, 827&#8211;832 (2019).<pub-id pub-id-type="pmid">31727828</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aax3768</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Melber</surname><given-names>A</given-names></name><name name-style="western"><surname>Haynes</surname><given-names>CM</given-names></name></person-group><article-title>UPRmt regulation and output: A stress response mediated by mitochondrial-nuclear communication</article-title><source>Cell Res.</source><year>2018</year><volume>28</volume><fpage>281</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1038/cr.2018.16</pub-id><pub-id pub-id-type="pmid">29424373</pub-id><pub-id pub-id-type="pmcid">PMC5835775</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Melber, A. &amp; Haynes, C. M. UPRmt regulation and output: A stress response mediated by mitochondrial-nuclear communication. <italic toggle="yes">Cell Res</italic>. <bold>28</bold>, 281&#8211;295 (2018).<pub-id pub-id-type="pmid">29424373</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cr.2018.16</pub-id><pub-id pub-id-type="pmcid">PMC5835775</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suomalainen</surname><given-names>A</given-names></name><name name-style="western"><surname>Nunnari</surname><given-names>J</given-names></name></person-group><article-title>Mitochondria at the crossroads of health and disease</article-title><source>Cell</source><year>2024</year><volume>187</volume><fpage>2601</fpage><lpage>2627</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2024.04.037</pub-id><pub-id pub-id-type="pmid">38788685</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Suomalainen, A. &amp; Nunnari, J. Mitochondria at the crossroads of health and disease. <italic toggle="yes">Cell</italic><bold>187</bold>, 2601&#8211;2627 (2024).<pub-id pub-id-type="pmid">38788685</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2024.04.037</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lima</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>TY</given-names></name><name name-style="western"><surname>Mottis</surname><given-names>A</given-names></name><name name-style="western"><surname>Auwerx</surname><given-names>J</given-names></name></person-group><article-title>Pleiotropic effects of mitochondria in aging</article-title><source>Nat. Aging</source><year>2022</year><volume>2</volume><fpage>199</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1038/s43587-022-00191-2</pub-id><pub-id pub-id-type="pmid">37118378</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Lima, T., Li, T. Y., Mottis, A. &amp; Auwerx, J. Pleiotropic effects of mitochondria in aging. <italic toggle="yes">Nat. Aging</italic>. <bold>2</bold>, 199&#8211;213 (2022).<pub-id pub-id-type="pmid">37118378</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43587-022-00191-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sagan</surname><given-names>L</given-names></name></person-group><article-title>On the origin of mitosing cells</article-title><source>J. Theor. Biol.</source><year>1967</year><volume>14</volume><fpage>225</fpage><lpage>IN6</lpage><pub-id pub-id-type="doi">10.1016/0022-5193(67)90079-3</pub-id><pub-id pub-id-type="pmid">11541392</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Sagan, L. On the origin of mitosing cells. <italic toggle="yes">J. Theor. Biol.</italic><bold>14</bold>, 225&#8211;IN6 (1967).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0022-5193(67)90079-3</pub-id><pub-id pub-id-type="pmid">11541392</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwartz</surname><given-names>RM</given-names></name><name name-style="western"><surname>Dayhoff</surname><given-names>MO</given-names></name></person-group><article-title>Origins of prokaryotes, eukaryotes, mitochondria, and chloroplasts</article-title><source>Science</source><year>1978</year><volume>199</volume><fpage>395</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1126/science.202030</pub-id><pub-id pub-id-type="pmid">202030</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Schwartz, R. M. &amp; Dayhoff, M. O. Origins of prokaryotes, eukaryotes, mitochondria, and chloroplasts. <italic toggle="yes">Science</italic><bold>199</bold>, 395&#8211;403 (1978).<pub-id pub-id-type="pmid">202030</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.202030</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>S</given-names></name><etal/></person-group><article-title>Sequence and organization of the human mitochondrial genome</article-title><source>Nature</source><year>1981</year><volume>290</volume><fpage>457</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1038/290457a0</pub-id><pub-id pub-id-type="pmid">7219534</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Anderson, S. et al. Sequence and organization of the human mitochondrial genome. <italic toggle="yes">Nature</italic><bold>290</bold>, 457&#8211;465 (1981).<pub-id pub-id-type="pmid">7219534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/290457a0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pagliarini</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>A Mitochondrial protein compendium elucidates complex I disease biology</article-title><source>Cell</source><year>2008</year><volume>134</volume><fpage>112</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.06.016</pub-id><pub-id pub-id-type="pmid">18614015</pub-id><pub-id pub-id-type="pmcid">PMC2778844</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Pagliarini, D. J. et al. A Mitochondrial protein compendium elucidates complex I disease biology. <italic toggle="yes">Cell</italic><bold>134</bold>, 112&#8211;123 (2008).<pub-id pub-id-type="pmid">18614015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2008.06.016</pub-id><pub-id pub-id-type="pmcid">PMC2778844</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>MYW</given-names></name><name name-style="western"><surname>Wai</surname><given-names>T</given-names></name><name name-style="western"><surname>Simonsen</surname><given-names>A</given-names></name></person-group><article-title>Quality control of the mitochondrion</article-title><source>Dev. Cell</source><year>2021</year><volume>56</volume><fpage>881</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.02.009</pub-id><pub-id pub-id-type="pmid">33662258</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Ng, M. Y. W., Wai, T. &amp; Simonsen, A. Quality control of the mitochondrion. <italic toggle="yes">Dev. Cell</italic><bold>56</bold>, 881&#8211;905 (2021).<pub-id pub-id-type="pmid">33662258</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.devcel.2021.02.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deshwal</surname><given-names>S</given-names></name><name name-style="western"><surname>Fiedler</surname><given-names>KU</given-names></name><name name-style="western"><surname>Langer</surname><given-names>T</given-names></name></person-group><article-title>Mitochondrial proteases: Multifaceted regulators of mitochondrial plasticity</article-title><source>Annu. Rev. Biochem.</source><year>2020</year><volume>89</volume><fpage>501</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-062917-012739</pub-id><pub-id pub-id-type="pmid">32075415</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Deshwal, S., Fiedler, K. U. &amp; Langer, T. Mitochondrial proteases: Multifaceted regulators of mitochondrial plasticity. <italic toggle="yes">Annu. Rev. Biochem.</italic><bold>89</bold>, 501&#8211;528 (2020).<pub-id pub-id-type="pmid">32075415</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-biochem-062917-012739</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moehle</surname><given-names>EA</given-names></name><name name-style="western"><surname>Shen</surname><given-names>K</given-names></name><name name-style="western"><surname>Dillin</surname><given-names>A</given-names></name></person-group><article-title>Mitochondrial proteostasis in the context of cellular and organismal health and aging</article-title><source>J. Biol. Chem.</source><year>2019</year><volume>294</volume><fpage>5396</fpage><lpage>5407</lpage><pub-id pub-id-type="doi">10.1074/jbc.TM117.000893</pub-id><pub-id pub-id-type="pmid">29622680</pub-id><pub-id pub-id-type="pmcid">PMC6462515</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Moehle, E. A., Shen, K. &amp; Dillin, A. Mitochondrial proteostasis in the context of cellular and organismal health and aging. <italic toggle="yes">J. Biol. Chem.</italic><bold>294</bold>, 5396&#8211;5407 (2019).<pub-id pub-id-type="pmid">29622680</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.TM117.000893</pub-id><pub-id pub-id-type="pmcid">PMC6462515</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neuspiel</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers</article-title><source>Curr. Biol.</source><year>2008</year><volume>18</volume><fpage>102</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2007.12.038</pub-id><pub-id pub-id-type="pmid">18207745</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Neuspiel, M. et al. Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. <italic toggle="yes">Curr. Biol.</italic><bold>18</bold>, 102&#8211;108 (2008).<pub-id pub-id-type="pmid">18207745</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cub.2007.12.038</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soubannier</surname><given-names>V</given-names></name><etal/></person-group><article-title>A vesicular transport pathway shuttles cargo from mitochondria to lysosomes</article-title><source>Curr. Biol.</source><year>2012</year><volume>22</volume><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2011.11.057</pub-id><pub-id pub-id-type="pmid">22226745</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Soubannier, V. et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. <italic toggle="yes">Curr. Biol.</italic><bold>22</bold>, 135&#8211;141 (2012).<pub-id pub-id-type="pmid">22226745</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cub.2011.11.057</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Mitochondria shed their outer membrane in response to infection-induced stress</article-title><source>Science</source><year>2022</year><volume>375</volume><fpage>eabi4343</fpage><pub-id pub-id-type="doi">10.1126/science.abi4343</pub-id><pub-id pub-id-type="pmid">35025629</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Li, X. et al. Mitochondria shed their outer membrane in response to infection-induced stress. <italic toggle="yes">Science</italic><bold>375</bold>, eabi4343 (2022).<pub-id pub-id-type="pmid">35025629</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.abi4343</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prashar</surname><given-names>A</given-names></name><etal/></person-group><article-title>Lysosomes drive the piecemeal removal of mitochondrial inner membrane</article-title><source>Nature</source><year>2024</year><volume>632</volume><fpage>1110</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.1038/s41586-024-07835-w</pub-id><pub-id pub-id-type="pmid">39169179</pub-id><pub-id pub-id-type="pmcid">PMC7616637</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Prashar, A. et al. Lysosomes drive the piecemeal removal of mitochondrial inner membrane. <italic toggle="yes">Nature</italic><bold>632</bold>, 1110&#8211;1117 (2024).<pub-id pub-id-type="pmid">39169179</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-024-07835-w</pub-id><pub-id pub-id-type="pmcid">PMC7616637</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiao</surname><given-names>H</given-names></name><etal/></person-group><article-title>Mitocytosis, a migrasome-mediated mitochondrial quality-control process</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>2896</fpage><lpage>2910.e13</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.027</pub-id><pub-id pub-id-type="pmid">34048705</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Jiao, H. et al. Mitocytosis, a migrasome-mediated mitochondrial quality-control process. <italic toggle="yes">Cell</italic><bold>184</bold>, 2896&#8211;2910.e13 (2021).<pub-id pub-id-type="pmid">34048705</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2021.04.027</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Duve</surname><given-names>C</given-names></name><name name-style="western"><surname>Wattiaux</surname><given-names>R</given-names></name></person-group><article-title>Functions of lysosomes</article-title><source>Annu. Rev. Physiol.</source><year>1966</year><volume>28</volume><fpage>435</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1146/annurev.ph.28.030166.002251</pub-id><pub-id pub-id-type="pmid">5322983</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">De Duve, C. &amp; Wattiaux, R. Functions of lysosomes. <italic toggle="yes">Annu. Rev. Physiol.</italic><bold>28</bold>, 435&#8211;492 (1966).<pub-id pub-id-type="pmid">5322983</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.ph.28.030166.002251</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitada</surname><given-names>T</given-names></name><etal/></person-group><article-title>Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism</article-title><source>Nature</source><year>1998</year><volume>392</volume><fpage>605</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1038/33416</pub-id><pub-id pub-id-type="pmid">9560156</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. <italic toggle="yes">Nature</italic><bold>392</bold>, 605&#8211;608 (1998).<pub-id pub-id-type="pmid">9560156</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/33416</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valente</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Hereditary early-onset Parkinson&#8217;s disease caused by mutations in PINK1</article-title><source>Science</source><year>2004</year><volume>304</volume><fpage>1158</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1126/science.1096284</pub-id><pub-id pub-id-type="pmid">15087508</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Valente, E. M. et al. Hereditary early-onset Parkinson&#8217;s disease caused by mutations in PINK1. <italic toggle="yes">Science</italic><bold>304</bold>, 1158&#8211;1160 (2004).<pub-id pub-id-type="pmid">15087508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1096284</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Narendra</surname><given-names>DP</given-names></name><name name-style="western"><surname>Youle</surname><given-names>RJ</given-names></name></person-group><article-title>The role of PINK1&#8211;Parkin in mitochondrial quality control</article-title><source>Nat. Cell Biol.</source><year>2024</year><volume>26</volume><fpage>1639</fpage><lpage>1651</lpage><pub-id pub-id-type="doi">10.1038/s41556-024-01513-9</pub-id><pub-id pub-id-type="pmid">39358449</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Narendra, D. P. &amp; Youle, R. J. The role of PINK1&#8211;Parkin in mitochondrial quality control. <italic toggle="yes">Nat. Cell Biol.</italic><bold>26</bold>, 1639&#8211;1651 (2024).<pub-id pub-id-type="pmid">39358449</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41556-024-01513-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silvestri</surname><given-names>L</given-names></name><etal/></person-group><article-title>Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive Parkinsonism</article-title><source>Hum. Mol. Genet.</source><year>2005</year><volume>14</volume><fpage>3477</fpage><lpage>3492</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddi377</pub-id><pub-id pub-id-type="pmid">16207731</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Silvestri, L. et al. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive Parkinsonism. <italic toggle="yes">Hum. Mol. Genet.</italic><bold>14</bold>, 3477&#8211;3492 (2005).<pub-id pub-id-type="pmid">16207731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/hmg/ddi377</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takatori</surname><given-names>S</given-names></name><name name-style="western"><surname>Ito</surname><given-names>G</given-names></name><name name-style="western"><surname>Iwatsubo</surname><given-names>T</given-names></name></person-group><article-title>Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1</article-title><source>Neurosci. Lett.</source><year>2008</year><volume>430</volume><fpage>13</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2007.10.019</pub-id><pub-id pub-id-type="pmid">18031932</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Takatori, S., Ito, G. &amp; Iwatsubo, T. Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1. <italic toggle="yes">Neurosci. Lett.</italic><bold>430</bold>, 13&#8211;17 (2008).<pub-id pub-id-type="pmid">18031932</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neulet.2007.10.019</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haque</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Cytoplasmic PINK1 activity protects neurons from dopaminergic neurotoxin MPTP</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2008</year><volume>105</volume><fpage>1716</fpage><lpage>1721</lpage><pub-id pub-id-type="doi">10.1073/pnas.0705363105</pub-id><pub-id pub-id-type="pmid">18218782</pub-id><pub-id pub-id-type="pmcid">PMC2234210</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Haque, M. E. et al. Cytoplasmic PINK1 activity protects neurons from dopaminergic neurotoxin MPTP. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>105</bold>, 1716&#8211;1721 (2008).<pub-id pub-id-type="pmid">18218782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0705363105</pub-id><pub-id pub-id-type="pmcid">PMC2234210</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greene</surname><given-names>AW</given-names></name><etal/></person-group><article-title>Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment</article-title><source>EMBO Rep</source><year>2012</year><volume>13</volume><fpage>378</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1038/embor.2012.14</pub-id><pub-id pub-id-type="pmid">22354088</pub-id><pub-id pub-id-type="pmcid">PMC3321149</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Greene, A. W. et al. Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. <italic toggle="yes">EMBO Rep</italic>. <bold>13</bold>, 378&#8211;385 (2012).<pub-id pub-id-type="pmid">22354088</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/embor.2012.14</pub-id><pub-id pub-id-type="pmcid">PMC3321149</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitworth</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson&#8217;s disease factors Pink1 and Parkin</article-title><source>Dis. Model Mech.</source><year>2008</year><volume>1</volume><fpage>168</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1242/dmm.000109</pub-id><pub-id pub-id-type="pmid">19048081</pub-id><pub-id pub-id-type="pmcid">PMC2562193</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Whitworth, A. J. et al. Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson&#8217;s disease factors Pink1 and Parkin. <italic toggle="yes">Dis. Model Mech.</italic><bold>1</bold>, 168&#8211;174 (2008).<pub-id pub-id-type="pmid">19048081</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1242/dmm.000109</pub-id><pub-id pub-id-type="pmcid">PMC2562193</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL</article-title><source>J. Cell Biol.</source><year>2010</year><volume>191</volume><fpage>933</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1083/jcb.201008084</pub-id><pub-id pub-id-type="pmid">21115803</pub-id><pub-id pub-id-type="pmcid">PMC2995166</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Jin, S. M. et al. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. <italic toggle="yes">J. Cell Biol.</italic><bold>191</bold>, 933&#8211;942 (2010).<pub-id pub-id-type="pmid">21115803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.201008084</pub-id><pub-id pub-id-type="pmcid">PMC2995166</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deas</surname><given-names>E</given-names></name><etal/></person-group><article-title>PINK1 cleavage at position A103 by the mitochondrial protease PARL</article-title><source>Hum. Mol. Genet.</source><year>2011</year><volume>20</volume><fpage>867</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddq526</pub-id><pub-id pub-id-type="pmid">21138942</pub-id><pub-id pub-id-type="pmcid">PMC3033179</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Deas, E. et al. PINK1 cleavage at position A103 by the mitochondrial protease PARL. <italic toggle="yes">Hum. Mol. Genet.</italic><bold>20</bold>, 867&#8211;879 (2011).<pub-id pub-id-type="pmid">21138942</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/hmg/ddq526</pub-id><pub-id pub-id-type="pmcid">PMC3033179</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meissner</surname><given-names>C</given-names></name><name name-style="western"><surname>Lorenz</surname><given-names>H</given-names></name><name name-style="western"><surname>Weihofen</surname><given-names>A</given-names></name><name name-style="western"><surname>Selkoe</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Lemberg</surname><given-names>MK</given-names></name></person-group><article-title>The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking</article-title><source>J. Neurochem.</source><year>2011</year><volume>117</volume><fpage>856</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07253.x</pub-id><pub-id pub-id-type="pmid">21426348</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Meissner, C., Lorenz, H., Weihofen, A., Selkoe, D. J. &amp; Lemberg, M. K. The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. <italic toggle="yes">J. Neurochem.</italic><bold>117</bold>, 856&#8211;867 (2011).<pub-id pub-id-type="pmid">21426348</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1471-4159.2011.07253.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>W</given-names></name><name name-style="western"><surname>Kang</surname><given-names>UJ</given-names></name></person-group><article-title>Characterization of PINK1 processing, stability, and subcellular localization</article-title><source>J. Neurochem.</source><year>2008</year><volume>106</volume><fpage>464</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05398.x</pub-id><pub-id pub-id-type="pmid">18397367</pub-id><pub-id pub-id-type="pmcid">PMC3638740</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Lin, W. &amp; Kang, U. J. Characterization of PINK1 processing, stability, and subcellular localization. <italic toggle="yes">J. Neurochem.</italic><bold>106</bold>, 464&#8211;474 (2008).<pub-id pub-id-type="pmid">18397367</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1471-4159.2008.05398.x</pub-id><pub-id pub-id-type="pmcid">PMC3638740</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamano</surname><given-names>K</given-names></name><name name-style="western"><surname>Youle</surname><given-names>RJ</given-names></name></person-group><article-title>PINK1 is degraded through the N-end rule pathway</article-title><source>Autophagy</source><year>2013</year><volume>9</volume><fpage>1758</fpage><lpage>1769</lpage><pub-id pub-id-type="doi">10.4161/auto.24633</pub-id><pub-id pub-id-type="pmid">24121706</pub-id><pub-id pub-id-type="pmcid">PMC4028335</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Yamano, K. &amp; Youle, R. J. PINK1 is degraded through the N-end rule pathway. <italic toggle="yes">Autophagy</italic><bold>9</bold>, 1758&#8211;1769 (2013).<pub-id pub-id-type="pmid">24121706</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/auto.24633</pub-id><pub-id pub-id-type="pmcid">PMC4028335</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Narendra</surname><given-names>DP</given-names></name><etal/></person-group><article-title>PINK1 Is selectively stabilized on impaired mitochondria to activate Parkin</article-title><source>PLoS Biol</source><year>2010</year><volume>8</volume><fpage>e1000298</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.1000298</pub-id><pub-id pub-id-type="pmid">20126261</pub-id><pub-id pub-id-type="pmcid">PMC2811155</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Narendra, D. P. et al. PINK1 Is selectively stabilized on impaired mitochondria to activate Parkin. <italic toggle="yes">PLoS Biol</italic>. <bold>8</bold>, e1000298 (2010).<pub-id pub-id-type="pmid">20126261</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pbio.1000298</pub-id><pub-id pub-id-type="pmcid">PMC2811155</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuda</surname><given-names>N</given-names></name><etal/></person-group><article-title>PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy</article-title><source>J. Cell Biol.</source><year>2010</year><volume>189</volume><fpage>211</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1083/jcb.200910140</pub-id><pub-id pub-id-type="pmid">20404107</pub-id><pub-id pub-id-type="pmcid">PMC2856912</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Matsuda, N. et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. <italic toggle="yes">J. Cell Biol.</italic><bold>189</bold>, 211&#8211;221 (2010).<pub-id pub-id-type="pmid">20404107</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.200910140</pub-id><pub-id pub-id-type="pmcid">PMC2856912</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazarou</surname><given-names>M</given-names></name><name name-style="western"><surname>Jin</surname><given-names>SM</given-names></name><name name-style="western"><surname>Kane</surname><given-names>LA</given-names></name><name name-style="western"><surname>Youle</surname><given-names>RJ</given-names></name></person-group><article-title>Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin</article-title><source>Dev. Cell</source><year>2012</year><volume>22</volume><fpage>320</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.12.014</pub-id><pub-id pub-id-type="pmid">22280891</pub-id><pub-id pub-id-type="pmcid">PMC3288275</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Lazarou, M., Jin, S. M., Kane, L. A. &amp; Youle, R. J. Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. <italic toggle="yes">Dev. Cell</italic><bold>22</bold>, 320&#8211;333 (2012).<pub-id pub-id-type="pmid">22280891</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.devcel.2011.12.014</pub-id><pub-id pub-id-type="pmcid">PMC3288275</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okatsu</surname><given-names>K</given-names></name><etal/></person-group><article-title>PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria</article-title><source>Nat. Commun.</source><year>2012</year><volume>3</volume><fpage>1016</fpage><pub-id pub-id-type="doi">10.1038/ncomms2016</pub-id><pub-id pub-id-type="pmid">22910362</pub-id><pub-id pub-id-type="pmcid">PMC3432468</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Okatsu, K. et al. PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. <italic toggle="yes">Nat. Commun.</italic><bold>3</bold>, 1016 (2012).<pub-id pub-id-type="pmid">22910362</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms2016</pub-id><pub-id pub-id-type="pmcid">PMC3432468</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okatsu</surname><given-names>K</given-names></name><etal/></person-group><article-title>A dimeric PINK1-containing complex on depolarized mitochondria stimulates Parkin recruitment</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>36372</fpage><lpage>36384</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.509653</pub-id><pub-id pub-id-type="pmid">24189060</pub-id><pub-id pub-id-type="pmcid">PMC3868751</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Okatsu, K. et al. A dimeric PINK1-containing complex on depolarized mitochondria stimulates Parkin recruitment. <italic toggle="yes">J. Biol. Chem.</italic><bold>288</bold>, 36372&#8211;36384 (2013).<pub-id pub-id-type="pmid">24189060</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M113.509653</pub-id><pub-id pub-id-type="pmcid">PMC3868751</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schubert</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Structure of PINK1 in complex with its substrate ubiquitin</article-title><source>Nature</source><year>2017</year><volume>552</volume><fpage>51</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1038/nature24645</pub-id><pub-id pub-id-type="pmid">29160309</pub-id><pub-id pub-id-type="pmcid">PMC6020998</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Schubert, A. F. et al. Structure of PINK1 in complex with its substrate ubiquitin. <italic toggle="yes">Nature</italic><bold>552</bold>, 51&#8211;56 (2017).<pub-id pub-id-type="pmid">29160309</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature24645</pub-id><pub-id pub-id-type="pmcid">PMC6020998</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rasool</surname><given-names>S</given-names></name><etal/></person-group><article-title>PINK1 autophosphorylation is required for ubiquitin recognition</article-title><source>EMBO Rep</source><year>2018</year><volume>19</volume><fpage>e44981</fpage><pub-id pub-id-type="doi">10.15252/embr.201744981</pub-id><pub-id pub-id-type="pmid">29475881</pub-id><pub-id pub-id-type="pmcid">PMC5891426</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Rasool, S. et al. PINK1 autophosphorylation is required for ubiquitin recognition. <italic toggle="yes">EMBO Rep</italic>. <bold>19</bold>, e44981 (2018).<pub-id pub-id-type="pmid">29475881</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embr.201744981</pub-id><pub-id pub-id-type="pmcid">PMC5891426</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gan</surname><given-names>ZY</given-names></name><etal/></person-group><article-title>Activation mechanism of PINK1</article-title><source>Nature</source><year>2022</year><volume>602</volume><fpage>328</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-04340-2</pub-id><pub-id pub-id-type="pmid">34933320</pub-id><pub-id pub-id-type="pmcid">PMC8828467</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Gan, Z. Y. et al. Activation mechanism of PINK1. <italic toggle="yes">Nature</italic><bold>602</bold>, 328&#8211;335 (2022).<pub-id pub-id-type="pmid">34933320</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-04340-2</pub-id><pub-id pub-id-type="pmcid">PMC8828467</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rasool</surname><given-names>S</given-names></name><etal/></person-group><article-title>Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex</article-title><source>Mol. Cell</source><year>2022</year><volume>82</volume><fpage>44</fpage><lpage>59.e6</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2021.11.012</pub-id><pub-id pub-id-type="pmid">34875213</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Rasool, S. et al. Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex. <italic toggle="yes">Mol. Cell</italic><bold>82</bold>, 44&#8211;59.e6 (2022).<pub-id pub-id-type="pmid">34875213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2021.11.012</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koyano</surname><given-names>F</given-names></name><etal/></person-group><article-title>Ubiquitin is phosphorylated by PINK1 to activate parkin</article-title><source>Nature</source><year>2014</year><volume>510</volume><fpage>162</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1038/nature13392</pub-id><pub-id pub-id-type="pmid">24784582</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Koyano, F. et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. <italic toggle="yes">Nature</italic><bold>510</bold>, 162&#8211;166 (2014).<pub-id pub-id-type="pmid">24784582</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature13392</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kane</surname><given-names>LA</given-names></name><etal/></person-group><article-title>PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity</article-title><source>J. Cell Biol.</source><year>2014</year><volume>205</volume><fpage>143</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1083/jcb.201402104</pub-id><pub-id pub-id-type="pmid">24751536</pub-id><pub-id pub-id-type="pmcid">PMC4003245</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Kane, L. A. et al. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. <italic toggle="yes">J. Cell Biol.</italic><bold>205</bold>, 143&#8211;153 (2014).<pub-id pub-id-type="pmid">24751536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.201402104</pub-id><pub-id pub-id-type="pmcid">PMC4003245</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kazlauskaite</surname><given-names>A</given-names></name><etal/></person-group><article-title>Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65</article-title><source>Biochem. J.</source><year>2014</year><volume>460</volume><fpage>127</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1042/BJ20140334</pub-id><pub-id pub-id-type="pmid">24660806</pub-id><pub-id pub-id-type="pmcid">PMC4000136</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Kazlauskaite, A. et al. Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. <italic toggle="yes">Biochem. J.</italic><bold>460</bold>, 127&#8211;139 (2014).<pub-id pub-id-type="pmid">24660806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/BJ20140334</pub-id><pub-id pub-id-type="pmcid">PMC4000136</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vives-Bauza</surname><given-names>C</given-names></name><etal/></person-group><article-title>PINK1-dependent recruitment of Parkin to mitochondria in mitophagy</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>378</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1073/pnas.0911187107</pub-id><pub-id pub-id-type="pmid">19966284</pub-id><pub-id pub-id-type="pmcid">PMC2806779</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Vives-Bauza, C. et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>107</bold>, 378&#8211;383 (2010).<pub-id pub-id-type="pmid">19966284</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0911187107</pub-id><pub-id pub-id-type="pmcid">PMC2806779</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimura</surname><given-names>H</given-names></name><etal/></person-group><article-title>Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase</article-title><source>Nat. Genet.</source><year>2000</year><volume>25</volume><fpage>302</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1038/77060</pub-id><pub-id pub-id-type="pmid">10888878</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Shimura, H. et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. <italic toggle="yes">Nat. Genet.</italic><bold>25</bold>, 302&#8211;305 (2000).<pub-id pub-id-type="pmid">10888878</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/77060</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kondapalli</surname><given-names>C</given-names></name><etal/></person-group><article-title>PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65</article-title><source>Open Biol</source><year>2012</year><volume>2</volume><fpage>120080</fpage><pub-id pub-id-type="doi">10.1098/rsob.120080</pub-id><pub-id pub-id-type="pmid">22724072</pub-id><pub-id pub-id-type="pmcid">PMC3376738</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Kondapalli, C. et al. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. <italic toggle="yes">Open Biol</italic>. <bold>2</bold>, 120080 (2012).<pub-id pub-id-type="pmid">22724072</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1098/rsob.120080</pub-id><pub-id pub-id-type="pmcid">PMC3376738</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trempe</surname><given-names>J-F</given-names></name><etal/></person-group><article-title>Structure of Parkin reveals mechanisms for ubiquitin ligase activation</article-title><source>Science</source><year>2013</year><volume>340</volume><fpage>1451</fpage><lpage>1455</lpage><pub-id pub-id-type="doi">10.1126/science.1237908</pub-id><pub-id pub-id-type="pmid">23661642</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Trempe, J.-F. et al. Structure of Parkin reveals mechanisms for ubiquitin ligase activation. <italic toggle="yes">Science</italic><bold>340</bold>, 1451&#8211;1455 (2013).<pub-id pub-id-type="pmid">23661642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1237908</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riley</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases</article-title><source>Nat. Commun.</source><year>2013</year><volume>4</volume><fpage>1982</fpage><pub-id pub-id-type="doi">10.1038/ncomms2982</pub-id><pub-id pub-id-type="pmid">23770887</pub-id><pub-id pub-id-type="pmcid">PMC3709503</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Riley, B. E. et al. Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. <italic toggle="yes">Nat. Commun.</italic><bold>4</bold>, 1982 (2013).<pub-id pub-id-type="pmid">23770887</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms2982</pub-id><pub-id pub-id-type="pmcid">PMC3709503</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wauer</surname><given-names>T</given-names></name><name name-style="western"><surname>Komander</surname><given-names>D</given-names></name></person-group><article-title>Structure of the human Parkin ligase domain in an autoinhibited state</article-title><source>EMBO J</source><year>2013</year><volume>32</volume><fpage>2099</fpage><lpage>2112</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.125</pub-id><pub-id pub-id-type="pmid">23727886</pub-id><pub-id pub-id-type="pmcid">PMC3730226</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Wauer, T. &amp; Komander, D. Structure of the human Parkin ligase domain in an autoinhibited state. <italic toggle="yes">EMBO J</italic>. <bold>32</bold>, 2099&#8211;2112 (2013).<pub-id pub-id-type="pmid">23727886</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/emboj.2013.125</pub-id><pub-id pub-id-type="pmcid">PMC3730226</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wauer</surname><given-names>T</given-names></name><etal/></person-group><article-title>Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis</article-title><source>EMBO J</source><year>2015</year><volume>34</volume><fpage>307</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.15252/embj.201489847</pub-id><pub-id pub-id-type="pmid">25527291</pub-id><pub-id pub-id-type="pmcid">PMC4339119</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Wauer, T. et al. Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. <italic toggle="yes">EMBO J</italic>. <bold>34</bold>, 307&#8211;325 (2015).<pub-id pub-id-type="pmid">25527291</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.201489847</pub-id><pub-id pub-id-type="pmcid">PMC4339119</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wauer</surname><given-names>T</given-names></name><name name-style="western"><surname>Simicek</surname><given-names>M</given-names></name><name name-style="western"><surname>Schubert</surname><given-names>A</given-names></name><name name-style="western"><surname>Komander</surname><given-names>D</given-names></name></person-group><article-title>Mechanism of phospho-ubiquitin-induced PARKIN activation</article-title><source>Nature</source><year>2015</year><volume>524</volume><fpage>370</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1038/nature14879</pub-id><pub-id pub-id-type="pmid">26161729</pub-id><pub-id pub-id-type="pmcid">PMC4984986</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Wauer, T., Simicek, M., Schubert, A. &amp; Komander, D. Mechanism of phospho-ubiquitin-induced PARKIN activation. <italic toggle="yes">Nature</italic><bold>524</bold>, 370&#8211;374 (2015).<pub-id pub-id-type="pmid">26161729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature14879</pub-id><pub-id pub-id-type="pmcid">PMC4984986</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sauv&#233;</surname><given-names>V</given-names></name><etal/></person-group><article-title>A Ubl/ubiquitin switch in the activation of Parkin</article-title><source>EMBO J</source><year>2015</year><volume>34</volume><fpage>2492</fpage><lpage>2505</lpage><pub-id pub-id-type="doi">10.15252/embj.201592237</pub-id><pub-id pub-id-type="pmid">26254305</pub-id><pub-id pub-id-type="pmcid">PMC4609182</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Sauv&#233;, V. et al. A Ubl/ubiquitin switch in the activation of Parkin. <italic toggle="yes">EMBO J</italic>. <bold>34</bold>, 2492&#8211;2505 (2015).<pub-id pub-id-type="pmid">26254305</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.201592237</pub-id><pub-id pub-id-type="pmcid">PMC4609182</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geisler</surname><given-names>S</given-names></name><etal/></person-group><article-title>PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1</article-title><source>Nat. Cell Biol.</source><year>2010</year><volume>12</volume><fpage>119</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1038/ncb2012</pub-id><pub-id pub-id-type="pmid">20098416</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Geisler, S. et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. <italic toggle="yes">Nat. Cell Biol.</italic><bold>12</bold>, 119&#8211;131 (2010).<pub-id pub-id-type="pmid">20098416</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncb2012</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>NC</given-names></name><etal/></person-group><article-title>Broad activation of the ubiquitin&#8211;proteasome system by Parkin is critical for mitophagy</article-title><source>Hum. Mol. Genet.</source><year>2011</year><volume>20</volume><fpage>1726</fpage><lpage>1737</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr048</pub-id><pub-id pub-id-type="pmid">21296869</pub-id><pub-id pub-id-type="pmcid">PMC3071670</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Chan, N. C. et al. Broad activation of the ubiquitin&#8211;proteasome system by Parkin is critical for mitophagy. <italic toggle="yes">Hum. Mol. Genet.</italic><bold>20</bold>, 1726&#8211;1737 (2011).<pub-id pub-id-type="pmid">21296869</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/hmg/ddr048</pub-id><pub-id pub-id-type="pmcid">PMC3071670</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarraf</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Landscape of the Parkin-dependent ubiquitylome in response to mitochondrial depolarization</article-title><source>Nature</source><year>2013</year><volume>496</volume><fpage>372</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1038/nature12043</pub-id><pub-id pub-id-type="pmid">23503661</pub-id><pub-id pub-id-type="pmcid">PMC3641819</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Sarraf, S. A. et al. Landscape of the Parkin-dependent ubiquitylome in response to mitochondrial depolarization. <italic toggle="yes">Nature</italic><bold>496</bold>, 372&#8211;376 (2013).<pub-id pub-id-type="pmid">23503661</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature12043</pub-id><pub-id pub-id-type="pmcid">PMC3641819</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bingol</surname><given-names>B</given-names></name><etal/></person-group><article-title>The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy</article-title><source>Nature</source><year>2014</year><volume>510</volume><fpage>370</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1038/nature13418</pub-id><pub-id pub-id-type="pmid">24896179</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Bingol, B. et al. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. <italic toggle="yes">Nature</italic><bold>510</bold>, 370&#8211;375 (2014).<pub-id pub-id-type="pmid">24896179</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature13418</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cunningham</surname><given-names>CN</given-names></name><etal/></person-group><article-title>USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria</article-title><source>Nat. Cell Biol.</source><year>2015</year><volume>17</volume><fpage>160</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1038/ncb3097</pub-id><pub-id pub-id-type="pmid">25621951</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Cunningham, C. N. et al. USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria. <italic toggle="yes">Nat. Cell Biol.</italic><bold>17</bold>, 160&#8211;169 (2015).<pub-id pub-id-type="pmid">25621951</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncb3097</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>J-R</given-names></name><etal/></person-group><article-title>USP30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death</article-title><source>EMBO Rep</source><year>2015</year><volume>16</volume><fpage>618</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.15252/embr.201439820</pub-id><pub-id pub-id-type="pmid">25739811</pub-id><pub-id pub-id-type="pmcid">PMC4428036</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Liang, J.-R. et al. USP30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death. <italic toggle="yes">EMBO Rep</italic>. <bold>16</bold>, 618&#8211;627 (2015).<pub-id pub-id-type="pmid">25739811</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embr.201439820</pub-id><pub-id pub-id-type="pmcid">PMC4428036</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wild</surname><given-names>P</given-names></name><etal/></person-group><article-title>Phosphorylation of the autophagy receptor Optineurin restricts Salmonella growth</article-title><source>Science</source><year>2011</year><volume>333</volume><fpage>228</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1126/science.1205405</pub-id><pub-id pub-id-type="pmid">21617041</pub-id><pub-id pub-id-type="pmcid">PMC3714538</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Wild, P. et al. Phosphorylation of the autophagy receptor Optineurin restricts Salmonella growth. <italic toggle="yes">Science</italic><bold>333</bold>, 228&#8211;233 (2011).<pub-id pub-id-type="pmid">21617041</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1205405</pub-id><pub-id pub-id-type="pmcid">PMC3714538</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thurston</surname><given-names>TLM</given-names></name><name name-style="western"><surname>Ryzhakov</surname><given-names>G</given-names></name><name name-style="western"><surname>Bloor</surname><given-names>S</given-names></name><name name-style="western"><surname>von Muhlinen</surname><given-names>N</given-names></name><name name-style="western"><surname>Randow</surname><given-names>F</given-names></name></person-group><article-title>The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria</article-title><source>Nat. Immunol.</source><year>2009</year><volume>10</volume><fpage>1215</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1038/ni.1800</pub-id><pub-id pub-id-type="pmid">19820708</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Thurston, T. L. M., Ryzhakov, G., Bloor, S., von Muhlinen, N. &amp; Randow, F. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. <italic toggle="yes">Nat. Immunol.</italic><bold>10</bold>, 1215&#8211;1221 (2009).<pub-id pub-id-type="pmid">19820708</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.1800</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newman</surname><given-names>AC</given-names></name><etal/></person-group><article-title>TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-&#954;B signalling</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e50672</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0050672</pub-id><pub-id pub-id-type="pmid">23209807</pub-id><pub-id pub-id-type="pmcid">PMC3510188</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Newman, A. C. et al. TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-&#954;B signalling. <italic toggle="yes">PLoS One</italic><bold>7</bold>, e50672 (2012).<pub-id pub-id-type="pmid">23209807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0050672</pub-id><pub-id pub-id-type="pmcid">PMC3510188</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pankiv</surname><given-names>S</given-names></name><etal/></person-group><article-title>p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>24131</fpage><lpage>24145</lpage><pub-id pub-id-type="doi">10.1074/jbc.M702824200</pub-id><pub-id pub-id-type="pmid">17580304</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Pankiv, S. et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. <italic toggle="yes">J. Biol. Chem.</italic><bold>282</bold>, 24131&#8211;24145 (2007).<pub-id pub-id-type="pmid">17580304</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M702824200</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirkin</surname><given-names>V</given-names></name><etal/></person-group><article-title>A role for NBR1 in autophagosomal degradation of ubiquitinated substrates</article-title><source>Mol. Cell</source><year>2009</year><volume>33</volume><fpage>505</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2009.01.020</pub-id><pub-id pub-id-type="pmid">19250911</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Kirkin, V. et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. <italic toggle="yes">Mol. Cell</italic><bold>33</bold>, 505&#8211;516 (2009).<pub-id pub-id-type="pmid">19250911</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2009.01.020</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>TN</given-names></name><etal/></person-group><article-title>Atg8 family LC3/GABARAP proteins are crucial for autophagosome&#8211;lysosome fusion but not autophagosome formation during PINK1/Parkin mitophagy and starvation</article-title><source>J. Cell Biol.</source><year>2016</year><volume>215</volume><fpage>857</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1083/jcb.201607039</pub-id><pub-id pub-id-type="pmid">27864321</pub-id><pub-id pub-id-type="pmcid">PMC5166504</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Nguyen, T. N. et al. Atg8 family LC3/GABARAP proteins are crucial for autophagosome&#8211;lysosome fusion but not autophagosome formation during PINK1/Parkin mitophagy and starvation. <italic toggle="yes">J. Cell Biol.</italic><bold>215</bold>, 857&#8211;874 (2016).<pub-id pub-id-type="pmid">27864321</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.201607039</pub-id><pub-id pub-id-type="pmcid">PMC5166504</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaites</surname><given-names>LP</given-names></name><name name-style="western"><surname>Paulo</surname><given-names>JA</given-names></name><name name-style="western"><surname>Huttlin</surname><given-names>EL</given-names></name><name name-style="western"><surname>Harper</surname><given-names>JW</given-names></name></person-group><article-title>Systematic analysis of human cells lacking ATG8 proteins uncovers roles for GABARAPs and the CCZ1/MON1 regulator C18orf8/RMC1 in macroautophagic and selective autophagic flux</article-title><source>Mol. Cell. Biol.</source><year>2018</year><volume>38</volume><fpage>e00392</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1128/MCB.00392-17</pub-id><pub-id pub-id-type="pmid">29038162</pub-id><pub-id pub-id-type="pmcid">PMC5730722</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Vaites, L. P., Paulo, J. A., Huttlin, E. L. &amp; Harper, J. W. Systematic analysis of human cells lacking ATG8 proteins uncovers roles for GABARAPs and the CCZ1/MON1 regulator C18orf8/RMC1 in macroautophagic and selective autophagic flux. <italic toggle="yes">Mol. Cell. Biol.</italic><bold>38</bold>, e00392&#8211;17 (2018).<pub-id pub-id-type="pmid">29038162</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/MCB.00392-17</pub-id><pub-id pub-id-type="pmcid">PMC5730722</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazarou</surname><given-names>M</given-names></name><etal/></person-group><article-title>The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy</article-title><source>Nature</source><year>2015</year><volume>524</volume><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1038/nature14893</pub-id><pub-id pub-id-type="pmid">26266977</pub-id><pub-id pub-id-type="pmcid">PMC5018156</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">Lazarou, M. et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. <italic toggle="yes">Nature</italic><bold>524</bold>, 309&#8211;314 (2015).<pub-id pub-id-type="pmid">26266977</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature14893</pub-id><pub-id pub-id-type="pmcid">PMC5018156</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>YC</given-names></name><name name-style="western"><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><article-title>Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>E4439</fpage><lpage>E4448</lpage><pub-id pub-id-type="doi">10.1073/pnas.1405752111</pub-id><pub-id pub-id-type="pmid">25294927</pub-id><pub-id pub-id-type="pmcid">PMC4210283</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">Wong, Y. C. &amp; Holzbaur, E. L. F. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>111</bold>, E4439&#8211;E4448 (2014).<pub-id pub-id-type="pmid">25294927</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1405752111</pub-id><pub-id pub-id-type="pmcid">PMC4210283</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heo</surname><given-names>J-M</given-names></name><name name-style="western"><surname>Ordureau</surname><given-names>A</given-names></name><name name-style="western"><surname>Paulo</surname><given-names>JA</given-names></name><name name-style="western"><surname>Rinehart</surname><given-names>J</given-names></name><name name-style="western"><surname>Harper</surname><given-names>JW</given-names></name></person-group><article-title>The PINK1-Parkin mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy</article-title><source>Mol. Cell</source><year>2015</year><volume>60</volume><fpage>7</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.08.016</pub-id><pub-id pub-id-type="pmid">26365381</pub-id><pub-id pub-id-type="pmcid">PMC4592482</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Heo, J.-M., Ordureau, A., Paulo, J. A., Rinehart, J. &amp; Harper, J. W. The PINK1-Parkin mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. <italic toggle="yes">Mol. Cell</italic><bold>60</bold>, 7&#8211;20 (2015).<pub-id pub-id-type="pmid">26365381</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2015.08.016</pub-id><pub-id pub-id-type="pmcid">PMC4592482</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>AS</given-names></name><name name-style="western"><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><article-title>Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2016</year><volume>113</volume><fpage>E3349</fpage><lpage>E3358</lpage><pub-id pub-id-type="doi">10.1073/pnas.1523810113</pub-id><pub-id pub-id-type="pmid">27247382</pub-id><pub-id pub-id-type="pmcid">PMC4914160</pub-id></element-citation><mixed-citation id="mc-CR75" publication-type="journal">Moore, A. S. &amp; Holzbaur, E. L. F. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>113</bold>, E3349&#8211;E3358 (2016).<pub-id pub-id-type="pmid">27247382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1523810113</pub-id><pub-id pub-id-type="pmcid">PMC4914160</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Narendra</surname><given-names>D</given-names></name><name name-style="western"><surname>Kane</surname><given-names>LA</given-names></name><name name-style="western"><surname>Hauser</surname><given-names>DN</given-names></name><name name-style="western"><surname>Fearnley</surname><given-names>IM</given-names></name><name name-style="western"><surname>Youle</surname><given-names>RJ</given-names></name></person-group><article-title>p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both</article-title><source>Autophagy</source><year>2010</year><volume>6</volume><fpage>1090</fpage><lpage>1106</lpage><pub-id pub-id-type="doi">10.4161/auto.6.8.13426</pub-id><pub-id pub-id-type="pmid">20890124</pub-id><pub-id pub-id-type="pmcid">PMC3359490</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Narendra, D., Kane, L. A., Hauser, D. N., Fearnley, I. M. &amp; Youle, R. J. p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. <italic toggle="yes">Autophagy</italic><bold>6</bold>, 1090&#8211;1106 (2010).<pub-id pub-id-type="pmid">20890124</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/auto.6.8.13426</pub-id><pub-id pub-id-type="pmcid">PMC3359490</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okatsu</surname><given-names>K</given-names></name><etal/></person-group><article-title>p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria</article-title><source>Genes Cells</source><year>2010</year><volume>15</volume><fpage>887</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2443.2010.01426.x</pub-id><pub-id pub-id-type="pmid">20604804</pub-id><pub-id pub-id-type="pmcid">PMC2970908</pub-id></element-citation><mixed-citation id="mc-CR77" publication-type="journal">Okatsu, K. et al. p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. <italic toggle="yes">Genes Cells</italic><bold>15</bold>, 887&#8211;900 (2010).<pub-id pub-id-type="pmid">20604804</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2443.2010.01426.x</pub-id><pub-id pub-id-type="pmcid">PMC2970908</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vargas</surname><given-names>JNS</given-names></name><etal/></person-group><article-title>Spatiotemporal control of ULK1 activation by NDP52 and TBK1 during selective autophagy</article-title><source>Mol. Cell</source><year>2019</year><volume>74</volume><fpage>347</fpage><lpage>362.e6</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.02.010</pub-id><pub-id pub-id-type="pmid">30853401</pub-id><pub-id pub-id-type="pmcid">PMC6642318</pub-id></element-citation><mixed-citation id="mc-CR78" publication-type="journal">Vargas, J. N. S. et al. Spatiotemporal control of ULK1 activation by NDP52 and TBK1 during selective autophagy. <italic toggle="yes">Mol. Cell</italic><bold>74</bold>, 347&#8211;362.e6 (2019).<pub-id pub-id-type="pmid">30853401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2019.02.010</pub-id><pub-id pub-id-type="pmcid">PMC6642318</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name><name name-style="western"><surname>Chang</surname><given-names>C</given-names></name><name name-style="western"><surname>Yokom</surname><given-names>AL</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>LE</given-names></name><name name-style="western"><surname>Hurley</surname><given-names>JH</given-names></name></person-group><article-title>The autophagy adaptor NDP52 and the FIP200 coiled-coil allosterically activate ULK1 complex membrane recruitment</article-title><source>eLife</source><year>2020</year><volume>9</volume><fpage>e59099</fpage><pub-id pub-id-type="doi">10.7554/eLife.59099</pub-id><pub-id pub-id-type="pmid">32773036</pub-id><pub-id pub-id-type="pmcid">PMC7447430</pub-id></element-citation><mixed-citation id="mc-CR79" publication-type="journal">Shi, X., Chang, C., Yokom, A. L., Jensen, L. E. &amp; Hurley, J. H. The autophagy adaptor NDP52 and the FIP200 coiled-coil allosterically activate ULK1 complex membrane recruitment. <italic toggle="yes">eLife</italic><bold>9</bold>, e59099 (2020).<pub-id pub-id-type="pmid">32773036</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.59099</pub-id><pub-id pub-id-type="pmcid">PMC7447430</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamano</surname><given-names>K</given-names></name><etal/></person-group><article-title>Critical role of mitochondrial ubiquitination and the OPTN&#8211;ATG9A axis in mitophagy</article-title><source>J. Cell Biol.</source><year>2020</year><volume>219</volume><fpage>e201912144</fpage><pub-id pub-id-type="doi">10.1083/jcb.201912144</pub-id><pub-id pub-id-type="pmid">32556086</pub-id><pub-id pub-id-type="pmcid">PMC7480101</pub-id></element-citation><mixed-citation id="mc-CR80" publication-type="journal">Yamano, K. et al. Critical role of mitochondrial ubiquitination and the OPTN&#8211;ATG9A axis in mitophagy. <italic toggle="yes">J. Cell Biol.</italic><bold>219</bold>, e201912144 (2020).<pub-id pub-id-type="pmid">32556086</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.201912144</pub-id><pub-id pub-id-type="pmcid">PMC7480101</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Loughlin</surname><given-names>T</given-names></name><etal/></person-group><article-title>OPTN recruitment to a Golgi-proximal compartment regulates immune signalling and cytokine secretion</article-title><source>J. Cell Sci</source><year>2020</year><volume>133</volume><fpage>jcs239822</fpage><pub-id pub-id-type="doi">10.1242/jcs.239822</pub-id><pub-id pub-id-type="pmid">32376785</pub-id><pub-id pub-id-type="pmcid">PMC7328155</pub-id></element-citation><mixed-citation id="mc-CR81" publication-type="journal">O&#8217;Loughlin, T. et al. OPTN recruitment to a Golgi-proximal compartment regulates immune signalling and cytokine secretion. <italic toggle="yes">J. Cell Sci</italic>. <bold>133</bold>, jcs239822 (2020).<pub-id pub-id-type="pmid">32376785</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1242/jcs.239822</pub-id><pub-id pub-id-type="pmcid">PMC7328155</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ablasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Chen</surname><given-names>ZJ</given-names></name></person-group><article-title>cGAS in action: Expanding roles in immunity and inflammation</article-title><source>Science</source><year>2019</year><volume>363</volume><fpage>eaat8657</fpage><pub-id pub-id-type="doi">10.1126/science.aat8657</pub-id><pub-id pub-id-type="pmid">30846571</pub-id></element-citation><mixed-citation id="mc-CR82" publication-type="journal">Ablasser, A. &amp; Chen, Z. J. cGAS in action: Expanding roles in immunity and inflammation. <italic toggle="yes">Science</italic><bold>363</bold>, eaat8657 (2019).<pub-id pub-id-type="pmid">30846571</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aat8657</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hopfner</surname><given-names>K-P</given-names></name><name name-style="western"><surname>Hornung</surname><given-names>V</given-names></name></person-group><article-title>Molecular mechanisms and cellular functions of cGAS&#8211;STING signalling</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2020</year><volume>21</volume><fpage>501</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-0244-x</pub-id><pub-id pub-id-type="pmid">32424334</pub-id></element-citation><mixed-citation id="mc-CR83" publication-type="journal">Hopfner, K.-P. &amp; Hornung, V. Molecular mechanisms and cellular functions of cGAS&#8211;STING signalling. <italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic><bold>21</bold>, 501&#8211;521 (2020).<pub-id pub-id-type="pmid">32424334</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41580-020-0244-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richter</surname><given-names>B</given-names></name><etal/></person-group><article-title>Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2016</year><volume>113</volume><fpage>4039</fpage><lpage>4044</lpage><pub-id pub-id-type="doi">10.1073/pnas.1523926113</pub-id><pub-id pub-id-type="pmid">27035970</pub-id><pub-id pub-id-type="pmcid">PMC4839414</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Richter, B. et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>113</bold>, 4039&#8211;4044 (2016).<pub-id pub-id-type="pmid">27035970</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1523926113</pub-id><pub-id pub-id-type="pmcid">PMC4839414</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>TN</given-names></name><etal/></person-group><article-title>Unconventional initiation of PINK1/Parkin mitophagy by Optineurin</article-title><source>Mol. Cell</source><year>2023</year><volume>83</volume><fpage>1693</fpage><lpage>1709.e9</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2023.04.021</pub-id><pub-id pub-id-type="pmid">37207627</pub-id></element-citation><mixed-citation id="mc-CR85" publication-type="journal">Nguyen, T. N. et al. Unconventional initiation of PINK1/Parkin mitophagy by Optineurin. <italic toggle="yes">Mol. Cell</italic><bold>83</bold>, 1693&#8211;1709.e9 (2023).<pub-id pub-id-type="pmid">37207627</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2023.04.021</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Padman</surname><given-names>BS</given-names></name><etal/></person-group><article-title>LC3/GABARAPs drive ubiquitin-independent recruitment of Optineurin and NDP52 to amplify mitophagy</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>408</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-08335-6</pub-id><pub-id pub-id-type="pmid">30679426</pub-id><pub-id pub-id-type="pmcid">PMC6345886</pub-id></element-citation><mixed-citation id="mc-CR86" publication-type="journal">Padman, B. S. et al. LC3/GABARAPs drive ubiquitin-independent recruitment of Optineurin and NDP52 to amplify mitophagy. <italic toggle="yes">Nat. Commun.</italic><bold>10</bold>, 408 (2019).<pub-id pub-id-type="pmid">30679426</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-019-08335-6</pub-id><pub-id pub-id-type="pmcid">PMC6345886</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McWilliams</surname><given-names>TG</given-names></name><etal/></person-group><article-title>mito-QC illuminates mitophagy and mitochondrial architecture in vivo</article-title><source>J. Cell Biol.</source><year>2016</year><volume>214</volume><fpage>333</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1083/jcb.201603039</pub-id><pub-id pub-id-type="pmid">27458135</pub-id><pub-id pub-id-type="pmcid">PMC4970326</pub-id></element-citation><mixed-citation id="mc-CR87" publication-type="journal">McWilliams, T. G. et al. mito-QC illuminates mitophagy and mitochondrial architecture in vivo. <italic toggle="yes">J. Cell Biol.</italic><bold>214</bold>, 333&#8211;345 (2016).<pub-id pub-id-type="pmid">27458135</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.201603039</pub-id><pub-id pub-id-type="pmcid">PMC4970326</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McWilliams</surname><given-names>TG</given-names></name><etal/></person-group><article-title>Basal mitophagy occurs independently of PINK1 in mouse tissues of high metabolic demand</article-title><source>Cell Metab</source><year>2018</year><volume>27</volume><fpage>439</fpage><lpage>449.e5</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.12.008</pub-id><pub-id pub-id-type="pmid">29337137</pub-id><pub-id pub-id-type="pmcid">PMC5807059</pub-id></element-citation><mixed-citation id="mc-CR88" publication-type="journal">McWilliams, T. G. et al. Basal mitophagy occurs independently of PINK1 in mouse tissues of high metabolic demand. <italic toggle="yes">Cell Metab</italic>. <bold>27</bold>, 439&#8211;449.e5 (2018).<pub-id pub-id-type="pmid">29337137</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2017.12.008</pub-id><pub-id pub-id-type="pmcid">PMC5807059</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>N</given-names></name><etal/></person-group><article-title>Measuring in vivo mitophagy</article-title><source>Mol. Cell</source><year>2015</year><volume>60</volume><fpage>685</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.10.009</pub-id><pub-id pub-id-type="pmid">26549682</pub-id><pub-id pub-id-type="pmcid">PMC4656081</pub-id></element-citation><mixed-citation id="mc-CR89" publication-type="journal">Sun, N. et al. Measuring in vivo mitophagy. <italic toggle="yes">Mol. Cell</italic><bold>60</bold>, 685&#8211;696 (2015).<pub-id pub-id-type="pmid">26549682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2015.10.009</pub-id><pub-id pub-id-type="pmcid">PMC4656081</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Basal mitophagy is widespread in <italic toggle="yes">Drosophila</italic> but minimally affected by loss of Pink1 or parkin</article-title><source>J. Cell Biol.</source><year>2018</year><volume>217</volume><fpage>1613</fpage><lpage>1622</lpage><pub-id pub-id-type="doi">10.1083/jcb.201801044</pub-id><pub-id pub-id-type="pmid">29500189</pub-id><pub-id pub-id-type="pmcid">PMC5940313</pub-id></element-citation><mixed-citation id="mc-CR90" publication-type="journal">Lee, J. J. et al. Basal mitophagy is widespread in <italic toggle="yes">Drosophila</italic> but minimally affected by loss of Pink1 or parkin. <italic toggle="yes">J. Cell Biol.</italic><bold>217</bold>, 1613&#8211;1622 (2018).<pub-id pub-id-type="pmid">29500189</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.201801044</pub-id><pub-id pub-id-type="pmcid">PMC5940313</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>YY</given-names></name><etal/></person-group><article-title>Assessment of mitophagy in mt-Keima <italic toggle="yes">Drosophila</italic> revealed an essential role of the PINK1-Parkin pathway in mitophagy induction in vivo</article-title><source>FASEB J</source><year>2019</year><volume>33</volume><fpage>9742</fpage><lpage>9751</lpage><pub-id pub-id-type="doi">10.1096/fj.201900073R</pub-id><pub-id pub-id-type="pmid">31120803</pub-id><pub-id pub-id-type="pmcid">PMC12039051</pub-id></element-citation><mixed-citation id="mc-CR91" publication-type="journal">Kim, Y. Y. et al. Assessment of mitophagy in mt-Keima <italic toggle="yes">Drosophila</italic> revealed an essential role of the PINK1-Parkin pathway in mitophagy induction in vivo. <italic toggle="yes">FASEB J</italic>. <bold>33</bold>, 9742&#8211;9751 (2019).<pub-id pub-id-type="pmid">31120803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1096/fj.201900073R</pub-id><pub-id pub-id-type="pmcid">PMC12039051</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y-T</given-names></name><etal/></person-group><article-title>Mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than mito-QC</article-title><source>Autophagy</source><year>2021</year><volume>17</volume><fpage>3753</fpage><lpage>3762</lpage><pub-id pub-id-type="doi">10.1080/15548627.2021.1896924</pub-id><pub-id pub-id-type="pmid">33685343</pub-id><pub-id pub-id-type="pmcid">PMC8632312</pub-id></element-citation><mixed-citation id="mc-CR92" publication-type="journal">Liu, Y.-T. et al. Mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than mito-QC. <italic toggle="yes">Autophagy</italic><bold>17</bold>, 3753&#8211;3762 (2021).<pub-id pub-id-type="pmid">33685343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2021.1896924</pub-id><pub-id pub-id-type="pmcid">PMC8632312</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Onishi</surname><given-names>M</given-names></name><name name-style="western"><surname>Yamano</surname><given-names>K</given-names></name><name name-style="western"><surname>Sato</surname><given-names>M</given-names></name><name name-style="western"><surname>Matsuda</surname><given-names>N</given-names></name><name name-style="western"><surname>Okamoto</surname><given-names>K</given-names></name></person-group><article-title>Molecular mechanisms and physiological functions of mitophagy</article-title><source>EMBO J</source><year>2021</year><volume>40</volume><fpage>e104705</fpage><pub-id pub-id-type="doi">10.15252/embj.2020104705</pub-id><pub-id pub-id-type="pmid">33438778</pub-id><pub-id pub-id-type="pmcid">PMC7849173</pub-id></element-citation><mixed-citation id="mc-CR93" publication-type="journal">Onishi, M., Yamano, K., Sato, M., Matsuda, N. &amp; Okamoto, K. Molecular mechanisms and physiological functions of mitophagy. <italic toggle="yes">EMBO J</italic>. <bold>40</bold>, e104705 (2021).<pub-id pub-id-type="pmid">33438778</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.2020104705</pub-id><pub-id pub-id-type="pmcid">PMC7849173</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tere&#353;ak</surname><given-names>P</given-names></name><etal/></person-group><article-title>Regulation of PRKN-independent mitophagy</article-title><source>Autophagy</source><year>2022</year><volume>18</volume><fpage>24</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1080/15548627.2021.1888244</pub-id><pub-id pub-id-type="pmid">33570005</pub-id><pub-id pub-id-type="pmcid">PMC8865282</pub-id></element-citation><mixed-citation id="mc-CR94" publication-type="journal">Tere&#353;ak, P. et al. Regulation of PRKN-independent mitophagy. <italic toggle="yes">Autophagy</italic><bold>18</bold>, 24&#8211;39 (2022).<pub-id pub-id-type="pmid">33570005</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2021.1888244</pub-id><pub-id pub-id-type="pmcid">PMC8865282</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group><article-title>The mitophagy pathway and its implications in human diseases</article-title><source>Sig. Transduct. Target. Ther.</source><year>2023</year><volume>8</volume><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1038/s41392-023-01503-7</pub-id><pub-id pub-id-type="pmcid">PMC10427715</pub-id><pub-id pub-id-type="pmid">37582956</pub-id></element-citation><mixed-citation id="mc-CR95" publication-type="journal">Wang, S. et al. The mitophagy pathway and its implications in human diseases. <italic toggle="yes">Sig. Transduct. Target. Ther.</italic><bold>8</bold>, 1&#8211;28 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-023-01503-7</pub-id><pub-id pub-id-type="pmcid">PMC10427715</pub-id><pub-id pub-id-type="pmid">37582956</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>1099</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.399345</pub-id><pub-id pub-id-type="pmid">23209295</pub-id><pub-id pub-id-type="pmcid">PMC3542995</pub-id></element-citation><mixed-citation id="mc-CR96" publication-type="journal">Zhu, Y. et al. Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis. <italic toggle="yes">J. Biol. Chem.</italic><bold>288</bold>, 1099&#8211;1113 (2013).<pub-id pub-id-type="pmid">23209295</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M112.399345</pub-id><pub-id pub-id-type="pmcid">PMC3542995</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><etal/></person-group><article-title>Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins</article-title><source>J. Biol. Chem.</source><year>1999</year><volume>274</volume><fpage>7</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.1.7</pub-id><pub-id pub-id-type="pmid">9867803</pub-id></element-citation><mixed-citation id="mc-CR97" publication-type="journal">Chen, G. et al. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. <italic toggle="yes">J. Biol. Chem.</italic><bold>274</bold>, 7&#8211;10 (1999).<pub-id pub-id-type="pmid">9867803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.274.1.7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clague</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Urb&#233;</surname><given-names>S</given-names></name></person-group><article-title>Diverse routes to mitophagy governed by ubiquitylation and mitochondrial import</article-title><source>Trends Cell Biol</source><year>2025</year><volume>35</volume><fpage>527</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2025.01.003</pub-id><pub-id pub-id-type="pmid">39922712</pub-id></element-citation><mixed-citation id="mc-CR98" publication-type="journal">Clague, M. J. &amp; Urb&#233;, S. Diverse routes to mitophagy governed by ubiquitylation and mitochondrial import. <italic toggle="yes">Trends Cell Biol</italic>. <bold>35</bold>, 527&#8211;538 (2025).<pub-id pub-id-type="pmid">39922712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tcb.2025.01.003</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamacher-Brady</surname><given-names>A</given-names></name><etal/></person-group><article-title>Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy</article-title><source>Cell Death Differ</source><year>2007</year><volume>14</volume><fpage>146</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401936</pub-id><pub-id pub-id-type="pmid">16645637</pub-id></element-citation><mixed-citation id="mc-CR99" publication-type="journal">Hamacher-Brady, A. et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. <italic toggle="yes">Cell Death Differ</italic>. <bold>14</bold>, 146&#8211;157 (2007).<pub-id pub-id-type="pmid">16645637</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.cdd.4401936</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schweers</surname><given-names>RL</given-names></name><etal/></person-group><article-title>NIX is required for programmed mitochondrial clearance during reticulocyte maturation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>19500</fpage><lpage>19505</lpage><pub-id pub-id-type="doi">10.1073/pnas.0708818104</pub-id><pub-id pub-id-type="pmid">18048346</pub-id><pub-id pub-id-type="pmcid">PMC2148318</pub-id></element-citation><mixed-citation id="mc-CR100" publication-type="journal">Schweers, R. L. et al. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>104</bold>, 19500&#8211;19505 (2007).<pub-id pub-id-type="pmid">18048346</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0708818104</pub-id><pub-id pub-id-type="pmcid">PMC2148318</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sandoval</surname><given-names>H</given-names></name><etal/></person-group><article-title>Essential role for Nix in autophagic maturation of erythroid cells</article-title><source>Nature</source><year>2008</year><volume>454</volume><fpage>232</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1038/nature07006</pub-id><pub-id pub-id-type="pmid">18454133</pub-id><pub-id pub-id-type="pmcid">PMC2570948</pub-id></element-citation><mixed-citation id="mc-CR101" publication-type="journal">Sandoval, H. et al. Essential role for Nix in autophagic maturation of erythroid cells. <italic toggle="yes">Nature</italic><bold>454</bold>, 232&#8211;235 (2008).<pub-id pub-id-type="pmid">18454133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature07006</pub-id><pub-id pub-id-type="pmcid">PMC2570948</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bellot</surname><given-names>G</given-names></name><etal/></person-group><article-title>Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains</article-title><source>Mol. Cell Biol.</source><year>2009</year><volume>29</volume><fpage>2570</fpage><lpage>2581</lpage><pub-id pub-id-type="doi">10.1128/MCB.00166-09</pub-id><pub-id pub-id-type="pmid">19273585</pub-id><pub-id pub-id-type="pmcid">PMC2682037</pub-id></element-citation><mixed-citation id="mc-CR102" publication-type="journal">Bellot, G. et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. <italic toggle="yes">Mol. Cell Biol.</italic><bold>29</bold>, 2570&#8211;2581 (2009).<pub-id pub-id-type="pmid">19273585</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/MCB.00166-09</pub-id><pub-id pub-id-type="pmcid">PMC2682037</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Ney</surname><given-names>PA</given-names></name></person-group><article-title>Role of BNIP3 and NIX in cell death, autophagy, and mitophagy</article-title><source>Cell Death Differ</source><year>2009</year><volume>16</volume><fpage>939</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.16</pub-id><pub-id pub-id-type="pmid">19229244</pub-id><pub-id pub-id-type="pmcid">PMC2768230</pub-id></element-citation><mixed-citation id="mc-CR103" publication-type="journal">Zhang, J. &amp; Ney, P. A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. <italic toggle="yes">Cell Death Differ</italic>. <bold>16</bold>, 939&#8211;946 (2009).<pub-id pub-id-type="pmid">19229244</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cdd.2009.16</pub-id><pub-id pub-id-type="pmcid">PMC2768230</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Novak</surname><given-names>I</given-names></name><etal/></person-group><article-title>Nix is a selective autophagy receptor for mitochondrial clearance</article-title><source>EMBO Rep</source><year>2010</year><volume>11</volume><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1038/embor.2009.256</pub-id><pub-id pub-id-type="pmid">20010802</pub-id><pub-id pub-id-type="pmcid">PMC2816619</pub-id></element-citation><mixed-citation id="mc-CR104" publication-type="journal">Novak, I. et al. Nix is a selective autophagy receptor for mitochondrial clearance. <italic toggle="yes">EMBO Rep</italic>. <bold>11</bold>, 45&#8211;51 (2010).<pub-id pub-id-type="pmid">20010802</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/embor.2009.256</pub-id><pub-id pub-id-type="pmcid">PMC2816619</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Esteban-Mart&#237;nez</surname><given-names>L</given-names></name><etal/></person-group><article-title>Programmed mitophagy is essential for the glycolytic switch during cell differentiation</article-title><source>EMBO J</source><year>2017</year><volume>36</volume><fpage>1688</fpage><lpage>1706</lpage><pub-id pub-id-type="doi">10.15252/embj.201695916</pub-id><pub-id pub-id-type="pmid">28465321</pub-id><pub-id pub-id-type="pmcid">PMC5470043</pub-id></element-citation><mixed-citation id="mc-CR105" publication-type="journal">Esteban-Mart&#237;nez, L. et al. Programmed mitophagy is essential for the glycolytic switch during cell differentiation. <italic toggle="yes">EMBO J</italic>. <bold>36</bold>, 1688&#8211;1706 (2017).<pub-id pub-id-type="pmid">28465321</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.201695916</pub-id><pub-id pub-id-type="pmcid">PMC5470043</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koentjoro</surname><given-names>B</given-names></name><name name-style="western"><surname>Park</surname><given-names>J-S</given-names></name><name name-style="western"><surname>Sue</surname><given-names>CM</given-names></name></person-group><article-title>Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson&#8217;s disease</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>44373</fpage><pub-id pub-id-type="doi">10.1038/srep44373</pub-id><pub-id pub-id-type="pmid">28281653</pub-id><pub-id pub-id-type="pmcid">PMC5345073</pub-id></element-citation><mixed-citation id="mc-CR106" publication-type="journal">Koentjoro, B., Park, J.-S. &amp; Sue, C. M. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson&#8217;s disease. <italic toggle="yes">Sci. Rep.</italic><bold>7</bold>, 44373 (2017).<pub-id pub-id-type="pmid">28281653</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep44373</pub-id><pub-id pub-id-type="pmcid">PMC5345073</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><etal/></person-group><article-title>The E1B 19K/Bcl-2&#8211;binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis</article-title><source>J. Exp. Med.</source><year>1997</year><volume>186</volume><fpage>1975</fpage><lpage>1983</lpage><pub-id pub-id-type="doi">10.1084/jem.186.12.1975</pub-id><pub-id pub-id-type="pmid">9396766</pub-id><pub-id pub-id-type="pmcid">PMC2199165</pub-id></element-citation><mixed-citation id="mc-CR107" publication-type="journal">Chen, G. et al. The E1B 19K/Bcl-2&#8211;binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. <italic toggle="yes">J. Exp. Med.</italic><bold>186</bold>, 1975&#8211;1983 (1997).<pub-id pub-id-type="pmid">9396766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.186.12.1975</pub-id><pub-id pub-id-type="pmcid">PMC2199165</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yasuda</surname><given-names>M</given-names></name><name name-style="western"><surname>Theodorakis</surname><given-names>P</given-names></name><name name-style="western"><surname>Subramanian</surname><given-names>T</given-names></name><name name-style="western"><surname>Chinnadurai</surname><given-names>G</given-names></name></person-group><article-title>Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence</article-title><source>J. Biol. Chem.</source><year>1998</year><volume>273</volume><fpage>12415</fpage><lpage>12421</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.20.12415</pub-id><pub-id pub-id-type="pmid">9575197</pub-id></element-citation><mixed-citation id="mc-CR108" publication-type="journal">Yasuda, M., Theodorakis, P., Subramanian, T. &amp; Chinnadurai, G. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. <italic toggle="yes">J. Biol. Chem.</italic><bold>273</bold>, 12415&#8211;12421 (1998).<pub-id pub-id-type="pmid">9575197</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.273.20.12415</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ray</surname><given-names>R</given-names></name><etal/></person-group><article-title>BNIP3 heterodimerizes with Bcl-2/Bcl-XL and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>1439</fpage><lpage>1448</lpage><pub-id pub-id-type="doi">10.1074/jbc.275.2.1439</pub-id><pub-id pub-id-type="pmid">10625696</pub-id></element-citation><mixed-citation id="mc-CR109" publication-type="journal">Ray, R. et al. BNIP3 heterodimerizes with Bcl-2/Bcl-XL and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. <italic toggle="yes">J. Biol. Chem.</italic><bold>275</bold>, 1439&#8211;1448 (2000).<pub-id pub-id-type="pmid">10625696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.275.2.1439</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanna</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>19094</fpage><lpage>19104</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.322933</pub-id><pub-id pub-id-type="pmid">22505714</pub-id><pub-id pub-id-type="pmcid">PMC3365942</pub-id></element-citation><mixed-citation id="mc-CR110" publication-type="journal">Hanna, R. A. et al. Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. <italic toggle="yes">J. Biol. Chem.</italic><bold>287</bold>, 19094&#8211;19104 (2012).<pub-id pub-id-type="pmid">22505714</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M111.322933</pub-id><pub-id pub-id-type="pmcid">PMC3365942</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR111"><label>111.</label><citation-alternatives><element-citation id="ec-CR111" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marinkovi&#263;</surname><given-names>M</given-names></name><name name-style="western"><surname>&#352;prung</surname><given-names>M</given-names></name><name name-style="western"><surname>Novak</surname><given-names>I</given-names></name></person-group><article-title>Dimerization of mitophagy receptor BNIP3L/NIX is essential for recruitment of autophagic machinery</article-title><source>Autophagy</source><year>2021</year><volume>17</volume><fpage>1232</fpage><lpage>1243</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1755120</pub-id><pub-id pub-id-type="pmid">32286918</pub-id><pub-id pub-id-type="pmcid">PMC8143235</pub-id></element-citation><mixed-citation id="mc-CR111" publication-type="journal">Marinkovi&#263;, M., &#352;prung, M. &amp; Novak, I. Dimerization of mitophagy receptor BNIP3L/NIX is essential for recruitment of autophagic machinery. <italic toggle="yes">Autophagy</italic><bold>17</bold>, 1232&#8211;1243 (2021).<pub-id pub-id-type="pmid">32286918</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2020.1755120</pub-id><pub-id pub-id-type="pmcid">PMC8143235</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>P</given-names></name><name name-style="western"><surname>Chandel</surname><given-names>NS</given-names></name><name name-style="western"><surname>Simon</surname><given-names>MC</given-names></name></person-group><article-title>Cellular adaptation to hypoxia through hypoxia inducible factors and beyond</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2020</year><volume>21</volume><fpage>268</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-0227-y</pub-id><pub-id pub-id-type="pmid">32144406</pub-id><pub-id pub-id-type="pmcid">PMC7222024</pub-id></element-citation><mixed-citation id="mc-CR112" publication-type="journal">Lee, P., Chandel, N. S. &amp; Simon, M. C. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. <italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic><bold>21</bold>, 268&#8211;283 (2020).<pub-id pub-id-type="pmid">32144406</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41580-020-0227-y</pub-id><pub-id pub-id-type="pmcid">PMC7222024</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sowter</surname><given-names>HM</given-names></name><name name-style="western"><surname>Ratcliffe</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Watson</surname><given-names>P</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>AH</given-names></name><name name-style="western"><surname>Harris</surname><given-names>AL</given-names></name></person-group><article-title>HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors</article-title><source>Cancer Res.</source><year>2001</year><volume>61</volume><fpage>6669</fpage><lpage>6673</lpage><pub-id pub-id-type="pmid">11559532</pub-id></element-citation><mixed-citation id="mc-CR113" publication-type="journal">Sowter, H. M., Ratcliffe, P. J., Watson, P., Greenberg, A. H. &amp; Harris, A. L. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. <italic toggle="yes">Cancer Res.</italic><bold>61</bold>, 6669&#8211;6673 (2001).<pub-id pub-id-type="pmid">11559532</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR114"><label>114.</label><citation-alternatives><element-citation id="ec-CR114" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>K</given-names></name><etal/></person-group><article-title>Hypoxia induces the expression of the pro-apoptotic gene BNIP3</article-title><source>Cell Death Differ</source><year>2001</year><volume>8</volume><fpage>367</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4400810</pub-id><pub-id pub-id-type="pmid">11550088</pub-id></element-citation><mixed-citation id="mc-CR114" publication-type="journal">Guo, K. et al. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. <italic toggle="yes">Cell Death Differ</italic>. <bold>8</bold>, 367&#8211;376 (2001).<pub-id pub-id-type="pmid">11550088</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.cdd.4400810</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR115"><label>115.</label><citation-alternatives><element-citation id="ec-CR115" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>BNIP3L/NIX-mediated mitophagy: Molecular mechanisms and implications for human disease</article-title><source>Cell Death Dis</source><year>2021</year><volume>13</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s41419-021-04469-y</pub-id><pub-id pub-id-type="pmid">34930907</pub-id><pub-id pub-id-type="pmcid">PMC8688453</pub-id></element-citation><mixed-citation id="mc-CR115" publication-type="journal">Li, Y. et al. BNIP3L/NIX-mediated mitophagy: Molecular mechanisms and implications for human disease. <italic toggle="yes">Cell Death Dis</italic>. <bold>13</bold>, 1&#8211;11 (2021).<pub-id pub-id-type="pmid">34930907</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-021-04469-y</pub-id><pub-id pub-id-type="pmcid">PMC8688453</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR116"><label>116.</label><citation-alternatives><element-citation id="ec-CR116" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogov</surname><given-names>VV</given-names></name><etal/></person-group><article-title>Phosphorylation of the mitochondrial autophagy receptor Nix enhances its interaction with LC3 proteins</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>1131</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-01258-6</pub-id><pub-id pub-id-type="pmid">28442745</pub-id><pub-id pub-id-type="pmcid">PMC5430633</pub-id></element-citation><mixed-citation id="mc-CR116" publication-type="journal">Rogov, V. V. et al. Phosphorylation of the mitochondrial autophagy receptor Nix enhances its interaction with LC3 proteins. <italic toggle="yes">Sci. Rep.</italic><bold>7</bold>, 1131 (2017).<pub-id pub-id-type="pmid">28442745</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-017-01258-6</pub-id><pub-id pub-id-type="pmcid">PMC5430633</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR117"><label>117.</label><citation-alternatives><element-citation id="ec-CR117" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poole</surname><given-names>LP</given-names></name><name name-style="western"><surname>Bock-Hughes</surname><given-names>A</given-names></name><name name-style="western"><surname>Berardi</surname><given-names>DE</given-names></name><name name-style="western"><surname>Macleod</surname><given-names>KF</given-names></name></person-group><article-title>ULK1 promotes mitophagy via phosphorylation and stabilization of BNIP3</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><fpage>20526</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-00170-4</pub-id><pub-id pub-id-type="pmid">34654847</pub-id><pub-id pub-id-type="pmcid">PMC8519931</pub-id></element-citation><mixed-citation id="mc-CR117" publication-type="journal">Poole, L. P., Bock-Hughes, A., Berardi, D. E. &amp; Macleod, K. F. ULK1 promotes mitophagy via phosphorylation and stabilization of BNIP3. <italic toggle="yes">Sci. Rep.</italic><bold>11</bold>, 20526 (2021).<pub-id pub-id-type="pmid">34654847</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-021-00170-4</pub-id><pub-id pub-id-type="pmcid">PMC8519931</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR118"><label>118.</label><citation-alternatives><element-citation id="ec-CR118" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Y-L</given-names></name><etal/></person-group><article-title>BNIP3 phosphorylation by JNK1/2 promotes mitophagy via enhancing its stability under hypoxia</article-title><source>Cell Death Dis</source><year>2022</year><volume>13</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/s41419-022-05418-z</pub-id><pub-id pub-id-type="pmcid">PMC9672126</pub-id><pub-id pub-id-type="pmid">36396625</pub-id></element-citation><mixed-citation id="mc-CR118" publication-type="journal">He, Y.-L. et al. BNIP3 phosphorylation by JNK1/2 promotes mitophagy via enhancing its stability under hypoxia. <italic toggle="yes">Cell Death Dis</italic>. <bold>13</bold>, 1&#8211;13 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-022-05418-z</pub-id><pub-id pub-id-type="pmcid">PMC9672126</pub-id><pub-id pub-id-type="pmid">36396625</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR119"><label>119.</label><citation-alternatives><element-citation id="ec-CR119" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A mitochondrial SCF-FBXL4 ubiquitin E3 ligase complex degrades BNIP3 and NIX to restrain mitophagy and prevent mitochondrial disease</article-title><source>EMBO J</source><year>2023</year><volume>42</volume><fpage>e113033</fpage><pub-id pub-id-type="doi">10.15252/embj.2022113033</pub-id><pub-id pub-id-type="pmid">36896912</pub-id><pub-id pub-id-type="pmcid">PMC10308365</pub-id></element-citation><mixed-citation id="mc-CR119" publication-type="journal">Cao, Y. et al. A mitochondrial SCF-FBXL4 ubiquitin E3 ligase complex degrades BNIP3 and NIX to restrain mitophagy and prevent mitochondrial disease. <italic toggle="yes">EMBO J</italic>. <bold>42</bold>, e113033 (2023).<pub-id pub-id-type="pmid">36896912</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.2022113033</pub-id><pub-id pub-id-type="pmcid">PMC10308365</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR120"><label>120.</label><citation-alternatives><element-citation id="ec-CR120" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elcocks</surname><given-names>H</given-names></name><etal/></person-group><article-title>FBXL4 ubiquitin ligase deficiency promotes mitophagy by elevating NIX levels</article-title><source>EMBO J</source><year>2023</year><volume>42</volume><fpage>e112799</fpage><pub-id pub-id-type="doi">10.15252/embj.2022112799</pub-id><pub-id pub-id-type="pmid">37102372</pub-id><pub-id pub-id-type="pmcid">PMC10308357</pub-id></element-citation><mixed-citation id="mc-CR120" publication-type="journal">Elcocks, H. et al. FBXL4 ubiquitin ligase deficiency promotes mitophagy by elevating NIX levels. <italic toggle="yes">EMBO J</italic>. <bold>42</bold>, e112799 (2023).<pub-id pub-id-type="pmid">37102372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.2022112799</pub-id><pub-id pub-id-type="pmcid">PMC10308357</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR121"><label>121.</label><citation-alternatives><element-citation id="ec-CR121" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen-Dien</surname><given-names>GT</given-names></name><etal/></person-group><article-title>FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors</article-title><source>EMBO J</source><year>2023</year><volume>42</volume><fpage>e112767</fpage><pub-id pub-id-type="doi">10.15252/embj.2022112767</pub-id><pub-id pub-id-type="pmid">37161784</pub-id><pub-id pub-id-type="pmcid">PMC10308361</pub-id></element-citation><mixed-citation id="mc-CR121" publication-type="journal">Nguyen-Dien, G. T. et al. FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors. <italic toggle="yes">EMBO J</italic>. <bold>42</bold>, e112767 (2023).<pub-id pub-id-type="pmid">37161784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.2022112767</pub-id><pub-id pub-id-type="pmcid">PMC10308361</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR122"><label>122.</label><citation-alternatives><element-citation id="ec-CR122" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niemi</surname><given-names>NM</given-names></name><etal/></person-group><article-title>Pptc7 is an essential phosphatase for promoting mammalian mitochondrial metabolism and biogenesis</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>3197</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-11047-6</pub-id><pub-id pub-id-type="pmid">31324765</pub-id><pub-id pub-id-type="pmcid">PMC6642090</pub-id></element-citation><mixed-citation id="mc-CR122" publication-type="journal">Niemi, N. M. et al. Pptc7 is an essential phosphatase for promoting mammalian mitochondrial metabolism and biogenesis. <italic toggle="yes">Nat. Commun.</italic><bold>10</bold>, 3197 (2019).<pub-id pub-id-type="pmid">31324765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-019-11047-6</pub-id><pub-id pub-id-type="pmcid">PMC6642090</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR123"><label>123.</label><citation-alternatives><element-citation id="ec-CR123" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A mitophagy sensor PPTC7 controls BNIP3 and NIX degradation to regulate mitochondrial mass</article-title><source>Mol. Cell</source><year>2024</year><volume>84</volume><fpage>327</fpage><lpage>344.e9</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2023.11.038</pub-id><pub-id pub-id-type="pmid">38151018</pub-id></element-citation><mixed-citation id="mc-CR123" publication-type="journal">Sun, Y. et al. A mitophagy sensor PPTC7 controls BNIP3 and NIX degradation to regulate mitochondrial mass. <italic toggle="yes">Mol. Cell</italic><bold>84</bold>, 327&#8211;344.e9 (2024).<pub-id pub-id-type="pmid">38151018</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2023.11.038</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR124"><label>124.</label><citation-alternatives><element-citation id="ec-CR124" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen-Dien</surname><given-names>GT</given-names></name><etal/></person-group><article-title>PPTC7 antagonizes mitophagy by promoting BNIP3 and NIX degradation via SCFFBXL4</article-title><source>EMBO Rep</source><year>2024</year><volume>25</volume><fpage>3324</fpage><lpage>3347</lpage><pub-id pub-id-type="doi">10.1038/s44319-024-00181-y</pub-id><pub-id pub-id-type="pmid">38992176</pub-id><pub-id pub-id-type="pmcid">PMC11316107</pub-id></element-citation><mixed-citation id="mc-CR124" publication-type="journal">Nguyen-Dien, G. T. et al. PPTC7 antagonizes mitophagy by promoting BNIP3 and NIX degradation via SCFFBXL4. <italic toggle="yes">EMBO Rep</italic>. <bold>25</bold>, 3324&#8211;3347 (2024).<pub-id pub-id-type="pmid">38992176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s44319-024-00181-y</pub-id><pub-id pub-id-type="pmcid">PMC11316107</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR125"><label>125.</label><citation-alternatives><element-citation id="ec-CR125" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><etal/></person-group><article-title>PPTC7 acts as an essential co-factor of the SCFFBXL4 ubiquitin ligase complex to restrict BNIP3/3L-dependent mitophagy</article-title><source>Cell Death Dis</source><year>2025</year><volume>16</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s41419-025-07463-w</pub-id><pub-id pub-id-type="pmid">40025034</pub-id><pub-id pub-id-type="pmcid">PMC11873123</pub-id></element-citation><mixed-citation id="mc-CR125" publication-type="journal">Xu, X. et al. PPTC7 acts as an essential co-factor of the SCFFBXL4 ubiquitin ligase complex to restrict BNIP3/3L-dependent mitophagy. <italic toggle="yes">Cell Death Dis</italic>. <bold>16</bold>, 1&#8211;11 (2025).<pub-id pub-id-type="pmid">40025034</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-025-07463-w</pub-id><pub-id pub-id-type="pmcid">PMC11873123</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR126"><label>126.</label><citation-alternatives><element-citation id="ec-CR126" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name><etal/></person-group><article-title>BNIP3 protein suppresses PINK1 kinase proteolytic cleavage to promote mitophagy</article-title><source>J. Biol. Chem.</source><year>2016</year><volume>291</volume><fpage>21616</fpage><lpage>21629</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.733410</pub-id><pub-id pub-id-type="pmid">27528605</pub-id><pub-id pub-id-type="pmcid">PMC5076832</pub-id></element-citation><mixed-citation id="mc-CR126" publication-type="journal">Zhang, T. et al. BNIP3 protein suppresses PINK1 kinase proteolytic cleavage to promote mitophagy. <italic toggle="yes">J. Biol. Chem.</italic><bold>291</bold>, 21616&#8211;21629 (2016).<pub-id pub-id-type="pmid">27528605</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M116.733410</pub-id><pub-id pub-id-type="pmcid">PMC5076832</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR127"><label>127.</label><citation-alternatives><element-citation id="ec-CR127" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Landes</surname><given-names>T</given-names></name><etal/></person-group><article-title>The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms</article-title><source>EMBO Rep</source><year>2010</year><volume>11</volume><fpage>459</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1038/embor.2010.50</pub-id><pub-id pub-id-type="pmid">20436456</pub-id><pub-id pub-id-type="pmcid">PMC2892319</pub-id></element-citation><mixed-citation id="mc-CR127" publication-type="journal">Landes, T. et al. The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms. <italic toggle="yes">EMBO Rep</italic>. <bold>11</bold>, 459&#8211;465 (2010).<pub-id pub-id-type="pmid">20436456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/embor.2010.50</pub-id><pub-id pub-id-type="pmcid">PMC2892319</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR128"><label>128.</label><citation-alternatives><element-citation id="ec-CR128" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H-Y</given-names></name><name name-style="western"><surname>Hanna</surname><given-names>RA</given-names></name><name name-style="western"><surname>Gustafsson</surname><given-names>&#197;B</given-names></name></person-group><article-title>Mitochondrial autophagy by Bnip3 involves Drp1-mediated mitochondrial fission and recruitment of Parkin in cardiac myocytes</article-title><source>Am. J. Physiol. Heart Circ. Physiol.</source><year>2011</year><volume>301</volume><fpage>H1924</fpage><lpage>H1931</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00368.2011</pub-id><pub-id pub-id-type="pmid">21890690</pub-id><pub-id pub-id-type="pmcid">PMC3213962</pub-id></element-citation><mixed-citation id="mc-CR128" publication-type="journal">Lee, Y., Lee, H.-Y., Hanna, R. A. &amp; Gustafsson, &#197;. B. Mitochondrial autophagy by Bnip3 involves Drp1-mediated mitochondrial fission and recruitment of Parkin in cardiac myocytes. <italic toggle="yes">Am. J. Physiol. Heart Circ. Physiol.</italic><bold>301</bold>, H1924&#8211;H1931 (2011).<pub-id pub-id-type="pmid">21890690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpheart.00368.2011</pub-id><pub-id pub-id-type="pmcid">PMC3213962</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR129"><label>129.</label><citation-alternatives><element-citation id="ec-CR129" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>W-X</given-names></name><etal/></person-group><article-title>Nix Is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><fpage>27879</fpage><lpage>27890</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.119537</pub-id><pub-id pub-id-type="pmid">20573959</pub-id><pub-id pub-id-type="pmcid">PMC2934655</pub-id></element-citation><mixed-citation id="mc-CR129" publication-type="journal">Ding, W.-X. et al. Nix Is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. <italic toggle="yes">J. Biol. Chem.</italic><bold>285</bold>, 27879&#8211;27890 (2010).<pub-id pub-id-type="pmid">20573959</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M110.119537</pub-id><pub-id pub-id-type="pmcid">PMC2934655</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR130"><label>130.</label><citation-alternatives><element-citation id="ec-CR130" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>F</given-names></name><etal/></person-group><article-title>The mitochondrial protein BNIP3L is the substrate of PARK2 and mediates mitophagy in PINK1/PARK2 pathway</article-title><source>Hum. Mol. Genet.</source><year>2015</year><volume>24</volume><fpage>2528</fpage><lpage>2538</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv017</pub-id><pub-id pub-id-type="pmid">25612572</pub-id></element-citation><mixed-citation id="mc-CR130" publication-type="journal">Gao, F. et al. The mitochondrial protein BNIP3L is the substrate of PARK2 and mediates mitophagy in PINK1/PARK2 pathway. <italic toggle="yes">Hum. Mol. Genet.</italic><bold>24</bold>, 2528&#8211;2538 (2015).<pub-id pub-id-type="pmid">25612572</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/hmg/ddv017</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR131"><label>131.</label><citation-alternatives><element-citation id="ec-CR131" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells</article-title><source>Nat. Cell Biol.</source><year>2012</year><volume>14</volume><fpage>177</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1038/ncb2422</pub-id><pub-id pub-id-type="pmid">22267086</pub-id></element-citation><mixed-citation id="mc-CR131" publication-type="journal">Liu, L. et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. <italic toggle="yes">Nat. Cell Biol.</italic><bold>14</bold>, 177&#8211;185 (2012).<pub-id pub-id-type="pmid">22267086</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncb2422</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR132"><label>132.</label><citation-alternatives><element-citation id="ec-CR132" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><etal/></person-group><article-title>A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy</article-title><source>Mol. Cell</source><year>2014</year><volume>54</volume><fpage>362</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.02.034</pub-id><pub-id pub-id-type="pmid">24746696</pub-id></element-citation><mixed-citation id="mc-CR132" publication-type="journal">Chen, G. et al. A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy. <italic toggle="yes">Mol. Cell</italic><bold>54</bold>, 362&#8211;377 (2014).<pub-id pub-id-type="pmid">24746696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2014.02.034</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR133"><label>133.</label><citation-alternatives><element-citation id="ec-CR133" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lv</surname><given-names>M</given-names></name><etal/></person-group><article-title>Structural insights into the recognition of phosphorylated FUNDC1 by LC3B in mitophagy</article-title><source>Protein Cell</source><year>2017</year><volume>8</volume><fpage>25</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1007/s13238-016-0328-8</pub-id><pub-id pub-id-type="pmid">27757847</pub-id><pub-id pub-id-type="pmcid">PMC5233613</pub-id></element-citation><mixed-citation id="mc-CR133" publication-type="journal">Lv, M. et al. Structural insights into the recognition of phosphorylated FUNDC1 by LC3B in mitophagy. <italic toggle="yes">Protein Cell</italic><bold>8</bold>, 25&#8211;38 (2017).<pub-id pub-id-type="pmid">27757847</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13238-016-0328-8</pub-id><pub-id pub-id-type="pmcid">PMC5233613</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR134"><label>134.</label><citation-alternatives><element-citation id="ec-CR134" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>W</given-names></name><etal/></person-group><article-title>ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy</article-title><source>EMBO Rep</source><year>2014</year><volume>15</volume><fpage>566</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1002/embr.201438501</pub-id><pub-id pub-id-type="pmid">24671035</pub-id><pub-id pub-id-type="pmcid">PMC4210082</pub-id></element-citation><mixed-citation id="mc-CR134" publication-type="journal">Wu, W. et al. ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy. <italic toggle="yes">EMBO Rep</italic>. <bold>15</bold>, 566&#8211;575 (2014).<pub-id pub-id-type="pmid">24671035</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/embr.201438501</pub-id><pub-id pub-id-type="pmcid">PMC4210082</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR135"><label>135.</label><citation-alternatives><element-citation id="ec-CR135" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy</article-title><source>Autophagy</source><year>2016</year><volume>12</volume><fpage>689</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1080/15548627.2016.1151580</pub-id><pub-id pub-id-type="pmid">27050458</pub-id><pub-id pub-id-type="pmcid">PMC4836026</pub-id></element-citation><mixed-citation id="mc-CR135" publication-type="journal">Chen, M. et al. Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy. <italic toggle="yes">Autophagy</italic><bold>12</bold>, 689&#8211;702 (2016).<pub-id pub-id-type="pmid">27050458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2016.1151580</pub-id><pub-id pub-id-type="pmcid">PMC4836026</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR136"><label>136.</label><citation-alternatives><element-citation id="ec-CR136" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy</article-title><source>EMBO Rep</source><year>2017</year><volume>18</volume><fpage>495</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.15252/embr.201643309</pub-id><pub-id pub-id-type="pmid">28104734</pub-id><pub-id pub-id-type="pmcid">PMC5331199</pub-id></element-citation><mixed-citation id="mc-CR136" publication-type="journal">Chen, Z. et al. Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy. <italic toggle="yes">EMBO Rep</italic>. <bold>18</bold>, 495&#8211;509 (2017).<pub-id pub-id-type="pmid">28104734</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embr.201643309</pub-id><pub-id pub-id-type="pmcid">PMC5331199</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR137"><label>137.</label><citation-alternatives><element-citation id="ec-CR137" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chai</surname><given-names>P</given-names></name><etal/></person-group><article-title>USP19 promotes hypoxia-induced mitochondrial division via FUNDC1 at ER-mitochondria contact sites</article-title><source>J. Cell Biol.</source><year>2021</year><volume>220</volume><fpage>e202010006</fpage><pub-id pub-id-type="doi">10.1083/jcb.202010006</pub-id><pub-id pub-id-type="pmid">33978709</pub-id><pub-id pub-id-type="pmcid">PMC8127008</pub-id></element-citation><mixed-citation id="mc-CR137" publication-type="journal">Chai, P. et al. USP19 promotes hypoxia-induced mitochondrial division via FUNDC1 at ER-mitochondria contact sites. <italic toggle="yes">J. Cell Biol.</italic><bold>220</bold>, e202010006 (2021).<pub-id pub-id-type="pmid">33978709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.202010006</pub-id><pub-id pub-id-type="pmcid">PMC8127008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR138"><label>138.</label><citation-alternatives><element-citation id="ec-CR138" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murakawa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation</article-title><source>Nat. Commun.</source><year>2015</year><volume>6</volume><fpage>7527</fpage><pub-id pub-id-type="doi">10.1038/ncomms8527</pub-id><pub-id pub-id-type="pmid">26146385</pub-id><pub-id pub-id-type="pmcid">PMC4501433</pub-id></element-citation><mixed-citation id="mc-CR138" publication-type="journal">Murakawa, T. et al. Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation. <italic toggle="yes">Nat. Commun.</italic><bold>6</bold>, 7527 (2015).<pub-id pub-id-type="pmid">26146385</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms8527</pub-id><pub-id pub-id-type="pmcid">PMC4501433</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR139"><label>139.</label><citation-alternatives><element-citation id="ec-CR139" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kataoka</surname><given-names>T</given-names></name><etal/></person-group><article-title>Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>19548</fpage><lpage>19554</lpage><pub-id pub-id-type="doi">10.1074/jbc.M010520200</pub-id><pub-id pub-id-type="pmid">11262395</pub-id></element-citation><mixed-citation id="mc-CR139" publication-type="journal">Kataoka, T. et al. Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension. <italic toggle="yes">J. Biol. Chem.</italic><bold>276</bold>, 19548&#8211;19554 (2001).<pub-id pub-id-type="pmid">11262395</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M010520200</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR140"><label>140.</label><citation-alternatives><element-citation id="ec-CR140" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murakawa</surname><given-names>T</given-names></name><etal/></person-group><article-title>A mammalian mitophagy receptor, Bcl2-L-13, recruits the ULK1 complex to induce mitophagy</article-title><source>Cell Rep</source><year>2019</year><volume>26</volume><fpage>338</fpage><lpage>345.e6</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.12.050</pub-id><pub-id pub-id-type="pmid">30625316</pub-id><pub-id pub-id-type="pmcid">PMC6326162</pub-id></element-citation><mixed-citation id="mc-CR140" publication-type="journal">Murakawa, T. et al. A mammalian mitophagy receptor, Bcl2-L-13, recruits the ULK1 complex to induce mitophagy. <italic toggle="yes">Cell Rep</italic>. <bold>26</bold>, 338&#8211;345.e6 (2019).<pub-id pub-id-type="pmid">30625316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2018.12.050</pub-id><pub-id pub-id-type="pmcid">PMC6326162</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR141"><label>141.</label><citation-alternatives><element-citation id="ec-CR141" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>BCL2L13 promotes mitophagy through DNM1L-mediated mitochondrial fission in glioblastoma</article-title><source>Cell Death Dis</source><year>2023</year><volume>14</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">37660127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-023-06112-4</pub-id><pub-id pub-id-type="pmcid">PMC10475114</pub-id></element-citation><mixed-citation id="mc-CR141" publication-type="journal">Wang, J. et al. BCL2L13 promotes mitophagy through DNM1L-mediated mitochondrial fission in glioblastoma. <italic toggle="yes">Cell Death Dis</italic>. <bold>14</bold>, 1&#8211;13 (2023).<pub-id pub-id-type="pmid">37660127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-023-06112-4</pub-id><pub-id pub-id-type="pmcid">PMC10475114</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR142"><label>142.</label><citation-alternatives><element-citation id="ec-CR142" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>JH</given-names></name><etal/></person-group><article-title>ARL6IP1 gene delivery reduces neuroinflammation and neurodegenerative pathology in hereditary spastic paraplegia model</article-title><source>J. Exp. Med.</source><year>2023</year><volume>221</volume><fpage>e20230367</fpage><pub-id pub-id-type="doi">10.1084/jem.20230367</pub-id><pub-id pub-id-type="pmid">37934410</pub-id><pub-id pub-id-type="pmcid">PMC10630151</pub-id></element-citation><mixed-citation id="mc-CR142" publication-type="journal">Lim, J. H. et al. ARL6IP1 gene delivery reduces neuroinflammation and neurodegenerative pathology in hereditary spastic paraplegia model. <italic toggle="yes">J. Exp. Med.</italic><bold>221</bold>, e20230367 (2023).<pub-id pub-id-type="pmid">37934410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20230367</pub-id><pub-id pub-id-type="pmcid">PMC10630151</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR143"><label>143.</label><citation-alternatives><element-citation id="ec-CR143" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murakawa</surname><given-names>T</given-names></name><etal/></person-group><article-title>AMPK regulates Bcl2-L-13-mediated mitophagy induction for cardioprotection</article-title><source>Cell Rep</source><year>2024</year><volume>43</volume><fpage>115001</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2024.115001</pub-id><pub-id pub-id-type="pmid">39580803</pub-id><pub-id pub-id-type="pmcid">PMC11672683</pub-id></element-citation><mixed-citation id="mc-CR143" publication-type="journal">Murakawa, T. et al. AMPK regulates Bcl2-L-13-mediated mitophagy induction for cardioprotection. <italic toggle="yes">Cell Rep</italic>. <bold>43</bold>, 115001 (2024).<pub-id pub-id-type="pmid">39580803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2024.115001</pub-id><pub-id pub-id-type="pmcid">PMC11672683</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR144"><label>144.</label><citation-alternatives><element-citation id="ec-CR144" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shirane</surname><given-names>M</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>KI</given-names></name></person-group><article-title>Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis</article-title><source>Nat. Cell Biol.</source><year>2003</year><volume>5</volume><fpage>28</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/ncb894</pub-id><pub-id pub-id-type="pmid">12510191</pub-id></element-citation><mixed-citation id="mc-CR144" publication-type="journal">Shirane, M. &amp; Nakayama, K. I. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. <italic toggle="yes">Nat. Cell Biol.</italic><bold>5</bold>, 28&#8211;37 (2003).<pub-id pub-id-type="pmid">12510191</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncb894</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR145"><label>145.</label><citation-alternatives><element-citation id="ec-CR145" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhujabal</surname><given-names>Z</given-names></name><etal/></person-group><article-title>FKBP8 recruits LC3A to mediate Parkin-independent mitophagy</article-title><source>EMBO Rep</source><year>2017</year><volume>18</volume><fpage>947</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.15252/embr.201643147</pub-id><pub-id pub-id-type="pmid">28381481</pub-id><pub-id pub-id-type="pmcid">PMC5452039</pub-id></element-citation><mixed-citation id="mc-CR145" publication-type="journal">Bhujabal, Z. et al. FKBP8 recruits LC3A to mediate Parkin-independent mitophagy. <italic toggle="yes">EMBO Rep</italic>. <bold>18</bold>, 947&#8211;961 (2017).<pub-id pub-id-type="pmid">28381481</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embr.201643147</pub-id><pub-id pub-id-type="pmcid">PMC5452039</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR146"><label>146.</label><citation-alternatives><element-citation id="ec-CR146" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoo</surname><given-names>S-M</given-names></name><etal/></person-group><article-title>FKBP8 LIRL-dependent mitochondrial fragmentation facilitates mitophagy under stress conditions</article-title><source>FASEB J</source><year>2020</year><volume>34</volume><fpage>2944</fpage><lpage>2957</lpage><pub-id pub-id-type="doi">10.1096/fj.201901735R</pub-id><pub-id pub-id-type="pmid">31908024</pub-id></element-citation><mixed-citation id="mc-CR146" publication-type="journal">Yoo, S.-M. et al. FKBP8 LIRL-dependent mitochondrial fragmentation facilitates mitophagy under stress conditions. <italic toggle="yes">FASEB J</italic>. <bold>34</bold>, 2944&#8211;2957 (2020).<pub-id pub-id-type="pmid">31908024</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1096/fj.201901735R</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR147"><label>147.</label><citation-alternatives><element-citation id="ec-CR147" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saita</surname><given-names>S</given-names></name><name name-style="western"><surname>Shirane</surname><given-names>M</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>KI</given-names></name></person-group><article-title>Selective escape of proteins from the mitochondria during mitophagy</article-title><source>Nat. Commun.</source><year>2013</year><volume>4</volume><fpage>1410</fpage><pub-id pub-id-type="doi">10.1038/ncomms2400</pub-id><pub-id pub-id-type="pmid">23361001</pub-id></element-citation><mixed-citation id="mc-CR147" publication-type="journal">Saita, S., Shirane, M. &amp; Nakayama, K. I. Selective escape of proteins from the mitochondria during mitophagy. <italic toggle="yes">Nat. Commun.</italic><bold>4</bold>, 1410 (2013).<pub-id pub-id-type="pmid">23361001</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms2400</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR148"><label>148.</label><citation-alternatives><element-citation id="ec-CR148" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maria Fimia</surname><given-names>G</given-names></name><etal/></person-group><article-title>Ambra1 regulates autophagy and development of the nervous system</article-title><source>Nature</source><year>2007</year><volume>447</volume><fpage>1121</fpage><lpage>1125</lpage><pub-id pub-id-type="doi">10.1038/nature05925</pub-id><pub-id pub-id-type="pmid">17589504</pub-id></element-citation><mixed-citation id="mc-CR148" publication-type="journal">Maria Fimia, G. et al. Ambra1 regulates autophagy and development of the nervous system. <italic toggle="yes">Nature</italic><bold>447</bold>, 1121&#8211;1125 (2007).<pub-id pub-id-type="pmid">17589504</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature05925</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR149"><label>149.</label><citation-alternatives><element-citation id="ec-CR149" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaikovsky</surname><given-names>AC</given-names></name><etal/></person-group><article-title>The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D</article-title><source>Nature</source><year>2021</year><volume>592</volume><fpage>794</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03474-7</pub-id><pub-id pub-id-type="pmid">33854239</pub-id><pub-id pub-id-type="pmcid">PMC8246597</pub-id></element-citation><mixed-citation id="mc-CR149" publication-type="journal">Chaikovsky, A. C. et al. The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D. <italic toggle="yes">Nature</italic><bold>592</bold>, 794&#8211;798 (2021).<pub-id pub-id-type="pmid">33854239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-03474-7</pub-id><pub-id pub-id-type="pmcid">PMC8246597</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR150"><label>150.</label><citation-alternatives><element-citation id="ec-CR150" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simoneschi</surname><given-names>D</given-names></name><etal/></person-group><article-title>CRL4AMBRA1 is a master regulator of D-type cyclins</article-title><source>Nature</source><year>2021</year><volume>592</volume><fpage>789</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03445-y</pub-id><pub-id pub-id-type="pmid">33854235</pub-id><pub-id pub-id-type="pmcid">PMC8875297</pub-id></element-citation><mixed-citation id="mc-CR150" publication-type="journal">Simoneschi, D. et al. CRL4AMBRA1 is a master regulator of D-type cyclins. <italic toggle="yes">Nature</italic><bold>592</bold>, 789&#8211;793 (2021).<pub-id pub-id-type="pmid">33854235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-03445-y</pub-id><pub-id pub-id-type="pmcid">PMC8875297</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR151"><label>151.</label><citation-alternatives><element-citation id="ec-CR151" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maiani</surname><given-names>E</given-names></name><etal/></person-group><article-title>AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity</article-title><source>Nature</source><year>2021</year><volume>592</volume><fpage>799</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03422-5</pub-id><pub-id pub-id-type="pmid">33854232</pub-id><pub-id pub-id-type="pmcid">PMC8864551</pub-id></element-citation><mixed-citation id="mc-CR151" publication-type="journal">Maiani, E. et al. AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity. <italic toggle="yes">Nature</italic><bold>592</bold>, 799&#8211;803 (2021).<pub-id pub-id-type="pmid">33854232</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-03422-5</pub-id><pub-id pub-id-type="pmcid">PMC8864551</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR152"><label>152.</label><citation-alternatives><element-citation id="ec-CR152" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strappazzon</surname><given-names>F</given-names></name><etal/></person-group><article-title>AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1</article-title><source>Cell Death Differ</source><year>2015</year><volume>22</volume><fpage>419</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.139</pub-id><pub-id pub-id-type="pmid">25215947</pub-id><pub-id pub-id-type="pmcid">PMC4326570</pub-id></element-citation><mixed-citation id="mc-CR152" publication-type="journal">Strappazzon, F. et al. AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1. <italic toggle="yes">Cell Death Differ</italic>. <bold>22</bold>, 419&#8211;432 (2015).<pub-id pub-id-type="pmid">25215947</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cdd.2014.139</pub-id><pub-id pub-id-type="pmcid">PMC4326570</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR153"><label>153.</label><citation-alternatives><element-citation id="ec-CR153" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Humbeeck</surname><given-names>CV</given-names></name><etal/></person-group><article-title>Parkin interacts with Ambra1 to induce mitophagy</article-title><source>J. Neurosci.</source><year>2011</year><volume>31</volume><fpage>10249</fpage><lpage>10261</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1917-11.2011</pub-id><pub-id pub-id-type="pmid">21753002</pub-id><pub-id pub-id-type="pmcid">PMC6623066</pub-id></element-citation><mixed-citation id="mc-CR153" publication-type="journal">Humbeeck, C. V. et al. Parkin interacts with Ambra1 to induce mitophagy. <italic toggle="yes">J. Neurosci.</italic><bold>31</bold>, 10249&#8211;10261 (2011).<pub-id pub-id-type="pmid">21753002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1523/JNEUROSCI.1917-11.2011</pub-id><pub-id pub-id-type="pmcid">PMC6623066</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR154"><label>154.</label><citation-alternatives><element-citation id="ec-CR154" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Rienzo</surname><given-names>M</given-names></name><etal/></person-group><article-title>AMBRA1 regulates mitophagy by interacting with ATAD3A and promoting PINK1 stability</article-title><source>Autophagy</source><year>2022</year><volume>18</volume><fpage>1752</fpage><lpage>1762</lpage><pub-id pub-id-type="doi">10.1080/15548627.2021.1997052</pub-id><pub-id pub-id-type="pmid">34798798</pub-id><pub-id pub-id-type="pmcid">PMC9450973</pub-id></element-citation><mixed-citation id="mc-CR154" publication-type="journal">Di Rienzo, M. et al. AMBRA1 regulates mitophagy by interacting with ATAD3A and promoting PINK1 stability. <italic toggle="yes">Autophagy</italic><bold>18</bold>, 1752&#8211;1762 (2022).<pub-id pub-id-type="pmid">34798798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2021.1997052</pub-id><pub-id pub-id-type="pmcid">PMC9450973</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR155"><label>155.</label><citation-alternatives><element-citation id="ec-CR155" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Rita</surname><given-names>A</given-names></name><etal/></person-group><article-title>HUWE1 E3 ligase promotes PINK1/PARKIN-independent mitophagy by regulating AMBRA1 activation via IKK&#945;</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>3755</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-05722-3</pub-id><pub-id pub-id-type="pmid">30217973</pub-id><pub-id pub-id-type="pmcid">PMC6138665</pub-id></element-citation><mixed-citation id="mc-CR155" publication-type="journal">Di Rita, A. et al. HUWE1 E3 ligase promotes PINK1/PARKIN-independent mitophagy by regulating AMBRA1 activation via IKK&#945;. <italic toggle="yes">Nat. Commun.</italic><bold>9</bold>, 3755 (2018).<pub-id pub-id-type="pmid">30217973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-018-05722-3</pub-id><pub-id pub-id-type="pmcid">PMC6138665</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR156"><label>156.</label><citation-alternatives><element-citation id="ec-CR156" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Rienzo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Role of AMBRA1 in mitophagy regulation: Emerging evidence in aging-related diseases</article-title><source>Autophagy</source><year>2024</year><volume>20</volume><fpage>2602</fpage><lpage>2615</lpage><pub-id pub-id-type="doi">10.1080/15548627.2024.2389474</pub-id><pub-id pub-id-type="pmid">39113560</pub-id><pub-id pub-id-type="pmcid">PMC11587829</pub-id></element-citation><mixed-citation id="mc-CR156" publication-type="journal">Di Rienzo, M. et al. Role of AMBRA1 in mitophagy regulation: Emerging evidence in aging-related diseases. <italic toggle="yes">Autophagy</italic><bold>20</bold>, 2602&#8211;2615 (2024).<pub-id pub-id-type="pmid">39113560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2024.2389474</pub-id><pub-id pub-id-type="pmcid">PMC11587829</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR157"><label>157.</label><citation-alternatives><element-citation id="ec-CR157" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steglich</surname><given-names>G</given-names></name><name name-style="western"><surname>Neupert</surname><given-names>W</given-names></name><name name-style="western"><surname>Langer</surname><given-names>T</given-names></name></person-group><article-title>Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria</article-title><source>Mol. Cell. Biol.</source><year>1999</year><volume>19</volume><fpage>3435</fpage><lpage>3442</lpage><pub-id pub-id-type="doi">10.1128/MCB.19.5.3435</pub-id><pub-id pub-id-type="pmid">10207067</pub-id><pub-id pub-id-type="pmcid">PMC84136</pub-id></element-citation><mixed-citation id="mc-CR157" publication-type="journal">Steglich, G., Neupert, W. &amp; Langer, T. Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria. <italic toggle="yes">Mol. Cell. Biol.</italic><bold>19</bold>, 3435&#8211;3442 (1999).<pub-id pub-id-type="pmid">10207067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mcb.19.5.3435</pub-id><pub-id pub-id-type="pmcid">PMC84136</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR158"><label>158.</label><citation-alternatives><element-citation id="ec-CR158" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nijtmans</surname><given-names>LGJ</given-names></name><etal/></person-group><article-title>Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins</article-title><source>EMBO J</source><year>2000</year><volume>19</volume><fpage>2444</fpage><lpage>2451</lpage><pub-id pub-id-type="doi">10.1093/emboj/19.11.2444</pub-id><pub-id pub-id-type="pmid">10835343</pub-id><pub-id pub-id-type="pmcid">PMC212747</pub-id></element-citation><mixed-citation id="mc-CR158" publication-type="journal">Nijtmans, L. G. J. et al. Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. <italic toggle="yes">EMBO J</italic>. <bold>19</bold>, 2444&#8211;2451 (2000).<pub-id pub-id-type="pmid">10835343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/emboj/19.11.2444</pub-id><pub-id pub-id-type="pmcid">PMC212747</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR159"><label>159.</label><citation-alternatives><element-citation id="ec-CR159" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merkwirth</surname><given-names>C</given-names></name><name name-style="western"><surname>Langer</surname><given-names>T</given-names></name></person-group><article-title>Prohibitin function within mitochondria: Essential roles for cell proliferation and cristae morphogenesis</article-title><source>Biochim. Biophys. Acta</source><year>2009</year><volume>1793</volume><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2008.05.013</pub-id><pub-id pub-id-type="pmid">18558096</pub-id></element-citation><mixed-citation id="mc-CR159" publication-type="journal">Merkwirth, C. &amp; Langer, T. Prohibitin function within mitochondria: Essential roles for cell proliferation and cristae morphogenesis. <italic toggle="yes">Biochim. Biophys. Acta</italic>. <bold>1793</bold>, 27&#8211;32 (2009).<pub-id pub-id-type="pmid">18558096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbamcr.2008.05.013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR160"><label>160.</label><citation-alternatives><element-citation id="ec-CR160" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Artal-Sanz</surname><given-names>M</given-names></name><name name-style="western"><surname>Tavernarakis</surname><given-names>N</given-names></name></person-group><article-title>Prohibitin and mitochondrial biology</article-title><source>Trends Endocrinol. Metab.</source><year>2009</year><volume>20</volume><fpage>394</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2009.04.004</pub-id><pub-id pub-id-type="pmid">19733482</pub-id></element-citation><mixed-citation id="mc-CR160" publication-type="journal">Artal-Sanz, M. &amp; Tavernarakis, N. Prohibitin and mitochondrial biology. <italic toggle="yes">Trends Endocrinol. Metab.</italic><bold>20</bold>, 394&#8211;401 (2009).<pub-id pub-id-type="pmid">19733482</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tem.2009.04.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR161"><label>161.</label><citation-alternatives><element-citation id="ec-CR161" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>W-C</given-names></name><name name-style="western"><surname>Sumpter</surname><given-names>R</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>P</given-names></name><name name-style="western"><surname>Levine</surname><given-names>B</given-names></name></person-group><article-title>Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor</article-title><source>Cell</source><year>2017</year><volume>168</volume><fpage>224</fpage><lpage>238.e10</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.11.042</pub-id><pub-id pub-id-type="pmid">28017329</pub-id><pub-id pub-id-type="pmcid">PMC5235968</pub-id></element-citation><mixed-citation id="mc-CR161" publication-type="journal">Wei, Y., Chiang, W.-C., Sumpter, R., Mishra, P. &amp; Levine, B. Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor. <italic toggle="yes">Cell</italic><bold>168</bold>, 224&#8211;238.e10 (2017).<pub-id pub-id-type="pmid">28017329</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2016.11.042</pub-id><pub-id pub-id-type="pmcid">PMC5235968</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR162"><label>162.</label><citation-alternatives><element-citation id="ec-CR162" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>C</given-names></name><etal/></person-group><article-title>PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis</article-title><source>Autophagy</source><year>2020</year><volume>16</volume><fpage>419</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1080/15548627.2019.1628520</pub-id><pub-id pub-id-type="pmid">31177901</pub-id><pub-id pub-id-type="pmcid">PMC6999623</pub-id></element-citation><mixed-citation id="mc-CR162" publication-type="journal">Yan, C. et al. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis. <italic toggle="yes">Autophagy</italic><bold>16</bold>, 419&#8211;434 (2020).<pub-id pub-id-type="pmid">31177901</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2019.1628520</pub-id><pub-id pub-id-type="pmcid">PMC6999623</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR163"><label>163.</label><citation-alternatives><element-citation id="ec-CR163" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daum</surname><given-names>G</given-names></name></person-group><article-title>Lipids of mitochondria</article-title><source>Biochim. Biophys. Acta</source><year>1985</year><volume>822</volume><fpage>1</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/0304-4157(85)90002-4</pub-id><pub-id pub-id-type="pmid">2408671</pub-id></element-citation><mixed-citation id="mc-CR163" publication-type="journal">Daum, G. Lipids of mitochondria. <italic toggle="yes">Biochim. Biophys. Acta</italic>. <bold>822</bold>, 1&#8211;42 (1985).<pub-id pub-id-type="pmid">2408671</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0304-4157(85)90002-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR164"><label>164.</label><citation-alternatives><element-citation id="ec-CR164" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Decker</surname><given-names>ST</given-names></name><name name-style="western"><surname>Funai</surname><given-names>K</given-names></name></person-group><article-title>Mitochondrial membrane lipids in the regulation of bioenergetic flux</article-title><source>Cell Metab</source><year>2024</year><volume>36</volume><fpage>1963</fpage><lpage>1978</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2024.07.024</pub-id><pub-id pub-id-type="pmid">39178855</pub-id><pub-id pub-id-type="pmcid">PMC11374467</pub-id></element-citation><mixed-citation id="mc-CR164" publication-type="journal">Decker, S. T. &amp; Funai, K. Mitochondrial membrane lipids in the regulation of bioenergetic flux. <italic toggle="yes">Cell Metab</italic><bold>36</bold>, 1963&#8211;1978 (2024).<pub-id pub-id-type="pmid">39178855</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2024.07.024</pub-id><pub-id pub-id-type="pmcid">PMC11374467</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR165"><label>165.</label><citation-alternatives><element-citation id="ec-CR165" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Claypool</surname><given-names>SM</given-names></name><name name-style="western"><surname>Koehler</surname><given-names>CM</given-names></name></person-group><article-title>The complexity of cardiolipin in health and disease</article-title><source>Trends Biochem. Sci.</source><year>2012</year><volume>37</volume><fpage>32</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2011.09.003</pub-id><pub-id pub-id-type="pmid">22014644</pub-id><pub-id pub-id-type="pmcid">PMC3259273</pub-id></element-citation><mixed-citation id="mc-CR165" publication-type="journal">Claypool, S. M. &amp; Koehler, C. M. The complexity of cardiolipin in health and disease. <italic toggle="yes">Trends Biochem. Sci.</italic><bold>37</bold>, 32&#8211;41 (2012).<pub-id pub-id-type="pmid">22014644</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tibs.2011.09.003</pub-id><pub-id pub-id-type="pmcid">PMC3259273</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR166"><label>166.</label><citation-alternatives><element-citation id="ec-CR166" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>SB</given-names></name><etal/></person-group><article-title>Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria</article-title><source>Nat. Cell Biol.</source><year>2010</year><volume>12</volume><fpage>1154</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1038/ncb2119</pub-id><pub-id pub-id-type="pmid">21102437</pub-id><pub-id pub-id-type="pmcid">PMC2996476</pub-id></element-citation><mixed-citation id="mc-CR166" publication-type="journal">Singh, S. B. et al. Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. <italic toggle="yes">Nat. Cell Biol.</italic><bold>12</bold>, 1154&#8211;1165 (2010).<pub-id pub-id-type="pmid">21102437</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncb2119</pub-id><pub-id pub-id-type="pmcid">PMC2996476</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR167"><label>167.</label><citation-alternatives><element-citation id="ec-CR167" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>CT</given-names></name><etal/></person-group><article-title>Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells</article-title><source>Nat. Cell Biol.</source><year>2013</year><volume>15</volume><fpage>1197</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1038/ncb2837</pub-id><pub-id pub-id-type="pmid">24036476</pub-id><pub-id pub-id-type="pmcid">PMC3806088</pub-id></element-citation><mixed-citation id="mc-CR167" publication-type="journal">Chu, C. T. et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. <italic toggle="yes">Nat. Cell Biol.</italic><bold>15</bold>, 1197&#8211;1205 (2013).<pub-id pub-id-type="pmid">24036476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncb2837</pub-id><pub-id pub-id-type="pmcid">PMC3806088</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR168"><label>168.</label><mixed-citation publication-type="other">Iriondo, M. N. et al. LC3 subfamily in cardiolipin-mediated mitophagy: A comparison of the LC3A, LC3B and LC3C homologs. <italic toggle="yes">Autophagy</italic><bold>18</bold>, 2985&#8211;3003.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2022.2062111</pub-id><pub-id pub-id-type="pmcid">PMC9673933</pub-id><pub-id pub-id-type="pmid">35414338</pub-id></mixed-citation></ref><ref id="CR169"><label>169.</label><citation-alternatives><element-citation id="ec-CR169" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chao</surname><given-names>H</given-names></name><etal/></person-group><article-title>Cardiolipin-dependent mitophagy guides outcome after traumatic brain injury</article-title><source>J. Neurosci.</source><year>2019</year><volume>39</volume><fpage>1930</fpage><lpage>1943</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3415-17.2018</pub-id><pub-id pub-id-type="pmid">30626699</pub-id><pub-id pub-id-type="pmcid">PMC6407296</pub-id></element-citation><mixed-citation id="mc-CR169" publication-type="journal">Chao, H. et al. Cardiolipin-dependent mitophagy guides outcome after traumatic brain injury. <italic toggle="yes">J. Neurosci.</italic><bold>39</bold>, 1930&#8211;1943 (2019).<pub-id pub-id-type="pmid">30626699</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1523/JNEUROSCI.3415-17.2018</pub-id><pub-id pub-id-type="pmcid">PMC6407296</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR170"><label>170.</label><citation-alternatives><element-citation id="ec-CR170" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsu</surname><given-names>P</given-names></name><etal/></person-group><article-title>Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy</article-title><source>Autophagy</source><year>2015</year><volume>11</volume><fpage>643</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1080/15548627.2015.1023984</pub-id><pub-id pub-id-type="pmid">25919711</pub-id><pub-id pub-id-type="pmcid">PMC4502692</pub-id></element-citation><mixed-citation id="mc-CR170" publication-type="journal">Hsu, P. et al. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy. <italic toggle="yes">Autophagy</italic><bold>11</bold>, 643&#8211;652 (2015).<pub-id pub-id-type="pmid">25919711</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2015.1023984</pub-id><pub-id pub-id-type="pmcid">PMC4502692</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR171"><label>171.</label><citation-alternatives><element-citation id="ec-CR171" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Crystal structure and biochemical analyses reveal Beclin 1 as a novel membrane binding protein</article-title><source>Cell Res.</source><year>2012</year><volume>22</volume><fpage>473</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1038/cr.2012.24</pub-id><pub-id pub-id-type="pmid">22310240</pub-id><pub-id pub-id-type="pmcid">PMC3292424</pub-id></element-citation><mixed-citation id="mc-CR171" publication-type="journal">Huang, W. et al. Crystal structure and biochemical analyses reveal Beclin 1 as a novel membrane binding protein. <italic toggle="yes">Cell Res.</italic><bold>22</bold>, 473&#8211;489 (2012).<pub-id pub-id-type="pmid">22310240</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cr.2012.24</pub-id><pub-id pub-id-type="pmcid">PMC3292424</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR172"><label>172.</label><citation-alternatives><element-citation id="ec-CR172" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ban</surname><given-names>T</given-names></name><name name-style="western"><surname>Heymann</surname><given-names>JAW</given-names></name><name name-style="western"><surname>Song</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hinshaw</surname><given-names>JE</given-names></name><name name-style="western"><surname>Chan</surname><given-names>DC</given-names></name></person-group><article-title>OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation</article-title><source>Hum. Mol. Genet.</source><year>2010</year><volume>19</volume><fpage>2113</fpage><lpage>2122</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddq088</pub-id><pub-id pub-id-type="pmid">20185555</pub-id><pub-id pub-id-type="pmcid">PMC2865371</pub-id></element-citation><mixed-citation id="mc-CR172" publication-type="journal">Ban, T., Heymann, J. A. W., Song, Z., Hinshaw, J. E. &amp; Chan, D. C. OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation. <italic toggle="yes">Hum. Mol. Genet.</italic><bold>19</bold>, 2113&#8211;2122 (2010).<pub-id pub-id-type="pmid">20185555</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/hmg/ddq088</pub-id><pub-id pub-id-type="pmcid">PMC2865371</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR173"><label>173.</label><citation-alternatives><element-citation id="ec-CR173" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montessuit</surname><given-names>S</given-names></name><etal/></person-group><article-title>Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization</article-title><source>Cell</source><year>2010</year><volume>142</volume><fpage>889</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.08.017</pub-id><pub-id pub-id-type="pmid">20850011</pub-id><pub-id pub-id-type="pmcid">PMC4115189</pub-id></element-citation><mixed-citation id="mc-CR173" publication-type="journal">Montessuit, S. et al. Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. <italic toggle="yes">Cell</italic><bold>142</bold>, 889&#8211;901 (2010).<pub-id pub-id-type="pmid">20850011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2010.08.017</pub-id><pub-id pub-id-type="pmcid">PMC4115189</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR174"><label>174.</label><citation-alternatives><element-citation id="ec-CR174" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bustillo-Zabalbeitia</surname><given-names>I</given-names></name><etal/></person-group><article-title>Specific interaction with cardiolipin triggers functional activation of dynamin-related protein 1</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e102738</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0102738</pub-id><pub-id pub-id-type="pmid">25036098</pub-id><pub-id pub-id-type="pmcid">PMC4103857</pub-id></element-citation><mixed-citation id="mc-CR174" publication-type="journal">Bustillo-Zabalbeitia, I. et al. Specific interaction with cardiolipin triggers functional activation of dynamin-related protein 1. <italic toggle="yes">PLoS One</italic><bold>9</bold>, e102738 (2014).<pub-id pub-id-type="pmid">25036098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0102738</pub-id><pub-id pub-id-type="pmcid">PMC4103857</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR175"><label>175.</label><citation-alternatives><element-citation id="ec-CR175" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tokarska-Schlattner</surname><given-names>M</given-names></name><etal/></person-group><article-title>The nucleoside diphosphate kinase D (NM23-H4) binds the inner mitochondrial membrane with high affinity to cardiolipin and couples nucleotide transfer with respiration</article-title><source>J. Biol. Chem.</source><year>2008</year><volume>283</volume><fpage>26198</fpage><lpage>26207</lpage><pub-id pub-id-type="doi">10.1074/jbc.M803132200</pub-id><pub-id pub-id-type="pmid">18635542</pub-id><pub-id pub-id-type="pmcid">PMC3258864</pub-id></element-citation><mixed-citation id="mc-CR175" publication-type="journal">Tokarska-Schlattner, M. et al. The nucleoside diphosphate kinase D (NM23-H4) binds the inner mitochondrial membrane with high affinity to cardiolipin and couples nucleotide transfer with respiration. <italic toggle="yes">J. Biol. Chem.</italic><bold>283</bold>, 26198&#8211;26207 (2008).<pub-id pub-id-type="pmid">18635542</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M803132200</pub-id><pub-id pub-id-type="pmcid">PMC3258864</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR176"><label>176.</label><citation-alternatives><element-citation id="ec-CR176" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kagan</surname><given-names>VE</given-names></name><etal/></person-group><article-title>NDPK-D (NM23-H4)-mediated externalization of cardiolipin enables elimination of depolarized mitochondria by mitophagy</article-title><source>Cell Death Differ</source><year>2016</year><volume>23</volume><fpage>1140</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1038/cdd.2015.160</pub-id><pub-id pub-id-type="pmid">26742431</pub-id><pub-id pub-id-type="pmcid">PMC4946882</pub-id></element-citation><mixed-citation id="mc-CR176" publication-type="journal">Kagan, V. E. et al. NDPK-D (NM23-H4)-mediated externalization of cardiolipin enables elimination of depolarized mitochondria by mitophagy. <italic toggle="yes">Cell Death Differ</italic>. <bold>23</bold>, 1140&#8211;1151 (2016).<pub-id pub-id-type="pmid">26742431</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cdd.2015.160</pub-id><pub-id pub-id-type="pmcid">PMC4946882</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR177"><label>177.</label><citation-alternatives><element-citation id="ec-CR177" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turpin-Nolan</surname><given-names>SM</given-names></name><name name-style="western"><surname>Br&#252;ning</surname><given-names>JC</given-names></name></person-group><article-title>The role of ceramides in metabolic disorders: When size and localization matters</article-title><source>Nat. Rev. Endocrinol.</source><year>2020</year><volume>16</volume><fpage>224</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1038/s41574-020-0320-5</pub-id><pub-id pub-id-type="pmid">32060415</pub-id></element-citation><mixed-citation id="mc-CR177" publication-type="journal">Turpin-Nolan, S. M. &amp; Br&#252;ning, J. C. The role of ceramides in metabolic disorders: When size and localization matters. <italic toggle="yes">Nat. Rev. Endocrinol.</italic><bold>16</bold>, 224&#8211;233 (2020).<pub-id pub-id-type="pmid">32060415</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41574-020-0320-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR178"><label>178.</label><citation-alternatives><element-citation id="ec-CR178" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sentelle</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy</article-title><source>Nat. Chem. Biol.</source><year>2012</year><volume>8</volume><fpage>831</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1059</pub-id><pub-id pub-id-type="pmid">22922758</pub-id><pub-id pub-id-type="pmcid">PMC3689583</pub-id></element-citation><mixed-citation id="mc-CR178" publication-type="journal">Sentelle, R. D. et al. Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. <italic toggle="yes">Nat. Chem. Biol.</italic><bold>8</bold>, 831&#8211;838 (2012).<pub-id pub-id-type="pmid">22922758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nchembio.1059</pub-id><pub-id pub-id-type="pmcid">PMC3689583</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR179"><label>179.</label><citation-alternatives><element-citation id="ec-CR179" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oleinik</surname><given-names>N</given-names></name><etal/></person-group><article-title>Alterations of lipid-mediated mitophagy result in aging-dependent sensorimotor defects</article-title><source>Aging Cell</source><year>2023</year><volume>22</volume><fpage>e13954</fpage><pub-id pub-id-type="doi">10.1111/acel.13954</pub-id><pub-id pub-id-type="pmid">37614052</pub-id><pub-id pub-id-type="pmcid">PMC10577547</pub-id></element-citation><mixed-citation id="mc-CR179" publication-type="journal">Oleinik, N. et al. Alterations of lipid-mediated mitophagy result in aging-dependent sensorimotor defects. <italic toggle="yes">Aging Cell</italic><bold>22</bold>, e13954 (2023).<pub-id pub-id-type="pmid">37614052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/acel.13954</pub-id><pub-id pub-id-type="pmcid">PMC10577547</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR180"><label>180.</label><citation-alternatives><element-citation id="ec-CR180" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wohlwend</surname><given-names>M</given-names></name><etal/></person-group><article-title>Inhibition of CERS1 in skeletal muscle exacerbates age-related muscle dysfunction</article-title><source>eLife</source><year>2024</year><volume>12</volume><fpage>RP90522</fpage><pub-id pub-id-type="doi">10.7554/eLife.90522.3</pub-id><pub-id pub-id-type="pmid">38506902</pub-id><pub-id pub-id-type="pmcid">PMC10954306</pub-id></element-citation><mixed-citation id="mc-CR180" publication-type="journal">Wohlwend, M. et al. Inhibition of CERS1 in skeletal muscle exacerbates age-related muscle dysfunction. <italic toggle="yes">eLife</italic><bold>12</bold>, RP90522 (2024).<pub-id pub-id-type="pmid">38506902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.90522</pub-id><pub-id pub-id-type="pmcid">PMC10954306</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR181"><label>181.</label><citation-alternatives><element-citation id="ec-CR181" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vos</surname><given-names>M</given-names></name><etal/></person-group><article-title>Ceramide accumulation induces mitophagy and impairs &#946;-oxidation in PINK1 deficiency</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2021</year><volume>118</volume><fpage>e2025347118</fpage><pub-id pub-id-type="doi">10.1073/pnas.2025347118</pub-id><pub-id pub-id-type="pmid">34686591</pub-id><pub-id pub-id-type="pmcid">PMC8639384</pub-id></element-citation><mixed-citation id="mc-CR181" publication-type="journal">Vos, M. et al. Ceramide accumulation induces mitophagy and impairs &#946;-oxidation in PINK1 deficiency. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>118</bold>, e2025347118 (2021).<pub-id pub-id-type="pmid">34686591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2025347118</pub-id><pub-id pub-id-type="pmcid">PMC8639384</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR182"><label>182.</label><citation-alternatives><element-citation id="ec-CR182" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Guerrou&#233;</surname><given-names>F</given-names></name><etal/></person-group><article-title>Autophagosomal content profiling reveals an LC3C-dependent piecemeal mitophagy pathway</article-title><source>Mol. Cell</source><year>2017</year><volume>68</volume><fpage>786</fpage><lpage>796.e6</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.10.029</pub-id><pub-id pub-id-type="pmid">29149599</pub-id></element-citation><mixed-citation id="mc-CR182" publication-type="journal">Le Guerrou&#233;, F. et al. Autophagosomal content profiling reveals an LC3C-dependent piecemeal mitophagy pathway. <italic toggle="yes">Mol. Cell</italic><bold>68</bold>, 786&#8211;796.e6 (2017).<pub-id pub-id-type="pmid">29149599</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2017.10.029</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR183"><label>183.</label><citation-alternatives><element-citation id="ec-CR183" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abudu</surname><given-names>YP</given-names></name><etal/></person-group><article-title>SAMM50 acts with p62 in piecemeal basal- and OXPHOS-induced mitophagy of SAM and MICOS components</article-title><source>J. Cell Biol.</source><year>2021</year><volume>220</volume><fpage>e202009092</fpage><pub-id pub-id-type="doi">10.1083/jcb.202009092</pub-id><pub-id pub-id-type="pmid">34037656</pub-id><pub-id pub-id-type="pmcid">PMC8160579</pub-id></element-citation><mixed-citation id="mc-CR183" publication-type="journal">Abudu, Y. P. et al. SAMM50 acts with p62 in piecemeal basal- and OXPHOS-induced mitophagy of SAM and MICOS components. <italic toggle="yes">J. Cell Biol.</italic><bold>220</bold>, e202009092 (2021).<pub-id pub-id-type="pmid">34037656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.202009092</pub-id><pub-id pub-id-type="pmcid">PMC8160579</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR184"><label>184.</label><citation-alternatives><element-citation id="ec-CR184" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trachsel-Moncho</surname><given-names>L</given-names></name><etal/></person-group><article-title>SNX10 functions as a modulator of piecemeal mitophagy and mitochondrial bioenergetics</article-title><source>J. Cell Biol.</source><year>2025</year><volume>224</volume><fpage>e202404009</fpage><pub-id pub-id-type="doi">10.1083/jcb.202404009</pub-id><pub-id pub-id-type="pmid">40052924</pub-id><pub-id pub-id-type="pmcid">PMC11893173</pub-id></element-citation><mixed-citation id="mc-CR184" publication-type="journal">Trachsel-Moncho, L. et al. SNX10 functions as a modulator of piecemeal mitophagy and mitochondrial bioenergetics. <italic toggle="yes">J. Cell Biol.</italic><bold>224</bold>, e202404009 (2025).<pub-id pub-id-type="pmid">40052924</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.202404009</pub-id><pub-id pub-id-type="pmcid">PMC11893173</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR185"><label>185.</label><citation-alternatives><element-citation id="ec-CR185" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shu</surname><given-names>L</given-names></name><etal/></person-group><article-title>ATAD3B is a mitophagy receptor mediating clearance of oxidative stress-induced damaged mitochondrial DNA</article-title><source>EMBO J</source><year>2021</year><volume>40</volume><fpage>e106283</fpage><pub-id pub-id-type="doi">10.15252/embj.2020106283</pub-id><pub-id pub-id-type="pmid">33665835</pub-id><pub-id pub-id-type="pmcid">PMC8047441</pub-id></element-citation><mixed-citation id="mc-CR185" publication-type="journal">Shu, L. et al. ATAD3B is a mitophagy receptor mediating clearance of oxidative stress-induced damaged mitochondrial DNA. <italic toggle="yes">EMBO J</italic>. <bold>40</bold>, e106283 (2021).<pub-id pub-id-type="pmid">33665835</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.2020106283</pub-id><pub-id pub-id-type="pmcid">PMC8047441</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR186"><label>186.</label><citation-alternatives><element-citation id="ec-CR186" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Inter-tissue communication of mitochondrial stress and metabolic health</article-title><source>Life Metab.</source><year>2023</year><volume>2</volume><fpage>load001</fpage><pub-id pub-id-type="doi">10.1093/lifemeta/load001</pub-id><pub-id pub-id-type="pmid">37538245</pub-id><pub-id pub-id-type="pmcid">PMC10399134</pub-id></element-citation><mixed-citation id="mc-CR186" publication-type="journal">Zhang, H. et al. Inter-tissue communication of mitochondrial stress and metabolic health. <italic toggle="yes">Life Metab.</italic><bold>2</bold>, load001 (2023).<pub-id pub-id-type="pmid">37538245</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/lifemeta/load001</pub-id><pub-id pub-id-type="pmcid">PMC10399134</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR187"><label>187.</label><citation-alternatives><element-citation id="ec-CR187" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Menzies</surname><given-names>RA</given-names></name><name name-style="western"><surname>Gold</surname><given-names>PH</given-names></name></person-group><article-title>The turnover of mitochondria in a variety of tissues of young adult and aged rats</article-title><source>J. Biol. Chem.</source><year>1971</year><volume>246</volume><fpage>2425</fpage><lpage>2429</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)62305-1</pub-id><pub-id pub-id-type="pmid">5553400</pub-id></element-citation><mixed-citation id="mc-CR187" publication-type="journal">Menzies, R. A. &amp; Gold, P. H. The turnover of mitochondria in a variety of tissues of young adult and aged rats. <italic toggle="yes">J. Biol. Chem.</italic><bold>246</bold>, 2425&#8211;2429 (1971).<pub-id pub-id-type="pmid">5553400</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR188"><label>188.</label><citation-alternatives><element-citation id="ec-CR188" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodolfo</surname><given-names>C</given-names></name><name name-style="western"><surname>Campello</surname><given-names>S</given-names></name><name name-style="western"><surname>Cecconi</surname><given-names>F</given-names></name></person-group><article-title>Mitophagy in neurodegenerative diseases</article-title><source>Neurochem. Int.</source><year>2018</year><volume>117</volume><fpage>156</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2017.08.004</pub-id><pub-id pub-id-type="pmid">28797885</pub-id></element-citation><mixed-citation id="mc-CR188" publication-type="journal">Rodolfo, C., Campello, S. &amp; Cecconi, F. Mitophagy in neurodegenerative diseases. <italic toggle="yes">Neurochem. Int.</italic><bold>117</bold>, 156&#8211;166 (2018).<pub-id pub-id-type="pmid">28797885</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuint.2017.08.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR189"><label>189.</label><citation-alternatives><element-citation id="ec-CR189" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Killackey</surname><given-names>SA</given-names></name><name name-style="western"><surname>Philpott</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Girardin</surname><given-names>SE</given-names></name></person-group><article-title>Mitophagy pathways in health and disease</article-title><source>J. Cell Biol.</source><year>2020</year><volume>219</volume><fpage>e202004029</fpage><pub-id pub-id-type="doi">10.1083/jcb.202004029</pub-id><pub-id pub-id-type="pmid">32926082</pub-id><pub-id pub-id-type="pmcid">PMC7594502</pub-id></element-citation><mixed-citation id="mc-CR189" publication-type="journal">Killackey, S. A., Philpott, D. J. &amp; Girardin, S. E. Mitophagy pathways in health and disease. <italic toggle="yes">J. Cell Biol.</italic><bold>219</bold>, e202004029 (2020).<pub-id pub-id-type="pmid">32926082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.202004029</pub-id><pub-id pub-id-type="pmcid">PMC7594502</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR190"><label>190.</label><citation-alternatives><element-citation id="ec-CR190" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antico</surname><given-names>O</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>PW</given-names></name><name name-style="western"><surname>Hertz</surname><given-names>NT</given-names></name><name name-style="western"><surname>Muqit</surname><given-names>MMK</given-names></name><name name-style="western"><surname>Parton</surname><given-names>LE</given-names></name></person-group><article-title>Targeting mitophagy in neurodegenerative diseases</article-title><source>Nat. Rev. Drug Discov.</source><year>2025</year><volume>24</volume><fpage>276</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1038/s41573-024-01105-0</pub-id><pub-id pub-id-type="pmid">39809929</pub-id></element-citation><mixed-citation id="mc-CR190" publication-type="journal">Antico, O., Thompson, P. W., Hertz, N. T., Muqit, M. M. K. &amp; Parton, L. E. Targeting mitophagy in neurodegenerative diseases. <italic toggle="yes">Nat. Rev. Drug Discov.</italic><bold>24</bold>, 276&#8211;299 (2025).<pub-id pub-id-type="pmid">39809929</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41573-024-01105-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR191"><label>191.</label><citation-alternatives><element-citation id="ec-CR191" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pickrell</surname><given-names>AM</given-names></name><name name-style="western"><surname>Youle</surname><given-names>RJ</given-names></name></person-group><article-title>The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson&#8217;s disease</article-title><source>Neuron</source><year>2015</year><volume>85</volume><fpage>257</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.007</pub-id><pub-id pub-id-type="pmid">25611507</pub-id><pub-id pub-id-type="pmcid">PMC4764997</pub-id></element-citation><mixed-citation id="mc-CR191" publication-type="journal">Pickrell, A. M. &amp; Youle, R. J. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson&#8217;s disease. <italic toggle="yes">Neuron</italic><bold>85</bold>, 257&#8211;273 (2015).<pub-id pub-id-type="pmid">25611507</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuron.2014.12.007</pub-id><pub-id pub-id-type="pmcid">PMC4764997</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR192"><label>192.</label><citation-alternatives><element-citation id="ec-CR192" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ge</surname><given-names>P</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>VL</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>TM</given-names></name></person-group><article-title>PINK1 and Parkin mitochondrial quality control: A source of regional vulnerability in Parkinson&#8217;s disease</article-title><source>Mol. Neurodegener.</source><year>2020</year><volume>15</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.1186/s13024-020-00367-7</pub-id><pub-id pub-id-type="pmid">32169097</pub-id><pub-id pub-id-type="pmcid">PMC7071653</pub-id></element-citation><mixed-citation id="mc-CR192" publication-type="journal">Ge, P., Dawson, V. L. &amp; Dawson, T. M. PINK1 and Parkin mitochondrial quality control: A source of regional vulnerability in Parkinson&#8217;s disease. <italic toggle="yes">Mol. Neurodegener.</italic><bold>15</bold>, 20 (2020).<pub-id pub-id-type="pmid">32169097</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13024-020-00367-7</pub-id><pub-id pub-id-type="pmcid">PMC7071653</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR193"><label>193.</label><citation-alternatives><element-citation id="ec-CR193" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bandres-Ciga</surname><given-names>S</given-names></name><name name-style="western"><surname>Diez-Fairen</surname><given-names>M</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Singleton</surname><given-names>AB</given-names></name></person-group><article-title>Genetics of Parkinson&#8217;s disease: An introspection of its journey towards precision medicine</article-title><source>Neurobiol. Dis.</source><year>2020</year><volume>137</volume><fpage>104782</fpage><pub-id pub-id-type="doi">10.1016/j.nbd.2020.104782</pub-id><pub-id pub-id-type="pmid">31991247</pub-id><pub-id pub-id-type="pmcid">PMC7064061</pub-id></element-citation><mixed-citation id="mc-CR193" publication-type="journal">Bandres-Ciga, S., Diez-Fairen, M., Kim, J. J. &amp; Singleton, A. B. Genetics of Parkinson&#8217;s disease: An introspection of its journey towards precision medicine. <italic toggle="yes">Neurobiol. Dis.</italic><bold>137</bold>, 104782 (2020).<pub-id pub-id-type="pmid">31991247</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nbd.2020.104782</pub-id><pub-id pub-id-type="pmcid">PMC7064061</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR194"><label>194.</label><citation-alternatives><element-citation id="ec-CR194" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>H</given-names></name><name name-style="western"><surname>Robak</surname><given-names>LA</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M</given-names></name><name name-style="western"><surname>Cykowski</surname><given-names>M</given-names></name><name name-style="western"><surname>Shulman</surname><given-names>JM</given-names></name></person-group><article-title>Genetics and pathogenesis of Parkinson&#8217;s syndrome</article-title><source>Annu. Rev. Pathol.</source><year>2023</year><volume>18</volume><fpage>95</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1146/annurev-pathmechdis-031521-034145</pub-id><pub-id pub-id-type="pmid">36100231</pub-id><pub-id pub-id-type="pmcid">PMC10290758</pub-id></element-citation><mixed-citation id="mc-CR194" publication-type="journal">Ye, H., Robak, L. A., Yu, M., Cykowski, M. &amp; Shulman, J. M. Genetics and pathogenesis of Parkinson&#8217;s syndrome. <italic toggle="yes">Annu. Rev. Pathol.</italic><bold>18</bold>, 95&#8211;121 (2023).<pub-id pub-id-type="pmid">36100231</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-pathmechdis-031521-034145</pub-id><pub-id pub-id-type="pmcid">PMC10290758</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR195"><label>195.</label><citation-alternatives><element-citation id="ec-CR195" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Multi-ancestry genome-wide association meta-analysis of Parkinson&#8217;s disease</article-title><source>Nat. Genet.</source><year>2024</year><volume>56</volume><fpage>27</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1038/s41588-023-01584-8</pub-id><pub-id pub-id-type="pmid">38155330</pub-id><pub-id pub-id-type="pmcid">PMC10786718</pub-id></element-citation><mixed-citation id="mc-CR195" publication-type="journal">Kim, J. J. et al. Multi-ancestry genome-wide association meta-analysis of Parkinson&#8217;s disease. <italic toggle="yes">Nat. Genet.</italic><bold>56</bold>, 27&#8211;36 (2024).<pub-id pub-id-type="pmid">38155330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41588-023-01584-8</pub-id><pub-id pub-id-type="pmcid">PMC10786718</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR196"><label>196.</label><citation-alternatives><element-citation id="ec-CR196" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winklhofer</surname><given-names>KF</given-names></name><name name-style="western"><surname>Henn</surname><given-names>IH</given-names></name><name name-style="western"><surname>Kay-Jackson</surname><given-names>PC</given-names></name><name name-style="western"><surname>Heller</surname><given-names>U</given-names></name><name name-style="western"><surname>Tatzelt</surname><given-names>J</given-names></name></person-group><article-title>Inactivation of Parkin by oxidative stress and C-terminal truncations: A protective role of molecular chaperones</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>47199</fpage><lpage>47208</lpage><pub-id pub-id-type="doi">10.1074/jbc.M306769200</pub-id><pub-id pub-id-type="pmid">12972428</pub-id></element-citation><mixed-citation id="mc-CR196" publication-type="journal">Winklhofer, K. F., Henn, I. H., Kay-Jackson, P. C., Heller, U. &amp; Tatzelt, J. Inactivation of Parkin by oxidative stress and C-terminal truncations: A protective role of molecular chaperones. <italic toggle="yes">J. Biol. Chem.</italic><bold>278</bold>, 47199&#8211;47208 (2003).<pub-id pub-id-type="pmid">12972428</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M306769200</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR197"><label>197.</label><citation-alternatives><element-citation id="ec-CR197" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><etal/></person-group><article-title>Alterations in the solubility and intracellular localization of parkin by several familial Parkinson&#8217;s disease-linked point mutations</article-title><source>J. Neurochem.</source><year>2005</year><volume>93</volume><fpage>422</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03023.x</pub-id><pub-id pub-id-type="pmid">15816865</pub-id></element-citation><mixed-citation id="mc-CR197" publication-type="journal">Wang, C. et al. Alterations in the solubility and intracellular localization of parkin by several familial Parkinson&#8217;s disease-linked point mutations. <italic toggle="yes">J. Neurochem.</italic><bold>93</bold>, 422&#8211;431 (2005).<pub-id pub-id-type="pmid">15816865</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1471-4159.2005.03023.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR198"><label>198.</label><citation-alternatives><element-citation id="ec-CR198" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuda</surname><given-names>N</given-names></name><etal/></person-group><article-title>Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>3204</fpage><lpage>3209</lpage><pub-id pub-id-type="doi">10.1074/jbc.M510393200</pub-id><pub-id pub-id-type="pmid">16339143</pub-id></element-citation><mixed-citation id="mc-CR198" publication-type="journal">Matsuda, N. et al. Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro. <italic toggle="yes">J. Biol. Chem.</italic><bold>281</bold>, 3204&#8211;3209 (2006).<pub-id pub-id-type="pmid">16339143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M510393200</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR199"><label>199.</label><citation-alternatives><element-citation id="ec-CR199" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krzystek</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Differential mitochondrial roles for &#945;-synuclein in DRP1-dependent fission and PINK1/Parkin-mediated oxidation</article-title><source>Cell Death Dis</source><year>2021</year><volume>12</volume><fpage>796</fpage><pub-id pub-id-type="doi">10.1038/s41419-021-04046-3</pub-id><pub-id pub-id-type="pmid">34404758</pub-id><pub-id pub-id-type="pmcid">PMC8371151</pub-id></element-citation><mixed-citation id="mc-CR199" publication-type="journal">Krzystek, T. J. et al. Differential mitochondrial roles for &#945;-synuclein in DRP1-dependent fission and PINK1/Parkin-mediated oxidation. <italic toggle="yes">Cell Death Dis</italic>. <bold>12</bold>, 796 (2021).<pub-id pub-id-type="pmid">34404758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-021-04046-3</pub-id><pub-id pub-id-type="pmcid">PMC8371151</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR200"><label>200.</label><citation-alternatives><element-citation id="ec-CR200" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>X</given-names></name><etal/></person-group><article-title>Alpha-synuclein-associated changes in PINK1-PRKN-mediated mitophagy are disease context dependent</article-title><source>Brain Pathol</source><year>2023</year><volume>33</volume><fpage>e13175</fpage><pub-id pub-id-type="doi">10.1111/bpa.13175</pub-id><pub-id pub-id-type="pmid">37259617</pub-id><pub-id pub-id-type="pmcid">PMC10467041</pub-id></element-citation><mixed-citation id="mc-CR200" publication-type="journal">Hou, X. et al. Alpha-synuclein-associated changes in PINK1-PRKN-mediated mitophagy are disease context dependent. <italic toggle="yes">Brain Pathol</italic>. <bold>33</bold>, e13175 (2023).<pub-id pub-id-type="pmid">37259617</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/bpa.13175</pub-id><pub-id pub-id-type="pmcid">PMC10467041</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR201"><label>201.</label><citation-alternatives><element-citation id="ec-CR201" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T &#945;-synuclein model of Parkinson&#8217;s disease</article-title><source>Cell Death Dis</source><year>2018</year><volume>9</volume><fpage>700</fpage><pub-id pub-id-type="doi">10.1038/s41419-018-0722-7</pub-id><pub-id pub-id-type="pmid">29899409</pub-id><pub-id pub-id-type="pmcid">PMC5999948</pub-id></element-citation><mixed-citation id="mc-CR201" publication-type="journal">Chen, J. et al. Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T &#945;-synuclein model of Parkinson&#8217;s disease. <italic toggle="yes">Cell Death Dis</italic>. <bold>9</bold>, 700 (2018).<pub-id pub-id-type="pmid">29899409</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-018-0722-7</pub-id><pub-id pub-id-type="pmcid">PMC5999948</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR202"><label>202.</label><citation-alternatives><element-citation id="ec-CR202" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>IE</given-names></name><etal/></person-group><article-title><italic toggle="yes">Drosophila</italic> pink1 is required for mitochondrial function and interacts genetically with parkin</article-title><source>Nature</source><year>2006</year><volume>441</volume><fpage>1162</fpage><lpage>1166</lpage><pub-id pub-id-type="doi">10.1038/nature04779</pub-id><pub-id pub-id-type="pmid">16672981</pub-id></element-citation><mixed-citation id="mc-CR202" publication-type="journal">Clark, I. E. et al. <italic toggle="yes">Drosophila</italic> pink1 is required for mitochondrial function and interacts genetically with parkin. <italic toggle="yes">Nature</italic><bold>441</bold>, 1162&#8211;1166 (2006).<pub-id pub-id-type="pmid">16672981</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature04779</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR203"><label>203.</label><citation-alternatives><element-citation id="ec-CR203" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>J</given-names></name><etal/></person-group><article-title>Mitochondrial dysfunction in <italic toggle="yes">Drosophila</italic> PINK1 mutants is complemented by parkin</article-title><source>Nature</source><year>2006</year><volume>441</volume><fpage>1157</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1038/nature04788</pub-id><pub-id pub-id-type="pmid">16672980</pub-id></element-citation><mixed-citation id="mc-CR203" publication-type="journal">Park, J. et al. Mitochondrial dysfunction in <italic toggle="yes">Drosophila</italic> PINK1 mutants is complemented by parkin. <italic toggle="yes">Nature</italic><bold>441</bold>, 1157&#8211;1161 (2006).<pub-id pub-id-type="pmid">16672980</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature04788</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR204"><label>204.</label><citation-alternatives><element-citation id="ec-CR204" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsieh</surname><given-names>C-H</given-names></name><etal/></person-group><article-title>Functional impairment in Miro degradation and mitophagy is a shared feature in familial and sporadic Parkinson&#8217;s disease</article-title><source>Cell Stem Cell</source><year>2016</year><volume>19</volume><fpage>709</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2016.08.002</pub-id><pub-id pub-id-type="pmid">27618216</pub-id><pub-id pub-id-type="pmcid">PMC5135570</pub-id></element-citation><mixed-citation id="mc-CR204" publication-type="journal">Hsieh, C.-H. et al. Functional impairment in Miro degradation and mitophagy is a shared feature in familial and sporadic Parkinson&#8217;s disease. <italic toggle="yes">Cell Stem Cell</italic><bold>19</bold>, 709&#8211;724 (2016).<pub-id pub-id-type="pmid">27618216</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.stem.2016.08.002</pub-id><pub-id pub-id-type="pmcid">PMC5135570</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR205"><label>205.</label><citation-alternatives><element-citation id="ec-CR205" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Destructive cellular paths underlying familial and sporadic Parkinson disease converge on mitophagy</article-title><source>Autophagy</source><year>2017</year><volume>13</volume><fpage>1998</fpage><lpage>1999</lpage><pub-id pub-id-type="doi">10.1080/15548627.2017.1327511</pub-id><pub-id pub-id-type="pmid">28598236</pub-id><pub-id pub-id-type="pmcid">PMC5788483</pub-id></element-citation><mixed-citation id="mc-CR205" publication-type="journal">Wang, X. Destructive cellular paths underlying familial and sporadic Parkinson disease converge on mitophagy. <italic toggle="yes">Autophagy</italic><bold>13</bold>, 1998&#8211;1999 (2017).<pub-id pub-id-type="pmid">28598236</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2017.1327511</pub-id><pub-id pub-id-type="pmcid">PMC5788483</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR206"><label>206.</label><citation-alternatives><element-citation id="ec-CR206" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsieh</surname><given-names>C-H</given-names></name><etal/></person-group><article-title>Miro1 marks Parkinson&#8217;s disease subset and Miro1 reducer rescues neuron loss in Parkinson&#8217;s models</article-title><source>Cell Metab.</source><year>2019</year><volume>30</volume><fpage>1131</fpage><lpage>1140.e7</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2019.08.023</pub-id><pub-id pub-id-type="pmid">31564441</pub-id><pub-id pub-id-type="pmcid">PMC6893131</pub-id></element-citation><mixed-citation id="mc-CR206" publication-type="journal">Hsieh, C.-H. et al. Miro1 marks Parkinson&#8217;s disease subset and Miro1 reducer rescues neuron loss in Parkinson&#8217;s models. <italic toggle="yes">Cell Metab.</italic><bold>30</bold>, 1131&#8211;1140.e7 (2019).<pub-id pub-id-type="pmid">31564441</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2019.08.023</pub-id><pub-id pub-id-type="pmcid">PMC6893131</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR207"><label>207.</label><citation-alternatives><element-citation id="ec-CR207" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>F</given-names></name><etal/></person-group><article-title>Pharmacological rescue of impaired mitophagy in Parkinson&#8217;s disease-related LRRK2 G2019S knock-in mice</article-title><source>eLife</source><year>2021</year><volume>10</volume><fpage>e67604</fpage><pub-id pub-id-type="doi">10.7554/eLife.67604</pub-id><pub-id pub-id-type="pmid">34340748</pub-id><pub-id pub-id-type="pmcid">PMC8331189</pub-id></element-citation><mixed-citation id="mc-CR207" publication-type="journal">Singh, F. et al. Pharmacological rescue of impaired mitophagy in Parkinson&#8217;s disease-related LRRK2 G2019S knock-in mice. <italic toggle="yes">eLife</italic><bold>10</bold>, e67604 (2021).<pub-id pub-id-type="pmid">34340748</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.67604</pub-id><pub-id pub-id-type="pmcid">PMC8331189</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR208"><label>208.</label><citation-alternatives><element-citation id="ec-CR208" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Strooper</surname><given-names>B</given-names></name><name name-style="western"><surname>Karran</surname><given-names>E</given-names></name></person-group><article-title>The cellular phase of Alzheimer&#8217;s disease</article-title><source>Cell</source><year>2016</year><volume>164</volume><fpage>603</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.12.056</pub-id><pub-id pub-id-type="pmid">26871627</pub-id></element-citation><mixed-citation id="mc-CR208" publication-type="journal">De Strooper, B. &amp; Karran, E. The cellular phase of Alzheimer&#8217;s disease. <italic toggle="yes">Cell</italic><bold>164</bold>, 603&#8211;615 (2016).<pub-id pub-id-type="pmid">26871627</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2015.12.056</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR209"><label>209.</label><citation-alternatives><element-citation id="ec-CR209" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>MT</given-names></name><name name-style="western"><surname>Beal</surname><given-names>MF</given-names></name></person-group><article-title>Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</article-title><source>Nature</source><year>2006</year><volume>443</volume><fpage>787</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1038/nature05292</pub-id><pub-id pub-id-type="pmid">17051205</pub-id></element-citation><mixed-citation id="mc-CR209" publication-type="journal">Lin, M. T. &amp; Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. <italic toggle="yes">Nature</italic><bold>443</bold>, 787&#8211;795 (2006).<pub-id pub-id-type="pmid">17051205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature05292</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR210"><label>210.</label><citation-alternatives><element-citation id="ec-CR210" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>EF</given-names></name><etal/></person-group><article-title>Mitophagy inhibits amyloid-&#946; and tau pathology and reverses cognitive deficits in models of Alzheimer&#8217;s disease</article-title><source>Nat. Neurosci.</source><year>2019</year><volume>22</volume><fpage>401</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0332-9</pub-id><pub-id pub-id-type="pmid">30742114</pub-id><pub-id pub-id-type="pmcid">PMC6693625</pub-id></element-citation><mixed-citation id="mc-CR210" publication-type="journal">Fang, E. F. et al. Mitophagy inhibits amyloid-&#946; and tau pathology and reverses cognitive deficits in models of Alzheimer&#8217;s disease. <italic toggle="yes">Nat. Neurosci.</italic><bold>22</bold>, 401&#8211;412 (2019).<pub-id pub-id-type="pmid">30742114</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41593-018-0332-9</pub-id><pub-id pub-id-type="pmcid">PMC6693625</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR211"><label>211.</label><citation-alternatives><element-citation id="ec-CR211" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirai</surname><given-names>K</given-names></name><etal/></person-group><article-title>Mitochondrial abnormalities in Alzheimer&#8217;s disease</article-title><source>J. Neurosci.</source><year>2001</year><volume>21</volume><fpage>3017</fpage><lpage>3023</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-09-03017.2001</pub-id><pub-id pub-id-type="pmid">11312286</pub-id><pub-id pub-id-type="pmcid">PMC6762571</pub-id></element-citation><mixed-citation id="mc-CR211" publication-type="journal">Hirai, K. et al. Mitochondrial abnormalities in Alzheimer&#8217;s disease. <italic toggle="yes">J. Neurosci.</italic><bold>21</bold>, 3017&#8211;3023 (2001).<pub-id pub-id-type="pmid">11312286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1523/JNEUROSCI.21-09-03017.2001</pub-id><pub-id pub-id-type="pmcid">PMC6762571</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR212"><label>212.</label><citation-alternatives><element-citation id="ec-CR212" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabar</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Association of mitochondrial DNA variants with Alzheimer&#8217;s disease phenotypes in 500K participants with whole genome sequencing from the UK Biobank</article-title><source>Alzheimers Dement</source><year>2024</year><volume>20</volume><fpage>e090861</fpage><pub-id pub-id-type="doi">10.1002/alz.090861</pub-id></element-citation><mixed-citation id="mc-CR212" publication-type="journal">Tabar, M. S. et al. Association of mitochondrial DNA variants with Alzheimer&#8217;s disease phenotypes in 500K participants with whole genome sequencing from the UK Biobank. <italic toggle="yes">Alzheimers Dement</italic><bold>20</bold>, e090861 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR213"><label>213.</label><citation-alternatives><element-citation id="ec-CR213" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kerr</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Mitophagy and Alzheimer&#8217;s disease: Cellular and molecular mechanisms</article-title><source>Trends Neurosci.</source><year>2017</year><volume>40</volume><fpage>151</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2017.01.002</pub-id><pub-id pub-id-type="pmid">28190529</pub-id><pub-id pub-id-type="pmcid">PMC5341618</pub-id></element-citation><mixed-citation id="mc-CR213" publication-type="journal">Kerr, J. S. et al. Mitophagy and Alzheimer&#8217;s disease: Cellular and molecular mechanisms. <italic toggle="yes">Trends Neurosci.</italic><bold>40</bold>, 151&#8211;166 (2017).<pub-id pub-id-type="pmid">28190529</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tins.2017.01.002</pub-id><pub-id pub-id-type="pmcid">PMC5341618</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR214"><label>214.</label><citation-alternatives><element-citation id="ec-CR214" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>X</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><name name-style="western"><surname>Starovoytov</surname><given-names>V</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Q</given-names></name></person-group><article-title>Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer&#8217;s disease patient brains</article-title><source>Hum. Mol. Genet.</source><year>2015</year><volume>24</volume><fpage>2938</fpage><lpage>2951</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv056</pub-id><pub-id pub-id-type="pmid">25678552</pub-id><pub-id pub-id-type="pmcid">PMC4406302</pub-id></element-citation><mixed-citation id="mc-CR214" publication-type="journal">Ye, X., Sun, X., Starovoytov, V. &amp; Cai, Q. Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer&#8217;s disease patient brains. <italic toggle="yes">Hum. Mol. Genet.</italic><bold>24</bold>, 2938&#8211;2951 (2015).<pub-id pub-id-type="pmid">25678552</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/hmg/ddv056</pub-id><pub-id pub-id-type="pmcid">PMC4406302</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR215"><label>215.</label><citation-alternatives><element-citation id="ec-CR215" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;n-Maestro</surname><given-names>P</given-names></name><name name-style="western"><surname>Gargini</surname><given-names>R</given-names></name><name name-style="western"><surname>Perry</surname><given-names>G</given-names></name><name name-style="western"><surname>Avila</surname><given-names>J</given-names></name><name name-style="western"><surname>Garc&#237;a-Escudero</surname><given-names>V</given-names></name></person-group><article-title>PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer&#8217;s disease</article-title><source>Hum. Mol. Genet</source><year>2016</year><volume>25</volume><fpage>792</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv616</pub-id><pub-id pub-id-type="pmid">26721933</pub-id><pub-id pub-id-type="pmcid">PMC4743695</pub-id></element-citation><mixed-citation id="mc-CR215" publication-type="journal">Mart&#237;n-Maestro, P., Gargini, R., Perry, G., Avila, J. &amp; Garc&#237;a-Escudero, V. PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer&#8217;s disease. <italic toggle="yes">Hum. Mol. Genet</italic>. <bold>25</bold>, 792&#8211;806 (2016).<pub-id pub-id-type="pmid">26721933</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/hmg/ddv616</pub-id><pub-id pub-id-type="pmcid">PMC4743695</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR216"><label>216.</label><citation-alternatives><element-citation id="ec-CR216" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corsetti</surname><given-names>V</given-names></name><etal/></person-group><article-title>NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: Implications in Alzheimer&#8217;s disease</article-title><source>Hum. Mol. Genet.</source><year>2015</year><volume>24</volume><fpage>3058</fpage><lpage>3081</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv059</pub-id><pub-id pub-id-type="pmid">25687137</pub-id></element-citation><mixed-citation id="mc-CR216" publication-type="journal">Corsetti, V. et al. NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: Implications in Alzheimer&#8217;s disease. <italic toggle="yes">Hum. Mol. Genet.</italic><bold>24</bold>, 3058&#8211;3081 (2015).<pub-id pub-id-type="pmid">25687137</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/hmg/ddv059</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR217"><label>217.</label><citation-alternatives><element-citation id="ec-CR217" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>17356</fpage><lpage>17368</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.7861</pub-id><pub-id pub-id-type="pmid">26943044</pub-id><pub-id pub-id-type="pmcid">PMC4951217</pub-id></element-citation><mixed-citation id="mc-CR217" publication-type="journal">Hu, Y. et al. Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin. <italic toggle="yes">Oncotarget</italic><bold>7</bold>, 17356&#8211;17368 (2016).<pub-id pub-id-type="pmid">26943044</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.7861</pub-id><pub-id pub-id-type="pmcid">PMC4951217</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR218"><label>218.</label><citation-alternatives><element-citation id="ec-CR218" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabrizi</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Flower</surname><given-names>MD</given-names></name><name name-style="western"><surname>Ross</surname><given-names>CA</given-names></name><name name-style="western"><surname>Wild</surname><given-names>EJ</given-names></name></person-group><article-title>Huntington disease: New insights into molecular pathogenesis and therapeutic opportunities</article-title><source>Nat. Rev. Neurol.</source><year>2020</year><volume>16</volume><fpage>529</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1038/s41582-020-0389-4</pub-id><pub-id pub-id-type="pmid">32796930</pub-id></element-citation><mixed-citation id="mc-CR218" publication-type="journal">Tabrizi, S. J., Flower, M. D., Ross, C. A. &amp; Wild, E. J. Huntington disease: New insights into molecular pathogenesis and therapeutic opportunities. <italic toggle="yes">Nat. Rev. Neurol.</italic><bold>16</bold>, 529&#8211;546 (2020).<pub-id pub-id-type="pmid">32796930</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41582-020-0389-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR219"><label>219.</label><citation-alternatives><element-citation id="ec-CR219" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milakovic</surname><given-names>T</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>GVW</given-names></name></person-group><article-title>Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>30773</fpage><lpage>30782</lpage><pub-id pub-id-type="doi">10.1074/jbc.M504749200</pub-id><pub-id pub-id-type="pmid">15983033</pub-id></element-citation><mixed-citation id="mc-CR219" publication-type="journal">Milakovic, T. &amp; Johnson, G. V. W. Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. <italic toggle="yes">J. Biol. Chem.</italic><bold>280</bold>, 30773&#8211;30782 (2005).<pub-id pub-id-type="pmid">15983033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M504749200</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR220"><label>220.</label><citation-alternatives><element-citation id="ec-CR220" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinez-Vicente</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cargo recognition failure is responsible for inefficient autophagy in Huntington&#8217;s disease</article-title><source>Nat. Neurosci.</source><year>2010</year><volume>13</volume><fpage>567</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1038/nn.2528</pub-id><pub-id pub-id-type="pmid">20383138</pub-id><pub-id pub-id-type="pmcid">PMC2860687</pub-id></element-citation><mixed-citation id="mc-CR220" publication-type="journal">Martinez-Vicente, M. et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington&#8217;s disease. <italic toggle="yes">Nat. Neurosci.</italic><bold>13</bold>, 567&#8211;576 (2010).<pub-id pub-id-type="pmid">20383138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nn.2528</pub-id><pub-id pub-id-type="pmcid">PMC2860687</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR221"><label>221.</label><citation-alternatives><element-citation id="ec-CR221" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Franco-Iborra</surname><given-names>S</given-names></name><etal/></person-group><article-title>Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease</article-title><source>Autophagy</source><year>2021</year><volume>17</volume><fpage>672</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1728096</pub-id><pub-id pub-id-type="pmid">32093570</pub-id><pub-id pub-id-type="pmcid">PMC8032238</pub-id></element-citation><mixed-citation id="mc-CR221" publication-type="journal">Franco-Iborra, S. et al. Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease. <italic toggle="yes">Autophagy</italic><bold>17</bold>, 672&#8211;689 (2021).<pub-id pub-id-type="pmid">32093570</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2020.1728096</pub-id><pub-id pub-id-type="pmcid">PMC8032238</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR222"><label>222.</label><citation-alternatives><element-citation id="ec-CR222" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khalil</surname><given-names>B</given-names></name><etal/></person-group><article-title>PINK1-induced mitophagy promotes neuroprotection in Huntington&#8217;s disease</article-title><source>Cell Death Dis</source><year>2015</year><volume>6</volume><fpage>e1617</fpage><pub-id pub-id-type="doi">10.1038/cddis.2014.581</pub-id><pub-id pub-id-type="pmid">25611391</pub-id><pub-id pub-id-type="pmcid">PMC4669776</pub-id></element-citation><mixed-citation id="mc-CR222" publication-type="journal">Khalil, B. et al. PINK1-induced mitophagy promotes neuroprotection in Huntington&#8217;s disease. <italic toggle="yes">Cell Death Dis</italic>. <bold>6</bold>, e1617 (2015).<pub-id pub-id-type="pmid">25611391</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cddis.2014.581</pub-id><pub-id pub-id-type="pmcid">PMC4669776</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR223"><label>223.</label><citation-alternatives><element-citation id="ec-CR223" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diedrich</surname><given-names>M</given-names></name><etal/></person-group><article-title>Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson&#8217;s disease</article-title><source>Proteome Sci</source><year>2011</year><volume>9</volume><fpage>59</fpage><pub-id pub-id-type="doi">10.1186/1477-5956-9-59</pub-id><pub-id pub-id-type="pmid">21943346</pub-id><pub-id pub-id-type="pmcid">PMC3196908</pub-id></element-citation><mixed-citation id="mc-CR223" publication-type="journal">Diedrich, M. et al. Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson&#8217;s disease. <italic toggle="yes">Proteome Sci</italic>. <bold>9</bold>, 59 (2011).<pub-id pub-id-type="pmid">21943346</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1477-5956-9-59</pub-id><pub-id pub-id-type="pmcid">PMC3196908</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR224"><label>224.</label><citation-alternatives><element-citation id="ec-CR224" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>G</given-names></name><name name-style="western"><surname>Gautier</surname><given-names>O</given-names></name><name name-style="western"><surname>Tassoni-Tsuchida</surname><given-names>E</given-names></name><name name-style="western"><surname>Ma</surname><given-names>XR</given-names></name><name name-style="western"><surname>Gitler</surname><given-names>AD</given-names></name></person-group><article-title>ALS genetics: Gains, losses, and implications for future therapies</article-title><source>Neuron</source><year>2020</year><volume>108</volume><fpage>822</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.08.022</pub-id><pub-id pub-id-type="pmid">32931756</pub-id><pub-id pub-id-type="pmcid">PMC7736125</pub-id></element-citation><mixed-citation id="mc-CR224" publication-type="journal">Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R. &amp; Gitler, A. D. ALS genetics: Gains, losses, and implications for future therapies. <italic toggle="yes">Neuron</italic><bold>108</bold>, 822&#8211;842 (2020).<pub-id pub-id-type="pmid">32931756</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuron.2020.08.022</pub-id><pub-id pub-id-type="pmcid">PMC7736125</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR225"><label>225.</label><citation-alternatives><element-citation id="ec-CR225" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muyderman</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>T</given-names></name></person-group><article-title>Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?</article-title><source>Br. J. Pharmacol.</source><year>2014</year><volume>171</volume><fpage>2191</fpage><lpage>2205</lpage><pub-id pub-id-type="doi">10.1111/bph.12476</pub-id><pub-id pub-id-type="pmid">24148000</pub-id><pub-id pub-id-type="pmcid">PMC3976630</pub-id></element-citation><mixed-citation id="mc-CR225" publication-type="journal">Muyderman, H. &amp; Chen, T. Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target? <italic toggle="yes">Br. J. Pharmacol.</italic><bold>171</bold>, 2191&#8211;2205 (2014).<pub-id pub-id-type="pmid">24148000</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/bph.12476</pub-id><pub-id pub-id-type="pmcid">PMC3976630</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR226"><label>226.</label><citation-alternatives><element-citation id="ec-CR226" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Calbiac</surname><given-names>H</given-names></name><etal/></person-group><article-title>Poly-GP accumulation due to C9orf72 loss of function induces motor neuron apoptosis through autophagy and mitophagy defects</article-title><source>Autophagy</source><year>2024</year><volume>20</volume><fpage>2164</fpage><lpage>2185</lpage><pub-id pub-id-type="doi">10.1080/15548627.2024.2358736</pub-id><pub-id pub-id-type="pmid">39316747</pub-id><pub-id pub-id-type="pmcid">PMC11423671</pub-id></element-citation><mixed-citation id="mc-CR226" publication-type="journal">de Calbiac, H. et al. Poly-GP accumulation due to C9orf72 loss of function induces motor neuron apoptosis through autophagy and mitophagy defects. <italic toggle="yes">Autophagy</italic><bold>20</bold>, 2164&#8211;2185 (2024).<pub-id pub-id-type="pmid">39316747</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2024.2358736</pub-id><pub-id pub-id-type="pmcid">PMC11423671</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR227"><label>227.</label><citation-alternatives><element-citation id="ec-CR227" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tak</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Park</surname><given-names>J-H</given-names></name><name name-style="western"><surname>Rhim</surname><given-names>H</given-names></name><name name-style="western"><surname>Kang</surname><given-names>S</given-names></name></person-group><article-title>ALS-related mutant SOD1 aggregates interfere with mitophagy by sequestering the autophagy receptor optineurin</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><fpage>7525</fpage><pub-id pub-id-type="doi">10.3390/ijms21207525</pub-id><pub-id pub-id-type="pmid">33065963</pub-id><pub-id pub-id-type="pmcid">PMC7590160</pub-id></element-citation><mixed-citation id="mc-CR227" publication-type="journal">Tak, Y. J., Park, J.-H., Rhim, H. &amp; Kang, S. ALS-related mutant SOD1 aggregates interfere with mitophagy by sequestering the autophagy receptor optineurin. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>21</bold>, 7525 (2020).<pub-id pub-id-type="pmid">33065963</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21207525</pub-id><pub-id pub-id-type="pmcid">PMC7590160</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR228"><label>228.</label><citation-alternatives><element-citation id="ec-CR228" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maruyama</surname><given-names>H</given-names></name><etal/></person-group><article-title>Mutations of optineurin in amyotrophic lateral sclerosis</article-title><source>Nature</source><year>2010</year><volume>465</volume><fpage>223</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1038/nature08971</pub-id><pub-id pub-id-type="pmid">20428114</pub-id></element-citation><mixed-citation id="mc-CR228" publication-type="journal">Maruyama, H. et al. Mutations of optineurin in amyotrophic lateral sclerosis. <italic toggle="yes">Nature</italic><bold>465</bold>, 223&#8211;226 (2010).<pub-id pub-id-type="pmid">20428114</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature08971</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR229"><label>229.</label><citation-alternatives><element-citation id="ec-CR229" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cirulli</surname><given-names>ET</given-names></name><etal/></person-group><article-title>Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways</article-title><source>Science</source><year>2015</year><volume>347</volume><fpage>1436</fpage><lpage>1441</lpage><pub-id pub-id-type="doi">10.1126/science.aaa3650</pub-id><pub-id pub-id-type="pmid">25700176</pub-id><pub-id pub-id-type="pmcid">PMC4437632</pub-id></element-citation><mixed-citation id="mc-CR229" publication-type="journal">Cirulli, E. T. et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. <italic toggle="yes">Science</italic><bold>347</bold>, 1436&#8211;1441 (2015).<pub-id pub-id-type="pmid">25700176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aaa3650</pub-id><pub-id pub-id-type="pmcid">PMC4437632</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR230"><label>230.</label><citation-alternatives><element-citation id="ec-CR230" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freischmidt</surname><given-names>A</given-names></name><etal/></person-group><article-title>Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia</article-title><source>Nat. Neurosci.</source><year>2015</year><volume>18</volume><fpage>631</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1038/nn.4000</pub-id><pub-id pub-id-type="pmid">25803835</pub-id></element-citation><mixed-citation id="mc-CR230" publication-type="journal">Freischmidt, A. et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. <italic toggle="yes">Nat. Neurosci.</italic><bold>18</bold>, 631&#8211;636 (2015).<pub-id pub-id-type="pmid">25803835</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nn.4000</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR231"><label>231.</label><citation-alternatives><element-citation id="ec-CR231" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>SA</given-names></name><etal/></person-group><article-title>TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics</article-title><source>Neurosci. Lett.</source><year>2018</year><volume>678</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2018.04.053</pub-id><pub-id pub-id-type="pmid">29715546</pub-id><pub-id pub-id-type="pmcid">PMC5975202</pub-id></element-citation><mixed-citation id="mc-CR231" publication-type="journal">Davis, S. A. et al. TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics. <italic toggle="yes">Neurosci. Lett.</italic><bold>678</bold>, 8&#8211;15 (2018).<pub-id pub-id-type="pmid">29715546</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neulet.2018.04.053</pub-id><pub-id pub-id-type="pmcid">PMC5975202</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR232"><label>232.</label><citation-alternatives><element-citation id="ec-CR232" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palomo</surname><given-names>GM</given-names></name><etal/></person-group><article-title>Parkin is a disease modifier in the mutant SOD1 mouse model of ALS</article-title><source>EMBO Mol. Med.</source><year>2018</year><volume>10</volume><fpage>e8888</fpage><pub-id pub-id-type="doi">10.15252/emmm.201808888</pub-id><pub-id pub-id-type="pmid">30126943</pub-id><pub-id pub-id-type="pmcid">PMC6180298</pub-id></element-citation><mixed-citation id="mc-CR232" publication-type="journal">Palomo, G. M. et al. Parkin is a disease modifier in the mutant SOD1 mouse model of ALS. <italic toggle="yes">EMBO Mol. Med.</italic><bold>10</bold>, e8888 (2018).<pub-id pub-id-type="pmid">30126943</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/emmm.201808888</pub-id><pub-id pub-id-type="pmcid">PMC6180298</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR233"><label>233.</label><citation-alternatives><element-citation id="ec-CR233" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riley</surname><given-names>JS</given-names></name><name name-style="western"><surname>Tait</surname><given-names>SW</given-names></name></person-group><article-title>Mitochondrial DNA in inflammation and immunity</article-title><source>EMBO Rep</source><year>2020</year><volume>21</volume><fpage>e49799</fpage><pub-id pub-id-type="doi">10.15252/embr.201949799</pub-id><pub-id pub-id-type="pmid">32202065</pub-id><pub-id pub-id-type="pmcid">PMC7132203</pub-id></element-citation><mixed-citation id="mc-CR233" publication-type="journal">Riley, J. S. &amp; Tait, S. W. Mitochondrial DNA in inflammation and immunity. <italic toggle="yes">EMBO Rep</italic>. <bold>21</bold>, e49799 (2020).<pub-id pub-id-type="pmid">32202065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embr.201949799</pub-id><pub-id pub-id-type="pmcid">PMC7132203</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR234"><label>234.</label><citation-alternatives><element-citation id="ec-CR234" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heilig</surname><given-names>R</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Tait</surname><given-names>SWG</given-names></name></person-group><article-title>Mitochondrial DNA in cell death and inflammation</article-title><source>Biochem. Soc. Trans.</source><year>2023</year><volume>51</volume><fpage>457</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1042/BST20221525</pub-id><pub-id pub-id-type="pmid">36815695</pub-id><pub-id pub-id-type="pmcid">PMC9988000</pub-id></element-citation><mixed-citation id="mc-CR234" publication-type="journal">Heilig, R., Lee, J. &amp; Tait, S. W. G. Mitochondrial DNA in cell death and inflammation. <italic toggle="yes">Biochem. Soc. Trans.</italic><bold>51</bold>, 457&#8211;472 (2023).<pub-id pub-id-type="pmid">36815695</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/BST20221525</pub-id><pub-id pub-id-type="pmcid">PMC9988000</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR235"><label>235.</label><citation-alternatives><element-citation id="ec-CR235" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vringer</surname><given-names>E</given-names></name><name name-style="western"><surname>Tait</surname><given-names>SWG</given-names></name></person-group><article-title>Mitochondria and cell death-associated inflammation</article-title><source>Cell Death Differ</source><year>2023</year><volume>30</volume><fpage>304</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1038/s41418-022-01094-w</pub-id><pub-id pub-id-type="pmid">36447047</pub-id><pub-id pub-id-type="pmcid">PMC9950460</pub-id></element-citation><mixed-citation id="mc-CR235" publication-type="journal">Vringer, E. &amp; Tait, S. W. G. Mitochondria and cell death-associated inflammation. <italic toggle="yes">Cell Death Differ</italic>. <bold>30</bold>, 304&#8211;312 (2023).<pub-id pub-id-type="pmid">36447047</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41418-022-01094-w</pub-id><pub-id pub-id-type="pmcid">PMC9950460</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR236"><label>236.</label><citation-alternatives><element-citation id="ec-CR236" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marques</surname><given-names>E</given-names></name><name name-style="western"><surname>Kramer</surname><given-names>R</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>DG</given-names></name></person-group><article-title>Multifaceted mitochondria in innate immunity</article-title><source>npj Metab. Health Dis</source><year>2024</year><volume>2</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1038/s44324-024-00008-3</pub-id><pub-id pub-id-type="pmid">38812744</pub-id><pub-id pub-id-type="pmcid">PMC11129950</pub-id></element-citation><mixed-citation id="mc-CR236" publication-type="journal">Marques, E., Kramer, R. &amp; Ryan, D. G. Multifaceted mitochondria in innate immunity. <italic toggle="yes">npj Metab. Health Dis</italic>. <bold>2</bold>, 6 (2024).<pub-id pub-id-type="pmid">38812744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s44324-024-00008-3</pub-id><pub-id pub-id-type="pmcid">PMC11129950</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR237"><label>237.</label><citation-alternatives><element-citation id="ec-CR237" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>M-M</given-names></name><name name-style="western"><surname>Shu</surname><given-names>H-B</given-names></name></person-group><article-title>Mitochondrial DNA-triggered innate immune response: Mechanisms and diseases</article-title><source>Cell Mol. Immunol.</source><year>2023</year><volume>20</volume><fpage>1403</fpage><lpage>1412</lpage><pub-id pub-id-type="doi">10.1038/s41423-023-01086-x</pub-id><pub-id pub-id-type="pmid">37932533</pub-id><pub-id pub-id-type="pmcid">PMC10687031</pub-id></element-citation><mixed-citation id="mc-CR237" publication-type="journal">Hu, M.-M. &amp; Shu, H.-B. Mitochondrial DNA-triggered innate immune response: Mechanisms and diseases. <italic toggle="yes">Cell Mol. Immunol.</italic><bold>20</bold>, 1403&#8211;1412 (2023).<pub-id pub-id-type="pmid">37932533</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41423-023-01086-x</pub-id><pub-id pub-id-type="pmcid">PMC10687031</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR238"><label>238.</label><citation-alternatives><element-citation id="ec-CR238" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Du</surname><given-names>F</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>ZJ</given-names></name></person-group><article-title>Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway</article-title><source>Science</source><year>2013</year><volume>339</volume><fpage>786</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1126/science.1232458</pub-id><pub-id pub-id-type="pmid">23258413</pub-id><pub-id pub-id-type="pmcid">PMC3863629</pub-id></element-citation><mixed-citation id="mc-CR238" publication-type="journal">Sun, L., Wu, J., Du, F., Chen, X. &amp; Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. <italic toggle="yes">Science</italic><bold>339</bold>, 786&#8211;791 (2013).<pub-id pub-id-type="pmid">23258413</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1232458</pub-id><pub-id pub-id-type="pmcid">PMC3863629</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR239"><label>239.</label><citation-alternatives><element-citation id="ec-CR239" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Apoptotic caspases suppress mtDNA-Induced STING-mediated type I IFN production</article-title><source>Cell</source><year>2014</year><volume>159</volume><fpage>1549</fpage><lpage>1562</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.036</pub-id><pub-id pub-id-type="pmid">25525874</pub-id><pub-id pub-id-type="pmcid">PMC4520319</pub-id></element-citation><mixed-citation id="mc-CR239" publication-type="journal">White, M. J. et al. Apoptotic caspases suppress mtDNA-Induced STING-mediated type I IFN production. <italic toggle="yes">Cell</italic><bold>159</bold>, 1549&#8211;1562 (2014).<pub-id pub-id-type="pmid">25525874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2014.11.036</pub-id><pub-id pub-id-type="pmcid">PMC4520319</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR240"><label>240.</label><citation-alternatives><element-citation id="ec-CR240" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rongvaux</surname><given-names>A</given-names></name><etal/></person-group><article-title>Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA</article-title><source>Cell</source><year>2014</year><volume>159</volume><fpage>1563</fpage><lpage>1577</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.037</pub-id><pub-id pub-id-type="pmid">25525875</pub-id><pub-id pub-id-type="pmcid">PMC4272443</pub-id></element-citation><mixed-citation id="mc-CR240" publication-type="journal">Rongvaux, A. et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. <italic toggle="yes">Cell</italic><bold>159</bold>, 1563&#8211;1577 (2014).<pub-id pub-id-type="pmid">25525875</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2014.11.037</pub-id><pub-id pub-id-type="pmcid">PMC4272443</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR241"><label>241.</label><citation-alternatives><element-citation id="ec-CR241" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>West</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Mitochondrial DNA stress primes the antiviral innate immune response</article-title><source>Nature</source><year>2015</year><volume>520</volume><fpage>553</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1038/nature14156</pub-id><pub-id pub-id-type="pmid">25642965</pub-id><pub-id pub-id-type="pmcid">PMC4409480</pub-id></element-citation><mixed-citation id="mc-CR241" publication-type="journal">West, A. P. et al. Mitochondrial DNA stress primes the antiviral innate immune response. <italic toggle="yes">Nature</italic><bold>520</bold>, 553&#8211;557 (2015).<pub-id pub-id-type="pmid">25642965</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature14156</pub-id><pub-id pub-id-type="pmcid">PMC4409480</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR242"><label>242.</label><citation-alternatives><element-citation id="ec-CR242" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dang</surname><given-names>EV</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>JG</given-names></name><name name-style="western"><surname>Russell</surname><given-names>DW</given-names></name><name name-style="western"><surname>Cyster</surname><given-names>JG</given-names></name></person-group><article-title>Oxysterol restraint of cholesterol synthesis prevents AIM2 inflammasome activation</article-title><source>Cell</source><year>2017</year><volume>171</volume><fpage>1057</fpage><lpage>1071.e11</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.029</pub-id><pub-id pub-id-type="pmid">29033131</pub-id><pub-id pub-id-type="pmcid">PMC5693620</pub-id></element-citation><mixed-citation id="mc-CR242" publication-type="journal">Dang, E. V., McDonald, J. G., Russell, D. W. &amp; Cyster, J. G. Oxysterol restraint of cholesterol synthesis prevents AIM2 inflammasome activation. <italic toggle="yes">Cell</italic><bold>171</bold>, 1057&#8211;1071.e11 (2017).<pub-id pub-id-type="pmid">29033131</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2017.09.029</pub-id><pub-id pub-id-type="pmcid">PMC5693620</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR243"><label>243.</label><citation-alternatives><element-citation id="ec-CR243" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>R</given-names></name><name name-style="western"><surname>Yazdi</surname><given-names>AS</given-names></name><name name-style="western"><surname>Menu</surname><given-names>P</given-names></name><name name-style="western"><surname>Tschopp</surname><given-names>J</given-names></name></person-group><article-title>A role for mitochondria in NLRP3 inflammasome activation</article-title><source>Nature</source><year>2011</year><volume>469</volume><fpage>221</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1038/nature09663</pub-id><pub-id pub-id-type="pmid">21124315</pub-id></element-citation><mixed-citation id="mc-CR243" publication-type="journal">Zhou, R., Yazdi, A. S., Menu, P. &amp; Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. <italic toggle="yes">Nature</italic><bold>469</bold>, 221&#8211;225 (2011).<pub-id pub-id-type="pmid">21124315</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature09663</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR244"><label>244.</label><citation-alternatives><element-citation id="ec-CR244" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakahira</surname><given-names>K</given-names></name><etal/></person-group><article-title>Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome</article-title><source>Nat. Immunol.</source><year>2011</year><volume>12</volume><fpage>222</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1038/ni.1980</pub-id><pub-id pub-id-type="pmid">21151103</pub-id><pub-id pub-id-type="pmcid">PMC3079381</pub-id></element-citation><mixed-citation id="mc-CR244" publication-type="journal">Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. <italic toggle="yes">Nat. Immunol.</italic><bold>12</bold>, 222&#8211;230 (2011).<pub-id pub-id-type="pmid">21151103</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.1980</pub-id><pub-id pub-id-type="pmcid">PMC3079381</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR245"><label>245.</label><citation-alternatives><element-citation id="ec-CR245" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimada</surname><given-names>K</given-names></name><etal/></person-group><article-title>Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis</article-title><source>Immunity</source><year>2012</year><volume>36</volume><fpage>401</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.01.009</pub-id><pub-id pub-id-type="pmid">22342844</pub-id><pub-id pub-id-type="pmcid">PMC3312986</pub-id></element-citation><mixed-citation id="mc-CR245" publication-type="journal">Shimada, K. et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. <italic toggle="yes">Immunity</italic><bold>36</bold>, 401&#8211;414 (2012).<pub-id pub-id-type="pmid">22342844</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2012.01.009</pub-id><pub-id pub-id-type="pmcid">PMC3312986</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR246"><label>246.</label><citation-alternatives><element-citation id="ec-CR246" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Latz</surname><given-names>E</given-names></name><etal/></person-group><article-title>TLR9 signals after translocating from the ER to CpG DNA in the lysosome</article-title><source>Nat. Immunol.</source><year>2004</year><volume>5</volume><fpage>190</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1038/ni1028</pub-id><pub-id pub-id-type="pmid">14716310</pub-id></element-citation><mixed-citation id="mc-CR246" publication-type="journal">Latz, E. et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. <italic toggle="yes">Nat. Immunol.</italic><bold>5</bold>, 190&#8211;198 (2004).<pub-id pub-id-type="pmid">14716310</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni1028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR247"><label>247.</label><citation-alternatives><element-citation id="ec-CR247" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Circulating mitochondrial DAMPs cause inflammatory responses to injury</article-title><source>Nature</source><year>2010</year><volume>464</volume><fpage>104</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1038/nature08780</pub-id><pub-id pub-id-type="pmid">20203610</pub-id><pub-id pub-id-type="pmcid">PMC2843437</pub-id></element-citation><mixed-citation id="mc-CR247" publication-type="journal">Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. <italic toggle="yes">Nature</italic><bold>464</bold>, 104&#8211;107 (2010).<pub-id pub-id-type="pmid">20203610</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature08780</pub-id><pub-id pub-id-type="pmcid">PMC2843437</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR248"><label>248.</label><citation-alternatives><element-citation id="ec-CR248" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>J</given-names></name><etal/></person-group><article-title>Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells</article-title><source>EMBO Rep</source><year>2018</year><volume>19</volume><fpage>e46182</fpage><pub-id pub-id-type="doi">10.15252/embr.201846182</pub-id><pub-id pub-id-type="pmid">29880709</pub-id><pub-id pub-id-type="pmcid">PMC6073071</pub-id></element-citation><mixed-citation id="mc-CR248" publication-type="journal">Lai, J. et al. Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells. <italic toggle="yes">EMBO Rep</italic>. <bold>19</bold>, e46182 (2018).<pub-id pub-id-type="pmid">29880709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embr.201846182</pub-id><pub-id pub-id-type="pmcid">PMC6073071</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR249"><label>249.</label><citation-alternatives><element-citation id="ec-CR249" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tigano</surname><given-names>M</given-names></name><name name-style="western"><surname>Vargas</surname><given-names>DC</given-names></name><name name-style="western"><surname>Tremblay-Belzile</surname><given-names>S</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sfeir</surname><given-names>A</given-names></name></person-group><article-title>Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance</article-title><source>Nature</source><year>2021</year><volume>591</volume><fpage>477</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03269-w</pub-id><pub-id pub-id-type="pmid">33627873</pub-id></element-citation><mixed-citation id="mc-CR249" publication-type="journal">Tigano, M., Vargas, D. C., Tremblay-Belzile, S., Fu, Y. &amp; Sfeir, A. Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance. <italic toggle="yes">Nature</italic><bold>591</bold>, 477&#8211;481 (2021).<pub-id pub-id-type="pmid">33627873</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-03269-w</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR250"><label>250.</label><citation-alternatives><element-citation id="ec-CR250" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhir</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mitochondrial double-stranded RNA triggers antiviral signalling in humans</article-title><source>Nature</source><year>2018</year><volume>560</volume><fpage>238</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0363-0</pub-id><pub-id pub-id-type="pmid">30046113</pub-id><pub-id pub-id-type="pmcid">PMC6570621</pub-id></element-citation><mixed-citation id="mc-CR250" publication-type="journal">Dhir, A. et al. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. <italic toggle="yes">Nature</italic><bold>560</bold>, 238&#8211;242 (2018).<pub-id pub-id-type="pmid">30046113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-018-0363-0</pub-id><pub-id pub-id-type="pmcid">PMC6570621</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR251"><label>251.</label><citation-alternatives><element-citation id="ec-CR251" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rabiet</surname><given-names>M-J</given-names></name><name name-style="western"><surname>Huet</surname><given-names>E</given-names></name><name name-style="western"><surname>Boulay</surname><given-names>F</given-names></name></person-group><article-title>Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR</article-title><source>Eur. J. Immunol.</source><year>2005</year><volume>35</volume><fpage>2486</fpage><lpage>2495</lpage><pub-id pub-id-type="doi">10.1002/eji.200526338</pub-id><pub-id pub-id-type="pmid">16025565</pub-id></element-citation><mixed-citation id="mc-CR251" publication-type="journal">Rabiet, M.-J., Huet, E. &amp; Boulay, F. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. <italic toggle="yes">Eur. J. Immunol.</italic><bold>35</bold>, 2486&#8211;2495 (2005).<pub-id pub-id-type="pmid">16025565</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eji.200526338</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR252"><label>252.</label><citation-alternatives><element-citation id="ec-CR252" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>West</surname><given-names>AP</given-names></name><etal/></person-group><article-title>TLR signalling augments macrophage bactericidal activity through mitochondrial ROS</article-title><source>Nature</source><year>2011</year><volume>472</volume><fpage>476</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1038/nature09973</pub-id><pub-id pub-id-type="pmid">21525932</pub-id><pub-id pub-id-type="pmcid">PMC3460538</pub-id></element-citation><mixed-citation id="mc-CR252" publication-type="journal">West, A. P. et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. <italic toggle="yes">Nature</italic><bold>472</bold>, 476&#8211;480 (2011).<pub-id pub-id-type="pmid">21525932</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature09973</pub-id><pub-id pub-id-type="pmcid">PMC3460538</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR253"><label>253.</label><citation-alternatives><element-citation id="ec-CR253" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mills</surname><given-names>EL</given-names></name><etal/></person-group><article-title>Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages</article-title><source>Cell</source><year>2016</year><volume>167</volume><fpage>457</fpage><lpage>470.e13</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.08.064</pub-id><pub-id pub-id-type="pmid">27667687</pub-id><pub-id pub-id-type="pmcid">PMC5863951</pub-id></element-citation><mixed-citation id="mc-CR253" publication-type="journal">Mills, E. L. et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. <italic toggle="yes">Cell</italic><bold>167</bold>, 457&#8211;470.e13 (2016).<pub-id pub-id-type="pmid">27667687</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2016.08.064</pub-id><pub-id pub-id-type="pmcid">PMC5863951</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR254"><label>254.</label><citation-alternatives><element-citation id="ec-CR254" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oka</surname><given-names>T</given-names></name><etal/></person-group><article-title>Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure</article-title><source>Nature</source><year>2012</year><volume>485</volume><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1038/nature10992</pub-id><pub-id pub-id-type="pmid">22535248</pub-id><pub-id pub-id-type="pmcid">PMC3378041</pub-id></element-citation><mixed-citation id="mc-CR254" publication-type="journal">Oka, T. et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. <italic toggle="yes">Nature</italic><bold>485</bold>, 251&#8211;255 (2012).<pub-id pub-id-type="pmid">22535248</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature10992</pub-id><pub-id pub-id-type="pmcid">PMC3378041</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR255"><label>255.</label><citation-alternatives><element-citation id="ec-CR255" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>Z</given-names></name><etal/></person-group><article-title>NF-&#954;B restricts inflammasome activation via elimination of damaged mitochondria</article-title><source>Cell</source><year>2016</year><volume>164</volume><fpage>896</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.12.057</pub-id><pub-id pub-id-type="pmid">26919428</pub-id><pub-id pub-id-type="pmcid">PMC4769378</pub-id></element-citation><mixed-citation id="mc-CR255" publication-type="journal">Zhong, Z. et al. NF-&#954;B restricts inflammasome activation via elimination of damaged mitochondria. <italic toggle="yes">Cell</italic><bold>164</bold>, 896&#8211;910 (2016).<pub-id pub-id-type="pmid">26919428</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2015.12.057</pub-id><pub-id pub-id-type="pmcid">PMC4769378</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR256"><label>256.</label><citation-alternatives><element-citation id="ec-CR256" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>W</given-names></name><etal/></person-group><article-title>Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation</article-title><source>Aging Cell</source><year>2022</year><volume>21</volume><fpage>e13622</fpage><pub-id pub-id-type="doi">10.1111/acel.13622</pub-id><pub-id pub-id-type="pmid">35599014</pub-id><pub-id pub-id-type="pmcid">PMC9197407</pub-id></element-citation><mixed-citation id="mc-CR256" publication-type="journal">Zhong, W. et al. Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation. <italic toggle="yes">Aging Cell</italic><bold>21</bold>, e13622 (2022).<pub-id pub-id-type="pmid">35599014</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/acel.13622</pub-id><pub-id pub-id-type="pmcid">PMC9197407</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR257"><label>257.</label><citation-alternatives><element-citation id="ec-CR257" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ip</surname><given-names>WKE</given-names></name><name name-style="western"><surname>Hoshi</surname><given-names>N</given-names></name><name name-style="western"><surname>Shouval</surname><given-names>DS</given-names></name><name name-style="western"><surname>Snapper</surname><given-names>S</given-names></name><name name-style="western"><surname>Medzhitov</surname><given-names>R</given-names></name></person-group><article-title>Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages</article-title><source>Science</source><year>2017</year><volume>356</volume><fpage>513</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1126/science.aal3535</pub-id><pub-id pub-id-type="pmid">28473584</pub-id><pub-id pub-id-type="pmcid">PMC6260791</pub-id></element-citation><mixed-citation id="mc-CR257" publication-type="journal">Ip, W. K. E., Hoshi, N., Shouval, D. S., Snapper, S. &amp; Medzhitov, R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. <italic toggle="yes">Science</italic><bold>356</bold>, 513&#8211;519 (2017).<pub-id pub-id-type="pmid">28473584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aal3535</pub-id><pub-id pub-id-type="pmcid">PMC6260791</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR258"><label>258.</label><citation-alternatives><element-citation id="ec-CR258" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation</article-title><source>Science</source><year>2015</year><volume>347</volume><fpage>aaa2630</fpage><pub-id pub-id-type="doi">10.1126/science.aaa2630</pub-id><pub-id pub-id-type="pmid">25636800</pub-id></element-citation><mixed-citation id="mc-CR258" publication-type="journal">Liu, S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. <italic toggle="yes">Science</italic><bold>347</bold>, aaa2630 (2015).<pub-id pub-id-type="pmid">25636800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aaa2630</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR259"><label>259.</label><citation-alternatives><element-citation id="ec-CR259" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><etal/></person-group><article-title>MAVS maintains mitochondrial homeostasis via autophagy</article-title><source>Cell Discov</source><year>2016</year><volume>2</volume><fpage>16024</fpage><pub-id pub-id-type="doi">10.1038/celldisc.2016.24</pub-id><pub-id pub-id-type="pmid">27551434</pub-id><pub-id pub-id-type="pmcid">PMC4986202</pub-id></element-citation><mixed-citation id="mc-CR259" publication-type="journal">Sun, X. et al. MAVS maintains mitochondrial homeostasis via autophagy. <italic toggle="yes">Cell Discov</italic>. <bold>2</bold>, 16024 (2016).<pub-id pub-id-type="pmid">27551434</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/celldisc.2016.24</pub-id><pub-id pub-id-type="pmcid">PMC4986202</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR260"><label>260.</label><citation-alternatives><element-citation id="ec-CR260" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriyama</surname><given-names>M</given-names></name><name name-style="western"><surname>Koshiba</surname><given-names>T</given-names></name><name name-style="western"><surname>Ichinohe</surname><given-names>T</given-names></name></person-group><article-title>Influenza A virus M2 protein triggers mitochondrial DNA-mediated antiviral immune responses</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>4624</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-12632-5</pub-id><pub-id pub-id-type="pmid">31604929</pub-id><pub-id pub-id-type="pmcid">PMC6789137</pub-id></element-citation><mixed-citation id="mc-CR260" publication-type="journal">Moriyama, M., Koshiba, T. &amp; Ichinohe, T. Influenza A virus M2 protein triggers mitochondrial DNA-mediated antiviral immune responses. <italic toggle="yes">Nat. Commun.</italic><bold>10</bold>, 4624 (2019).<pub-id pub-id-type="pmid">31604929</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-019-12632-5</pub-id><pub-id pub-id-type="pmcid">PMC6789137</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR261"><label>261.</label><citation-alternatives><element-citation id="ec-CR261" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>B</given-names></name><etal/></person-group><article-title>Dengue virus activates cGAS through the release of mitochondrial DNA</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>3594</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-03932-1</pub-id><pub-id pub-id-type="pmid">28620207</pub-id><pub-id pub-id-type="pmcid">PMC5472572</pub-id></element-citation><mixed-citation id="mc-CR261" publication-type="journal">Sun, B. et al. Dengue virus activates cGAS through the release of mitochondrial DNA. <italic toggle="yes">Sci. Rep.</italic><bold>7</bold>, 3594 (2017).<pub-id pub-id-type="pmid">28620207</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-017-03932-1</pub-id><pub-id pub-id-type="pmcid">PMC5472572</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR262"><label>262.</label><citation-alternatives><element-citation id="ec-CR262" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Domizio</surname><given-names>JD</given-names></name><etal/></person-group><article-title>The cGAS&#8211;STING pathway drives type I IFN immunopathology in COVID-19</article-title><source>Nature</source><year>2022</year><volume>603</volume><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04421-w</pub-id><pub-id pub-id-type="pmid">35045565</pub-id><pub-id pub-id-type="pmcid">PMC8891013</pub-id></element-citation><mixed-citation id="mc-CR262" publication-type="journal">Domizio, J. D. et al. The cGAS&#8211;STING pathway drives type I IFN immunopathology in COVID-19. <italic toggle="yes">Nature</italic><bold>603</bold>, 145&#8211;151 (2022).<pub-id pub-id-type="pmid">35045565</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-022-04421-w</pub-id><pub-id pub-id-type="pmcid">PMC8891013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR263"><label>263.</label><citation-alternatives><element-citation id="ec-CR263" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>C</given-names></name><etal/></person-group><article-title>Identification of cGAS as an innate immune sensor of extracellular bacterium <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>iScience</source><year>2021</year><volume>24</volume><fpage>101928</fpage><pub-id pub-id-type="doi">10.1016/j.isci.2020.101928</pub-id><pub-id pub-id-type="pmid">33385121</pub-id><pub-id pub-id-type="pmcid">PMC7772558</pub-id></element-citation><mixed-citation id="mc-CR263" publication-type="journal">Zhou, C. et al. Identification of cGAS as an innate immune sensor of extracellular bacterium <italic toggle="yes">Pseudomonas aeruginosa</italic>. <italic toggle="yes">iScience</italic><bold>24</bold>, 101928 (2021).<pub-id pub-id-type="pmid">33385121</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.isci.2020.101928</pub-id><pub-id pub-id-type="pmcid">PMC7772558</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR264"><label>264.</label><citation-alternatives><element-citation id="ec-CR264" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jim&#233;nez-Loygorri</surname><given-names>JI</given-names></name><etal/></person-group><article-title>Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during aging</article-title><source>Nat. Commun.</source><year>2024</year><volume>15</volume><fpage>830</fpage><pub-id pub-id-type="doi">10.1038/s41467-024-45044-1</pub-id><pub-id pub-id-type="pmid">38280852</pub-id><pub-id pub-id-type="pmcid">PMC10821893</pub-id></element-citation><mixed-citation id="mc-CR264" publication-type="journal">Jim&#233;nez-Loygorri, J. I. et al. Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during aging. <italic toggle="yes">Nat. Commun.</italic><bold>15</bold>, 830 (2024).<pub-id pub-id-type="pmid">38280852</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-45044-1</pub-id><pub-id pub-id-type="pmcid">PMC10821893</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR265"><label>265.</label><citation-alternatives><element-citation id="ec-CR265" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caza</surname><given-names>TN</given-names></name><etal/></person-group><article-title>HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE</article-title><source>Ann. Rheum. Dis.</source><year>2014</year><volume>73</volume><fpage>1888</fpage><lpage>1897</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2013-203794</pub-id><pub-id pub-id-type="pmid">23897774</pub-id><pub-id pub-id-type="pmcid">PMC4047212</pub-id></element-citation><mixed-citation id="mc-CR265" publication-type="journal">Caza, T. N. et al. HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. <italic toggle="yes">Ann. Rheum. Dis.</italic><bold>73</bold>, 1888&#8211;1897 (2014).<pub-id pub-id-type="pmid">23897774</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/annrheumdis-2013-203794</pub-id><pub-id pub-id-type="pmcid">PMC4047212</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR266"><label>266.</label><citation-alternatives><element-citation id="ec-CR266" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caielli</surname><given-names>S</given-names></name><etal/></person-group><article-title>Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus</article-title><source>J. Exp. Med.</source><year>2016</year><volume>213</volume><fpage>697</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1084/jem.20151876</pub-id><pub-id pub-id-type="pmid">27091841</pub-id><pub-id pub-id-type="pmcid">PMC4854735</pub-id></element-citation><mixed-citation id="mc-CR266" publication-type="journal">Caielli, S. et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. <italic toggle="yes">J. Exp. Med.</italic><bold>213</bold>, 697&#8211;713 (2016).<pub-id pub-id-type="pmid">27091841</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20151876</pub-id><pub-id pub-id-type="pmcid">PMC4854735</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR267"><label>267.</label><citation-alternatives><element-citation id="ec-CR267" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Benedittis</surname><given-names>G</given-names></name><etal/></person-group><article-title>The dysregulation of mitochondrial homeostasis-related genes could be involved in the decrease of mtDNA copy number in systemic lupus erythematosus patients</article-title><source>Immunol. Res.</source><year>2024</year><volume>72</volume><fpage>1384</fpage><lpage>1392</lpage><pub-id pub-id-type="doi">10.1007/s12026-024-09535-z</pub-id><pub-id pub-id-type="pmid">39230799</pub-id><pub-id pub-id-type="pmcid">PMC11618193</pub-id></element-citation><mixed-citation id="mc-CR267" publication-type="journal">De Benedittis, G. et al. The dysregulation of mitochondrial homeostasis-related genes could be involved in the decrease of mtDNA copy number in systemic lupus erythematosus patients. <italic toggle="yes">Immunol. Res.</italic><bold>72</bold>, 1384&#8211;1392 (2024).<pub-id pub-id-type="pmid">39230799</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12026-024-09535-z</pub-id><pub-id pub-id-type="pmcid">PMC11618193</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR268"><label>268.</label><citation-alternatives><element-citation id="ec-CR268" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Myeloid ATG16L1 facilitates host-bacteria interactions in maintaining intestinal homeostasis</article-title><source>J. Immunol.</source><year>2017</year><volume>198</volume><fpage>2133</fpage><lpage>2146</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601293</pub-id><pub-id pub-id-type="pmid">28130498</pub-id><pub-id pub-id-type="pmcid">PMC5322190</pub-id></element-citation><mixed-citation id="mc-CR268" publication-type="journal">Zhang, H. et al. Myeloid ATG16L1 facilitates host-bacteria interactions in maintaining intestinal homeostasis. <italic toggle="yes">J. Immunol.</italic><bold>198</bold>, 2133&#8211;2146 (2017).<pub-id pub-id-type="pmid">28130498</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1601293</pub-id><pub-id pub-id-type="pmcid">PMC5322190</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR269"><label>269.</label><citation-alternatives><element-citation id="ec-CR269" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><etal/></person-group><article-title>Irgm1-deficient mice exhibit Paneth cell abnormalities and increased susceptibility to acute intestinal inflammation</article-title><source>Am. J. Physiol. Gastrointest. Liver Physiol.</source><year>2013</year><volume>305</volume><fpage>G573</fpage><lpage>G584</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00071.2013</pub-id><pub-id pub-id-type="pmid">23989005</pub-id><pub-id pub-id-type="pmcid">PMC3798734</pub-id></element-citation><mixed-citation id="mc-CR269" publication-type="journal">Liu, B. et al. Irgm1-deficient mice exhibit Paneth cell abnormalities and increased susceptibility to acute intestinal inflammation. <italic toggle="yes">Am. J. Physiol. Gastrointest. Liver Physiol.</italic><bold>305</bold>, G573&#8211;G584 (2013).<pub-id pub-id-type="pmid">23989005</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpgi.00071.2013</pub-id><pub-id pub-id-type="pmcid">PMC3798734</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR270"><label>270.</label><citation-alternatives><element-citation id="ec-CR270" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patoli</surname><given-names>D</given-names></name><etal/></person-group><article-title>Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis</article-title><source>J. Clin. Invest.</source><year>2020</year><volume>130</volume><fpage>5858</fpage><lpage>5874</lpage><pub-id pub-id-type="doi">10.1172/JCI130996</pub-id><pub-id pub-id-type="pmid">32759503</pub-id><pub-id pub-id-type="pmcid">PMC7598049</pub-id></element-citation><mixed-citation id="mc-CR270" publication-type="journal">Patoli, D. et al. Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis. <italic toggle="yes">J. Clin. Invest.</italic><bold>130</bold>, 5858&#8211;5874 (2020).<pub-id pub-id-type="pmid">32759503</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI130996</pub-id><pub-id pub-id-type="pmcid">PMC7598049</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR271"><label>271.</label><citation-alternatives><element-citation id="ec-CR271" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Parkin impairs antiviral immunity by suppressing the mitochondrial reactive oxygen species-Nlrp3 axis and antiviral inflammation</article-title><source>iScience</source><year>2019</year><volume>16</volume><fpage>468</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1016/j.isci.2019.06.008</pub-id><pub-id pub-id-type="pmid">31229895</pub-id><pub-id pub-id-type="pmcid">PMC6593176</pub-id></element-citation><mixed-citation id="mc-CR271" publication-type="journal">Li, J. et al. Parkin impairs antiviral immunity by suppressing the mitochondrial reactive oxygen species-Nlrp3 axis and antiviral inflammation. <italic toggle="yes">iScience</italic><bold>16</bold>, 468&#8211;484 (2019).<pub-id pub-id-type="pmid">31229895</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.isci.2019.06.008</pub-id><pub-id pub-id-type="pmcid">PMC6593176</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR272"><label>272.</label><citation-alternatives><element-citation id="ec-CR272" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>B</given-names></name><etal/></person-group><article-title>The matrix protein of human parainfluenza virus type 3 induces mitophagy that suppresses interferon responses</article-title><source>Cell Host Microbe.</source><year>2017</year><volume>21</volume><fpage>538</fpage><lpage>547.e4</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2017.03.004</pub-id><pub-id pub-id-type="pmid">28407488</pub-id></element-citation><mixed-citation id="mc-CR272" publication-type="journal">Ding, B. et al. The matrix protein of human parainfluenza virus type 3 induces mitophagy that suppresses interferon responses. <italic toggle="yes">Cell Host Microbe.</italic><bold>21</bold>, 538&#8211;547.e4 (2017).<pub-id pub-id-type="pmid">28407488</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chom.2017.03.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR273"><label>273.</label><citation-alternatives><element-citation id="ec-CR273" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><etal/></person-group><article-title>Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy</article-title><source>Autophagy</source><year>2021</year><volume>17</volume><fpage>496</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1725375</pub-id><pub-id pub-id-type="pmid">32013669</pub-id><pub-id pub-id-type="pmcid">PMC8007153</pub-id></element-citation><mixed-citation id="mc-CR273" publication-type="journal">Wang, R. et al. Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy. <italic toggle="yes">Autophagy</italic><bold>17</bold>, 496&#8211;511 (2021).<pub-id pub-id-type="pmid">32013669</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2020.1725375</pub-id><pub-id pub-id-type="pmcid">PMC8007153</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR274"><label>274.</label><citation-alternatives><element-citation id="ec-CR274" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshizumi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity</article-title><source>Nat. Commun.</source><year>2014</year><volume>5</volume><fpage>4713</fpage><pub-id pub-id-type="doi">10.1038/ncomms5713</pub-id><pub-id pub-id-type="pmid">25140902</pub-id></element-citation><mixed-citation id="mc-CR274" publication-type="journal">Yoshizumi, T. et al. Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity. <italic toggle="yes">Nat. Commun.</italic><bold>5</bold>, 4713 (2014).<pub-id pub-id-type="pmid">25140902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms5713</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR275"><label>275.</label><citation-alternatives><element-citation id="ec-CR275" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy</article-title><source>Cell Mol. Immunol.</source><year>2022</year><volume>19</volume><fpage>67</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1038/s41423-021-00807-4</pub-id><pub-id pub-id-type="pmid">34845370</pub-id><pub-id pub-id-type="pmcid">PMC8628139</pub-id></element-citation><mixed-citation id="mc-CR275" publication-type="journal">Li, X. et al. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy. <italic toggle="yes">Cell Mol. Immunol.</italic><bold>19</bold>, 67&#8211;78 (2022).<pub-id pub-id-type="pmid">34845370</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41423-021-00807-4</pub-id><pub-id pub-id-type="pmcid">PMC8628139</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR276"><label>276.</label><citation-alternatives><element-citation id="ec-CR276" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Humpton</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Oncogenic KRAS induces NIX-mediated mitophagy to promote pancreatic cancer</article-title><source>Cancer Discov.</source><year>2019</year><volume>9</volume><fpage>1268</fpage><lpage>1287</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-18-1409</pub-id><pub-id pub-id-type="pmid">31263025</pub-id><pub-id pub-id-type="pmcid">PMC6726540</pub-id></element-citation><mixed-citation id="mc-CR276" publication-type="journal">Humpton, T. J. et al. Oncogenic KRAS induces NIX-mediated mitophagy to promote pancreatic cancer. <italic toggle="yes">Cancer Discov.</italic><bold>9</bold>, 1268&#8211;1287 (2019).<pub-id pub-id-type="pmid">31263025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/2159-8290.CD-18-1409</pub-id><pub-id pub-id-type="pmcid">PMC6726540</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR277"><label>277.</label><citation-alternatives><element-citation id="ec-CR277" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Parkin regulates the activity of pyruvate kinase M2</article-title><source>J. Biol. Chem.</source><year>2016</year><volume>291</volume><fpage>10307</fpage><lpage>10317</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.703066</pub-id><pub-id pub-id-type="pmid">26975375</pub-id><pub-id pub-id-type="pmcid">PMC4858978</pub-id></element-citation><mixed-citation id="mc-CR277" publication-type="journal">Liu, K. et al. Parkin regulates the activity of pyruvate kinase M2. <italic toggle="yes">J. Biol. Chem.</italic><bold>291</bold>, 10307&#8211;10317 (2016).<pub-id pub-id-type="pmid">26975375</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M115.703066</pub-id><pub-id pub-id-type="pmcid">PMC4858978</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR278"><label>278.</label><citation-alternatives><element-citation id="ec-CR278" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Parkin targets HIF-1&#945; for ubiquitination and degradation to inhibit breast tumor progression</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>1823</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-01947-w</pub-id><pub-id pub-id-type="pmid">29180628</pub-id><pub-id pub-id-type="pmcid">PMC5703960</pub-id></element-citation><mixed-citation id="mc-CR278" publication-type="journal">Liu, J. et al. Parkin targets HIF-1&#945; for ubiquitination and degradation to inhibit breast tumor progression. <italic toggle="yes">Nat. Commun.</italic><bold>8</bold>, 1823 (2017).<pub-id pub-id-type="pmid">29180628</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-017-01947-w</pub-id><pub-id pub-id-type="pmcid">PMC5703960</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR279"><label>279.</label><citation-alternatives><element-citation id="ec-CR279" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>A</given-names></name><etal/></person-group><article-title>PARK2 depletion connects energy and oxidative stress to PI3K/Akt activation via PTEN S-nitrosylation</article-title><source>Mol. Cell</source><year>2017</year><volume>65</volume><fpage>999</fpage><lpage>1013.e7</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.02.019</pub-id><pub-id pub-id-type="pmid">28306514</pub-id><pub-id pub-id-type="pmcid">PMC5426642</pub-id></element-citation><mixed-citation id="mc-CR279" publication-type="journal">Gupta, A. et al. PARK2 depletion connects energy and oxidative stress to PI3K/Akt activation via PTEN S-nitrosylation. <italic toggle="yes">Mol. Cell</italic><bold>65</bold>, 999&#8211;1013.e7 (2017).<pub-id pub-id-type="pmid">28306514</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2017.02.019</pub-id><pub-id pub-id-type="pmcid">PMC5426642</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR280"><label>280.</label><citation-alternatives><element-citation id="ec-CR280" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2)</article-title><source>Autophagy</source><year>2018</year><volume>14</volume><fpage>671</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1080/15548627.2017.1381804</pub-id><pub-id pub-id-type="pmid">28980855</pub-id><pub-id pub-id-type="pmcid">PMC5959330</pub-id></element-citation><mixed-citation id="mc-CR280" publication-type="journal">Jiao, L. et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). <italic toggle="yes">Autophagy</italic><bold>14</bold>, 671&#8211;684 (2018).<pub-id pub-id-type="pmid">28980855</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2017.1381804</pub-id><pub-id pub-id-type="pmcid">PMC5959330</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR281"><label>281.</label><citation-alternatives><element-citation id="ec-CR281" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veeriah</surname><given-names>S</given-names></name><etal/></person-group><article-title>Somatic mutations of the Parkinson&#8217;s disease-associated gene PARK2 in glioblastoma and other human malignancies</article-title><source>Nat. Genet.</source><year>2010</year><volume>42</volume><fpage>77</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/ng.491</pub-id><pub-id pub-id-type="pmid">19946270</pub-id><pub-id pub-id-type="pmcid">PMC4002225</pub-id></element-citation><mixed-citation id="mc-CR281" publication-type="journal">Veeriah, S. et al. Somatic mutations of the Parkinson&#8217;s disease-associated gene PARK2 in glioblastoma and other human malignancies. <italic toggle="yes">Nat. Genet.</italic><bold>42</bold>, 77&#8211;82 (2010).<pub-id pub-id-type="pmid">19946270</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng.491</pub-id><pub-id pub-id-type="pmcid">PMC4002225</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR282"><label>282.</label><citation-alternatives><element-citation id="ec-CR282" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>SP</given-names></name><etal/></person-group><article-title>The clonal and mutational evolution spectrum of primary triple-negative breast cancers</article-title><source>Nature</source><year>2012</year><volume>486</volume><fpage>395</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1038/nature10933</pub-id><pub-id pub-id-type="pmid">22495314</pub-id><pub-id pub-id-type="pmcid">PMC3863681</pub-id></element-citation><mixed-citation id="mc-CR282" publication-type="journal">Shah, S. P. et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. <italic toggle="yes">Nature</italic><bold>486</bold>, 395&#8211;399 (2012).<pub-id pub-id-type="pmid">22495314</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature10933</pub-id><pub-id pub-id-type="pmcid">PMC3863681</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR283"><label>283.</label><citation-alternatives><element-citation id="ec-CR283" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poulogiannis</surname><given-names>G</given-names></name><etal/></person-group><article-title>PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>15145</fpage><lpage>15150</lpage><pub-id pub-id-type="doi">10.1073/pnas.1009941107</pub-id><pub-id pub-id-type="pmid">20696900</pub-id><pub-id pub-id-type="pmcid">PMC2930574</pub-id></element-citation><mixed-citation id="mc-CR283" publication-type="journal">Poulogiannis, G. et al. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>107</bold>, 15145&#8211;15150 (2010).<pub-id pub-id-type="pmid">20696900</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1009941107</pub-id><pub-id pub-id-type="pmcid">PMC2930574</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR284"><label>284.</label><citation-alternatives><element-citation id="ec-CR284" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denison</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Alterations in the common fragile site gene Parkin in ovarian and other cancers</article-title><source>Oncogene</source><year>2003</year><volume>22</volume><fpage>8370</fpage><lpage>8378</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1207072</pub-id><pub-id pub-id-type="pmid">14614460</pub-id></element-citation><mixed-citation id="mc-CR284" publication-type="journal">Denison, S. R. et al. Alterations in the common fragile site gene Parkin in ovarian and other cancers. <italic toggle="yes">Oncogene</italic><bold>22</bold>, 8370&#8211;8378 (2003).<pub-id pub-id-type="pmid">14614460</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.onc.1207072</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR285"><label>285.</label><citation-alternatives><element-citation id="ec-CR285" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fujiwara</surname><given-names>M</given-names></name><etal/></person-group><article-title>Parkin as a tumor suppressor gene for hepatocellular carcinoma</article-title><source>Oncogene</source><year>2008</year><volume>27</volume><fpage>6002</fpage><lpage>6011</lpage><pub-id pub-id-type="doi">10.1038/onc.2008.199</pub-id><pub-id pub-id-type="pmid">18574468</pub-id></element-citation><mixed-citation id="mc-CR285" publication-type="journal">Fujiwara, M. et al. Parkin as a tumor suppressor gene for hepatocellular carcinoma. <italic toggle="yes">Oncogene</italic><bold>27</bold>, 6002&#8211;6011 (2008).<pub-id pub-id-type="pmid">18574468</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/onc.2008.199</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR286"><label>286.</label><citation-alternatives><element-citation id="ec-CR286" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma</article-title><source>J. Hepatol.</source><year>2019</year><volume>70</volume><fpage>66</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2018.09.022</pub-id><pub-id pub-id-type="pmid">30287340</pub-id></element-citation><mixed-citation id="mc-CR286" publication-type="journal">Chen, Y. et al. Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. <italic toggle="yes">J. Hepatol.</italic><bold>70</bold>, 66&#8211;77 (2019).<pub-id pub-id-type="pmid">30287340</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2018.09.022</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR287"><label>287.</label><citation-alternatives><element-citation id="ec-CR287" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denk</surname><given-names>D</given-names></name><etal/></person-group><article-title>Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy</article-title><source>Immunity</source><year>2022</year><volume>55</volume><fpage>2059</fpage><lpage>2073.e8</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2022.09.014</pub-id><pub-id pub-id-type="pmid">36351375</pub-id></element-citation><mixed-citation id="mc-CR287" publication-type="journal">Denk, D. et al. Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy. <italic toggle="yes">Immunity</italic><bold>55</bold>, 2059&#8211;2073.e8 (2022).<pub-id pub-id-type="pmid">36351375</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2022.09.014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR288"><label>288.</label><citation-alternatives><element-citation id="ec-CR288" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehra</surname><given-names>S</given-names></name><etal/></person-group><article-title>Remodeling of stromal immune microenvironment by Urolithin A improves survival with immune checkpoint blockade in pancreatic cancer</article-title><source>Cancer Res. Commun.</source><year>2023</year><volume>3</volume><fpage>1224</fpage><lpage>1236</lpage><pub-id pub-id-type="doi">10.1158/2767-9764.CRC-22-0329</pub-id><pub-id pub-id-type="pmid">37448553</pub-id><pub-id pub-id-type="pmcid">PMC10337606</pub-id></element-citation><mixed-citation id="mc-CR288" publication-type="journal">Mehra, S. et al. Remodeling of stromal immune microenvironment by Urolithin A improves survival with immune checkpoint blockade in pancreatic cancer. <italic toggle="yes">Cancer Res. Commun.</italic><bold>3</bold>, 1224&#8211;1236 (2023).<pub-id pub-id-type="pmid">37448553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/2767-9764.CRC-22-0329</pub-id><pub-id pub-id-type="pmcid">PMC10337606</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR289"><label>289.</label><citation-alternatives><element-citation id="ec-CR289" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>YS</given-names></name><etal/></person-group><article-title>Deficiency of parkin suppresses melanoma tumor development and metastasis through inhibition of MFN2 ubiquitination</article-title><source>Cancer Lett</source><year>2018</year><volume>433</volume><fpage>156</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2018.07.007</pub-id><pub-id pub-id-type="pmid">29981809</pub-id></element-citation><mixed-citation id="mc-CR289" publication-type="journal">Lee, Y. S. et al. Deficiency of parkin suppresses melanoma tumor development and metastasis through inhibition of MFN2 ubiquitination. <italic toggle="yes">Cancer Lett</italic>. <bold>433</bold>, 156&#8211;164 (2018).<pub-id pub-id-type="pmid">29981809</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.canlet.2018.07.007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR290"><label>290.</label><citation-alternatives><element-citation id="ec-CR290" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agnihotri</surname><given-names>S</given-names></name><etal/></person-group><article-title>PINK1 is a negative regulator of growth and the Warburg effect in glioblastoma</article-title><source>Cancer Res.</source><year>2016</year><volume>76</volume><fpage>4708</fpage><lpage>4719</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-15-3079</pub-id><pub-id pub-id-type="pmid">27325644</pub-id></element-citation><mixed-citation id="mc-CR290" publication-type="journal">Agnihotri, S. et al. PINK1 is a negative regulator of growth and the Warburg effect in glioblastoma. <italic toggle="yes">Cancer Res.</italic><bold>76</bold>, 4708&#8211;4719 (2016).<pub-id pub-id-type="pmid">27325644</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-15-3079</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR291"><label>291.</label><citation-alternatives><element-citation id="ec-CR291" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Silencing of PINK1 represses cell growth, migration and induces apoptosis of lung cancer cells</article-title><source>Biomed. Pharmacother.</source><year>2018</year><volume>106</volume><fpage>333</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.06.128</pub-id><pub-id pub-id-type="pmid">29966978</pub-id></element-citation><mixed-citation id="mc-CR291" publication-type="journal">Liu, L. et al. Silencing of PINK1 represses cell growth, migration and induces apoptosis of lung cancer cells. <italic toggle="yes">Biomed. Pharmacother.</italic><bold>106</bold>, 333&#8211;341 (2018).<pub-id pub-id-type="pmid">29966978</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2018.06.128</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR292"><label>292.</label><citation-alternatives><element-citation id="ec-CR292" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giatromanolaki</surname><given-names>A</given-names></name><etal/></person-group><article-title>BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer</article-title><source>Clin. Cancer Res.</source><year>2004</year><volume>10</volume><fpage>5566</fpage><lpage>5571</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-0076</pub-id><pub-id pub-id-type="pmid">15328198</pub-id></element-citation><mixed-citation id="mc-CR292" publication-type="journal">Giatromanolaki, A. et al. BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer. <italic toggle="yes">Clin. Cancer Res.</italic><bold>10</bold>, 5566&#8211;5571 (2004).<pub-id pub-id-type="pmid">15328198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1078-0432.CCR-04-0076</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR293"><label>293.</label><citation-alternatives><element-citation id="ec-CR293" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chourasia</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis</article-title><source>EMBO Rep</source><year>2015</year><volume>16</volume><fpage>1145</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.15252/embr.201540759</pub-id><pub-id pub-id-type="pmid">26232272</pub-id><pub-id pub-id-type="pmcid">PMC4576983</pub-id></element-citation><mixed-citation id="mc-CR293" publication-type="journal">Chourasia, A. H. et al. Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis. <italic toggle="yes">EMBO Rep</italic>. <bold>16</bold>, 1145&#8211;1163 (2015).<pub-id pub-id-type="pmid">26232272</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embr.201540759</pub-id><pub-id pub-id-type="pmcid">PMC4576983</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR294"><label>294.</label><citation-alternatives><element-citation id="ec-CR294" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>H</given-names></name><etal/></person-group><article-title>High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer</article-title><source>Cancer Med</source><year>2017</year><volume>6</volume><fpage>1871</fpage><lpage>1881</lpage><pub-id pub-id-type="doi">10.1002/cam4.1112</pub-id><pub-id pub-id-type="pmid">28719148</pub-id><pub-id pub-id-type="pmcid">PMC5548885</pub-id></element-citation><mixed-citation id="mc-CR294" publication-type="journal">Hou, H. et al. High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer. <italic toggle="yes">Cancer Med</italic>. <bold>6</bold>, 1871&#8211;1881 (2017).<pub-id pub-id-type="pmid">28719148</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cam4.1112</pub-id><pub-id pub-id-type="pmcid">PMC5548885</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR295"><label>295.</label><citation-alternatives><element-citation id="ec-CR295" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><etal/></person-group><article-title>FUN14 domain-containing 1-mediated mitophagy suppresses hepatocarcinogenesis by inhibition of inflammasome activation in mice</article-title><source>Hepatology</source><year>2019</year><volume>69</volume><fpage>604</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1002/hep.30191</pub-id><pub-id pub-id-type="pmid">30053328</pub-id></element-citation><mixed-citation id="mc-CR295" publication-type="journal">Li, W. et al. FUN14 domain-containing 1-mediated mitophagy suppresses hepatocarcinogenesis by inhibition of inflammasome activation in mice. <italic toggle="yes">Hepatology</italic><bold>69</bold>, 604&#8211;621 (2019).<pub-id pub-id-type="pmid">30053328</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hep.30191</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR296"><label>296.</label><citation-alternatives><element-citation id="ec-CR296" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ito</surname><given-names>K</given-names></name><etal/></person-group><article-title>Self-renewal of a purified Tie2+ hematopoietic stem cell population relies on mitochondrial clearance</article-title><source>Science</source><year>2016</year><volume>354</volume><fpage>1156</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1126/science.aaf5530</pub-id><pub-id pub-id-type="pmid">27738012</pub-id><pub-id pub-id-type="pmcid">PMC5164878</pub-id></element-citation><mixed-citation id="mc-CR296" publication-type="journal">Ito, K. et al. Self-renewal of a purified Tie2+ hematopoietic stem cell population relies on mitochondrial clearance. <italic toggle="yes">Science</italic><bold>354</bold>, 1156&#8211;1160 (2016).<pub-id pub-id-type="pmid">27738012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aaf5530</pub-id><pub-id pub-id-type="pmcid">PMC5164878</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR297"><label>297.</label><citation-alternatives><element-citation id="ec-CR297" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Mitophagy controls the activities of tumor suppressor p53 to regulate hepatic cancer stem cells</article-title><source>Mol. Cell</source><year>2017</year><volume>68</volume><fpage>281</fpage><lpage>292.e5</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.09.022</pub-id><pub-id pub-id-type="pmid">29033320</pub-id><pub-id pub-id-type="pmcid">PMC5687282</pub-id></element-citation><mixed-citation id="mc-CR297" publication-type="journal">Liu, K. et al. Mitophagy controls the activities of tumor suppressor p53 to regulate hepatic cancer stem cells. <italic toggle="yes">Mol. Cell</italic><bold>68</bold>, 281&#8211;292.e5 (2017).<pub-id pub-id-type="pmid">29033320</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2017.09.022</pub-id><pub-id pub-id-type="pmcid">PMC5687282</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR298"><label>298.</label><citation-alternatives><element-citation id="ec-CR298" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pei</surname><given-names>S</given-names></name><etal/></person-group><article-title>AMPK/FIS1-mediated mitophagy is required for self-renewal of human AML stem cells</article-title><source>Cell Stem Cell</source><year>2018</year><volume>23</volume><fpage>86</fpage><lpage>100.e6</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2018.05.021</pub-id><pub-id pub-id-type="pmid">29910151</pub-id><pub-id pub-id-type="pmcid">PMC6035102</pub-id></element-citation><mixed-citation id="mc-CR298" publication-type="journal">Pei, S. et al. AMPK/FIS1-mediated mitophagy is required for self-renewal of human AML stem cells. <italic toggle="yes">Cell Stem Cell</italic><bold>23</bold>, 86&#8211;100.e6 (2018).<pub-id pub-id-type="pmid">29910151</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.stem.2018.05.021</pub-id><pub-id pub-id-type="pmcid">PMC6035102</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR299"><label>299.</label><citation-alternatives><element-citation id="ec-CR299" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Epigenetic induction of mitochondrial fission is required for maintenance of liver cancer-initiating cells</article-title><source>Cancer Res.</source><year>2021</year><volume>81</volume><fpage>3835</fpage><lpage>3848</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-21-0436</pub-id><pub-id pub-id-type="pmid">34049973</pub-id></element-citation><mixed-citation id="mc-CR299" publication-type="journal">Tang, M. et al. Epigenetic induction of mitochondrial fission is required for maintenance of liver cancer-initiating cells. <italic toggle="yes">Cancer Res.</italic><bold>81</bold>, 3835&#8211;3848 (2021).<pub-id pub-id-type="pmid">34049973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-21-0436</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR300"><label>300.</label><citation-alternatives><element-citation id="ec-CR300" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villa</surname><given-names>E</given-names></name><etal/></person-group><article-title>Parkin-independent mitophagy controls chemotherapeutic response in cancer cells</article-title><source>Cell Rep.</source><year>2017</year><volume>20</volume><fpage>2846</fpage><lpage>2859</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.08.087</pub-id><pub-id pub-id-type="pmid">28930681</pub-id></element-citation><mixed-citation id="mc-CR300" publication-type="journal">Villa, E. et al. Parkin-independent mitophagy controls chemotherapeutic response in cancer cells. <italic toggle="yes">Cell Rep.</italic><bold>20</bold>, 2846&#8211;2859 (2017).<pub-id pub-id-type="pmid">28930681</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2017.08.087</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR301"><label>301.</label><citation-alternatives><element-citation id="ec-CR301" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>X-Q</given-names></name><etal/></person-group><article-title>Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria</article-title><source>Cell Res.</source><year>2023</year><volume>33</volume><fpage>215</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1038/s41422-022-00766-z</pub-id><pub-id pub-id-type="pmid">36627348</pub-id><pub-id pub-id-type="pmcid">PMC9977947</pub-id></element-citation><mixed-citation id="mc-CR301" publication-type="journal">Xie, X.-Q. et al. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria. <italic toggle="yes">Cell Res.</italic><bold>33</bold>, 215&#8211;228 (2023).<pub-id pub-id-type="pmid">36627348</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41422-022-00766-z</pub-id><pub-id pub-id-type="pmcid">PMC9977947</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR302"><label>302.</label><citation-alternatives><element-citation id="ec-CR302" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamazaki</surname><given-names>T</given-names></name><etal/></person-group><article-title>Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy</article-title><source>Nat. Immunol.</source><year>2020</year><volume>21</volume><fpage>1160</fpage><lpage>1171</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0751-0</pub-id><pub-id pub-id-type="pmid">32747819</pub-id></element-citation><mixed-citation id="mc-CR302" publication-type="journal">Yamazaki, T. et al. Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. <italic toggle="yes">Nat. Immunol.</italic><bold>21</bold>, 1160&#8211;1171 (2020).<pub-id pub-id-type="pmid">32747819</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-020-0751-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR303"><label>303.</label><citation-alternatives><element-citation id="ec-CR303" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>C</given-names></name><etal/></person-group><article-title>Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling</article-title><source>Nat. Immunol.</source><year>2020</year><volume>21</volume><fpage>546</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0641-5</pub-id><pub-id pub-id-type="pmid">32231300</pub-id></element-citation><mixed-citation id="mc-CR303" publication-type="journal">Han, C. et al. Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling. <italic toggle="yes">Nat. Immunol.</italic><bold>21</bold>, 546&#8211;554 (2020).<pub-id pub-id-type="pmid">32231300</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-020-0641-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR304"><label>304.</label><citation-alternatives><element-citation id="ec-CR304" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Selective BCL-2 inhibitor triggers STING-dependent antitumor immunity via inducing mtDNA release</article-title><source>J. Immunother. Cancer</source><year>2025</year><volume>13</volume><fpage>e010889</fpage><pub-id pub-id-type="doi">10.1136/jitc-2024-010889</pub-id><pub-id pub-id-type="pmid">40300857</pub-id><pub-id pub-id-type="pmcid">PMC12056644</pub-id></element-citation><mixed-citation id="mc-CR304" publication-type="journal">Zhang, W. et al. Selective BCL-2 inhibitor triggers STING-dependent antitumor immunity via inducing mtDNA release. <italic toggle="yes">J. Immunother. Cancer</italic><bold>13</bold>, e010889 (2025).<pub-id pub-id-type="pmid">40300857</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jitc-2024-010889</pub-id><pub-id pub-id-type="pmcid">PMC12056644</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR305"><label>305.</label><citation-alternatives><element-citation id="ec-CR305" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name><etal/></person-group><article-title>USP30 inhibition augments mitophagy to prevent T cell exhaustion</article-title><source>Sci. Adv</source><year>2025</year><volume>11</volume><fpage>eadv6902</fpage><pub-id pub-id-type="doi">10.1126/sciadv.adv6902</pub-id><pub-id pub-id-type="pmid">40815646</pub-id><pub-id pub-id-type="pmcid">PMC12356266</pub-id></element-citation><mixed-citation id="mc-CR305" publication-type="journal">Zhang, R. et al. USP30 inhibition augments mitophagy to prevent T cell exhaustion. <italic toggle="yes">Sci. Adv</italic>. <bold>11</bold>, eadv6902 (2025).<pub-id pub-id-type="pmid">40815646</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciadv.adv6902</pub-id><pub-id pub-id-type="pmcid">PMC12356266</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR306"><label>306.</label><citation-alternatives><element-citation id="ec-CR306" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindqvist</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Autophagy induced during apoptosis degrades mitochondria and inhibits type I interferon secretion</article-title><source>Cell Death Differ</source><year>2018</year><volume>25</volume><fpage>784</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1038/s41418-017-0017-z</pub-id><pub-id pub-id-type="pmid">29229994</pub-id><pub-id pub-id-type="pmcid">PMC5864185</pub-id></element-citation><mixed-citation id="mc-CR306" publication-type="journal">Lindqvist, L. M. et al. Autophagy induced during apoptosis degrades mitochondria and inhibits type I interferon secretion. <italic toggle="yes">Cell Death Differ</italic>. <bold>25</bold>, 784&#8211;796 (2018).<pub-id pub-id-type="pmid">29229994</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41418-017-0017-z</pub-id><pub-id pub-id-type="pmcid">PMC5864185</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR307"><label>307.</label><citation-alternatives><element-citation id="ec-CR307" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heymsfield</surname><given-names>SB</given-names></name><name name-style="western"><surname>Wadden</surname><given-names>TA</given-names></name></person-group><article-title>Mechanisms, pathophysiology, and management of obesity</article-title><source>N. Engl. J. Med.</source><year>2017</year><volume>376</volume><fpage>254</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1514009</pub-id><pub-id pub-id-type="pmid">28099824</pub-id></element-citation><mixed-citation id="mc-CR307" publication-type="journal">Heymsfield, S. B. &amp; Wadden, T. A. Mechanisms, pathophysiology, and management of obesity. <italic toggle="yes">N. Engl. J. Med.</italic><bold>376</bold>, 254&#8211;266 (2017).<pub-id pub-id-type="pmid">28099824</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMra1514009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR308"><label>308.</label><citation-alternatives><element-citation id="ec-CR308" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liesa</surname><given-names>M</given-names></name><name name-style="western"><surname>Shirihai</surname><given-names>OS</given-names></name></person-group><article-title>Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure</article-title><source>Cell Metab</source><year>2013</year><volume>17</volume><fpage>491</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2013.03.002</pub-id><pub-id pub-id-type="pmid">23562075</pub-id><pub-id pub-id-type="pmcid">PMC5967396</pub-id></element-citation><mixed-citation id="mc-CR308" publication-type="journal">Liesa, M. &amp; Shirihai, O. S. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. <italic toggle="yes">Cell Metab</italic>. <bold>17</bold>, 491&#8211;506 (2013).<pub-id pub-id-type="pmid">23562075</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2013.03.002</pub-id><pub-id pub-id-type="pmcid">PMC5967396</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR309"><label>309.</label><citation-alternatives><element-citation id="ec-CR309" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice</article-title><source>Autophagy</source><year>2021</year><volume>17</volume><fpage>1205</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1753002</pub-id><pub-id pub-id-type="pmid">32400277</pub-id><pub-id pub-id-type="pmcid">PMC8143238</pub-id></element-citation><mixed-citation id="mc-CR309" publication-type="journal">Ko, M. S. et al. Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice. <italic toggle="yes">Autophagy</italic><bold>17</bold>, 1205&#8211;1221 (2021).<pub-id pub-id-type="pmid">32400277</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2020.1753002</pub-id><pub-id pub-id-type="pmcid">PMC8143238</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR310"><label>310.</label><citation-alternatives><element-citation id="ec-CR310" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome</article-title><source>Autophagy</source><year>2019</year><volume>15</volume><fpage>1882</fpage><lpage>1898</lpage><pub-id pub-id-type="doi">10.1080/15548627.2019.1596482</pub-id><pub-id pub-id-type="pmid">30898010</pub-id><pub-id pub-id-type="pmcid">PMC6844496</pub-id></element-citation><mixed-citation id="mc-CR310" publication-type="journal">Wu, H. et al. Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome. <italic toggle="yes">Autophagy</italic><bold>15</bold>, 1882&#8211;1898 (2019).<pub-id pub-id-type="pmid">30898010</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2019.1596482</pub-id><pub-id pub-id-type="pmcid">PMC6844496</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR311"><label>311.</label><citation-alternatives><element-citation id="ec-CR311" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>F</given-names></name><etal/></person-group><article-title>Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance</article-title><source>J. Exp. Med.</source><year>2020</year><volume>218</volume><fpage>e20201416</fpage><pub-id pub-id-type="doi">10.1084/jem.20201416</pub-id><pub-id pub-id-type="pmcid">PMC7927432</pub-id><pub-id pub-id-type="pmid">33315085</pub-id></element-citation><mixed-citation id="mc-CR311" publication-type="journal">He, F. et al. Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance. <italic toggle="yes">J. Exp. Med.</italic><bold>218</bold>, e20201416 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20201416</pub-id><pub-id pub-id-type="pmcid">PMC7927432</pub-id><pub-id pub-id-type="pmid">33315085</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR312"><label>312.</label><citation-alternatives><element-citation id="ec-CR312" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeFronzo</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Type 2 diabetes mellitus</article-title><source>Nat. Rev. Dis. Prim.</source><year>2015</year><volume>1</volume><fpage>15019</fpage><pub-id pub-id-type="doi">10.1038/nrdp.2015.19</pub-id><pub-id pub-id-type="pmid">27189025</pub-id></element-citation><mixed-citation id="mc-CR312" publication-type="journal">DeFronzo, R. A. et al. Type 2 diabetes mellitus. <italic toggle="yes">Nat. Rev. Dis. Prim.</italic><bold>1</bold>, 15019 (2015).<pub-id pub-id-type="pmid">27189025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrdp.2015.19</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR313"><label>313.</label><citation-alternatives><element-citation id="ec-CR313" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Apostolova</surname><given-names>N</given-names></name><name name-style="western"><surname>Vezza</surname><given-names>T</given-names></name><name name-style="western"><surname>Muntane</surname><given-names>J</given-names></name><name name-style="western"><surname>Rocha</surname><given-names>M</given-names></name><name name-style="western"><surname>V&#237;ctor</surname><given-names>VM</given-names></name></person-group><article-title>Mitochondrial dysfunction and mitophagy in type 2 diabetes: Pathophysiology and therapeutic targets</article-title><source>Antioxid. Redox Signal.</source><year>2023</year><volume>39</volume><fpage>278</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1089/ars.2022.0016</pub-id><pub-id pub-id-type="pmid">36641637</pub-id></element-citation><mixed-citation id="mc-CR313" publication-type="journal">Apostolova, N., Vezza, T., Muntane, J., Rocha, M. &amp; V&#237;ctor, V. M. Mitochondrial dysfunction and mitophagy in type 2 diabetes: Pathophysiology and therapeutic targets. <italic toggle="yes">Antioxid. Redox Signal.</italic><bold>39</bold>, 278&#8211;320 (2023).<pub-id pub-id-type="pmid">36641637</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/ars.2022.0016</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR314"><label>314.</label><citation-alternatives><element-citation id="ec-CR314" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiang</surname><given-names>R-L</given-names></name><etal/></person-group><article-title>Type 2 diabetes-induced hyposalivation of the submandibular gland through PINK1/Parkin-mediated mitophagy</article-title><source>J. Cell Physiol.</source><year>2020</year><volume>235</volume><fpage>232</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1002/jcp.28962</pub-id><pub-id pub-id-type="pmid">31190343</pub-id><pub-id pub-id-type="pmcid">PMC6851669</pub-id></element-citation><mixed-citation id="mc-CR314" publication-type="journal">Xiang, R.-L. et al. Type 2 diabetes-induced hyposalivation of the submandibular gland through PINK1/Parkin-mediated mitophagy. <italic toggle="yes">J. Cell Physiol.</italic><bold>235</bold>, 232&#8211;244 (2020).<pub-id pub-id-type="pmid">31190343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcp.28962</pub-id><pub-id pub-id-type="pmcid">PMC6851669</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR315"><label>315.</label><citation-alternatives><element-citation id="ec-CR315" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhansali</surname><given-names>S</given-names></name><name name-style="western"><surname>Bhansali</surname><given-names>A</given-names></name><name name-style="western"><surname>Walia</surname><given-names>R</given-names></name><name name-style="western"><surname>Saikia</surname><given-names>UN</given-names></name><name name-style="western"><surname>Dhawan</surname><given-names>V</given-names></name></person-group><article-title>Alterations in mitochondrial oxidative stress and mitophagy in subjects with prediabetes and type 2 diabetes mellitus</article-title><source>Front. Endocrinol.</source><year>2017</year><volume>8</volume><fpage>347</fpage><pub-id pub-id-type="doi">10.3389/fendo.2017.00347</pub-id><pub-id pub-id-type="pmcid">PMC5737033</pub-id><pub-id pub-id-type="pmid">29326655</pub-id></element-citation><mixed-citation id="mc-CR315" publication-type="journal">Bhansali, S., Bhansali, A., Walia, R., Saikia, U. N. &amp; Dhawan, V. Alterations in mitochondrial oxidative stress and mitophagy in subjects with prediabetes and type 2 diabetes mellitus. <italic toggle="yes">Front. Endocrinol.</italic><bold>8</bold>, 347 (2017).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2017.00347</pub-id><pub-id pub-id-type="pmcid">PMC5737033</pub-id><pub-id pub-id-type="pmid">29326655</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR316"><label>316.</label><citation-alternatives><element-citation id="ec-CR316" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>H-S</given-names></name><etal/></person-group><article-title>The PARK2 gene is involved in the maintenance of pancreatic &#946;-cell functions related to insulin production and secretion</article-title><source>Mol. Cell Endocrinol.</source><year>2014</year><volume>382</volume><fpage>178</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2013.09.031</pub-id><pub-id pub-id-type="pmid">24096089</pub-id></element-citation><mixed-citation id="mc-CR316" publication-type="journal">Jin, H.-S. et al. The PARK2 gene is involved in the maintenance of pancreatic &#946;-cell functions related to insulin production and secretion. <italic toggle="yes">Mol. Cell Endocrinol.</italic><bold>382</bold>, 178&#8211;189 (2014).<pub-id pub-id-type="pmid">24096089</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mce.2013.09.031</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR317"><label>317.</label><citation-alternatives><element-citation id="ec-CR317" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soleimanpour</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Diabetes susceptibility genes Pdx1 and Clec16a function in a pathway regulating mitophagy in &#946;-cells</article-title><source>Diabetes</source><year>2015</year><volume>64</volume><fpage>3475</fpage><lpage>3484</lpage><pub-id pub-id-type="doi">10.2337/db15-0376</pub-id><pub-id pub-id-type="pmid">26085571</pub-id><pub-id pub-id-type="pmcid">PMC4587637</pub-id></element-citation><mixed-citation id="mc-CR317" publication-type="journal">Soleimanpour, S. A. et al. Diabetes susceptibility genes Pdx1 and Clec16a function in a pathway regulating mitophagy in &#946;-cells. <italic toggle="yes">Diabetes</italic><bold>64</bold>, 3475&#8211;3484 (2015).<pub-id pub-id-type="pmid">26085571</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/db15-0376</pub-id><pub-id pub-id-type="pmcid">PMC4587637</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR318"><label>318.</label><citation-alternatives><element-citation id="ec-CR318" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soleimanpour</surname><given-names>SA</given-names></name><etal/></person-group><article-title>The diabetes susceptibility gene Clec16a regulates mitophagy</article-title><source>Cell</source><year>2014</year><volume>157</volume><fpage>1577</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.05.016</pub-id><pub-id pub-id-type="pmid">24949970</pub-id><pub-id pub-id-type="pmcid">PMC4184276</pub-id></element-citation><mixed-citation id="mc-CR318" publication-type="journal">Soleimanpour, S. A. et al. The diabetes susceptibility gene Clec16a regulates mitophagy. <italic toggle="yes">Cell</italic><bold>157</bold>, 1577&#8211;1590 (2014).<pub-id pub-id-type="pmid">24949970</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2014.05.016</pub-id><pub-id pub-id-type="pmcid">PMC4184276</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR319"><label>319.</label><citation-alternatives><element-citation id="ec-CR319" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kusminski</surname><given-names>CM</given-names></name><etal/></person-group><article-title>MitoNEET-Parkin effects in pancreatic &#945;- and &#946;-cells, cellular survival, and intrainsular cross talk</article-title><source>Diabetes</source><year>2016</year><volume>65</volume><fpage>1534</fpage><lpage>1555</lpage><pub-id pub-id-type="doi">10.2337/db15-1323</pub-id><pub-id pub-id-type="pmid">26895793</pub-id><pub-id pub-id-type="pmcid">PMC5310214</pub-id></element-citation><mixed-citation id="mc-CR319" publication-type="journal">Kusminski, C. M. et al. MitoNEET-Parkin effects in pancreatic &#945;- and &#946;-cells, cellular survival, and intrainsular cross talk. <italic toggle="yes">Diabetes</italic><bold>65</bold>, 1534&#8211;1555 (2016).<pub-id pub-id-type="pmid">26895793</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/db15-1323</pub-id><pub-id pub-id-type="pmcid">PMC5310214</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR320"><label>320.</label><citation-alternatives><element-citation id="ec-CR320" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Friedman</surname><given-names>SL</given-names></name><name name-style="western"><surname>Neuschwander-Tetri</surname><given-names>BA</given-names></name><name name-style="western"><surname>Rinella</surname><given-names>M</given-names></name><name name-style="western"><surname>Sanyal</surname><given-names>AJ</given-names></name></person-group><article-title>Mechanisms of NAFLD development and therapeutic strategies</article-title><source>Nat. Med.</source><year>2018</year><volume>24</volume><fpage>908</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0104-9</pub-id><pub-id pub-id-type="pmid">29967350</pub-id><pub-id pub-id-type="pmcid">PMC6553468</pub-id></element-citation><mixed-citation id="mc-CR320" publication-type="journal">Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. &amp; Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. <italic toggle="yes">Nat. Med.</italic><bold>24</bold>, 908&#8211;922 (2018).<pub-id pub-id-type="pmid">29967350</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-018-0104-9</pub-id><pub-id pub-id-type="pmcid">PMC6553468</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR321"><label>321.</label><citation-alternatives><element-citation id="ec-CR321" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice</article-title><source>Br. J. Pharmacol.</source><year>2020</year><volume>177</volume><fpage>3591</fpage><lpage>3607</lpage><pub-id pub-id-type="doi">10.1111/bph.15083</pub-id><pub-id pub-id-type="pmid">32343398</pub-id><pub-id pub-id-type="pmcid">PMC7348088</pub-id></element-citation><mixed-citation id="mc-CR321" publication-type="journal">Li, X. et al. Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice. <italic toggle="yes">Br. J. Pharmacol.</italic><bold>177</bold>, 3591&#8211;3607 (2020).<pub-id pub-id-type="pmid">32343398</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/bph.15083</pub-id><pub-id pub-id-type="pmcid">PMC7348088</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR322"><label>322.</label><citation-alternatives><element-citation id="ec-CR322" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Undamatla</surname><given-names>R</given-names></name><etal/></person-group><article-title>Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosis</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><fpage>7575</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-34710-x</pub-id><pub-id pub-id-type="pmid">37165006</pub-id><pub-id pub-id-type="pmcid">PMC10172344</pub-id></element-citation><mixed-citation id="mc-CR322" publication-type="journal">Undamatla, R. et al. Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosis. <italic toggle="yes">Sci. Rep.</italic><bold>13</bold>, 7575 (2023).<pub-id pub-id-type="pmid">37165006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-34710-x</pub-id><pub-id pub-id-type="pmcid">PMC10172344</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR323"><label>323.</label><citation-alternatives><element-citation id="ec-CR323" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>H</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name></person-group><article-title>PINK1/Park2-mediated mitophagy relieve non-alcoholic fatty liver disease</article-title><source>Physiol. Res.</source><year>2024</year><volume>73</volume><fpage>253</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">38710055</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.33549/physiolres.934925</pub-id><pub-id pub-id-type="pmcid">PMC11081181</pub-id></element-citation><mixed-citation id="mc-CR323" publication-type="journal">He, H., Tang, Y., Zhuang, L., Zheng, Y. &amp; Huang, X. PINK1/Park2-mediated mitophagy relieve non-alcoholic fatty liver disease. <italic toggle="yes">Physiol. Res.</italic><bold>73</bold>, 253&#8211;263 (2024).<pub-id pub-id-type="pmid">38710055</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.33549/physiolres.934925</pub-id><pub-id pub-id-type="pmcid">PMC11081181</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR324"><label>324.</label><citation-alternatives><element-citation id="ec-CR324" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>N-P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X-J</given-names></name><name name-style="western"><surname>Xie</surname><given-names>L</given-names></name><name name-style="western"><surname>Shen</surname><given-names>X-Z</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name></person-group><article-title>Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis</article-title><source>Lab Invest.</source><year>2019</year><volume>99</volume><fpage>749</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1038/s41374-018-0177-6</pub-id><pub-id pub-id-type="pmid">30700851</pub-id></element-citation><mixed-citation id="mc-CR324" publication-type="journal">Zhang, N.-P., Liu, X.-J., Xie, L., Shen, X.-Z. &amp; Wu, J. Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. <italic toggle="yes">Lab Invest.</italic><bold>99</bold>, 749&#8211;763 (2019).<pub-id pub-id-type="pmid">30700851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41374-018-0177-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR325"><label>325.</label><citation-alternatives><element-citation id="ec-CR325" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><etal/></person-group><article-title>Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy</article-title><source>Redox Biol</source><year>2018</year><volume>18</volume><fpage>229</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2018.07.011</pub-id><pub-id pub-id-type="pmid">30056271</pub-id><pub-id pub-id-type="pmcid">PMC6079484</pub-id></element-citation><mixed-citation id="mc-CR325" publication-type="journal">Li, R. et al. Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy. <italic toggle="yes">Redox Biol</italic>. <bold>18</bold>, 229&#8211;243 (2018).<pub-id pub-id-type="pmid">30056271</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.redox.2018.07.011</pub-id><pub-id pub-id-type="pmcid">PMC6079484</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR326"><label>326.</label><citation-alternatives><element-citation id="ec-CR326" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>T</given-names></name><etal/></person-group><article-title>Mitochondrial stasis reveals p62-mediated ubiquitination in Parkin-independent mitophagy and mitigates nonalcoholic fatty liver disease</article-title><source>Cell Metab.</source><year>2018</year><volume>28</volume><fpage>588</fpage><lpage>604.e5</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.06.014</pub-id><pub-id pub-id-type="pmid">30017357</pub-id><pub-id pub-id-type="pmcid">PMC6170673</pub-id></element-citation><mixed-citation id="mc-CR326" publication-type="journal">Yamada, T. et al. Mitochondrial stasis reveals p62-mediated ubiquitination in Parkin-independent mitophagy and mitigates nonalcoholic fatty liver disease. <italic toggle="yes">Cell Metab.</italic><bold>28</bold>, 588&#8211;604.e5 (2018).<pub-id pub-id-type="pmid">30017357</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2018.06.014</pub-id><pub-id pub-id-type="pmcid">PMC6170673</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR327"><label>327.</label><citation-alternatives><element-citation id="ec-CR327" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bravo-San Pedro</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name></person-group><article-title>Autophagy and mitophagy in cardiovascular disease</article-title><source>Circ. Res.</source><year>2017</year><volume>120</volume><fpage>1812</fpage><lpage>1824</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.311082</pub-id><pub-id pub-id-type="pmid">28546358</pub-id></element-citation><mixed-citation id="mc-CR327" publication-type="journal">Bravo-San Pedro, J. M., Kroemer, G. &amp; Galluzzi, L. Autophagy and mitophagy in cardiovascular disease. <italic toggle="yes">Circ. Res.</italic><bold>120</bold>, 1812&#8211;1824 (2017).<pub-id pub-id-type="pmid">28546358</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCRESAHA.117.311082</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR328"><label>328.</label><citation-alternatives><element-citation id="ec-CR328" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers</article-title><source>iScience</source><year>2025</year><volume>28</volume><fpage>111814</fpage><pub-id pub-id-type="doi">10.1016/j.isci.2025.111814</pub-id><pub-id pub-id-type="pmid">40034121</pub-id><pub-id pub-id-type="pmcid">PMC11875685</pub-id></element-citation><mixed-citation id="mc-CR328" publication-type="journal">Liu, S. et al. Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers. <italic toggle="yes">iScience</italic><bold>28</bold>, 111814 (2025).<pub-id pub-id-type="pmid">40034121</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.isci.2025.111814</pub-id><pub-id pub-id-type="pmcid">PMC11875685</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR329"><label>329.</label><citation-alternatives><element-citation id="ec-CR329" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mitochondrial autophagy: Molecular mechanisms and implications for cardiovascular disease</article-title><source>Cell Death Dis.</source><year>2022</year><volume>13</volume><fpage>444</fpage><pub-id pub-id-type="doi">10.1038/s41419-022-04906-6</pub-id><pub-id pub-id-type="pmid">35534453</pub-id><pub-id pub-id-type="pmcid">PMC9085840</pub-id></element-citation><mixed-citation id="mc-CR329" publication-type="journal">Li, A. et al. Mitochondrial autophagy: Molecular mechanisms and implications for cardiovascular disease. <italic toggle="yes">Cell Death Dis.</italic><bold>13</bold>, 444 (2022).<pub-id pub-id-type="pmid">35534453</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-022-04906-6</pub-id><pub-id pub-id-type="pmcid">PMC9085840</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR330"><label>330.</label><citation-alternatives><element-citation id="ec-CR330" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Russell</surname><given-names>RR</given-names></name><etal/></person-group><article-title>AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury</article-title><source>J. Clin. Invest.</source><year>2004</year><volume>114</volume><fpage>495</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1172/JCI19297</pub-id><pub-id pub-id-type="pmid">15314686</pub-id><pub-id pub-id-type="pmcid">PMC503766</pub-id></element-citation><mixed-citation id="mc-CR330" publication-type="journal">Russell, R. R. et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. <italic toggle="yes">J. Clin. Invest.</italic><bold>114</bold>, 495&#8211;503 (2004).<pub-id pub-id-type="pmid">15314686</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI19297</pub-id><pub-id pub-id-type="pmcid">PMC503766</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR331"><label>331.</label><citation-alternatives><element-citation id="ec-CR331" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><etal/></person-group><article-title>The PINK1/Parkin signaling pathway-mediated mitophagy: A forgotten protagonist in myocardial ischemia/reperfusion injury</article-title><source>Pharmacol. Res.</source><year>2024</year><volume>209</volume><fpage>107466</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2024.107466</pub-id><pub-id pub-id-type="pmid">39419133</pub-id></element-citation><mixed-citation id="mc-CR331" publication-type="journal">Zhao, X. et al. The PINK1/Parkin signaling pathway-mediated mitophagy: A forgotten protagonist in myocardial ischemia/reperfusion injury. <italic toggle="yes">Pharmacol. Res.</italic><bold>209</bold>, 107466 (2024).<pub-id pub-id-type="pmid">39419133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phrs.2024.107466</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR332"><label>332.</label><citation-alternatives><element-citation id="ec-CR332" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kubli</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>915</fpage><lpage>926</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.411363</pub-id><pub-id pub-id-type="pmid">23152496</pub-id><pub-id pub-id-type="pmcid">PMC3543040</pub-id></element-citation><mixed-citation id="mc-CR332" publication-type="journal">Kubli, D. A. et al. Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction. <italic toggle="yes">J. Biol. Chem.</italic><bold>288</bold>, 915&#8211;926 (2013).<pub-id pub-id-type="pmid">23152496</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M112.411363</pub-id><pub-id pub-id-type="pmcid">PMC3543040</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR333"><label>333.</label><citation-alternatives><element-citation id="ec-CR333" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsui</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Distinct roles of autophagy in the heart during ischemia and reperfusion: Roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy</article-title><source>Circ. Res.</source><year>2007</year><volume>100</volume><fpage>914</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000261924.76669.36</pub-id><pub-id pub-id-type="pmid">17332429</pub-id></element-citation><mixed-citation id="mc-CR333" publication-type="journal">Matsui, Y. et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: Roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. <italic toggle="yes">Circ. Res.</italic><bold>100</bold>, 914&#8211;922 (2007).<pub-id pub-id-type="pmid">17332429</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.RES.0000261924.76669.36</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR334"><label>334.</label><citation-alternatives><element-citation id="ec-CR334" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kassiotis</surname><given-names>C</given-names></name><etal/></person-group><article-title>Markers of autophagy are downregulated in failing human heart after mechanical unloading</article-title><source>Circulation</source><year>2009</year><volume>120</volume><fpage>S191</fpage><lpage>S197</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.842252</pub-id><pub-id pub-id-type="pmid">19752367</pub-id><pub-id pub-id-type="pmcid">PMC2778323</pub-id></element-citation><mixed-citation id="mc-CR334" publication-type="journal">Kassiotis, C. et al. Markers of autophagy are downregulated in failing human heart after mechanical unloading. <italic toggle="yes">Circulation</italic><bold>120</bold>, S191&#8211;S197 (2009).<pub-id pub-id-type="pmid">19752367</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.108.842252</pub-id><pub-id pub-id-type="pmcid">PMC2778323</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR335"><label>335.</label><citation-alternatives><element-citation id="ec-CR335" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Billia</surname><given-names>F</given-names></name><etal/></person-group><article-title>PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>9572</fpage><lpage>9577</lpage><pub-id pub-id-type="doi">10.1073/pnas.1106291108</pub-id><pub-id pub-id-type="pmid">21606348</pub-id><pub-id pub-id-type="pmcid">PMC3111326</pub-id></element-citation><mixed-citation id="mc-CR335" publication-type="journal">Billia, F. et al. PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>108</bold>, 9572&#8211;9577 (2011).<pub-id pub-id-type="pmid">21606348</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1106291108</pub-id><pub-id pub-id-type="pmcid">PMC3111326</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR336"><label>336.</label><citation-alternatives><element-citation id="ec-CR336" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><etal/></person-group><article-title>AMPK&#945;2 protects against the development of heart failure by enhancing mitophagy via PINK1 phosphorylation</article-title><source>Circ. Res.</source><year>2018</year><volume>122</volume><fpage>712</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.312317</pub-id><pub-id pub-id-type="pmid">29284690</pub-id><pub-id pub-id-type="pmcid">PMC5834386</pub-id></element-citation><mixed-citation id="mc-CR336" publication-type="journal">Wang, B. et al. AMPK&#945;2 protects against the development of heart failure by enhancing mitophagy via PINK1 phosphorylation. <italic toggle="yes">Circ. Res.</italic><bold>122</bold>, 712&#8211;729 (2018).<pub-id pub-id-type="pmid">29284690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCRESAHA.117.312317</pub-id><pub-id pub-id-type="pmcid">PMC5834386</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR337"><label>337.</label><citation-alternatives><element-citation id="ec-CR337" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>T</given-names></name><etal/></person-group><article-title>Central role of mitofusin 2 in autophagosome-lysosome fusion in cardiomyocytes</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>23615</fpage><lpage>23625</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.379164</pub-id><pub-id pub-id-type="pmid">22619176</pub-id><pub-id pub-id-type="pmcid">PMC3390636</pub-id></element-citation><mixed-citation id="mc-CR337" publication-type="journal">Zhao, T. et al. Central role of mitofusin 2 in autophagosome-lysosome fusion in cardiomyocytes. <italic toggle="yes">J. Biol. Chem.</italic><bold>287</bold>, 23615&#8211;23625 (2012).<pub-id pub-id-type="pmid">22619176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M112.379164</pub-id><pub-id pub-id-type="pmcid">PMC3390636</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR338"><label>338.</label><citation-alternatives><element-citation id="ec-CR338" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>M</given-names></name><etal/></person-group><article-title>Super-suppression of mitochondrial reactive oxygen species signaling impairs compensatory autophagy in primary mitophagic cardiomyopathy</article-title><source>Circ. Res.</source><year>2014</year><volume>115</volume><fpage>348</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.304384</pub-id><pub-id pub-id-type="pmid">24874428</pub-id><pub-id pub-id-type="pmcid">PMC4106429</pub-id></element-citation><mixed-citation id="mc-CR338" publication-type="journal">Song, M. et al. Super-suppression of mitochondrial reactive oxygen species signaling impairs compensatory autophagy in primary mitophagic cardiomyopathy. <italic toggle="yes">Circ. Res.</italic><bold>115</bold>, 348&#8211;353 (2014).<pub-id pub-id-type="pmid">24874428</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCRESAHA.115.304384</pub-id><pub-id pub-id-type="pmcid">PMC4106429</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR339"><label>339.</label><citation-alternatives><element-citation id="ec-CR339" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Urolithin A induces mitophagy and prolongs lifespan in <italic toggle="yes">C. elegans</italic> and increases muscle function in rodents</article-title><source>Nat. Med.</source><year>2016</year><volume>22</volume><fpage>879</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1038/nm.4132</pub-id><pub-id pub-id-type="pmid">27400265</pub-id></element-citation><mixed-citation id="mc-CR339" publication-type="journal">Ryu, D. et al. Urolithin A induces mitophagy and prolongs lifespan in <italic toggle="yes">C. elegans</italic> and increases muscle function in rodents. <italic toggle="yes">Nat. Med.</italic><bold>22</bold>, 879&#8211;888 (2016).<pub-id pub-id-type="pmid">27400265</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nm.4132</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR340"><label>340.</label><citation-alternatives><element-citation id="ec-CR340" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy</article-title><source>Sci. Transl. Med</source><year>2021</year><volume>13</volume><fpage>eabb0319</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.abb0319</pub-id><pub-id pub-id-type="pmid">33827972</pub-id></element-citation><mixed-citation id="mc-CR340" publication-type="journal">Luan, P. et al. Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy. <italic toggle="yes">Sci. Transl. Med</italic>. <bold>13</bold>, eabb0319 (2021).<pub-id pub-id-type="pmid">33827972</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.abb0319</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR341"><label>341.</label><citation-alternatives><element-citation id="ec-CR341" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andreux</surname><given-names>PA</given-names></name><etal/></person-group><article-title>The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans</article-title><source>Nat. Metab.</source><year>2019</year><volume>1</volume><fpage>595</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1038/s42255-019-0073-4</pub-id><pub-id pub-id-type="pmid">32694802</pub-id></element-citation><mixed-citation id="mc-CR341" publication-type="journal">Andreux, P. A. et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. <italic toggle="yes">Nat. Metab.</italic><bold>1</bold>, 595&#8211;603 (2019).<pub-id pub-id-type="pmid">32694802</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42255-019-0073-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR342"><label>342.</label><citation-alternatives><element-citation id="ec-CR342" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name><etal/></person-group><article-title>Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults</article-title><source>Cell Rep. Med.</source><year>2022</year><volume>3</volume><fpage>100633</fpage><pub-id pub-id-type="doi">10.1016/j.xcrm.2022.100633</pub-id><pub-id pub-id-type="pmid">35584623</pub-id><pub-id pub-id-type="pmcid">PMC9133463</pub-id></element-citation><mixed-citation id="mc-CR342" publication-type="journal">Singh, A. et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. <italic toggle="yes">Cell Rep. Med.</italic><bold>3</bold>, 100633 (2022).<pub-id pub-id-type="pmid">35584623</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.xcrm.2022.100633</pub-id><pub-id pub-id-type="pmcid">PMC9133463</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR343"><label>343.</label><citation-alternatives><element-citation id="ec-CR343" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Civiletto</surname><given-names>G</given-names></name><etal/></person-group><article-title>Herbal terpenoids activate autophagy and mitophagy through modulation of bioenergetics and protect from metabolic stress, sarcopenia and epigenetic aging</article-title><source>Nat. Aging</source><year>2025</year><volume>5</volume><fpage>2003</fpage><lpage>2021</lpage><pub-id pub-id-type="doi">10.1038/s43587-025-00957-4</pub-id><pub-id pub-id-type="pmid">40993327</pub-id><pub-id pub-id-type="pmcid">PMC12532568</pub-id></element-citation><mixed-citation id="mc-CR343" publication-type="journal">Civiletto, G. et al. Herbal terpenoids activate autophagy and mitophagy through modulation of bioenergetics and protect from metabolic stress, sarcopenia and epigenetic aging. <italic toggle="yes">Nat. Aging</italic><bold>5</bold>, 2003&#8211;2021 (2025).<pub-id pub-id-type="pmid">40993327</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43587-025-00957-4</pub-id><pub-id pub-id-type="pmcid">PMC12532568</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR344"><label>344.</label><citation-alternatives><element-citation id="ec-CR344" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>EF</given-names></name><etal/></person-group><article-title>NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair</article-title><source>Cell Metab</source><year>2016</year><volume>24</volume><fpage>566</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.09.004</pub-id><pub-id pub-id-type="pmid">27732836</pub-id><pub-id pub-id-type="pmcid">PMC5777858</pub-id></element-citation><mixed-citation id="mc-CR344" publication-type="journal">Fang, E. F. et al. NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. <italic toggle="yes">Cell Metab</italic>. <bold>24</bold>, 566&#8211;581 (2016).<pub-id pub-id-type="pmid">27732836</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2016.09.004</pub-id><pub-id pub-id-type="pmcid">PMC5777858</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR345"><label>345.</label><citation-alternatives><element-citation id="ec-CR345" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorrentino</surname><given-names>V</given-names></name><etal/></person-group><article-title>Enhancing mitochondrial proteostasis reduces amyloid-&#946; proteotoxicity</article-title><source>Nature</source><year>2017</year><volume>552</volume><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1038/nature25143</pub-id><pub-id pub-id-type="pmid">29211722</pub-id><pub-id pub-id-type="pmcid">PMC5730497</pub-id></element-citation><mixed-citation id="mc-CR345" publication-type="journal">Sorrentino, V. et al. Enhancing mitochondrial proteostasis reduces amyloid-&#946; proteotoxicity. <italic toggle="yes">Nature</italic><bold>552</bold>, 187&#8211;193 (2017).<pub-id pub-id-type="pmid">29211722</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature25143</pub-id><pub-id pub-id-type="pmcid">PMC5730497</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR346"><label>346.</label><citation-alternatives><element-citation id="ec-CR346" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>EF</given-names></name><etal/></person-group><article-title>NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>5284</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-13172-8</pub-id><pub-id pub-id-type="pmid">31754102</pub-id><pub-id pub-id-type="pmcid">PMC6872719</pub-id></element-citation><mixed-citation id="mc-CR346" publication-type="journal">Fang, E. F. et al. NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome. <italic toggle="yes">Nat. Commun.</italic><bold>10</bold>, 5284 (2019).<pub-id pub-id-type="pmid">31754102</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-019-13172-8</pub-id><pub-id pub-id-type="pmcid">PMC6872719</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR347"><label>347.</label><citation-alternatives><element-citation id="ec-CR347" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jang</surname><given-names>S</given-names></name><name name-style="western"><surname>Kang</surname><given-names>HT</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>ES</given-names></name></person-group><article-title>Nicotinamide-induced Mitophagy: Event mediated by high NAD+/NADH ratio and Sirt1 protein activation</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>19304</fpage><lpage>19314</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.363747</pub-id><pub-id pub-id-type="pmid">22493485</pub-id><pub-id pub-id-type="pmcid">PMC3365962</pub-id></element-citation><mixed-citation id="mc-CR347" publication-type="journal">Jang, S., Kang, H. T. &amp; Hwang, E. S. Nicotinamide-induced Mitophagy: Event mediated by high NAD+/NADH ratio and Sirt1 protein activation. <italic toggle="yes">J. Biol. Chem.</italic><bold>287</bold>, 19304&#8211;19314 (2012).<pub-id pub-id-type="pmid">22493485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M112.363747</pub-id><pub-id pub-id-type="pmcid">PMC3365962</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR348"><label>348.</label><citation-alternatives><element-citation id="ec-CR348" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brakedal</surname><given-names>B</given-names></name><etal/></person-group><article-title>The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson&#8217;s disease</article-title><source>Cell Metab</source><year>2022</year><volume>34</volume><fpage>396</fpage><lpage>407.e6</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2022.02.001</pub-id><pub-id pub-id-type="pmid">35235774</pub-id></element-citation><mixed-citation id="mc-CR348" publication-type="journal">Brakedal, B. et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson&#8217;s disease. <italic toggle="yes">Cell Metab</italic>. <bold>34</bold>, 396&#8211;407.e6 (2022).<pub-id pub-id-type="pmid">35235774</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2022.02.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR349"><label>349.</label><citation-alternatives><element-citation id="ec-CR349" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berven</surname><given-names>H</given-names></name><etal/></person-group><article-title>NR-SAFE: A randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson&#8217;s disease</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>7793</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-43514-6</pub-id><pub-id pub-id-type="pmid">38016950</pub-id><pub-id pub-id-type="pmcid">PMC10684646</pub-id></element-citation><mixed-citation id="mc-CR349" publication-type="journal">Berven, H. et al. NR-SAFE: A randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson&#8217;s disease. <italic toggle="yes">Nat. Commun.</italic><bold>14</bold>, 7793 (2023).<pub-id pub-id-type="pmid">38016950</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-023-43514-6</pub-id><pub-id pub-id-type="pmcid">PMC10684646</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR350"><label>350.</label><citation-alternatives><element-citation id="ec-CR350" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eisenberg</surname><given-names>T</given-names></name><etal/></person-group><article-title>Cardioprotection and lifespan extension by the natural polyamine spermidine</article-title><source>Nat. Med.</source><year>2016</year><volume>22</volume><fpage>1428</fpage><lpage>1438</lpage><pub-id pub-id-type="doi">10.1038/nm.4222</pub-id><pub-id pub-id-type="pmid">27841876</pub-id><pub-id pub-id-type="pmcid">PMC5806691</pub-id></element-citation><mixed-citation id="mc-CR350" publication-type="journal">Eisenberg, T. et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. <italic toggle="yes">Nat. Med.</italic><bold>22</bold>, 1428&#8211;1438 (2016).<pub-id pub-id-type="pmid">27841876</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nm.4222</pub-id><pub-id pub-id-type="pmcid">PMC5806691</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR351"><label>351.</label><citation-alternatives><element-citation id="ec-CR351" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Gu</surname><given-names>X</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>ATM mediates spermidine-induced mitophagy via PINK1 and Parkin regulation in human fibroblasts</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>24700</fpage><pub-id pub-id-type="doi">10.1038/srep24700</pub-id><pub-id pub-id-type="pmid">27089984</pub-id><pub-id pub-id-type="pmcid">PMC4835770</pub-id></element-citation><mixed-citation id="mc-CR351" publication-type="journal">Qi, Y., Qiu, Q., Gu, X., Tian, Y. &amp; Zhang, Y. ATM mediates spermidine-induced mitophagy via PINK1 and Parkin regulation in human fibroblasts. <italic toggle="yes">Sci. Rep.</italic><bold>6</bold>, 24700 (2016).<pub-id pub-id-type="pmid">27089984</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep24700</pub-id><pub-id pub-id-type="pmcid">PMC4835770</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR352"><label>352.</label><citation-alternatives><element-citation id="ec-CR352" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madeo</surname><given-names>F</given-names></name><name name-style="western"><surname>Eisenberg</surname><given-names>T</given-names></name><name name-style="western"><surname>Pietrocola</surname><given-names>F</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Spermidine in health and disease</article-title><source>Science</source><year>2018</year><volume>359</volume><fpage>eaan2788</fpage><pub-id pub-id-type="doi">10.1126/science.aan2788</pub-id><pub-id pub-id-type="pmid">29371440</pub-id></element-citation><mixed-citation id="mc-CR352" publication-type="journal">Madeo, F., Eisenberg, T., Pietrocola, F. &amp; Kroemer, G. Spermidine in health and disease. <italic toggle="yes">Science</italic><bold>359</bold>, eaan2788 (2018).<pub-id pub-id-type="pmid">29371440</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aan2788</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR353"><label>353.</label><citation-alternatives><element-citation id="ec-CR353" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laker</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Ampk phosphorylation of Ulk1 is required for targeting of mitochondria to lysosomes in exercise-induced mitophagy</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>548</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-00520-9</pub-id><pub-id pub-id-type="pmid">28916822</pub-id><pub-id pub-id-type="pmcid">PMC5601463</pub-id></element-citation><mixed-citation id="mc-CR353" publication-type="journal">Laker, R. C. et al. Ampk phosphorylation of Ulk1 is required for targeting of mitochondria to lysosomes in exercise-induced mitophagy. <italic toggle="yes">Nat. Commun.</italic><bold>8</bold>, 548 (2017).<pub-id pub-id-type="pmid">28916822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-017-00520-9</pub-id><pub-id pub-id-type="pmcid">PMC5601463</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR354"><label>354.</label><citation-alternatives><element-citation id="ec-CR354" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drake</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Mitochondria-localized AMPK responds to local energetics and contributes to exercise and energetic stress-induced mitophagy</article-title><source>Proc. Natl. Acad. Sci. USA.</source><year>2021</year><volume>118</volume><fpage>e2025932118</fpage><pub-id pub-id-type="doi">10.1073/pnas.2025932118</pub-id><pub-id pub-id-type="pmid">34493662</pub-id><pub-id pub-id-type="pmcid">PMC8449344</pub-id></element-citation><mixed-citation id="mc-CR354" publication-type="journal">Drake, J. C. et al. Mitochondria-localized AMPK responds to local energetics and contributes to exercise and energetic stress-induced mitophagy. <italic toggle="yes">Proc. Natl. Acad. Sci. USA.</italic><bold>118</bold>, e2025932118 (2021).<pub-id pub-id-type="pmid">34493662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2025932118</pub-id><pub-id pub-id-type="pmcid">PMC8449344</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR355"><label>355.</label><citation-alternatives><element-citation id="ec-CR355" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bujak</surname><given-names>AL</given-names></name><etal/></person-group><article-title>AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging</article-title><source>Cell Metab.</source><year>2015</year><volume>21</volume><fpage>883</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.05.016</pub-id><pub-id pub-id-type="pmid">26039451</pub-id><pub-id pub-id-type="pmcid">PMC5233441</pub-id></element-citation><mixed-citation id="mc-CR355" publication-type="journal">Bujak, A. L. et al. AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging. <italic toggle="yes">Cell Metab.</italic><bold>21</bold>, 883&#8211;890 (2015).<pub-id pub-id-type="pmid">26039451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2015.05.016</pub-id><pub-id pub-id-type="pmcid">PMC5233441</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR356"><label>356.</label><citation-alternatives><element-citation id="ec-CR356" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>EF</given-names></name><etal/></person-group><article-title>Defective mitophagy in XPA via PARP-1 hyperactivation and NAD+/SIRT1 reduction</article-title><source>Cell</source><year>2014</year><volume>157</volume><fpage>882</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.03.026</pub-id><pub-id pub-id-type="pmid">24813611</pub-id><pub-id pub-id-type="pmcid">PMC4625837</pub-id></element-citation><mixed-citation id="mc-CR356" publication-type="journal">Fang, E. F. et al. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD+/SIRT1 reduction. <italic toggle="yes">Cell</italic><bold>157</bold>, 882&#8211;896 (2014).<pub-id pub-id-type="pmid">24813611</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2014.03.026</pub-id><pub-id pub-id-type="pmcid">PMC4625837</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR357"><label>357.</label><citation-alternatives><element-citation id="ec-CR357" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arun</surname><given-names>B</given-names></name><name name-style="western"><surname>Akar</surname><given-names>U</given-names></name><name name-style="western"><surname>Gutierrez-Barrera</surname><given-names>AM</given-names></name><name name-style="western"><surname>Hortobagyi</surname><given-names>GN</given-names></name><name name-style="western"><surname>Ozpolat</surname><given-names>B</given-names></name></person-group><article-title>The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells</article-title><source>Int. J. Oncol.</source><year>2015</year><volume>47</volume><fpage>262</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.3892/ijo.2015.3003</pub-id><pub-id pub-id-type="pmid">25975349</pub-id><pub-id pub-id-type="pmcid">PMC6904111</pub-id></element-citation><mixed-citation id="mc-CR357" publication-type="journal">Arun, B., Akar, U., Gutierrez-Barrera, A. M., Hortobagyi, G. N. &amp; Ozpolat, B. The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells. <italic toggle="yes">Int. J. Oncol.</italic><bold>47</bold>, 262&#8211;268 (2015).<pub-id pub-id-type="pmid">25975349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/ijo.2015.3003</pub-id><pub-id pub-id-type="pmcid">PMC6904111</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR358"><label>358.</label><citation-alternatives><element-citation id="ec-CR358" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mito</surname><given-names>T</given-names></name><etal/></person-group><article-title>Mosaic dysfunction of mitophagy in mitochondrial muscle disease</article-title><source>Cell Metab</source><year>2022</year><volume>34</volume><fpage>197</fpage><lpage>208.e5</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2021.12.017</pub-id><pub-id pub-id-type="pmid">35030325</pub-id><pub-id pub-id-type="pmcid">PMC8815775</pub-id></element-citation><mixed-citation id="mc-CR358" publication-type="journal">Mito, T. et al. Mosaic dysfunction of mitophagy in mitochondrial muscle disease. <italic toggle="yes">Cell Metab</italic>. <bold>34</bold>, 197&#8211;208.e5 (2022).<pub-id pub-id-type="pmid">35030325</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2021.12.017</pub-id><pub-id pub-id-type="pmcid">PMC8815775</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR359"><label>359.</label><citation-alternatives><element-citation id="ec-CR359" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tom&#225;s-Barber&#225;n</surname><given-names>FA</given-names></name><etal/></person-group><article-title>Urolithins, the rescue of &#8220;old&#8221; metabolites to understand a &#8220;new&#8221; concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status</article-title><source>Mol. Nutr. Food Res.</source><year>2017</year><volume>61</volume><fpage>1500901</fpage><pub-id pub-id-type="doi">10.1002/mnfr.201500901</pub-id><pub-id pub-id-type="pmid">27158799</pub-id></element-citation><mixed-citation id="mc-CR359" publication-type="journal">Tom&#225;s-Barber&#225;n, F. A. et al. Urolithins, the rescue of &#8220;old&#8221; metabolites to understand a &#8220;new&#8221; concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. <italic toggle="yes">Mol. Nutr. Food Res.</italic><bold>61</bold>, 1500901 (2017).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mnfr.201500901</pub-id><pub-id pub-id-type="pmid">27158799</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR360"><label>360.</label><citation-alternatives><element-citation id="ec-CR360" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#8217;Amico</surname><given-names>D</given-names></name><etal/></person-group><article-title>Impact of the natural compound urolithin A on health, disease, and aging</article-title><source>Trends Mol. Med.</source><year>2021</year><volume>27</volume><fpage>687</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2021.04.009</pub-id><pub-id pub-id-type="pmid">34030963</pub-id></element-citation><mixed-citation id="mc-CR360" publication-type="journal">D&#8217;Amico, D. et al. Impact of the natural compound urolithin A on health, disease, and aging. <italic toggle="yes">Trends Mol. Med.</italic><bold>27</bold>, 687&#8211;699 (2021).<pub-id pub-id-type="pmid">34030963</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molmed.2021.04.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR361"><label>361.</label><citation-alternatives><element-citation id="ec-CR361" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name><etal/></person-group><article-title>Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population</article-title><source>Eur. J. Clin. Nutr.</source><year>2022</year><volume>76</volume><fpage>297</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1038/s41430-021-00950-1</pub-id><pub-id pub-id-type="pmid">34117375</pub-id><pub-id pub-id-type="pmcid">PMC8821002</pub-id></element-citation><mixed-citation id="mc-CR361" publication-type="journal">Singh, A. et al. Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population. <italic toggle="yes">Eur. J. Clin. Nutr.</italic><bold>76</bold>, 297&#8211;308 (2022).<pub-id pub-id-type="pmid">34117375</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41430-021-00950-1</pub-id><pub-id pub-id-type="pmcid">PMC8821002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR362"><label>362.</label><citation-alternatives><element-citation id="ec-CR362" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faitg</surname><given-names>J</given-names></name><name name-style="western"><surname>D&#8217;Amico</surname><given-names>D</given-names></name><name name-style="western"><surname>Rinsch</surname><given-names>C</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name></person-group><article-title>Mitophagy activation by urolithin A to target muscle aging</article-title><source>Calcif. Tissue Int.</source><year>2024</year><volume>114</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1007/s00223-023-01145-5</pub-id><pub-id pub-id-type="pmid">37925671</pub-id><pub-id pub-id-type="pmcid">PMC10791945</pub-id></element-citation><mixed-citation id="mc-CR362" publication-type="journal">Faitg, J., D&#8217;Amico, D., Rinsch, C. &amp; Singh, A. Mitophagy activation by urolithin A to target muscle aging. <italic toggle="yes">Calcif. Tissue Int.</italic><bold>114</bold>, 53&#8211;59 (2024).<pub-id pub-id-type="pmid">37925671</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00223-023-01145-5</pub-id><pub-id pub-id-type="pmcid">PMC10791945</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR363"><label>363.</label><citation-alternatives><element-citation id="ec-CR363" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Hallmarks of neurodegenerative diseases</article-title><source>Cell</source><year>2023</year><volume>186</volume><fpage>693</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.12.032</pub-id><pub-id pub-id-type="pmid">36803602</pub-id></element-citation><mixed-citation id="mc-CR363" publication-type="journal">Wilson, D. M. et al. Hallmarks of neurodegenerative diseases. <italic toggle="yes">Cell</italic><bold>186</bold>, 693&#8211;714 (2023).<pub-id pub-id-type="pmid">36803602</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2022.12.032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR364"><label>364.</label><citation-alternatives><element-citation id="ec-CR364" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson&#8217;s disease model</article-title><source>Neuropharmacology</source><year>2022</year><volume>207</volume><fpage>108963</fpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2022.108963</pub-id><pub-id pub-id-type="pmid">35065082</pub-id></element-citation><mixed-citation id="mc-CR364" publication-type="journal">Qiu, J. et al. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson&#8217;s disease model. <italic toggle="yes">Neuropharmacology</italic><bold>207</bold>, 108963 (2022).<pub-id pub-id-type="pmid">35065082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuropharm.2022.108963</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR365"><label>365.</label><citation-alternatives><element-citation id="ec-CR365" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Urolithin A protects dopaminergic neurons in experimental models of Parkinson&#8217;s disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1&#945; signaling pathway</article-title><source>Food Funct</source><year>2022</year><volume>13</volume><fpage>375</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1039/D1FO02534A</pub-id><pub-id pub-id-type="pmid">34905594</pub-id></element-citation><mixed-citation id="mc-CR365" publication-type="journal">Liu, J. et al. Urolithin A protects dopaminergic neurons in experimental models of Parkinson&#8217;s disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1&#945; signaling pathway. <italic toggle="yes">Food Funct</italic>. <bold>13</bold>, 375&#8211;385 (2022).<pub-id pub-id-type="pmid">34905594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d1fo02534a</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR366"><label>366.</label><citation-alternatives><element-citation id="ec-CR366" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice</article-title><source>J. Neuroinflamm.</source><year>2019</year><volume>16</volume><fpage>62</fpage><pub-id pub-id-type="doi">10.1186/s12974-019-1450-3</pub-id><pub-id pub-id-type="pmcid">PMC6417212</pub-id><pub-id pub-id-type="pmid">30871577</pub-id></element-citation><mixed-citation id="mc-CR366" publication-type="journal">Gong, Z. et al. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice. <italic toggle="yes">J. Neuroinflamm.</italic><bold>16</bold>, 62 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12974-019-1450-3</pub-id><pub-id pub-id-type="pmcid">PMC6417212</pub-id><pub-id pub-id-type="pmid">30871577</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR367"><label>367.</label><citation-alternatives><element-citation id="ec-CR367" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballesteros-&#193;lvarez</surname><given-names>J</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>W</given-names></name><name name-style="western"><surname>Sivapatham</surname><given-names>R</given-names></name><name name-style="western"><surname>Rane</surname><given-names>A</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>JK</given-names></name></person-group><article-title>Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer&#8217;s disease</article-title><source>GeroScience</source><year>2023</year><volume>45</volume><fpage>1095</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1007/s11357-022-00708-y</pub-id><pub-id pub-id-type="pmid">36576642</pub-id><pub-id pub-id-type="pmcid">PMC9886708</pub-id></element-citation><mixed-citation id="mc-CR367" publication-type="journal">Ballesteros-&#193;lvarez, J., Nguyen, W., Sivapatham, R., Rane, A. &amp; Andersen, J. K. Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer&#8217;s disease. <italic toggle="yes">GeroScience</italic><bold>45</bold>, 1095&#8211;1113 (2023).<pub-id pub-id-type="pmid">36576642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11357-022-00708-y</pub-id><pub-id pub-id-type="pmcid">PMC9886708</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR368"><label>368.</label><citation-alternatives><element-citation id="ec-CR368" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Urolithin A improves Alzheimer&#8217;s disease cognition and restores mitophagy and lysosomal functions</article-title><source>Alzheimers Dement.</source><year>2024</year><volume>20</volume><fpage>4212</fpage><lpage>4233</lpage><pub-id pub-id-type="doi">10.1002/alz.13847</pub-id><pub-id pub-id-type="pmid">38753870</pub-id><pub-id pub-id-type="pmcid">PMC11180933</pub-id></element-citation><mixed-citation id="mc-CR368" publication-type="journal">Hou, Y. et al. Urolithin A improves Alzheimer&#8217;s disease cognition and restores mitophagy and lysosomal functions. <italic toggle="yes">Alzheimers Dement.</italic><bold>20</bold>, 4212&#8211;4233 (2024).<pub-id pub-id-type="pmid">38753870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/alz.13847</pub-id><pub-id pub-id-type="pmcid">PMC11180933</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR369"><label>369.</label><citation-alternatives><element-citation id="ec-CR369" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Urolithin a improves motor dysfunction induced by copper exposure in SOD1G93A transgenic mice via activation of mitophagy</article-title><source>Mol. Neurobiol.</source><year>2025</year><volume>62</volume><fpage>6922</fpage><lpage>6937</lpage><pub-id pub-id-type="doi">10.1007/s12035-024-04473-1</pub-id><pub-id pub-id-type="pmid">39292338</pub-id><pub-id pub-id-type="pmcid">PMC12078357</pub-id></element-citation><mixed-citation id="mc-CR369" publication-type="journal">Zhang, H. et al. Urolithin a improves motor dysfunction induced by copper exposure in SOD1G93A transgenic mice via activation of mitophagy. <italic toggle="yes">Mol. Neurobiol.</italic><bold>62</bold>, 6922&#8211;6937 (2025).<pub-id pub-id-type="pmid">39292338</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12035-024-04473-1</pub-id><pub-id pub-id-type="pmcid">PMC12078357</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR370"><label>370.</label><citation-alternatives><element-citation id="ec-CR370" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>P-X</given-names></name><etal/></person-group><article-title>Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor</article-title><source>eBioMed.</source><year>2021</year><volume>64</volume><fpage>103227</fpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2021.103227</pub-id><pub-id pub-id-type="pmcid">PMC7851346</pub-id><pub-id pub-id-type="pmid">33530002</pub-id></element-citation><mixed-citation id="mc-CR370" publication-type="journal">Shen, P.-X. et al. Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor. <italic toggle="yes">eBioMed.</italic><bold>64</bold>, 103227 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ebiom.2021.103227</pub-id><pub-id pub-id-type="pmcid">PMC7851346</pub-id><pub-id pub-id-type="pmid">33530002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR371"><label>371.</label><citation-alternatives><element-citation id="ec-CR371" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boakye</surname><given-names>YD</given-names></name><name name-style="western"><surname>Groyer</surname><given-names>L</given-names></name><name name-style="western"><surname>Heiss</surname><given-names>EH</given-names></name></person-group><article-title>An increased autophagic flux contributes to the anti-inflammatory potential of urolithin A in macrophages</article-title><source>Biochim. Biophys. Acta. Gen. Subj.</source><year>2018</year><volume>1862</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2017.10.006</pub-id><pub-id pub-id-type="pmid">29031765</pub-id><pub-id pub-id-type="pmcid">PMC5823236</pub-id></element-citation><mixed-citation id="mc-CR371" publication-type="journal">Boakye, Y. D., Groyer, L. &amp; Heiss, E. H. An increased autophagic flux contributes to the anti-inflammatory potential of urolithin A in macrophages. <italic toggle="yes">Biochim. Biophys. Acta. Gen. Subj.</italic><bold>1862</bold>, 61&#8211;70 (2018).<pub-id pub-id-type="pmid">29031765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbagen.2017.10.006</pub-id><pub-id pub-id-type="pmcid">PMC5823236</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR372"><label>372.</label><citation-alternatives><element-citation id="ec-CR372" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Komatsu</surname><given-names>W</given-names></name><name name-style="western"><surname>Kishi</surname><given-names>H</given-names></name><name name-style="western"><surname>Yagasaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Ohhira</surname><given-names>S</given-names></name></person-group><article-title>Urolithin A attenuates pro-inflammatory mediator production by suppressing PI3-K/Akt/NF-&#954;B and JNK/AP-1 signaling pathways in lipopolysaccharide-stimulated RAW264 macrophages: Possible involvement of NADPH oxidase-derived reactive oxygen species</article-title><source>Eur. J. Pharmacol.</source><year>2018</year><volume>833</volume><fpage>411</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2018.06.023</pub-id><pub-id pub-id-type="pmid">29932926</pub-id></element-citation><mixed-citation id="mc-CR372" publication-type="journal">Komatsu, W., Kishi, H., Yagasaki, K. &amp; Ohhira, S. Urolithin A attenuates pro-inflammatory mediator production by suppressing PI3-K/Akt/NF-&#954;B and JNK/AP-1 signaling pathways in lipopolysaccharide-stimulated RAW264 macrophages: Possible involvement of NADPH oxidase-derived reactive oxygen species. <italic toggle="yes">Eur. J. Pharmacol.</italic><bold>833</bold>, 411&#8211;424 (2018).<pub-id pub-id-type="pmid">29932926</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejphar.2018.06.023</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR373"><label>373.</label><citation-alternatives><element-citation id="ec-CR373" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdelazeem</surname><given-names>KNM</given-names></name><name name-style="western"><surname>Kalo</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Beer-Hammer</surname><given-names>S</given-names></name><name name-style="western"><surname>Lang</surname><given-names>F</given-names></name></person-group><article-title>The gut microbiota metabolite urolithin A inhibits NF-&#954;B activation in LPS stimulated BMDMs</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><fpage>7117</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-86514-6</pub-id><pub-id pub-id-type="pmid">33782464</pub-id><pub-id pub-id-type="pmcid">PMC8007722</pub-id></element-citation><mixed-citation id="mc-CR373" publication-type="journal">Abdelazeem, K. N. M., Kalo, M. Z., Beer-Hammer, S. &amp; Lang, F. The gut microbiota metabolite urolithin A inhibits NF-&#954;B activation in LPS stimulated BMDMs. <italic toggle="yes">Sci. Rep.</italic><bold>11</bold>, 7117 (2021).<pub-id pub-id-type="pmid">33782464</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-021-86514-6</pub-id><pub-id pub-id-type="pmcid">PMC8007722</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR374"><label>374.</label><citation-alternatives><element-citation id="ec-CR374" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Girotra</surname><given-names>M</given-names></name><etal/></person-group><article-title>Induction of mitochondrial recycling reverts age-associated decline of the hematopoietic and immune systems</article-title><source>Nat. Aging</source><year>2023</year><volume>3</volume><fpage>1057</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1038/s43587-023-00473-3</pub-id><pub-id pub-id-type="pmid">37653255</pub-id></element-citation><mixed-citation id="mc-CR374" publication-type="journal">Girotra, M. et al. Induction of mitochondrial recycling reverts age-associated decline of the hematopoietic and immune systems. <italic toggle="yes">Nat. Aging</italic><bold>3</bold>, 1057&#8211;1066 (2023).<pub-id pub-id-type="pmid">37653255</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43587-023-00473-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR375"><label>375.</label><citation-alternatives><element-citation id="ec-CR375" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ginefra</surname><given-names>P</given-names></name><etal/></person-group><article-title>Urolithin-A promotes CD8+ T cell&#8211;mediated cancer immunosurveillance via FOXO1 activation</article-title><source>Cancer Res. Commun.</source><year>2024</year><volume>4</volume><fpage>1189</fpage><lpage>1198</lpage><pub-id pub-id-type="doi">10.1158/2767-9764.CRC-24-0022</pub-id><pub-id pub-id-type="pmid">38626334</pub-id><pub-id pub-id-type="pmcid">PMC11067828</pub-id></element-citation><mixed-citation id="mc-CR375" publication-type="journal">Ginefra, P. et al. Urolithin-A promotes CD8+ T cell&#8211;mediated cancer immunosurveillance via FOXO1 activation. <italic toggle="yes">Cancer Res. Commun.</italic><bold>4</bold>, 1189&#8211;1198 (2024).<pub-id pub-id-type="pmid">38626334</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/2767-9764.CRC-24-0022</pub-id><pub-id pub-id-type="pmcid">PMC11067828</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR376"><label>376.</label><citation-alternatives><element-citation id="ec-CR376" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>S</given-names></name><etal/></person-group><article-title>Urolithin A hijacks ERK1/2-ULK1 cascade to improve CD8+ T cell fitness for antitumor immunity</article-title><source>Adv. Sci.</source><year>2024</year><volume>11</volume><fpage>2310065</fpage><pub-id pub-id-type="doi">10.1002/advs.202310065</pub-id><pub-id pub-id-type="pmcid">PMC11095213</pub-id><pub-id pub-id-type="pmid">38447147</pub-id></element-citation><mixed-citation id="mc-CR376" publication-type="journal">Ma, S. et al. Urolithin A hijacks ERK1/2-ULK1 cascade to improve CD8+ T cell fitness for antitumor immunity. <italic toggle="yes">Adv. Sci.</italic><bold>11</bold>, 2310065 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/advs.202310065</pub-id><pub-id pub-id-type="pmcid">PMC11095213</pub-id><pub-id pub-id-type="pmid">38447147</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR377"><label>377.</label><citation-alternatives><element-citation id="ec-CR377" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denk</surname><given-names>D</given-names></name><etal/></person-group><article-title>Effect of the mitophagy inducer urolithin A on age-related immune decline: A randomized, placebo-controlled trial</article-title><source>Nat. Aging</source><year>2025</year><volume>5</volume><fpage>2309</fpage><lpage>2322</lpage><pub-id pub-id-type="doi">10.1038/s43587-025-00996-x</pub-id><pub-id pub-id-type="pmid">41174221</pub-id><pub-id pub-id-type="pmcid">PMC12618261</pub-id></element-citation><mixed-citation id="mc-CR377" publication-type="journal">Denk, D. et al. Effect of the mitophagy inducer urolithin A on age-related immune decline: A randomized, placebo-controlled trial. <italic toggle="yes">Nat. Aging</italic><bold>5</bold>, 2309&#8211;2322 (2025).<pub-id pub-id-type="pmid">41174221</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43587-025-00996-x</pub-id><pub-id pub-id-type="pmcid">PMC12618261</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR378"><label>378.</label><citation-alternatives><element-citation id="ec-CR378" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toney</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Urolithin A, a gut metabolite, improves insulin sensitivity through augmentation of mitochondrial function and biogenesis</article-title><source>Obesity</source><year>2019</year><volume>27</volume><fpage>612</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1002/oby.22404</pub-id><pub-id pub-id-type="pmid">30768775</pub-id></element-citation><mixed-citation id="mc-CR378" publication-type="journal">Toney, A. M. et al. Urolithin A, a gut metabolite, improves insulin sensitivity through augmentation of mitochondrial function and biogenesis. <italic toggle="yes">Obesity</italic><bold>27</bold>, 612&#8211;620 (2019).<pub-id pub-id-type="pmid">30768775</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/oby.22404</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR379"><label>379.</label><citation-alternatives><element-citation id="ec-CR379" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: A randomized clinical trial. <italic toggle="yes">JAMA Netw</italic></article-title><source>Open</source><year>2022</year><volume>5</volume><fpage>e2144279</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2021.44279</pub-id><pub-id pub-id-type="pmcid">PMC8777576</pub-id><pub-id pub-id-type="pmid">35050355</pub-id></element-citation><mixed-citation id="mc-CR379" publication-type="journal">Liu, S. et al. Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: A randomized clinical trial. <italic toggle="yes">JAMA Netw</italic>. <italic toggle="yes">Open</italic><bold>5</bold>, e2144279 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2021.44279</pub-id><pub-id pub-id-type="pmcid">PMC8777576</pub-id><pub-id pub-id-type="pmid">35050355</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR380"><label>380.</label><mixed-citation publication-type="other">Whitfield, J. et al. Evaluating the impact of urolithin A supplementation on running performance, recovery, and mitochondrial biomarkers in highly trained male distance runners. <italic toggle="yes">Sports Med</italic>. 10.1007/s40279-025-02292-5 (2025).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40279-025-02292-5</pub-id><pub-id pub-id-type="pmcid">PMC12628386</pub-id><pub-id pub-id-type="pmid">40839339</pub-id></mixed-citation></ref><ref id="CR381"><label>381.</label><citation-alternatives><element-citation id="ec-CR381" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Urolithin A ameliorates obesity-induced metabolic cardiomyopathy in mice via mitophagy activation</article-title><source>Acta Pharmacol. Sin.</source><year>2023</year><volume>44</volume><fpage>321</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1038/s41401-022-00919-1</pub-id><pub-id pub-id-type="pmid">35655094</pub-id><pub-id pub-id-type="pmcid">PMC9889402</pub-id></element-citation><mixed-citation id="mc-CR381" publication-type="journal">Huang, J. et al. Urolithin A ameliorates obesity-induced metabolic cardiomyopathy in mice via mitophagy activation. <italic toggle="yes">Acta Pharmacol. Sin.</italic><bold>44</bold>, 321&#8211;331 (2023).<pub-id pub-id-type="pmid">35655094</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41401-022-00919-1</pub-id><pub-id pub-id-type="pmcid">PMC9889402</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR382"><label>382.</label><citation-alternatives><element-citation id="ec-CR382" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinaffi-Langley</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Urolithin A supplementation to improve endothelial and cerebrovascular function in middle-aged adults with obesity: Study protocol for a double-blind placebo-controlled randomized study</article-title><source>Clin. Nutr. Open Sci.</source><year>2025</year><volume>61</volume><fpage>217</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/j.nutos.2025.04.004</pub-id></element-citation><mixed-citation id="mc-CR382" publication-type="journal">Pinaffi-Langley, A. C. et al. Urolithin A supplementation to improve endothelial and cerebrovascular function in middle-aged adults with obesity: Study protocol for a double-blind placebo-controlled randomized study. <italic toggle="yes">Clin. Nutr. Open Sci.</italic><bold>61</bold>, 217&#8211;230 (2025).</mixed-citation></citation-alternatives></ref><ref id="CR383"><label>383.</label><citation-alternatives><element-citation id="ec-CR383" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>B</given-names></name><etal/></person-group><article-title>Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice</article-title><source>PLoS Biol.</source><year>2020</year><volume>18</volume><fpage>e3000688</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.3000688</pub-id><pub-id pub-id-type="pmid">32218572</pub-id><pub-id pub-id-type="pmcid">PMC7141696</pub-id></element-citation><mixed-citation id="mc-CR383" publication-type="journal">Xia, B. et al. Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice. <italic toggle="yes">PLoS Biol.</italic><bold>18</bold>, e3000688 (2020).<pub-id pub-id-type="pmid">32218572</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pbio.3000688</pub-id><pub-id pub-id-type="pmcid">PMC7141696</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR384"><label>384.</label><citation-alternatives><element-citation id="ec-CR384" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pegg</surname><given-names>AE</given-names></name></person-group><article-title>Mammalian polyamine metabolism and function</article-title><source>IUBMB Life</source><year>2009</year><volume>61</volume><fpage>880</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1002/iub.230</pub-id><pub-id pub-id-type="pmid">19603518</pub-id><pub-id pub-id-type="pmcid">PMC2753421</pub-id></element-citation><mixed-citation id="mc-CR384" publication-type="journal">Pegg, A. E. Mammalian polyamine metabolism and function. <italic toggle="yes">IUBMB Life</italic><bold>61</bold>, 880&#8211;894 (2009).<pub-id pub-id-type="pmid">19603518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/iub.230</pub-id><pub-id pub-id-type="pmcid">PMC2753421</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR385"><label>385.</label><citation-alternatives><element-citation id="ec-CR385" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Igarashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Kashiwagi</surname><given-names>K</given-names></name></person-group><article-title>Modulation of cellular function by polyamines</article-title><source>Int. J. Biochem. Cell Biol.</source><year>2010</year><volume>42</volume><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2009.07.009</pub-id><pub-id pub-id-type="pmid">19643201</pub-id></element-citation><mixed-citation id="mc-CR385" publication-type="journal">Igarashi, K. &amp; Kashiwagi, K. Modulation of cellular function by polyamines. <italic toggle="yes">Int. J. Biochem. Cell Biol.</italic><bold>42</bold>, 39&#8211;51 (2010).<pub-id pub-id-type="pmid">19643201</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biocel.2009.07.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR386"><label>386.</label><citation-alternatives><element-citation id="ec-CR386" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eisenberg</surname><given-names>T</given-names></name><etal/></person-group><article-title>Induction of autophagy by spermidine promotes longevity</article-title><source>Nat. Cell Biol.</source><year>2009</year><volume>11</volume><fpage>1305</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1038/ncb1975</pub-id><pub-id pub-id-type="pmid">19801973</pub-id></element-citation><mixed-citation id="mc-CR386" publication-type="journal">Eisenberg, T. et al. Induction of autophagy by spermidine promotes longevity. <italic toggle="yes">Nat. Cell Biol.</italic><bold>11</bold>, 1305&#8211;1314 (2009).<pub-id pub-id-type="pmid">19801973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncb1975</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR387"><label>387.</label><citation-alternatives><element-citation id="ec-CR387" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pucciarelli</surname><given-names>S</given-names></name><etal/></person-group><article-title>Spermidine and spermine are enriched in whole blood of nona/centenarians</article-title><source>Rejuvenation Res.</source><year>2012</year><volume>15</volume><fpage>590</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1089/rej.2012.1349</pub-id><pub-id pub-id-type="pmid">22950434</pub-id></element-citation><mixed-citation id="mc-CR387" publication-type="journal">Pucciarelli, S. et al. Spermidine and spermine are enriched in whole blood of nona/centenarians. <italic toggle="yes">Rejuvenation Res.</italic><bold>15</bold>, 590&#8211;595 (2012).<pub-id pub-id-type="pmid">22950434</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/rej.2012.1349</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR388"><label>388.</label><citation-alternatives><element-citation id="ec-CR388" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rhodes</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Absorption, anti-inflammatory, antioxidant, and cardioprotective impacts of a novel fasting mimetic containing spermidine, nicotinamide, palmitoylethanolamide, and oleoylethanolamide: A pilot dose-escalation study in healthy young adult men</article-title><source>Nutr. Res.</source><year>2024</year><volume>132</volume><fpage>125</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2024.10.006</pub-id><pub-id pub-id-type="pmid">39549554</pub-id></element-citation><mixed-citation id="mc-CR388" publication-type="journal">Rhodes, C. H. et al. Absorption, anti-inflammatory, antioxidant, and cardioprotective impacts of a novel fasting mimetic containing spermidine, nicotinamide, palmitoylethanolamide, and oleoylethanolamide: A pilot dose-escalation study in healthy young adult men. <italic toggle="yes">Nutr. Res.</italic><bold>132</bold>, 125&#8211;135 (2024).<pub-id pub-id-type="pmid">39549554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nutres.2024.10.006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR389"><label>389.</label><citation-alternatives><element-citation id="ec-CR389" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiechl</surname><given-names>S</given-names></name><etal/></person-group><article-title>Higher spermidine intake is linked to lower mortality: A prospective population-based study</article-title><source>Am. J. Clin. Nutr.</source><year>2018</year><volume>108</volume><fpage>371</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1093/ajcn/nqy102</pub-id><pub-id pub-id-type="pmid">29955838</pub-id></element-citation><mixed-citation id="mc-CR389" publication-type="journal">Kiechl, S. et al. Higher spermidine intake is linked to lower mortality: A prospective population-based study. <italic toggle="yes">Am. J. Clin. Nutr.</italic><bold>108</bold>, 371&#8211;380 (2018).<pub-id pub-id-type="pmid">29955838</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajcn/nqy102</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR390"><label>390.</label><citation-alternatives><element-citation id="ec-CR390" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garc&#237;a-Prat</surname><given-names>L</given-names></name><etal/></person-group><article-title>Autophagy maintains stemness by preventing senescence</article-title><source>Nature</source><year>2016</year><volume>529</volume><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1038/nature16187</pub-id><pub-id pub-id-type="pmid">26738589</pub-id></element-citation><mixed-citation id="mc-CR390" publication-type="journal">Garc&#237;a-Prat, L. et al. Autophagy maintains stemness by preventing senescence. <italic toggle="yes">Nature</italic><bold>529</bold>, 37&#8211;42 (2016).<pub-id pub-id-type="pmid">26738589</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature16187</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR391"><label>391.</label><citation-alternatives><element-citation id="ec-CR391" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Spermidine coupled with exercise rescues skeletal muscle atrophy from D-gal-induced aging rats through enhanced autophagy and reduced apoptosis via AMPK-FOXO3a signal pathway</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>17475</fpage><lpage>17490</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.15728</pub-id><pub-id pub-id-type="pmid">28407698</pub-id><pub-id pub-id-type="pmcid">PMC5392263</pub-id></element-citation><mixed-citation id="mc-CR391" publication-type="journal">Fan, J. et al. Spermidine coupled with exercise rescues skeletal muscle atrophy from D-gal-induced aging rats through enhanced autophagy and reduced apoptosis via AMPK-FOXO3a signal pathway. <italic toggle="yes">Oncotarget</italic><bold>8</bold>, 17475&#8211;17490 (2017).<pub-id pub-id-type="pmid">28407698</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.15728</pub-id><pub-id pub-id-type="pmcid">PMC5392263</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR392"><label>392.</label><citation-alternatives><element-citation id="ec-CR392" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Polyamine metabolite spermidine rejuvenates oocyte quality by enhancing mitophagy during female reproductive aging</article-title><source>Nat. Aging</source><year>2023</year><volume>3</volume><fpage>1372</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.1038/s43587-023-00498-8</pub-id><pub-id pub-id-type="pmid">37845508</pub-id></element-citation><mixed-citation id="mc-CR392" publication-type="journal">Zhang, Y. et al. Polyamine metabolite spermidine rejuvenates oocyte quality by enhancing mitophagy during female reproductive aging. <italic toggle="yes">Nat. Aging</italic><bold>3</bold>, 1372&#8211;1386 (2023).<pub-id pub-id-type="pmid">37845508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43587-023-00498-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR393"><label>393.</label><citation-alternatives><element-citation id="ec-CR393" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schroeder</surname><given-names>S</given-names></name><etal/></person-group><article-title>Dietary spermidine improves cognitive function</article-title><source>Cell Rep</source><year>2021</year><volume>35</volume><fpage>108985</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2021.108985</pub-id><pub-id pub-id-type="pmid">33852843</pub-id></element-citation><mixed-citation id="mc-CR393" publication-type="journal">Schroeder, S. et al. Dietary spermidine improves cognitive function. <italic toggle="yes">Cell Rep</italic>. <bold>35</bold>, 108985 (2021).<pub-id pub-id-type="pmid">33852843</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2021.108985</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR394"><label>394.</label><citation-alternatives><element-citation id="ec-CR394" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwarz</surname><given-names>C</given-names></name><etal/></person-group><article-title>Spermidine intake is associated with cortical thickness and hippocampal volume in older adults</article-title><source>NeuroImage</source><year>2020</year><volume>221</volume><fpage>117132</fpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2020.117132</pub-id><pub-id pub-id-type="pmid">32629145</pub-id></element-citation><mixed-citation id="mc-CR394" publication-type="journal">Schwarz, C. et al. Spermidine intake is associated with cortical thickness and hippocampal volume in older adults. <italic toggle="yes">NeuroImage</italic><bold>221</bold>, 117132 (2020).<pub-id pub-id-type="pmid">32629145</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroimage.2020.117132</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR395"><label>395.</label><citation-alternatives><element-citation id="ec-CR395" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wirth</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)&#8212;study protocol for a randomized controlled trial</article-title><source>Alzheimer&#8217;s Res. Ther</source><year>2019</year><volume>11</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.1186/s13195-019-0484-1</pub-id><pub-id pub-id-type="pmid">31039826</pub-id><pub-id pub-id-type="pmcid">PMC6492385</pub-id></element-citation><mixed-citation id="mc-CR395" publication-type="journal">Wirth, M. et al. Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)&#8212;study protocol for a randomized controlled trial. <italic toggle="yes">Alzheimer&#8217;s Res. Ther</italic>. <bold>11</bold>, 36 (2019).<pub-id pub-id-type="pmid">31039826</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13195-019-0484-1</pub-id><pub-id pub-id-type="pmcid">PMC6492385</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR396"><label>396.</label><citation-alternatives><element-citation id="ec-CR396" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>EH</given-names></name><name name-style="western"><surname>V&#225;zquez de la Torre</surname><given-names>A</given-names></name><name name-style="western"><surname>Hoshikawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Briston</surname><given-names>T</given-names></name></person-group><article-title>Targeting mitophagy in Parkinson&#8217;s disease</article-title><source>J. Biol. Chem.</source><year>2021</year><volume>296</volume><fpage>100209</fpage><pub-id pub-id-type="doi">10.1074/jbc.REV120.014294</pub-id><pub-id pub-id-type="pmid">33372898</pub-id><pub-id pub-id-type="pmcid">PMC7948953</pub-id></element-citation><mixed-citation id="mc-CR396" publication-type="journal">Clark, E. H., V&#225;zquez de la Torre, A., Hoshikawa, T. &amp; Briston, T. Targeting mitophagy in Parkinson&#8217;s disease. <italic toggle="yes">J. Biol. Chem.</italic><bold>296</bold>, 100209 (2021).<pub-id pub-id-type="pmid">33372898</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.REV120.014294</pub-id><pub-id pub-id-type="pmcid">PMC7948953</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR397"><label>397.</label><citation-alternatives><element-citation id="ec-CR397" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hertz</surname><given-names>NT</given-names></name><etal/></person-group><article-title>A neo-substrate that amplifies catalytic activity of Parkinson&#8217;s-disease-related kinase PINK1</article-title><source>Cell</source><year>2013</year><volume>154</volume><fpage>737</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.07.030</pub-id><pub-id pub-id-type="pmid">23953109</pub-id><pub-id pub-id-type="pmcid">PMC3950538</pub-id></element-citation><mixed-citation id="mc-CR397" publication-type="journal">Hertz, N. T. et al. A neo-substrate that amplifies catalytic activity of Parkinson&#8217;s-disease-related kinase PINK1. <italic toggle="yes">Cell</italic><bold>154</bold>, 737&#8211;747 (2013).<pub-id pub-id-type="pmid">23953109</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2013.07.030</pub-id><pub-id pub-id-type="pmcid">PMC3950538</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR398"><label>398.</label><citation-alternatives><element-citation id="ec-CR398" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osgerby</surname><given-names>L</given-names></name><etal/></person-group><article-title>Kinetin riboside and its ProTides activate the Parkinson&#8217;s disease associated PTEN-Induced Putative Kinase 1 (PINK1) independent of mitochondrial depolarization</article-title><source>J. Med. Chem.</source><year>2017</year><volume>60</volume><fpage>3518</fpage><lpage>3524</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.6b01897</pub-id><pub-id pub-id-type="pmid">28323427</pub-id><pub-id pub-id-type="pmcid">PMC5410652</pub-id></element-citation><mixed-citation id="mc-CR398" publication-type="journal">Osgerby, L. et al. Kinetin riboside and its ProTides activate the Parkinson&#8217;s disease associated PTEN-Induced Putative Kinase 1 (PINK1) independent of mitochondrial depolarization. <italic toggle="yes">J. Med. Chem.</italic><bold>60</bold>, 3518&#8211;3524 (2017).<pub-id pub-id-type="pmid">28323427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jmedchem.6b01897</pub-id><pub-id pub-id-type="pmcid">PMC5410652</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR399"><label>399.</label><citation-alternatives><element-citation id="ec-CR399" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orr</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Long-term oral kinetin does not protect against &#945;-synuclein-induced neurodegeneration in rodent models of Parkinson&#8217;s disease</article-title><source>Neurochem. Int.</source><year>2017</year><volume>109</volume><fpage>106</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2017.04.006</pub-id><pub-id pub-id-type="pmid">28434973</pub-id><pub-id pub-id-type="pmcid">PMC5641232</pub-id></element-citation><mixed-citation id="mc-CR399" publication-type="journal">Orr, A. L. et al. Long-term oral kinetin does not protect against &#945;-synuclein-induced neurodegeneration in rodent models of Parkinson&#8217;s disease. <italic toggle="yes">Neurochem. Int.</italic><bold>109</bold>, 106&#8211;116 (2017).<pub-id pub-id-type="pmid">28434973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuint.2017.04.006</pub-id><pub-id pub-id-type="pmcid">PMC5641232</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR400"><label>400.</label><citation-alternatives><element-citation id="ec-CR400" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gan</surname><given-names>ZY</given-names></name><etal/></person-group><article-title>Interaction of PINK1 with nucleotides and kinetin</article-title><source>Sci. Adv</source><year>2024</year><volume>10</volume><fpage>eadj7408</fpage><pub-id pub-id-type="doi">10.1126/sciadv.adj7408</pub-id><pub-id pub-id-type="pmid">38241364</pub-id><pub-id pub-id-type="pmcid">PMC10798554</pub-id></element-citation><mixed-citation id="mc-CR400" publication-type="journal">Gan, Z. Y. et al. Interaction of PINK1 with nucleotides and kinetin. <italic toggle="yes">Sci. Adv</italic>. <bold>10</bold>, eadj7408 (2024).<pub-id pub-id-type="pmid">38241364</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciadv.adj7408</pub-id><pub-id pub-id-type="pmcid">PMC10798554</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR401"><label>401.</label><citation-alternatives><element-citation id="ec-CR401" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambourne</surname><given-names>OA</given-names></name><etal/></person-group><article-title>PINK1-dependent mitophagy inhibits elevated ubiquitin phosphorylation caused by mitochondrial damage</article-title><source>J. Med. Chem.</source><year>2023</year><volume>66</volume><fpage>7645</fpage><lpage>7656</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.3c00555</pub-id><pub-id pub-id-type="pmid">37248632</pub-id><pub-id pub-id-type="pmcid">PMC10258795</pub-id></element-citation><mixed-citation id="mc-CR401" publication-type="journal">Lambourne, O. A. et al. PINK1-dependent mitophagy inhibits elevated ubiquitin phosphorylation caused by mitochondrial damage. <italic toggle="yes">J. Med. Chem.</italic><bold>66</bold>, 7645&#8211;7656 (2023).<pub-id pub-id-type="pmid">37248632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jmedchem.3c00555</pub-id><pub-id pub-id-type="pmcid">PMC10258795</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR402"><label>402.</label><citation-alternatives><element-citation id="ec-CR402" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehellou</surname><given-names>Y</given-names></name></person-group><article-title>Parkinson&#8217;s disease: Are PINK1 activators inching closer to the clinic?</article-title><source>ACS Med. Chem. Lett.</source><year>2023</year><volume>14</volume><fpage>870</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1021/acsmedchemlett.3c00070</pub-id><pub-id pub-id-type="pmid">37465300</pub-id><pub-id pub-id-type="pmcid">PMC10350934</pub-id></element-citation><mixed-citation id="mc-CR402" publication-type="journal">Mehellou, Y. Parkinson&#8217;s disease: Are PINK1 activators inching closer to the clinic? <italic toggle="yes">ACS Med. Chem. Lett.</italic><bold>14</bold>, 870&#8211;874 (2023).<pub-id pub-id-type="pmid">37465300</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsmedchemlett.3c00070</pub-id><pub-id pub-id-type="pmcid">PMC10350934</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR403"><label>403.</label><mixed-citation publication-type="other">Hertz, N. et al. Pharmacological PINK1 activation ameliorates pathology in Parkinson&#8217;s disease models. <italic toggle="yes">Res. Sq</italic>. 10.21203/rs.3.rs-4356493/v1 (2024).</mixed-citation></ref><ref id="CR404"><label>404.</label><citation-alternatives><element-citation id="ec-CR404" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tich&#225;</surname><given-names>A</given-names></name><etal/></person-group><article-title>General and modular strategy for designing potent, selective, and pharmacologically compliant inhibitors of Rhomboid proteases</article-title><source>Cell Chem. Biol.</source><year>2017</year><volume>24</volume><fpage>1523</fpage><lpage>1536.e4</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2017.09.007</pub-id><pub-id pub-id-type="pmid">29107700</pub-id><pub-id pub-id-type="pmcid">PMC5746060</pub-id></element-citation><mixed-citation id="mc-CR404" publication-type="journal">Tich&#225;, A. et al. General and modular strategy for designing potent, selective, and pharmacologically compliant inhibitors of Rhomboid proteases. <italic toggle="yes">Cell Chem. Biol.</italic><bold>24</bold>, 1523&#8211;1536.e4 (2017).<pub-id pub-id-type="pmid">29107700</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chembiol.2017.09.007</pub-id><pub-id pub-id-type="pmcid">PMC5746060</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR405"><label>405.</label><citation-alternatives><element-citation id="ec-CR405" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pol&#225;chov&#225;</surname><given-names>E</given-names></name><etal/></person-group><article-title>Chemical blockage of the mitochondrial Rhomboid protease PARL by novel ketoamide inhibitors reveals its role in PINK1/Parkin-dependent mitophagy</article-title><source>J. Med. Chem.</source><year>2023</year><volume>66</volume><fpage>251</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.2c01092</pub-id><pub-id pub-id-type="pmid">36540942</pub-id><pub-id pub-id-type="pmcid">PMC9841525</pub-id></element-citation><mixed-citation id="mc-CR405" publication-type="journal">Pol&#225;chov&#225;, E. et al. Chemical blockage of the mitochondrial Rhomboid protease PARL by novel ketoamide inhibitors reveals its role in PINK1/Parkin-dependent mitophagy. <italic toggle="yes">J. Med. Chem.</italic><bold>66</bold>, 251&#8211;265 (2023).<pub-id pub-id-type="pmid">36540942</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jmedchem.2c01092</pub-id><pub-id pub-id-type="pmcid">PMC9841525</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR406"><label>406.</label><citation-alternatives><element-citation id="ec-CR406" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shlevkov</surname><given-names>E</given-names></name><etal/></person-group><article-title>Discovery of small-molecule positive allosteric modulators of Parkin E3 ligase</article-title><source>iScience</source><year>2022</year><volume>25</volume><fpage>103650</fpage><pub-id pub-id-type="doi">10.1016/j.isci.2021.103650</pub-id><pub-id pub-id-type="pmid">35024585</pub-id><pub-id pub-id-type="pmcid">PMC8733272</pub-id></element-citation><mixed-citation id="mc-CR406" publication-type="journal">Shlevkov, E. et al. Discovery of small-molecule positive allosteric modulators of Parkin E3 ligase. <italic toggle="yes">iScience</italic><bold>25</bold>, 103650 (2022).<pub-id pub-id-type="pmid">35024585</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.isci.2021.103650</pub-id><pub-id pub-id-type="pmcid">PMC8733272</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR407"><label>407.</label><citation-alternatives><element-citation id="ec-CR407" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sauv&#233;</surname><given-names>V</given-names></name><etal/></person-group><article-title>Activation of parkin by a molecular glue</article-title><source>Nat. Commun.</source><year>2024</year><volume>15</volume><fpage>7707</fpage><pub-id pub-id-type="doi">10.1038/s41467-024-51889-3</pub-id><pub-id pub-id-type="pmid">39300082</pub-id><pub-id pub-id-type="pmcid">PMC11412986</pub-id></element-citation><mixed-citation id="mc-CR407" publication-type="journal">Sauv&#233;, V. et al. Activation of parkin by a molecular glue. <italic toggle="yes">Nat. Commun.</italic><bold>15</bold>, 7707 (2024).<pub-id pub-id-type="pmid">39300082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-51889-3</pub-id><pub-id pub-id-type="pmcid">PMC11412986</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR408"><label>408.</label><citation-alternatives><element-citation id="ec-CR408" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Traynor</surname><given-names>R</given-names></name><etal/></person-group><article-title>Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity</article-title><source>Cell Rep. Methods</source><year>2024</year><volume>4</volume><fpage>100712</fpage><pub-id pub-id-type="doi">10.1016/j.crmeth.2024.100712</pub-id><pub-id pub-id-type="pmid">38382522</pub-id><pub-id pub-id-type="pmcid">PMC10921019</pub-id></element-citation><mixed-citation id="mc-CR408" publication-type="journal">Traynor, R. et al. Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity. <italic toggle="yes">Cell Rep. Methods</italic><bold>4</bold>, 100712 (2024).<pub-id pub-id-type="pmid">38382522</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.crmeth.2024.100712</pub-id><pub-id pub-id-type="pmcid">PMC10921019</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR409"><label>409.</label><citation-alternatives><element-citation id="ec-CR409" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Komander</surname><given-names>D</given-names></name><name name-style="western"><surname>Clague</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Urb&#233;</surname><given-names>S</given-names></name></person-group><article-title>Breaking the chains: Structure and function of the deubiquitinases</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2009</year><volume>10</volume><fpage>550</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1038/nrm2731</pub-id><pub-id pub-id-type="pmid">19626045</pub-id></element-citation><mixed-citation id="mc-CR409" publication-type="journal">Komander, D., Clague, M. J. &amp; Urb&#233;, S. Breaking the chains: Structure and function of the deubiquitinases. <italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic><bold>10</bold>, 550&#8211;563 (2009).<pub-id pub-id-type="pmid">19626045</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm2731</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR410"><label>410.</label><citation-alternatives><element-citation id="ec-CR410" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nielsen</surname><given-names>PY&#216;</given-names></name><name name-style="western"><surname>Okarmus</surname><given-names>J</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>M</given-names></name></person-group><article-title>Role of deubiquitinases in Parkinson&#8217;s disease&#8212;therapeutic perspectives</article-title><source>Cells</source><year>2023</year><volume>12</volume><fpage>651</fpage><pub-id pub-id-type="doi">10.3390/cells12040651</pub-id><pub-id pub-id-type="pmid">36831318</pub-id><pub-id pub-id-type="pmcid">PMC9954239</pub-id></element-citation><mixed-citation id="mc-CR410" publication-type="journal">Nielsen, P. Y. &#216;., Okarmus, J. &amp; Meyer, M. Role of deubiquitinases in Parkinson&#8217;s disease&#8212;therapeutic perspectives. <italic toggle="yes">Cells</italic><bold>12</bold>, 651 (2023).<pub-id pub-id-type="pmid">36831318</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells12040651</pub-id><pub-id pub-id-type="pmcid">PMC9954239</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR411"><label>411.</label><citation-alternatives><element-citation id="ec-CR411" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harrigan</surname><given-names>JA</given-names></name><name name-style="western"><surname>Jacq</surname><given-names>X</given-names></name><name name-style="western"><surname>Martin</surname><given-names>NM</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>SP</given-names></name></person-group><article-title>Deubiquitylating enzymes and drug discovery: Emerging opportunities</article-title><source>Nat. Rev. Drug Discov.</source><year>2018</year><volume>17</volume><fpage>57</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1038/nrd.2017.152</pub-id><pub-id pub-id-type="pmid">28959952</pub-id><pub-id pub-id-type="pmcid">PMC7097658</pub-id></element-citation><mixed-citation id="mc-CR411" publication-type="journal">Harrigan, J. A., Jacq, X., Martin, N. M. &amp; Jackson, S. P. Deubiquitylating enzymes and drug discovery: Emerging opportunities. <italic toggle="yes">Nat. Rev. Drug Discov.</italic><bold>17</bold>, 57&#8211;78 (2018).<pub-id pub-id-type="pmid">28959952</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrd.2017.152</pub-id><pub-id pub-id-type="pmcid">PMC7097658</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR412"><label>412.</label><citation-alternatives><element-citation id="ec-CR412" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cornelissen</surname><given-names>T</given-names></name><etal/></person-group><article-title>The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy</article-title><source>Hum. Mol. Genet.</source><year>2014</year><volume>23</volume><fpage>5227</fpage><lpage>5242</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu244</pub-id><pub-id pub-id-type="pmid">24852371</pub-id><pub-id pub-id-type="pmcid">PMC7108632</pub-id></element-citation><mixed-citation id="mc-CR412" publication-type="journal">Cornelissen, T. et al. The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy. <italic toggle="yes">Hum. Mol. Genet.</italic><bold>23</bold>, 5227&#8211;5242 (2014).<pub-id pub-id-type="pmid">24852371</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/hmg/ddu244</pub-id><pub-id pub-id-type="pmcid">PMC7108632</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR413"><label>413.</label><citation-alternatives><element-citation id="ec-CR413" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durcan</surname><given-names>TM</given-names></name><etal/></person-group><article-title>USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin</article-title><source>EMBO J</source><year>2014</year><volume>33</volume><fpage>2473</fpage><lpage>2491</lpage><pub-id pub-id-type="doi">10.15252/embj.201489729</pub-id><pub-id pub-id-type="pmid">25216678</pub-id><pub-id pub-id-type="pmcid">PMC4283406</pub-id></element-citation><mixed-citation id="mc-CR413" publication-type="journal">Durcan, T. M. et al. USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin. <italic toggle="yes">EMBO J</italic>. <bold>33</bold>, 2473&#8211;2491 (2014).<pub-id pub-id-type="pmid">25216678</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.201489729</pub-id><pub-id pub-id-type="pmcid">PMC4283406</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR414"><label>414.</label><citation-alternatives><element-citation id="ec-CR414" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakamura</surname><given-names>N</given-names></name><name name-style="western"><surname>Hirose</surname><given-names>S</given-names></name></person-group><article-title>Regulation of mitochondrial morphology by USP30, a deubiquitinating enzyme present in the mitochondrial outer membrane</article-title><source>Mol. Biol. Cell</source><year>2008</year><volume>19</volume><fpage>1903</fpage><lpage>1911</lpage><pub-id pub-id-type="doi">10.1091/mbc.e07-11-1103</pub-id><pub-id pub-id-type="pmid">18287522</pub-id><pub-id pub-id-type="pmcid">PMC2366858</pub-id></element-citation><mixed-citation id="mc-CR414" publication-type="journal">Nakamura, N. &amp; Hirose, S. Regulation of mitochondrial morphology by USP30, a deubiquitinating enzyme present in the mitochondrial outer membrane. <italic toggle="yes">Mol. Biol. Cell</italic><bold>19</bold>, 1903&#8211;1911 (2008).<pub-id pub-id-type="pmid">18287522</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1091/mbc.E07-11-1103</pub-id><pub-id pub-id-type="pmcid">PMC2366858</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR415"><label>415.</label><citation-alternatives><element-citation id="ec-CR415" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>T-SZ</given-names></name><etal/></person-group><article-title>Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson&#8217;s disease mouse model</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>7295</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-42876-1</pub-id><pub-id pub-id-type="pmid">37957154</pub-id><pub-id pub-id-type="pmcid">PMC10643470</pub-id></element-citation><mixed-citation id="mc-CR415" publication-type="journal">Fang, T.-S. Z. et al. Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson&#8217;s disease mouse model. <italic toggle="yes">Nat. Commun.</italic><bold>14</bold>, 7295 (2023).<pub-id pub-id-type="pmid">37957154</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-023-42876-1</pub-id><pub-id pub-id-type="pmcid">PMC10643470</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR416"><label>416.</label><citation-alternatives><element-citation id="ec-CR416" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunmore</surname><given-names>R</given-names></name><etal/></person-group><article-title>Abstract 4135531: The ubiquitin-specific protease 30 inhibitor, MTX652, attenuates cardiac dysfunction and remodelling in a murine model of transverse aortic constriction</article-title><source>Am. Heart Association&#8217;s 2024 Sci. Sessions</source><year>2024</year><volume>150</volume><fpage>A4135531</fpage><lpage>A4135531</lpage></element-citation><mixed-citation id="mc-CR416" publication-type="journal">Dunmore, R. et al. Abstract 4135531: The ubiquitin-specific protease 30 inhibitor, MTX652, attenuates cardiac dysfunction and remodelling in a murine model of transverse aortic constriction. <italic toggle="yes">Am. Heart Association&#8217;s 2024 Sci. Sessions</italic><bold>150</bold>, A4135531&#8211;A4135531 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR417"><label>417.</label><citation-alternatives><element-citation id="ec-CR417" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aceves</surname><given-names>P</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>PW</given-names></name><name name-style="western"><surname>Jones</surname><given-names>N</given-names></name><name name-style="western"><surname>Nurbhai</surname><given-names>S</given-names></name></person-group><article-title>Abstract TH-OR93: MTX652, a novel selective USP30 inhibitor for the treatment of AKI: Phase 1 results in healthy subjects and model-driven human efficacious dose pojections</article-title><source>Am. Soc. Nephrol. Kidney Week 2023</source><year>2023</year><volume>34</volume><fpage>27</fpage></element-citation><mixed-citation id="mc-CR417" publication-type="journal">Aceves, P., Thompson, P. W., Jones, N. &amp; Nurbhai, S. Abstract TH-OR93: MTX652, a novel selective USP30 inhibitor for the treatment of AKI: Phase 1 results in healthy subjects and model-driven human efficacious dose pojections. <italic toggle="yes">Am. Soc. Nephrol. Kidney Week 2023</italic><bold>34</bold>, 27 (2023).</mixed-citation></citation-alternatives></ref><ref id="CR418"><label>418.</label><citation-alternatives><element-citation id="ec-CR418" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rusilowicz-Jones</surname><given-names>EV</given-names></name><etal/></person-group><article-title>USP30 sets a trigger threshold for PINK1&#8211;PARKIN amplification of mitochondrial ubiquitylation</article-title><source>Life Sci. Alliance</source><year>2020</year><volume>3</volume><fpage>e202000768</fpage><pub-id pub-id-type="doi">10.26508/lsa.202000768</pub-id><pub-id pub-id-type="pmid">32636217</pub-id><pub-id pub-id-type="pmcid">PMC7362391</pub-id></element-citation><mixed-citation id="mc-CR418" publication-type="journal">Rusilowicz-Jones, E. V. et al. USP30 sets a trigger threshold for PINK1&#8211;PARKIN amplification of mitochondrial ubiquitylation. <italic toggle="yes">Life Sci. Alliance</italic><bold>3</bold>, e202000768 (2020).<pub-id pub-id-type="pmid">32636217</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.26508/lsa.202000768</pub-id><pub-id pub-id-type="pmcid">PMC7362391</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR419"><label>419.</label><citation-alternatives><element-citation id="ec-CR419" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>W</given-names></name><etal/></person-group><article-title>A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30</article-title><source>Cell Res.</source><year>2014</year><volume>24</volume><fpage>482</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1038/cr.2014.20</pub-id><pub-id pub-id-type="pmid">24513856</pub-id><pub-id pub-id-type="pmcid">PMC3975501</pub-id></element-citation><mixed-citation id="mc-CR419" publication-type="journal">Yue, W. et al. A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30. <italic toggle="yes">Cell Res.</italic><bold>24</bold>, 482&#8211;496 (2014).<pub-id pub-id-type="pmid">24513856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cr.2014.20</pub-id><pub-id pub-id-type="pmcid">PMC3975501</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR420"><label>420.</label><citation-alternatives><element-citation id="ec-CR420" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kluge</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2018</year><volume>28</volume><fpage>2655</fpage><lpage>2659</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2018.05.013</pub-id><pub-id pub-id-type="pmid">29935771</pub-id></element-citation><mixed-citation id="mc-CR420" publication-type="journal">Kluge, A. F. et al. Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy. <italic toggle="yes">Bioorg. Med. Chem. Lett.</italic><bold>28</bold>, 2655&#8211;2659 (2018).<pub-id pub-id-type="pmid">29935771</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bmcl.2018.05.013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR421"><label>421.</label><citation-alternatives><element-citation id="ec-CR421" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rusilowicz-Jones</surname><given-names>EV</given-names></name><etal/></person-group><article-title>Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy</article-title><source>Life Sci. Alliance</source><year>2022</year><volume>5</volume><fpage>e202101287</fpage><pub-id pub-id-type="doi">10.26508/lsa.202101287</pub-id><pub-id pub-id-type="pmid">34844982</pub-id><pub-id pub-id-type="pmcid">PMC8645336</pub-id></element-citation><mixed-citation id="mc-CR421" publication-type="journal">Rusilowicz-Jones, E. V. et al. Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy. <italic toggle="yes">Life Sci. Alliance</italic><bold>5</bold>, e202101287 (2022).<pub-id pub-id-type="pmid">34844982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.26508/lsa.202101287</pub-id><pub-id pub-id-type="pmcid">PMC8645336</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR422"><label>422.</label><mixed-citation publication-type="other">Qin, X. et al. Identification of an autoinhibitory, mitophagy-inducing peptide derived from the transmembrane domain of USP30. <italic toggle="yes">Autophagy</italic><bold>18</bold>, 2178&#8211;2197.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2021.2022360</pub-id><pub-id pub-id-type="pmcid">PMC9397470</pub-id><pub-id pub-id-type="pmid">34989313</pub-id></mixed-citation></ref><ref id="CR423"><label>423.</label><citation-alternatives><element-citation id="ec-CR423" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>L</given-names></name><etal/></person-group><article-title>The IKK&#946;-USP30-ACLY axis controls lipogenesis and tumorigenesis</article-title><source>Hepatology</source><year>2021</year><volume>73</volume><fpage>160</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1002/hep.31249</pub-id><pub-id pub-id-type="pmid">32221968</pub-id></element-citation><mixed-citation id="mc-CR423" publication-type="journal">Gu, L. et al. The IKK&#946;-USP30-ACLY axis controls lipogenesis and tumorigenesis. <italic toggle="yes">Hepatology</italic><bold>73</bold>, 160&#8211;174 (2021).<pub-id pub-id-type="pmid">32221968</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hep.31249</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR424"><label>424.</label><citation-alternatives><element-citation id="ec-CR424" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>H</given-names></name><name name-style="western"><surname>Krigman</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><name name-style="western"><surname>Sun</surname><given-names>N</given-names></name></person-group><article-title>Pharmacological inhibition of USP30 activates tissue-specific mitophagy</article-title><source>Acta Physiol.</source><year>2021</year><volume>232</volume><fpage>e13666</fpage><pub-id pub-id-type="doi">10.1111/apha.13666</pub-id><pub-id pub-id-type="pmcid">PMC8266733</pub-id><pub-id pub-id-type="pmid">33890401</pub-id></element-citation><mixed-citation id="mc-CR424" publication-type="journal">Luo, H., Krigman, J., Zhang, R., Yang, M. &amp; Sun, N. Pharmacological inhibition of USP30 activates tissue-specific mitophagy. <italic toggle="yes">Acta Physiol.</italic><bold>232</bold>, e13666 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/apha.13666</pub-id><pub-id pub-id-type="pmcid">PMC8266733</pub-id><pub-id pub-id-type="pmid">33890401</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR425"><label>425.</label><citation-alternatives><element-citation id="ec-CR425" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perciavalle</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration</article-title><source>Nat. Cell Biol.</source><year>2012</year><volume>14</volume><fpage>575</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1038/ncb2488</pub-id><pub-id pub-id-type="pmid">22544066</pub-id><pub-id pub-id-type="pmcid">PMC3401947</pub-id></element-citation><mixed-citation id="mc-CR425" publication-type="journal">Perciavalle, R. M. et al. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. <italic toggle="yes">Nat. Cell Biol.</italic><bold>14</bold>, 575&#8211;583 (2012).<pub-id pub-id-type="pmid">22544066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncb2488</pub-id><pub-id pub-id-type="pmcid">PMC3401947</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR426"><label>426.</label><citation-alternatives><element-citation id="ec-CR426" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure</article-title><source>Genes Dev</source><year>2013</year><volume>27</volume><fpage>1365</fpage><lpage>1377</lpage><pub-id pub-id-type="doi">10.1101/gad.215871.113</pub-id><pub-id pub-id-type="pmid">23788623</pub-id><pub-id pub-id-type="pmcid">PMC3701192</pub-id></element-citation><mixed-citation id="mc-CR426" publication-type="journal">Thomas, R. L. et al. Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure. <italic toggle="yes">Genes Dev</italic>. <bold>27</bold>, 1365&#8211;1377 (2013).<pub-id pub-id-type="pmid">23788623</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gad.215871.113</pub-id><pub-id pub-id-type="pmcid">PMC3701192</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR427"><label>427.</label><citation-alternatives><element-citation id="ec-CR427" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moyzis</surname><given-names>AG</given-names></name><name name-style="western"><surname>Lally</surname><given-names>NS</given-names></name><name name-style="western"><surname>Liang</surname><given-names>W</given-names></name><name name-style="western"><surname>Najor</surname><given-names>RH</given-names></name><name name-style="western"><surname>Gustafsson</surname><given-names>&#197;B</given-names></name></person-group><article-title>Mcl-1 differentially regulates autophagy in response to changes in energy status and mitochondrial damage</article-title><source>Cells</source><year>2022</year><volume>11</volume><fpage>1469</fpage><pub-id pub-id-type="doi">10.3390/cells11091469</pub-id><pub-id pub-id-type="pmid">35563775</pub-id><pub-id pub-id-type="pmcid">PMC9102819</pub-id></element-citation><mixed-citation id="mc-CR427" publication-type="journal">Moyzis, A. G., Lally, N. S., Liang, W., Najor, R. H. &amp; Gustafsson, &#197;. B. Mcl-1 differentially regulates autophagy in response to changes in energy status and mitochondrial damage. <italic toggle="yes">Cells</italic><bold>11</bold>, 1469 (2022).<pub-id pub-id-type="pmid">35563775</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells11091469</pub-id><pub-id pub-id-type="pmcid">PMC9102819</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR428"><label>428.</label><citation-alternatives><element-citation id="ec-CR428" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hollville</surname><given-names>E</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>RG</given-names></name><name name-style="western"><surname>Cullen</surname><given-names>SP</given-names></name><name name-style="western"><surname>Martin</surname><given-names>SJ</given-names></name></person-group><article-title>Bcl-2 family proteins participate in mitochondrial quality control by regulating Parkin/PINK1-dependent mitophagy</article-title><source>Mol. Cell</source><year>2014</year><volume>55</volume><fpage>451</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.06.001</pub-id><pub-id pub-id-type="pmid">24999239</pub-id></element-citation><mixed-citation id="mc-CR428" publication-type="journal">Hollville, E., Carroll, R. G., Cullen, S. P. &amp; Martin, S. J. Bcl-2 family proteins participate in mitochondrial quality control by regulating Parkin/PINK1-dependent mitophagy. <italic toggle="yes">Mol. Cell</italic><bold>55</bold>, 451&#8211;466 (2014).<pub-id pub-id-type="pmid">24999239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2014.06.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR429"><label>429.</label><citation-alternatives><element-citation id="ec-CR429" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cen</surname><given-names>X</given-names></name><etal/></person-group><article-title>Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer&#8217;s disease mouse model</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>5731</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-19547-6</pub-id><pub-id pub-id-type="pmid">33184293</pub-id><pub-id pub-id-type="pmcid">PMC7665171</pub-id></element-citation><mixed-citation id="mc-CR429" publication-type="journal">Cen, X. et al. Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer&#8217;s disease mouse model. <italic toggle="yes">Nat. Commun.</italic><bold>11</bold>, 5731 (2020).<pub-id pub-id-type="pmid">33184293</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-020-19547-6</pub-id><pub-id pub-id-type="pmcid">PMC7665171</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR430"><label>430.</label><citation-alternatives><element-citation id="ec-CR430" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chamoli</surname><given-names>M</given-names></name><etal/></person-group><article-title>A drug-like molecule engages nuclear hormone receptor DAF-12/FXR to regulate mitophagy and extend lifespan</article-title><source>Nat. Aging</source><year>2023</year><volume>3</volume><fpage>1529</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1038/s43587-023-00524-9</pub-id><pub-id pub-id-type="pmid">37957360</pub-id><pub-id pub-id-type="pmcid">PMC10797806</pub-id></element-citation><mixed-citation id="mc-CR430" publication-type="journal">Chamoli, M. et al. A drug-like molecule engages nuclear hormone receptor DAF-12/FXR to regulate mitophagy and extend lifespan. <italic toggle="yes">Nat. Aging</italic><bold>3</bold>, 1529&#8211;1543 (2023).<pub-id pub-id-type="pmid">37957360</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43587-023-00524-9</pub-id><pub-id pub-id-type="pmcid">PMC10797806</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR431"><label>431.</label><mixed-citation publication-type="other">Gaffney, K., Erion, K. &amp; Rodgers, K. Poster S31: CAP-1902 enhances muscle function in mdx mice. MDA Clinical and Scientific Conference <italic toggle="yes">2025</italic><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.mdaconference.org/abstract-library/cap-1902-enhances-muscle-function-in-mdx-mice/">https://www.mdaconference.org/abstract-library/cap-1902-enhances-muscle-function-in-mdx-mice/</ext-link>.</mixed-citation></ref><ref id="CR432"><label>432.</label><citation-alternatives><element-citation id="ec-CR432" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Butler</surname><given-names>R</given-names></name><name name-style="western"><surname>Jadhav</surname><given-names>S</given-names></name><name name-style="western"><surname>Rodgers</surname><given-names>KE</given-names></name></person-group><article-title>Mechanisms of neuro- and cardioprotection of MAS agonists in the TAC model</article-title><source>Alzheimers Dement.</source><year>2021</year><volume>17</volume><fpage>e056311</fpage></element-citation><mixed-citation id="mc-CR432" publication-type="journal">Butler, R., Jadhav, S. &amp; Rodgers, K. E. Mechanisms of neuro- and cardioprotection of MAS agonists in the TAC model. <italic toggle="yes">Alzheimers Dement.</italic><bold>17</bold>, e056311 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR433"><label>433.</label><citation-alternatives><element-citation id="ec-CR433" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>M</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X</given-names></name><name name-style="western"><surname>Christian</surname><given-names>WV</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tieu</surname><given-names>K</given-names></name></person-group><article-title>Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><fpage>11740</fpage><lpage>11752</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.066662</pub-id><pub-id pub-id-type="pmid">20164189</pub-id><pub-id pub-id-type="pmcid">PMC2857048</pub-id></element-citation><mixed-citation id="mc-CR433" publication-type="journal">Cui, M., Tang, X., Christian, W. V., Yoon, Y. &amp; Tieu, K. Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1. <italic toggle="yes">J. Biol. Chem.</italic><bold>285</bold>, 11740&#8211;11752 (2010).<pub-id pub-id-type="pmid">20164189</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M109.066662</pub-id><pub-id pub-id-type="pmcid">PMC2857048</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR434"><label>434.</label><citation-alternatives><element-citation id="ec-CR434" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>H</given-names></name><etal/></person-group><article-title>PTEN&#945;, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism</article-title><source>Cell Metab.</source><year>2014</year><volume>19</volume><fpage>836</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.03.023</pub-id><pub-id pub-id-type="pmid">24768297</pub-id><pub-id pub-id-type="pmcid">PMC4097321</pub-id></element-citation><mixed-citation id="mc-CR434" publication-type="journal">Liang, H. et al. PTEN&#945;, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism. <italic toggle="yes">Cell Metab.</italic><bold>19</bold>, 836&#8211;848 (2014).<pub-id pub-id-type="pmid">24768297</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2014.03.023</pub-id><pub-id pub-id-type="pmcid">PMC4097321</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR435"><label>435.</label><citation-alternatives><element-citation id="ec-CR435" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title>PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1&#8211;Parkin-mediated mitophagy</article-title><source>Cell Res.</source><year>2018</year><volume>28</volume><fpage>787</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1038/s41422-018-0056-0</pub-id><pub-id pub-id-type="pmid">29934616</pub-id><pub-id pub-id-type="pmcid">PMC6082900</pub-id></element-citation><mixed-citation id="mc-CR435" publication-type="journal">Wang, L. et al. PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1&#8211;Parkin-mediated mitophagy. <italic toggle="yes">Cell Res.</italic><bold>28</bold>, 787&#8211;802 (2018).<pub-id pub-id-type="pmid">29934616</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41422-018-0056-0</pub-id><pub-id pub-id-type="pmcid">PMC6082900</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR436"><label>436.</label><citation-alternatives><element-citation id="ec-CR436" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maestro</surname><given-names>I</given-names></name><etal/></person-group><article-title>Discovery of mitophagy inhibitors with therapeutic potential in different familial amyotrophic lateral sclerosis mutations</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><fpage>12676</fpage><pub-id pub-id-type="doi">10.3390/ijms232012676</pub-id><pub-id pub-id-type="pmid">36293534</pub-id><pub-id pub-id-type="pmcid">PMC9603920</pub-id></element-citation><mixed-citation id="mc-CR436" publication-type="journal">Maestro, I. et al. Discovery of mitophagy inhibitors with therapeutic potential in different familial amyotrophic lateral sclerosis mutations. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>23</bold>, 12676 (2022).<pub-id pub-id-type="pmid">36293534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms232012676</pub-id><pub-id pub-id-type="pmcid">PMC9603920</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR437"><label>437.</label><citation-alternatives><element-citation id="ec-CR437" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>N</given-names></name><etal/></person-group><article-title>A fluorescence-based imaging method to measure in vitro and in vivo mitophagy using mt-Keima</article-title><source>Nat. Protoc.</source><year>2017</year><volume>12</volume><fpage>1576</fpage><lpage>1587</lpage><pub-id pub-id-type="doi">10.1038/nprot.2017.060</pub-id><pub-id pub-id-type="pmid">28703790</pub-id></element-citation><mixed-citation id="mc-CR437" publication-type="journal">Sun, N. et al. A fluorescence-based imaging method to measure in vitro and in vivo mitophagy using mt-Keima. <italic toggle="yes">Nat. Protoc.</italic><bold>12</bold>, 1576&#8211;1587 (2017).<pub-id pub-id-type="pmid">28703790</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nprot.2017.060</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR438"><label>438.</label><citation-alternatives><element-citation id="ec-CR438" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katayama</surname><given-names>H</given-names></name><etal/></person-group><article-title>Visualizing and modulating mitophagy for therapeutic studies of neurodegeneration</article-title><source>Cell</source><year>2020</year><volume>181</volume><fpage>1176</fpage><lpage>1187.e16</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.025</pub-id><pub-id pub-id-type="pmid">32437660</pub-id></element-citation><mixed-citation id="mc-CR438" publication-type="journal">Katayama, H. et al. Visualizing and modulating mitophagy for therapeutic studies of neurodegeneration. <italic toggle="yes">Cell</italic><bold>181</bold>, 1176&#8211;1187.e16 (2020).<pub-id pub-id-type="pmid">32437660</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2020.04.025</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR439"><label>439.</label><citation-alternatives><element-citation id="ec-CR439" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mizushima</surname><given-names>N</given-names></name><name name-style="western"><surname>Komatsu</surname><given-names>M</given-names></name></person-group><article-title>Autophagy: Renovation of cells and tissues</article-title><source>Cell</source><year>2011</year><volume>147</volume><fpage>728</fpage><lpage>741</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.10.026</pub-id><pub-id pub-id-type="pmid">22078875</pub-id></element-citation><mixed-citation id="mc-CR439" publication-type="journal">Mizushima, N. &amp; Komatsu, M. Autophagy: Renovation of cells and tissues. <italic toggle="yes">Cell</italic><bold>147</bold>, 728&#8211;741 (2011).<pub-id pub-id-type="pmid">22078875</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2011.10.026</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR440"><label>440.</label><citation-alternatives><element-citation id="ec-CR440" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hershko</surname><given-names>A</given-names></name><name name-style="western"><surname>Ciechanover</surname><given-names>A</given-names></name></person-group><article-title>The ubiquitin system</article-title><source>Annu. Rev. Biochem.</source><year>1998</year><volume>67</volume><fpage>425</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.67.1.425</pub-id><pub-id pub-id-type="pmid">9759494</pub-id></element-citation><mixed-citation id="mc-CR440" publication-type="journal">Hershko, A. &amp; Ciechanover, A. The ubiquitin system. <italic toggle="yes">Annu. Rev. Biochem.</italic><bold>67</bold>, 425&#8211;479 (1998).<pub-id pub-id-type="pmid">9759494</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.biochem.67.1.425</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR441"><label>441.</label><citation-alternatives><element-citation id="ec-CR441" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swatek</surname><given-names>KN</given-names></name><name name-style="western"><surname>Komander</surname><given-names>D</given-names></name></person-group><article-title>Ubiquitin modifications</article-title><source>Cell Res.</source><year>2016</year><volume>26</volume><fpage>399</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1038/cr.2016.39</pub-id><pub-id pub-id-type="pmid">27012465</pub-id><pub-id pub-id-type="pmcid">PMC4822133</pub-id></element-citation><mixed-citation id="mc-CR441" publication-type="journal">Swatek, K. N. &amp; Komander, D. Ubiquitin modifications. <italic toggle="yes">Cell Res.</italic><bold>26</bold>, 399&#8211;422 (2016).<pub-id pub-id-type="pmid">27012465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cr.2016.39</pub-id><pub-id pub-id-type="pmcid">PMC4822133</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR442"><label>442.</label><citation-alternatives><element-citation id="ec-CR442" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pohl</surname><given-names>C</given-names></name><name name-style="western"><surname>Dikic</surname><given-names>I</given-names></name></person-group><article-title>Cellular quality control by the ubiquitin-proteasome system and autophagy</article-title><source>Science</source><year>2019</year><volume>366</volume><fpage>818</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1126/science.aax3769</pub-id><pub-id pub-id-type="pmid">31727826</pub-id></element-citation><mixed-citation id="mc-CR442" publication-type="journal">Pohl, C. &amp; Dikic, I. Cellular quality control by the ubiquitin-proteasome system and autophagy. <italic toggle="yes">Science</italic><bold>366</bold>, 818&#8211;822 (2019).<pub-id pub-id-type="pmid">31727826</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aax3769</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR443"><label>443.</label><citation-alternatives><element-citation id="ec-CR443" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mizushima</surname><given-names>N</given-names></name></person-group><article-title>Ubiquitin in autophagy and non-protein ubiquitination</article-title><source>Nat. Struct. Mol. Biol.</source><year>2024</year><volume>31</volume><fpage>208</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1038/s41594-024-01217-6</pub-id><pub-id pub-id-type="pmid">38366228</pub-id></element-citation><mixed-citation id="mc-CR443" publication-type="journal">Mizushima, N. Ubiquitin in autophagy and non-protein ubiquitination. <italic toggle="yes">Nat. Struct. Mol. Biol.</italic><bold>31</bold>, 208&#8211;209 (2024).<pub-id pub-id-type="pmid">38366228</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41594-024-01217-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR444"><label>444.</label><citation-alternatives><element-citation id="ec-CR444" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pickart</surname><given-names>CM</given-names></name></person-group><article-title>Mechanisms underlying ubiquitination</article-title><source>Annu. Rev. Biochem.</source><year>2001</year><volume>70</volume><fpage>503</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.70.1.503</pub-id><pub-id pub-id-type="pmid">11395416</pub-id></element-citation><mixed-citation id="mc-CR444" publication-type="journal">Pickart, C. M. Mechanisms underlying ubiquitination. <italic toggle="yes">Annu. Rev. Biochem.</italic><bold>70</bold>, 503&#8211;533 (2001).<pub-id pub-id-type="pmid">11395416</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.biochem.70.1.503</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR445"><label>445.</label><citation-alternatives><element-citation id="ec-CR445" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulman</surname><given-names>BA</given-names></name><name name-style="western"><surname>Wade Harper</surname><given-names>J</given-names></name></person-group><article-title>Ubiquitin-like protein activation by E1 enzymes: The apex for downstream signalling pathways</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2009</year><volume>10</volume><fpage>319</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1038/nrm2673</pub-id><pub-id pub-id-type="pmid">19352404</pub-id><pub-id pub-id-type="pmcid">PMC2712597</pub-id></element-citation><mixed-citation id="mc-CR445" publication-type="journal">Schulman, B. A. &amp; Wade Harper, J. Ubiquitin-like protein activation by E1 enzymes: The apex for downstream signalling pathways. <italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic><bold>10</bold>, 319&#8211;331 (2009).<pub-id pub-id-type="pmid">19352404</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm2673</pub-id><pub-id pub-id-type="pmcid">PMC2712597</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR446"><label>446.</label><citation-alternatives><element-citation id="ec-CR446" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rape</surname><given-names>M</given-names></name></person-group><article-title>Building ubiquitin chains: E2 enzymes at work</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2009</year><volume>10</volume><fpage>755</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1038/nrm2780</pub-id><pub-id pub-id-type="pmid">19851334</pub-id><pub-id pub-id-type="pmcid">PMC3107738</pub-id></element-citation><mixed-citation id="mc-CR446" publication-type="journal">Ye, Y. &amp; Rape, M. Building ubiquitin chains: E2 enzymes at work. <italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic><bold>10</bold>, 755&#8211;764 (2009).<pub-id pub-id-type="pmid">19851334</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm2780</pub-id><pub-id pub-id-type="pmcid">PMC3107738</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR447"><label>447.</label><citation-alternatives><element-citation id="ec-CR447" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deshaies</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Joazeiro</surname><given-names>CAP</given-names></name></person-group><article-title>RING domain E3 ubiquitin ligases</article-title><source>Annu. Rev. Biochem.</source><year>2009</year><volume>78</volume><fpage>399</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.78.101807.093809</pub-id><pub-id pub-id-type="pmid">19489725</pub-id></element-citation><mixed-citation id="mc-CR447" publication-type="journal">Deshaies, R. J. &amp; Joazeiro, C. A. P. RING domain E3 ubiquitin ligases. <italic toggle="yes">Annu. Rev. Biochem.</italic><bold>78</bold>, 399&#8211;434 (2009).<pub-id pub-id-type="pmid">19489725</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.biochem.78.101807.093809</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR448"><label>448.</label><citation-alternatives><element-citation id="ec-CR448" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rotin</surname><given-names>D</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name></person-group><article-title>Physiological functions of the HECT family of ubiquitin ligases</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2009</year><volume>10</volume><fpage>398</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1038/nrm2690</pub-id><pub-id pub-id-type="pmid">19436320</pub-id></element-citation><mixed-citation id="mc-CR448" publication-type="journal">Rotin, D. &amp; Kumar, S. Physiological functions of the HECT family of ubiquitin ligases. <italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic><bold>10</bold>, 398&#8211;409 (2009).<pub-id pub-id-type="pmid">19436320</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm2690</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR449"><label>449.</label><citation-alternatives><element-citation id="ec-CR449" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>N</given-names></name><name name-style="western"><surname>Shabek</surname><given-names>N</given-names></name></person-group><article-title>Ubiquitin ligases: Structure, function, and regulation</article-title><source>Annu. Rev. Biochem.</source><year>2017</year><volume>86</volume><fpage>129</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-060815-014922</pub-id><pub-id pub-id-type="pmid">28375744</pub-id></element-citation><mixed-citation id="mc-CR449" publication-type="journal">Zheng, N. &amp; Shabek, N. Ubiquitin ligases: Structure, function, and regulation. <italic toggle="yes">Annu. Rev. Biochem.</italic><bold>86</bold>, 129&#8211;157 (2017).<pub-id pub-id-type="pmid">28375744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-biochem-060815-014922</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR450"><label>450.</label><citation-alternatives><element-citation id="ec-CR450" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hosokawa</surname><given-names>N</given-names></name><etal/></person-group><article-title>Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy</article-title><source>Mol. Biol. Cell</source><year>2009</year><volume>20</volume><fpage>1981</fpage><lpage>1991</lpage><pub-id pub-id-type="doi">10.1091/mbc.e08-12-1248</pub-id><pub-id pub-id-type="pmid">19211835</pub-id><pub-id pub-id-type="pmcid">PMC2663915</pub-id></element-citation><mixed-citation id="mc-CR450" publication-type="journal">Hosokawa, N. et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. <italic toggle="yes">Mol. Biol. Cell</italic><bold>20</bold>, 1981&#8211;1991 (2009).<pub-id pub-id-type="pmid">19211835</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1091/mbc.E08-12-1248</pub-id><pub-id pub-id-type="pmcid">PMC2663915</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR451"><label>451.</label><citation-alternatives><element-citation id="ec-CR451" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganley</surname><given-names>IG</given-names></name><etal/></person-group><article-title>ULK1&#183;ATG13&#183;FIP200 complex mediates mTOR signaling and is essential for autophagy</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>12297</fpage><lpage>12305</lpage><pub-id pub-id-type="doi">10.1074/jbc.M900573200</pub-id><pub-id pub-id-type="pmid">19258318</pub-id><pub-id pub-id-type="pmcid">PMC2673298</pub-id></element-citation><mixed-citation id="mc-CR451" publication-type="journal">Ganley, I. G. et al. ULK1&#183;ATG13&#183;FIP200 complex mediates mTOR signaling and is essential for autophagy. <italic toggle="yes">J. Biol. Chem.</italic><bold>284</bold>, 12297&#8211;12305 (2009).<pub-id pub-id-type="pmid">19258318</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M900573200</pub-id><pub-id pub-id-type="pmcid">PMC2673298</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR452"><label>452.</label><citation-alternatives><element-citation id="ec-CR452" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><name name-style="western"><surname>Kundu</surname><given-names>M</given-names></name><name name-style="western"><surname>Viollet</surname><given-names>B</given-names></name><name name-style="western"><surname>Guan</surname><given-names>K-L</given-names></name></person-group><article-title>AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1</article-title><source>Nat. Cell Biol.</source><year>2011</year><volume>13</volume><fpage>132</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1038/ncb2152</pub-id><pub-id pub-id-type="pmid">21258367</pub-id><pub-id pub-id-type="pmcid">PMC3987946</pub-id></element-citation><mixed-citation id="mc-CR452" publication-type="journal">Kim, J., Kundu, M., Viollet, B. &amp; Guan, K.-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. <italic toggle="yes">Nat. Cell Biol.</italic><bold>13</bold>, 132&#8211;141 (2011).<pub-id pub-id-type="pmid">21258367</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncb2152</pub-id><pub-id pub-id-type="pmcid">PMC3987946</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR453"><label>453.</label><citation-alternatives><element-citation id="ec-CR453" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alers</surname><given-names>S</given-names></name><name name-style="western"><surname>L&#246;ffler</surname><given-names>AS</given-names></name><name name-style="western"><surname>Wesselborg</surname><given-names>S</given-names></name><name name-style="western"><surname>Stork</surname><given-names>B</given-names></name></person-group><article-title>Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: Cross talk, shortcuts, and feedbacks</article-title><source>Mol. Cell Biol.</source><year>2012</year><volume>32</volume><fpage>2</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1128/MCB.06159-11</pub-id><pub-id pub-id-type="pmid">22025673</pub-id><pub-id pub-id-type="pmcid">PMC3255710</pub-id></element-citation><mixed-citation id="mc-CR453" publication-type="journal">Alers, S., L&#246;ffler, A. S., Wesselborg, S. &amp; Stork, B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: Cross talk, shortcuts, and feedbacks. <italic toggle="yes">Mol. Cell Biol.</italic><bold>32</bold>, 2&#8211;11 (2012).<pub-id pub-id-type="pmid">22025673</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/MCB.06159-11</pub-id><pub-id pub-id-type="pmcid">PMC3255710</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR454"><label>454.</label><citation-alternatives><element-citation id="ec-CR454" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>YC</given-names></name><name name-style="western"><surname>Guan</surname><given-names>K-L</given-names></name></person-group><article-title>mTOR: A pharmacologic target for autophagy regulation</article-title><source>J. Clin. Invest.</source><year>2015</year><volume>125</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1172/JCI73939</pub-id><pub-id pub-id-type="pmid">25654547</pub-id><pub-id pub-id-type="pmcid">PMC4382265</pub-id></element-citation><mixed-citation id="mc-CR454" publication-type="journal">Kim, Y. C. &amp; Guan, K.-L. mTOR: A pharmacologic target for autophagy regulation. <italic toggle="yes">J. Clin. Invest.</italic><bold>125</bold>, 25&#8211;32 (2015).<pub-id pub-id-type="pmid">25654547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI73939</pub-id><pub-id pub-id-type="pmcid">PMC4382265</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR455"><label>455.</label><citation-alternatives><element-citation id="ec-CR455" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sawa-Makarska</surname><given-names>J</given-names></name><etal/></person-group><article-title>Reconstitution of autophagosome nucleation defines Atg9 vesicles as seeds for membrane formation</article-title><source>Science</source><year>2020</year><volume>369</volume><fpage>eaaz7714</fpage><pub-id pub-id-type="doi">10.1126/science.aaz7714</pub-id><pub-id pub-id-type="pmid">32883836</pub-id><pub-id pub-id-type="pmcid">PMC7610778</pub-id></element-citation><mixed-citation id="mc-CR455" publication-type="journal">Sawa-Makarska, J. et al. Reconstitution of autophagosome nucleation defines Atg9 vesicles as seeds for membrane formation. <italic toggle="yes">Science</italic><bold>369</bold>, eaaz7714 (2020).<pub-id pub-id-type="pmid">32883836</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aaz7714</pub-id><pub-id pub-id-type="pmcid">PMC7610778</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR456"><label>456.</label><citation-alternatives><element-citation id="ec-CR456" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bilanges</surname><given-names>B</given-names></name><name name-style="western"><surname>Posor</surname><given-names>Y</given-names></name><name name-style="western"><surname>Vanhaesebroeck</surname><given-names>B</given-names></name></person-group><article-title>PI3K isoforms in cell signalling and vesicle trafficking</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2019</year><volume>20</volume><fpage>515</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/s41580-019-0129-z</pub-id><pub-id pub-id-type="pmid">31110302</pub-id></element-citation><mixed-citation id="mc-CR456" publication-type="journal">Bilanges, B., Posor, Y. &amp; Vanhaesebroeck, B. PI3K isoforms in cell signalling and vesicle trafficking. <italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic><bold>20</bold>, 515&#8211;534 (2019).<pub-id pub-id-type="pmid">31110302</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41580-019-0129-z</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR457"><label>457.</label><citation-alternatives><element-citation id="ec-CR457" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dooley</surname><given-names>HC</given-names></name><etal/></person-group><article-title>WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12&#8211;5-16L1</article-title><source>Mol. Cell</source><year>2014</year><volume>55</volume><fpage>238</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.05.021</pub-id><pub-id pub-id-type="pmid">24954904</pub-id><pub-id pub-id-type="pmcid">PMC4104028</pub-id></element-citation><mixed-citation id="mc-CR457" publication-type="journal">Dooley, H. C. et al. WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12&#8211;5-16L1. <italic toggle="yes">Mol. Cell</italic><bold>55</bold>, 238&#8211;252 (2014).<pub-id pub-id-type="pmid">24954904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2014.05.021</pub-id><pub-id pub-id-type="pmcid">PMC4104028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR458"><label>458.</label><citation-alternatives><element-citation id="ec-CR458" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Komatsu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice</article-title><source>J. Cell Biol.</source><year>2005</year><volume>169</volume><fpage>425</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1083/jcb.200412022</pub-id><pub-id pub-id-type="pmid">15866887</pub-id><pub-id pub-id-type="pmcid">PMC2171928</pub-id></element-citation><mixed-citation id="mc-CR458" publication-type="journal">Komatsu, M. et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. <italic toggle="yes">J. Cell Biol.</italic><bold>169</bold>, 425&#8211;434 (2005).<pub-id pub-id-type="pmid">15866887</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.200412022</pub-id><pub-id pub-id-type="pmcid">PMC2171928</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR459"><label>459.</label><citation-alternatives><element-citation id="ec-CR459" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collier</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Suomi</surname><given-names>F</given-names></name><name name-style="western"><surname>Ol&#225;hov&#225;</surname><given-names>M</given-names></name><name name-style="western"><surname>McWilliams</surname><given-names>TG</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>RW</given-names></name></person-group><article-title>Emerging roles of ATG7 in human health and disease</article-title><source>EMBO Mol. Med.</source><year>2021</year><volume>13</volume><fpage>e14824</fpage><pub-id pub-id-type="doi">10.15252/emmm.202114824</pub-id><pub-id pub-id-type="pmid">34725936</pub-id><pub-id pub-id-type="pmcid">PMC8649875</pub-id></element-citation><mixed-citation id="mc-CR459" publication-type="journal">Collier, J. J., Suomi, F., Ol&#225;hov&#225;, M., McWilliams, T. G. &amp; Taylor, R. W. Emerging roles of ATG7 in human health and disease. <italic toggle="yes">EMBO Mol. Med.</italic><bold>13</bold>, e14824 (2021).<pub-id pub-id-type="pmid">34725936</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/emmm.202114824</pub-id><pub-id pub-id-type="pmcid">PMC8649875</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR460"><label>460.</label><citation-alternatives><element-citation id="ec-CR460" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The crystal structure of Atg3, an autophagy-related Ubiquitin carrier protein (E2) enzyme that mediates Atg8 lipidation</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>8036</fpage><lpage>8043</lpage><pub-id pub-id-type="doi">10.1074/jbc.M611473200</pub-id><pub-id pub-id-type="pmid">17227760</pub-id></element-citation><mixed-citation id="mc-CR460" publication-type="journal">Yamada, Y. et al. The crystal structure of Atg3, an autophagy-related Ubiquitin carrier protein (E2) enzyme that mediates Atg8 lipidation. <italic toggle="yes">J. Biol. Chem.</italic><bold>282</bold>, 8036&#8211;8043 (2007).<pub-id pub-id-type="pmid">17227760</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M611473200</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR461"><label>461.</label><citation-alternatives><element-citation id="ec-CR461" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsuboyama</surname><given-names>K</given-names></name><etal/></person-group><article-title>The ATG conjugation systems are important for degradation of the inner autophagosomal membrane</article-title><source>Science</source><year>2016</year><volume>354</volume><fpage>1036</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1126/science.aaf6136</pub-id><pub-id pub-id-type="pmid">27885029</pub-id></element-citation><mixed-citation id="mc-CR461" publication-type="journal">Tsuboyama, K. et al. The ATG conjugation systems are important for degradation of the inner autophagosomal membrane. <italic toggle="yes">Science</italic><bold>354</bold>, 1036&#8211;1041 (2016).<pub-id pub-id-type="pmid">27885029</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aaf6136</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR462"><label>462.</label><citation-alternatives><element-citation id="ec-CR462" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johansen</surname><given-names>T</given-names></name><name name-style="western"><surname>Lamark</surname><given-names>T</given-names></name></person-group><article-title>Selective autophagy: ATG8 family proteins, LIR motifs and cargo receptors</article-title><source>J. Mol. Biol.</source><year>2020</year><volume>432</volume><fpage>80</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2019.07.016</pub-id><pub-id pub-id-type="pmid">31310766</pub-id></element-citation><mixed-citation id="mc-CR462" publication-type="journal">Johansen, T. &amp; Lamark, T. Selective autophagy: ATG8 family proteins, LIR motifs and cargo receptors. <italic toggle="yes">J. Mol. Biol.</italic><bold>432</bold>, 80&#8211;103 (2020).<pub-id pub-id-type="pmid">31310766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jmb.2019.07.016</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR463"><label>463.</label><citation-alternatives><element-citation id="ec-CR463" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fletcher</surname><given-names>K</given-names></name><etal/></person-group><article-title>The WD40 domain of ATG16L1 is required for its non-canonical role in lipidation of LC3 at single membranes</article-title><source>EMBO J</source><year>2018</year><volume>37</volume><fpage>e97840</fpage><pub-id pub-id-type="doi">10.15252/embj.201797840</pub-id><pub-id pub-id-type="pmid">29317426</pub-id><pub-id pub-id-type="pmcid">PMC5813257</pub-id></element-citation><mixed-citation id="mc-CR463" publication-type="journal">Fletcher, K. et al. The WD40 domain of ATG16L1 is required for its non-canonical role in lipidation of LC3 at single membranes. <italic toggle="yes">EMBO J</italic>. <bold>37</bold>, e97840 (2018).<pub-id pub-id-type="pmid">29317426</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.201797840</pub-id><pub-id pub-id-type="pmcid">PMC5813257</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR464"><label>464.</label><citation-alternatives><element-citation id="ec-CR464" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>S&#248;nder</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Restructuring of the plasma membrane upon damage by LC3-associated macropinocytosis</article-title><source>Sci. Adv</source><year>2021</year><volume>7</volume><fpage>eabg1969</fpage><pub-id pub-id-type="doi">10.1126/sciadv.abg1969</pub-id><pub-id pub-id-type="pmid">34215587</pub-id><pub-id pub-id-type="pmcid">PMC11057704</pub-id></element-citation><mixed-citation id="mc-CR464" publication-type="journal">S&#248;nder, S. L. et al. Restructuring of the plasma membrane upon damage by LC3-associated macropinocytosis. <italic toggle="yes">Sci. Adv</italic>. <bold>7</bold>, eabg1969 (2021).<pub-id pub-id-type="pmid">34215587</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciadv.abg1969</pub-id><pub-id pub-id-type="pmcid">PMC11057704</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR465"><label>465.</label><citation-alternatives><element-citation id="ec-CR465" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kakanj</surname><given-names>P</given-names></name><name name-style="western"><surname>Bhide</surname><given-names>S</given-names></name><name name-style="western"><surname>Moussian</surname><given-names>B</given-names></name><name name-style="western"><surname>Leptin</surname><given-names>M</given-names></name></person-group><article-title>Autophagy&#8211;mediated plasma membrane removal promotes the formation of epithelial syncytia</article-title><source>EMBO J</source><year>2022</year><volume>41</volume><fpage>e109992</fpage><pub-id pub-id-type="doi">10.15252/embj.2021109992</pub-id><pub-id pub-id-type="pmid">35262206</pub-id><pub-id pub-id-type="pmcid">PMC9194749</pub-id></element-citation><mixed-citation id="mc-CR465" publication-type="journal">Kakanj, P., Bhide, S., Moussian, B. &amp; Leptin, M. Autophagy&#8211;mediated plasma membrane removal promotes the formation of epithelial syncytia. <italic toggle="yes">EMBO J</italic>. <bold>41</bold>, e109992 (2022).<pub-id pub-id-type="pmid">35262206</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.2021109992</pub-id><pub-id pub-id-type="pmcid">PMC9194749</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR466"><label>466.</label><citation-alternatives><element-citation id="ec-CR466" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durgan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Non-canonical autophagy drives alternative ATG8 conjugation to phosphatidylserine</article-title><source>Mol. Cell</source><year>2021</year><volume>81</volume><fpage>2031</fpage><lpage>2040.e8</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2021.03.020</pub-id><pub-id pub-id-type="pmid">33909989</pub-id><pub-id pub-id-type="pmcid">PMC8122138</pub-id></element-citation><mixed-citation id="mc-CR466" publication-type="journal">Durgan, J. et al. Non-canonical autophagy drives alternative ATG8 conjugation to phosphatidylserine. <italic toggle="yes">Mol. Cell</italic><bold>81</bold>, 2031&#8211;2040.e8 (2021).<pub-id pub-id-type="pmid">33909989</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2021.03.020</pub-id><pub-id pub-id-type="pmcid">PMC8122138</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR467"><label>467.</label><citation-alternatives><element-citation id="ec-CR467" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hooper</surname><given-names>KM</given-names></name><etal/></person-group><article-title>V-ATPase is a universal regulator of LC3-associated phagocytosis and non-canonical autophagy</article-title><source>J. Cell Biol.</source><year>2022</year><volume>221</volume><fpage>e202105112</fpage><pub-id pub-id-type="doi">10.1083/jcb.202105112</pub-id><pub-id pub-id-type="pmid">35511089</pub-id><pub-id pub-id-type="pmcid">PMC9082624</pub-id></element-citation><mixed-citation id="mc-CR467" publication-type="journal">Hooper, K. M. et al. V-ATPase is a universal regulator of LC3-associated phagocytosis and non-canonical autophagy. <italic toggle="yes">J. Cell Biol.</italic><bold>221</bold>, e202105112 (2022).<pub-id pub-id-type="pmid">35511089</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.202105112</pub-id><pub-id pub-id-type="pmcid">PMC9082624</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR468"><label>468.</label><citation-alternatives><element-citation id="ec-CR468" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamark</surname><given-names>T</given-names></name><name name-style="western"><surname>Johansen</surname><given-names>T</given-names></name></person-group><article-title>Mechanisms of selective autophagy</article-title><source>Annu. Rev. Cell Dev. Biol.</source><year>2021</year><volume>37</volume><fpage>143</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-120219-035530</pub-id><pub-id pub-id-type="pmid">34152791</pub-id></element-citation><mixed-citation id="mc-CR468" publication-type="journal">Lamark, T. &amp; Johansen, T. Mechanisms of selective autophagy. <italic toggle="yes">Annu. Rev. Cell Dev. Biol.</italic><bold>37</bold>, 143&#8211;169 (2021).<pub-id pub-id-type="pmid">34152791</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-cellbio-120219-035530</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR469"><label>469.</label><citation-alternatives><element-citation id="ec-CR469" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calle</surname><given-names>X</given-names></name><etal/></person-group><article-title>Mitochondrial E3 ubiquitin ligase 1 (MUL1) as a novel therapeutic target for diseases associated with mitochondrial dysfunction</article-title><source>IUBMB Life</source><year>2022</year><volume>74</volume><fpage>850</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1002/iub.2657</pub-id><pub-id pub-id-type="pmid">35638168</pub-id></element-citation><mixed-citation id="mc-CR469" publication-type="journal">Calle, X. et al. Mitochondrial E3 ubiquitin ligase 1 (MUL1) as a novel therapeutic target for diseases associated with mitochondrial dysfunction. <italic toggle="yes">IUBMB Life</italic><bold>74</bold>, 850&#8211;865 (2022).<pub-id pub-id-type="pmid">35638168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/iub.2657</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR470"><label>470.</label><citation-alternatives><element-citation id="ec-CR470" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yun</surname><given-names>J</given-names></name><etal/></person-group><article-title>MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin</article-title><source>eLife</source><year>2014</year><volume>3</volume><fpage>e01958</fpage><pub-id pub-id-type="doi">10.7554/eLife.01958</pub-id><pub-id pub-id-type="pmid">24898855</pub-id><pub-id pub-id-type="pmcid">PMC4044952</pub-id></element-citation><mixed-citation id="mc-CR470" publication-type="journal">Yun, J. et al. MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin. <italic toggle="yes">eLife</italic><bold>3</bold>, e01958 (2014).<pub-id pub-id-type="pmid">24898855</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.01958</pub-id><pub-id pub-id-type="pmcid">PMC4044952</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR471"><label>471.</label><citation-alternatives><element-citation id="ec-CR471" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prudent</surname><given-names>J</given-names></name><etal/></person-group><article-title>MAPL SUMOylation of Drp1 stabilizes an ER/mitochondrial platform required for cell death</article-title><source>Mol. Cell</source><year>2015</year><volume>59</volume><fpage>941</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.08.001</pub-id><pub-id pub-id-type="pmid">26384664</pub-id></element-citation><mixed-citation id="mc-CR471" publication-type="journal">Prudent, J. et al. MAPL SUMOylation of Drp1 stabilizes an ER/mitochondrial platform required for cell death. <italic toggle="yes">Mol. Cell</italic><bold>59</bold>, 941&#8211;955 (2015).<pub-id pub-id-type="pmid">26384664</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2015.08.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR472"><label>472.</label><citation-alternatives><element-citation id="ec-CR472" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Mitochondrial outer-membrane E3 ligase MUL1 ubiquitinates ULK1 and regulates selenite-induced mitophagy</article-title><source>Autophagy</source><year>2015</year><volume>11</volume><fpage>1216</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1080/15548627.2015.1017180</pub-id><pub-id pub-id-type="pmid">26018823</pub-id><pub-id pub-id-type="pmcid">PMC4590677</pub-id></element-citation><mixed-citation id="mc-CR472" publication-type="journal">Li, J. et al. Mitochondrial outer-membrane E3 ligase MUL1 ubiquitinates ULK1 and regulates selenite-induced mitophagy. <italic toggle="yes">Autophagy</italic><bold>11</bold>, 1216&#8211;1229 (2015).<pub-id pub-id-type="pmid">26018823</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2015.1017180</pub-id><pub-id pub-id-type="pmcid">PMC4590677</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR473"><label>473.</label><citation-alternatives><element-citation id="ec-CR473" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rojansky</surname><given-names>R</given-names></name><name name-style="western"><surname>Cha</surname><given-names>M-Y</given-names></name><name name-style="western"><surname>Chan</surname><given-names>DC</given-names></name></person-group><article-title>Elimination of paternal mitochondria in mouse embryos occurs through autophagic degradation dependent on PARKIN and MUL1</article-title><source>eLife</source><year>2016</year><volume>5</volume><fpage>e17896</fpage><pub-id pub-id-type="doi">10.7554/eLife.17896</pub-id><pub-id pub-id-type="pmid">27852436</pub-id><pub-id pub-id-type="pmcid">PMC5127638</pub-id></element-citation><mixed-citation id="mc-CR473" publication-type="journal">Rojansky, R., Cha, M.-Y. &amp; Chan, D. C. Elimination of paternal mitochondria in mouse embryos occurs through autophagic degradation dependent on PARKIN and MUL1. <italic toggle="yes">eLife</italic><bold>5</bold>, e17896 (2016).<pub-id pub-id-type="pmid">27852436</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.17896</pub-id><pub-id pub-id-type="pmcid">PMC5127638</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR474"><label>474.</label><citation-alternatives><element-citation id="ec-CR474" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szargel</surname><given-names>R</given-names></name><etal/></person-group><article-title>The PINK1, synphilin-1 and SIAH-1 complex constitutes a novel mitophagy pathway</article-title><source>Hum. Mol. Genet.</source><year>2016</year><volume>25</volume><fpage>3476</fpage><lpage>3490</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw189</pub-id><pub-id pub-id-type="pmid">27334109</pub-id></element-citation><mixed-citation id="mc-CR474" publication-type="journal">Szargel, R. et al. The PINK1, synphilin-1 and SIAH-1 complex constitutes a novel mitophagy pathway. <italic toggle="yes">Hum. Mol. Genet.</italic><bold>25</bold>, 3476&#8211;3490 (2016).<pub-id pub-id-type="pmid">27334109</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/hmg/ddw189</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR475"><label>475.</label><citation-alternatives><element-citation id="ec-CR475" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soubannier</surname><given-names>V</given-names></name><name name-style="western"><surname>Rippstein</surname><given-names>P</given-names></name><name name-style="western"><surname>Kaufman</surname><given-names>BA</given-names></name><name name-style="western"><surname>Shoubridge</surname><given-names>EA</given-names></name><name name-style="western"><surname>McBride</surname><given-names>HM</given-names></name></person-group><article-title>Reconstitution of mitochondria derived vesicle formation demonstrates selective enrichment of oxidized cargo</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e52830</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0052830</pub-id><pub-id pub-id-type="pmid">23300790</pub-id><pub-id pub-id-type="pmcid">PMC3530470</pub-id></element-citation><mixed-citation id="mc-CR475" publication-type="journal">Soubannier, V., Rippstein, P., Kaufman, B. A., Shoubridge, E. A. &amp; McBride, H. M. Reconstitution of mitochondria derived vesicle formation demonstrates selective enrichment of oxidized cargo. <italic toggle="yes">PLoS One</italic><bold>7</bold>, e52830 (2012).<pub-id pub-id-type="pmid">23300790</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0052830</pub-id><pub-id pub-id-type="pmcid">PMC3530470</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR476"><label>476.</label><citation-alternatives><element-citation id="ec-CR476" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>K&#246;nig</surname><given-names>T</given-names></name><etal/></person-group><article-title>MIROs and DRP1 drive mitochondrial-derived vesicle biogenesis and promote quality control</article-title><source>Nat. Cell Biol.</source><year>2021</year><volume>23</volume><fpage>1271</fpage><lpage>1286</lpage><pub-id pub-id-type="doi">10.1038/s41556-021-00798-4</pub-id><pub-id pub-id-type="pmid">34873283</pub-id></element-citation><mixed-citation id="mc-CR476" publication-type="journal">K&#246;nig, T. et al. MIROs and DRP1 drive mitochondrial-derived vesicle biogenesis and promote quality control. <italic toggle="yes">Nat. Cell Biol.</italic><bold>23</bold>, 1271&#8211;1286 (2021).<pub-id pub-id-type="pmid">34873283</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41556-021-00798-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR477"><label>477.</label><citation-alternatives><element-citation id="ec-CR477" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLelland</surname><given-names>G</given-names></name><name name-style="western"><surname>Soubannier</surname><given-names>V</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CX</given-names></name><name name-style="western"><surname>McBride</surname><given-names>HM</given-names></name><name name-style="western"><surname>Fon</surname><given-names>EA</given-names></name></person-group><article-title>Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control</article-title><source>EMBO J</source><year>2014</year><volume>33</volume><fpage>282</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">24446486</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/embj.201385902</pub-id><pub-id pub-id-type="pmcid">PMC3989637</pub-id></element-citation><mixed-citation id="mc-CR477" publication-type="journal">McLelland, G., Soubannier, V., Chen, C. X., McBride, H. M. &amp; Fon, E. A. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. <italic toggle="yes">EMBO J</italic>. <bold>33</bold>, 282&#8211;295 (2014).<pub-id pub-id-type="pmid">24446486</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/embj.201385902</pub-id><pub-id pub-id-type="pmcid">PMC3989637</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR478"><label>478.</label><citation-alternatives><element-citation id="ec-CR478" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLelland</surname><given-names>G-L</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SA</given-names></name><name name-style="western"><surname>McBride</surname><given-names>HM</given-names></name><name name-style="western"><surname>Fon</surname><given-names>EA</given-names></name></person-group><article-title>Syntaxin-17 delivers PINK1/parkin-dependent mitochondrial vesicles to the endolysosomal system</article-title><source>J. Cell Biol.</source><year>2016</year><volume>214</volume><fpage>275</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1083/jcb.201603105</pub-id><pub-id pub-id-type="pmid">27458136</pub-id><pub-id pub-id-type="pmcid">PMC4970327</pub-id></element-citation><mixed-citation id="mc-CR478" publication-type="journal">McLelland, G.-L., Lee, S. A., McBride, H. M. &amp; Fon, E. A. Syntaxin-17 delivers PINK1/parkin-dependent mitochondrial vesicles to the endolysosomal system. <italic toggle="yes">J. Cell Biol.</italic><bold>214</bold>, 275&#8211;291 (2016).<pub-id pub-id-type="pmid">27458136</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.201603105</pub-id><pub-id pub-id-type="pmcid">PMC4970327</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR479"><label>479.</label><citation-alternatives><element-citation id="ec-CR479" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Towers</surname><given-names>CG</given-names></name><etal/></person-group><article-title>Mitochondrial-derived vesicles compensate for loss of LC3-mediated mitophagy</article-title><source>Dev. Cell</source><year>2021</year><volume>56</volume><fpage>2029</fpage><lpage>2042.e5</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.06.003</pub-id><pub-id pub-id-type="pmid">34171288</pub-id><pub-id pub-id-type="pmcid">PMC8319140</pub-id></element-citation><mixed-citation id="mc-CR479" publication-type="journal">Towers, C. G. et al. Mitochondrial-derived vesicles compensate for loss of LC3-mediated mitophagy. <italic toggle="yes">Dev. Cell</italic><bold>56</bold>, 2029&#8211;2042.e5 (2021).<pub-id pub-id-type="pmid">34171288</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.devcel.2021.06.003</pub-id><pub-id pub-id-type="pmcid">PMC8319140</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR480"><label>480.</label><citation-alternatives><element-citation id="ec-CR480" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>DC</given-names></name></person-group><article-title>Mitochondrial fusion and fission in mammals</article-title><source>Annu. Rev. Cell Dev. Biol.</source><year>2006</year><volume>22</volume><fpage>79</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1146/annurev.cellbio.22.010305.104638</pub-id><pub-id pub-id-type="pmid">16704336</pub-id></element-citation><mixed-citation id="mc-CR480" publication-type="journal">Chan, D. C. Mitochondrial fusion and fission in mammals. <italic toggle="yes">Annu. Rev. Cell Dev. Biol.</italic><bold>22</bold>, 79&#8211;99 (2006).<pub-id pub-id-type="pmid">16704336</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.cellbio.22.010305.104638</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR481"><label>481.</label><citation-alternatives><element-citation id="ec-CR481" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fenton</surname><given-names>AR</given-names></name><name name-style="western"><surname>Jongens</surname><given-names>TA</given-names></name><name name-style="western"><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><article-title>Mitochondrial dynamics: Shaping and remodeling an organelle network</article-title><source>Curr. Opin. Cell Biol.</source><year>2021</year><volume>68</volume><fpage>28</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2020.08.014</pub-id><pub-id pub-id-type="pmid">32961383</pub-id><pub-id pub-id-type="pmcid">PMC7925334</pub-id></element-citation><mixed-citation id="mc-CR481" publication-type="journal">Fenton, A. R., Jongens, T. A. &amp; Holzbaur, E. L. F. Mitochondrial dynamics: Shaping and remodeling an organelle network. <italic toggle="yes">Curr. Opin. Cell Biol.</italic><bold>68</bold>, 28&#8211;36 (2021).<pub-id pub-id-type="pmid">32961383</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ceb.2020.08.014</pub-id><pub-id pub-id-type="pmcid">PMC7925334</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR482"><label>482.</label><citation-alternatives><element-citation id="ec-CR482" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yapa</surname><given-names>NMB</given-names></name><name name-style="western"><surname>Lisnyak</surname><given-names>V</given-names></name><name name-style="western"><surname>Reljic</surname><given-names>B</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>MT</given-names></name></person-group><article-title>Mitochondrial dynamics in health and disease</article-title><source>FEBS Lett</source><year>2021</year><volume>595</volume><fpage>1184</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.14077</pub-id><pub-id pub-id-type="pmid">33742459</pub-id></element-citation><mixed-citation id="mc-CR482" publication-type="journal">Yapa, N. M. B., Lisnyak, V., Reljic, B. &amp; Ryan, M. T. Mitochondrial dynamics in health and disease. <italic toggle="yes">FEBS Lett</italic>. <bold>595</bold>, 1184&#8211;1204 (2021).<pub-id pub-id-type="pmid">33742459</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1873-3468.14077</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR483"><label>483.</label><citation-alternatives><element-citation id="ec-CR483" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ishihara</surname><given-names>N</given-names></name><name name-style="western"><surname>Yokota</surname><given-names>S</given-names></name><name name-style="western"><surname>Mihara</surname><given-names>K</given-names></name></person-group><article-title>Two Mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion</article-title><source>J. Biochem.</source><year>2003</year><volume>134</volume><fpage>333</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1093/jb/mvg150</pub-id><pub-id pub-id-type="pmid">14561718</pub-id></element-citation><mixed-citation id="mc-CR483" publication-type="journal">Eura, Y., Ishihara, N., Yokota, S. &amp; Mihara, K. Two Mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion. <italic toggle="yes">J. Biochem.</italic><bold>134</bold>, 333&#8211;344 (2003).<pub-id pub-id-type="pmid">14561718</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jb/mvg150</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR484"><label>484.</label><citation-alternatives><element-citation id="ec-CR484" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santel</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells</article-title><source>J. Cell Sci.</source><year>2003</year><volume>116</volume><fpage>2763</fpage><lpage>2774</lpage><pub-id pub-id-type="doi">10.1242/jcs.00479</pub-id><pub-id pub-id-type="pmid">12759376</pub-id></element-citation><mixed-citation id="mc-CR484" publication-type="journal">Santel, A. et al. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. <italic toggle="yes">J. Cell Sci.</italic><bold>116</bold>, 2763&#8211;2774 (2003).<pub-id pub-id-type="pmid">12759376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1242/jcs.00479</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR485"><label>485.</label><citation-alternatives><element-citation id="ec-CR485" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cipolat</surname><given-names>S</given-names></name><name name-style="western"><surname>de Brito</surname><given-names>OM</given-names></name><name name-style="western"><surname>Dal Zilio</surname><given-names>B</given-names></name><name name-style="western"><surname>Scorrano</surname><given-names>L</given-names></name></person-group><article-title>OPA1 requires mitofusin 1 to promote mitochondrial fusion</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>15927</fpage><lpage>15932</lpage><pub-id pub-id-type="doi">10.1073/pnas.0407043101</pub-id><pub-id pub-id-type="pmid">15509649</pub-id><pub-id pub-id-type="pmcid">PMC528769</pub-id></element-citation><mixed-citation id="mc-CR485" publication-type="journal">Cipolat, S., de Brito, O. M., Dal Zilio, B. &amp; Scorrano, L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>101</bold>, 15927&#8211;15932 (2004).<pub-id pub-id-type="pmid">15509649</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0407043101</pub-id><pub-id pub-id-type="pmcid">PMC528769</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR486"><label>486.</label><citation-alternatives><element-citation id="ec-CR486" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smirnova</surname><given-names>E</given-names></name><name name-style="western"><surname>Griparic</surname><given-names>L</given-names></name><name name-style="western"><surname>Shurland</surname><given-names>D-L</given-names></name><name name-style="western"><surname>van der Bliek</surname><given-names>AM</given-names></name></person-group><article-title>Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells</article-title><source>Mol. Biol. Cell</source><year>2001</year><volume>12</volume><fpage>2245</fpage><lpage>2256</lpage><pub-id pub-id-type="doi">10.1091/mbc.12.8.2245</pub-id><pub-id pub-id-type="pmid">11514614</pub-id><pub-id pub-id-type="pmcid">PMC58592</pub-id></element-citation><mixed-citation id="mc-CR486" publication-type="journal">Smirnova, E., Griparic, L., Shurland, D.-L. &amp; van der Bliek, A. M. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. <italic toggle="yes">Mol. Biol. Cell</italic><bold>12</bold>, 2245&#8211;2256 (2001).<pub-id pub-id-type="pmid">11514614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1091/mbc.12.8.2245</pub-id><pub-id pub-id-type="pmcid">PMC58592</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR487"><label>487.</label><citation-alternatives><element-citation id="ec-CR487" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korobova</surname><given-names>F</given-names></name><name name-style="western"><surname>Ramabhadran</surname><given-names>V</given-names></name><name name-style="western"><surname>Higgs</surname><given-names>HN</given-names></name></person-group><article-title>An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2</article-title><source>Science</source><year>2013</year><volume>339</volume><fpage>464</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1126/science.1228360</pub-id><pub-id pub-id-type="pmid">23349293</pub-id><pub-id pub-id-type="pmcid">PMC3843506</pub-id></element-citation><mixed-citation id="mc-CR487" publication-type="journal">Korobova, F., Ramabhadran, V. &amp; Higgs, H. N. An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2. <italic toggle="yes">Science</italic><bold>339</bold>, 464&#8211;467 (2013).<pub-id pub-id-type="pmid">23349293</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1228360</pub-id><pub-id pub-id-type="pmcid">PMC3843506</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR488"><label>488.</label><citation-alternatives><element-citation id="ec-CR488" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Friedman</surname><given-names>JR</given-names></name><etal/></person-group><article-title>ER tubules mark sites of mitochondrial division</article-title><source>Science</source><year>2011</year><volume>334</volume><fpage>358</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1126/science.1207385</pub-id><pub-id pub-id-type="pmid">21885730</pub-id><pub-id pub-id-type="pmcid">PMC3366560</pub-id></element-citation><mixed-citation id="mc-CR488" publication-type="journal">Friedman, J. R. et al. ER tubules mark sites of mitochondrial division. <italic toggle="yes">Science</italic><bold>334</bold>, 358&#8211;362 (2011).<pub-id pub-id-type="pmid">21885730</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1207385</pub-id><pub-id pub-id-type="pmcid">PMC3366560</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR489"><label>489.</label><citation-alternatives><element-citation id="ec-CR489" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Popov</surname><given-names>L-D</given-names></name></person-group><article-title>Mitochondrial biogenesis: An update</article-title><source>J. Cell. Mol. Med.</source><year>2020</year><volume>24</volume><fpage>4892</fpage><lpage>4899</lpage><pub-id pub-id-type="doi">10.1111/jcmm.15194</pub-id><pub-id pub-id-type="pmid">32279443</pub-id><pub-id pub-id-type="pmcid">PMC7205802</pub-id></element-citation><mixed-citation id="mc-CR489" publication-type="journal">Popov, L.-D. Mitochondrial biogenesis: An update. <italic toggle="yes">J. Cell. Mol. Med.</italic><bold>24</bold>, 4892&#8211;4899 (2020).<pub-id pub-id-type="pmid">32279443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jcmm.15194</pub-id><pub-id pub-id-type="pmcid">PMC7205802</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR490"><label>490.</label><citation-alternatives><element-citation id="ec-CR490" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Twig</surname><given-names>G</given-names></name><etal/></person-group><article-title>Fission and selective fusion govern mitochondrial segregation and elimination by autophagy</article-title><source>EMBO J</source><year>2008</year><volume>27</volume><fpage>433</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601963</pub-id><pub-id pub-id-type="pmid">18200046</pub-id><pub-id pub-id-type="pmcid">PMC2234339</pub-id></element-citation><mixed-citation id="mc-CR490" publication-type="journal">Twig, G. et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. <italic toggle="yes">EMBO J</italic>. <bold>27</bold>, 433&#8211;446 (2008).<pub-id pub-id-type="pmid">18200046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.emboj.7601963</pub-id><pub-id pub-id-type="pmcid">PMC2234339</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR491"><label>491.</label><citation-alternatives><element-citation id="ec-CR491" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomes</surname><given-names>LC</given-names></name><name name-style="western"><surname>Benedetto</surname><given-names>GD</given-names></name><name name-style="western"><surname>Scorrano</surname><given-names>L</given-names></name></person-group><article-title>During autophagy mitochondria elongate, are spared from degradation and sustain cell viability</article-title><source>Nat. Cell Biol.</source><year>2011</year><volume>13</volume><fpage>589</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1038/ncb2220</pub-id><pub-id pub-id-type="pmid">21478857</pub-id><pub-id pub-id-type="pmcid">PMC3088644</pub-id></element-citation><mixed-citation id="mc-CR491" publication-type="journal">Gomes, L. C., Benedetto, G. D. &amp; Scorrano, L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. <italic toggle="yes">Nat. Cell Biol.</italic><bold>13</bold>, 589&#8211;598 (2011).<pub-id pub-id-type="pmid">21478857</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncb2220</pub-id><pub-id pub-id-type="pmcid">PMC3088644</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR492"><label>492.</label><citation-alternatives><element-citation id="ec-CR492" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rambold</surname><given-names>AS</given-names></name><name name-style="western"><surname>Kostelecky</surname><given-names>B</given-names></name><name name-style="western"><surname>Elia</surname><given-names>N</given-names></name><name name-style="western"><surname>Lippincott-Schwartz</surname><given-names>J</given-names></name></person-group><article-title>Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>10190</fpage><lpage>10195</lpage><pub-id pub-id-type="doi">10.1073/pnas.1107402108</pub-id><pub-id pub-id-type="pmid">21646527</pub-id><pub-id pub-id-type="pmcid">PMC3121813</pub-id></element-citation><mixed-citation id="mc-CR492" publication-type="journal">Rambold, A. S., Kostelecky, B., Elia, N. &amp; Lippincott-Schwartz, J. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. <italic toggle="yes">Proc. Natl Acad. Sci. USA</italic><bold>108</bold>, 10190&#8211;10195 (2011).<pub-id pub-id-type="pmid">21646527</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1107402108</pub-id><pub-id pub-id-type="pmcid">PMC3121813</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR493"><label>493.</label><citation-alternatives><element-citation id="ec-CR493" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kleele</surname><given-names>T</given-names></name><etal/></person-group><article-title>Distinct fission signatures predict mitochondrial degradation or biogenesis</article-title><source>Nature</source><year>2021</year><volume>593</volume><fpage>435</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03510-6</pub-id><pub-id pub-id-type="pmid">33953403</pub-id></element-citation><mixed-citation id="mc-CR493" publication-type="journal">Kleele, T. et al. Distinct fission signatures predict mitochondrial degradation or biogenesis. <italic toggle="yes">Nature</italic><bold>593</bold>, 435&#8211;439 (2021).<pub-id pub-id-type="pmid">33953403</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-03510-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR494"><label>494.</label><citation-alternatives><element-citation id="ec-CR494" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dorn</surname><given-names>GW</given-names></name></person-group><article-title>PINK1-phosphorylated Mitofusin 2 Is a Parkin receptor for culling damaged mitochondria</article-title><source>Science</source><year>2013</year><volume>340</volume><fpage>471</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1126/science.1231031</pub-id><pub-id pub-id-type="pmid">23620051</pub-id><pub-id pub-id-type="pmcid">PMC3774525</pub-id></element-citation><mixed-citation id="mc-CR494" publication-type="journal">Chen, Y. &amp; Dorn, G. W. PINK1-phosphorylated Mitofusin 2 Is a Parkin receptor for culling damaged mitochondria. <italic toggle="yes">Science</italic><bold>340</bold>, 471&#8211;475 (2013).<pub-id pub-id-type="pmid">23620051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1231031</pub-id><pub-id pub-id-type="pmcid">PMC3774525</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR495"><label>495.</label><citation-alternatives><element-citation id="ec-CR495" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanaka</surname><given-names>A</given-names></name><etal/></person-group><article-title>Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin</article-title><source>J. Cell Biol.</source><year>2010</year><volume>191</volume><fpage>1367</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.1083/jcb.201007013</pub-id><pub-id pub-id-type="pmid">21173115</pub-id><pub-id pub-id-type="pmcid">PMC3010068</pub-id></element-citation><mixed-citation id="mc-CR495" publication-type="journal">Tanaka, A. et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. <italic toggle="yes">J. Cell Biol.</italic><bold>191</bold>, 1367&#8211;1380 (2010).<pub-id pub-id-type="pmid">21173115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.201007013</pub-id><pub-id pub-id-type="pmcid">PMC3010068</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR496"><label>496.</label><citation-alternatives><element-citation id="ec-CR496" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Brito</surname><given-names>OM</given-names></name><name name-style="western"><surname>Scorrano</surname><given-names>L</given-names></name></person-group><article-title>Mitofusin 2 tethers endoplasmic reticulum to mitochondria</article-title><source>Nature</source><year>2008</year><volume>456</volume><fpage>605</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1038/nature07534</pub-id><pub-id pub-id-type="pmid">19052620</pub-id></element-citation><mixed-citation id="mc-CR496" publication-type="journal">de Brito, O. M. &amp; Scorrano, L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. <italic toggle="yes">Nature</italic><bold>456</bold>, 605&#8211;610 (2008).<pub-id pub-id-type="pmid">19052620</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature07534</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR497"><label>497.</label><citation-alternatives><element-citation id="ec-CR497" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLelland</surname><given-names>G-L</given-names></name><etal/></person-group><article-title>Mfn2 ubiquitination by PINK1/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy</article-title><source>eLife</source><year>2018</year><volume>7</volume><fpage>e32866</fpage><pub-id pub-id-type="doi">10.7554/eLife.32866</pub-id><pub-id pub-id-type="pmid">29676259</pub-id><pub-id pub-id-type="pmcid">PMC5927771</pub-id></element-citation><mixed-citation id="mc-CR497" publication-type="journal">McLelland, G.-L. et al. Mfn2 ubiquitination by PINK1/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy. <italic toggle="yes">eLife</italic><bold>7</bold>, e32866 (2018).<pub-id pub-id-type="pmid">29676259</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.32866</pub-id><pub-id pub-id-type="pmcid">PMC5927771</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR498"><label>498.</label><citation-alternatives><element-citation id="ec-CR498" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name><etal/></person-group><article-title>The GTPase dMiro is required for axonal transport of mitochondria to <italic toggle="yes">Drosophila</italic> synapses</article-title><source>Neuron</source><year>2005</year><volume>47</volume><fpage>379</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.06.027</pub-id><pub-id pub-id-type="pmid">16055062</pub-id></element-citation><mixed-citation id="mc-CR498" publication-type="journal">Guo, X. et al. The GTPase dMiro is required for axonal transport of mitochondria to <italic toggle="yes">Drosophila</italic> synapses. <italic toggle="yes">Neuron</italic><bold>47</bold>, 379&#8211;393 (2005).<pub-id pub-id-type="pmid">16055062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuron.2005.06.027</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR499"><label>499.</label><citation-alternatives><element-citation id="ec-CR499" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stowers</surname><given-names>RS</given-names></name><name name-style="western"><surname>Megeath</surname><given-names>LJ</given-names></name><name name-style="western"><surname>G&#243;rska-Andrzejak</surname><given-names>J</given-names></name><name name-style="western"><surname>Meinertzhagen</surname><given-names>IA</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><article-title>Axonal transport of mitochondria to synapses depends on Milton, a novel <italic toggle="yes">Drosophila</italic> protein</article-title><source>Neuron</source><year>2002</year><volume>36</volume><fpage>1063</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(02)01094-2</pub-id><pub-id pub-id-type="pmid">12495622</pub-id></element-citation><mixed-citation id="mc-CR499" publication-type="journal">Stowers, R. S., Megeath, L. J., G&#243;rska-Andrzejak, J., Meinertzhagen, I. A. &amp; Schwarz, T. L. Axonal transport of mitochondria to synapses depends on Milton, a novel <italic toggle="yes">Drosophila</italic> protein. <italic toggle="yes">Neuron</italic><bold>36</bold>, 1063&#8211;1077 (2002).<pub-id pub-id-type="pmid">12495622</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0896-6273(02)01094-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR500"><label>500.</label><citation-alternatives><element-citation id="ec-CR500" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Spronsen</surname><given-names>M</given-names></name><etal/></person-group><article-title>TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites</article-title><source>Neuron</source><year>2013</year><volume>77</volume><fpage>485</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.11.027</pub-id><pub-id pub-id-type="pmid">23395375</pub-id></element-citation><mixed-citation id="mc-CR500" publication-type="journal">van Spronsen, M. et al. TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites. <italic toggle="yes">Neuron</italic><bold>77</bold>, 485&#8211;502 (2013).<pub-id pub-id-type="pmid">23395375</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuron.2012.11.027</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR501"><label>501.</label><citation-alternatives><element-citation id="ec-CR501" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misgeld</surname><given-names>T</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><article-title>Mitostasis in neurons: Maintaining mitochondria in an extended cellular architecture</article-title><source>Neuron</source><year>2017</year><volume>96</volume><fpage>651</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.09.055</pub-id><pub-id pub-id-type="pmid">29096078</pub-id><pub-id pub-id-type="pmcid">PMC5687842</pub-id></element-citation><mixed-citation id="mc-CR501" publication-type="journal">Misgeld, T. &amp; Schwarz, T. L. Mitostasis in neurons: Maintaining mitochondria in an extended cellular architecture. <italic toggle="yes">Neuron</italic><bold>96</bold>, 651&#8211;666 (2017).<pub-id pub-id-type="pmid">29096078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuron.2017.09.055</pub-id><pub-id pub-id-type="pmcid">PMC5687842</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR502"><label>502.</label><citation-alternatives><element-citation id="ec-CR502" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title>PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility</article-title><source>Cell</source><year>2011</year><volume>147</volume><fpage>893</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.10.018</pub-id><pub-id pub-id-type="pmid">22078885</pub-id><pub-id pub-id-type="pmcid">PMC3261796</pub-id></element-citation><mixed-citation id="mc-CR502" publication-type="journal">Wang, X. et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. <italic toggle="yes">Cell</italic><bold>147</bold>, 893&#8211;906 (2011).<pub-id pub-id-type="pmid">22078885</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2011.10.018</pub-id><pub-id pub-id-type="pmcid">PMC3261796</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR503"><label>503.</label><citation-alternatives><element-citation id="ec-CR503" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Safiulina</surname><given-names>D</given-names></name><etal/></person-group><article-title>Miro proteins prime mitochondria for Parkin translocation and mitophagy</article-title><source>EMBO J</source><year>2019</year><volume>38</volume><fpage>e99384</fpage><pub-id pub-id-type="doi">10.15252/embj.201899384</pub-id><pub-id pub-id-type="pmid">30504269</pub-id><pub-id pub-id-type="pmcid">PMC6331716</pub-id></element-citation><mixed-citation id="mc-CR503" publication-type="journal">Safiulina, D. et al. Miro proteins prime mitochondria for Parkin translocation and mitophagy. <italic toggle="yes">EMBO J</italic>. <bold>38</bold>, e99384 (2019).<pub-id pub-id-type="pmid">30504269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.201899384</pub-id><pub-id pub-id-type="pmcid">PMC6331716</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR504"><label>504.</label><citation-alternatives><element-citation id="ec-CR504" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harbauer</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Neuronal mitochondria transport <italic toggle="yes">Pink1</italic> mRNA via synaptojanin 2 to support local mitophagy</article-title><source>Neuron</source><year>2022</year><volume>110</volume><fpage>1516</fpage><lpage>1531.e9</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2022.01.035</pub-id><pub-id pub-id-type="pmid">35216662</pub-id><pub-id pub-id-type="pmcid">PMC9081165</pub-id></element-citation><mixed-citation id="mc-CR504" publication-type="journal">Harbauer, A. B. et al. Neuronal mitochondria transport <italic toggle="yes">Pink1</italic> mRNA via synaptojanin 2 to support local mitophagy. <italic toggle="yes">Neuron</italic><bold>110</bold>, 1516&#8211;1531.e9 (2022).<pub-id pub-id-type="pmid">35216662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuron.2022.01.035</pub-id><pub-id pub-id-type="pmcid">PMC9081165</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR505"><label>505.</label><citation-alternatives><element-citation id="ec-CR505" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borbolis</surname><given-names>F</given-names></name><name name-style="western"><surname>Palikaras</surname><given-names>K</given-names></name></person-group><article-title>The compartmentalised nature of neuronal mitophagy: Molecular insights and implications</article-title><source>Expert Rev. Mol. Med.</source><year>2022</year><volume>24</volume><fpage>e38</fpage><pub-id pub-id-type="doi">10.1017/erm.2022.31</pub-id><pub-id pub-id-type="pmid">36172898</pub-id><pub-id pub-id-type="pmcid">PMC9884780</pub-id></element-citation><mixed-citation id="mc-CR505" publication-type="journal">Borbolis, F. &amp; Palikaras, K. The compartmentalised nature of neuronal mitophagy: Molecular insights and implications. <italic toggle="yes">Expert Rev. Mol. Med.</italic><bold>24</bold>, e38 (2022).<pub-id pub-id-type="pmid">36172898</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/erm.2022.31</pub-id><pub-id pub-id-type="pmcid">PMC9884780</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>